data_2kt7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kt7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.561 . . . . 72.319999999999993 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 74.230000000000004 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.727 HG23 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.484 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.439999999999998 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.120000000000005 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 74.420000000000002 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.310000000000002 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.140000000000001 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.520000000000003 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.439999999999998 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 54.409999999999997 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.420000000000002 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.542 HG13 HD11 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 73.430000000000007 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.049999999999997 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.299999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 74.030000000000001 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.533 ' HA ' HG21 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.450000000000003 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 63.0 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.240000000000002 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.402 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.120000000000005 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.450000000000003 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 63.329999999999998 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 64.530000000000001 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.129999999999995 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.530000000000001 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 71.120000000000005 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 75.230000000000004 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' HD13 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.310000000000002 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.140000000000001 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.319999999999993 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.549999999999997 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.329999999999998 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 74.040000000000006 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.402 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.299999999999997 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.120000000000005 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 75.340000000000003 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.430000000000007 110.542 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.549999999999997 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.540000000000006 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 74.219999999999999 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.727 ' HB ' HG23 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.510000000000005 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.510000000000005 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.439999999999998 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 74.219999999999999 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.340000000000003 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.409999999999997 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.230000000000004 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.310000000000002 111.504 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 72.040000000000006 112.061 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.530000000000001 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 54.520000000000003 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.661 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.209999999999994 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 66' ' ' SER . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 72.109999999999999 110.656 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.647 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.450000000000003 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HD2' ' HH ' ' A' ' 98' ' ' TYR . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.319999999999993 108.974 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 75.510000000000005 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.140000000000001 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.420000000000002 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 53.0 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.420000000000002 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.329999999999998 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.439999999999998 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.240000000000002 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.020000000000003 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 71.319999999999993 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 72.340000000000003 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.329999999999998 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.020000000000003 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 74.109999999999999 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 HG23 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 75.120000000000005 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.696 ' HG ' HG12 ' A' ' 43' ' ' VAL . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 72.329999999999998 112.825 -174.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.020000000000003 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 71.310000000000002 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.239999999999995 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.439999999999998 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.239999999999995 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 71.040000000000006 113.853 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.340000000000003 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 74.310000000000002 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.120000000000005 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.129999999999995 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.310000000000002 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.430000000000007 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.43 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.329999999999998 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.019999999999996 112.046 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 73.230000000000004 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 74.099999999999994 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.230000000000004 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.239999999999995 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.140000000000001 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 73.349999999999994 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.430000000000007 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 54.140000000000001 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.329999999999998 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 83' ' ' ALA . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 75.340000000000003 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 71.510000000000005 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.299999999999997 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.428 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.530000000000001 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.230000000000004 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.230000000000004 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.549999999999997 110.53 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.754 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 72.219999999999999 110.915 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 75.109999999999999 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 61.340000000000003 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.129999999999995 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 73.5 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.340000000000003 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.540000000000006 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.329999999999998 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.450000000000003 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 72.140000000000001 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.310000000000002 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 74.450000000000003 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.439999999999998 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.049999999999997 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.530000000000001 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.019999999999996 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.120000000000005 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 71.099999999999994 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.310000000000002 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.409999999999997 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 73.109999999999999 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 75.25 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.150000000000006 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.420000000000002 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.540000000000006 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 74.310000000000002 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.009999999999998 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.019999999999996 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.400000000000006 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.140000000000001 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.329999999999998 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.409999999999997 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.25 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 74.310000000000002 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 73.129999999999995 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 64.420000000000002 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.209999999999994 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.540000000000006 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.468 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.439999999999998 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.010000000000005 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.230000000000004 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.519999999999996 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.557 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 71.109999999999999 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.439999999999998 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.120000000000005 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.150000000000006 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.329999999999998 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.109999999999999 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.119999999999997 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.664 ' HB ' HG21 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.400000000000006 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.140000000000001 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 65.530000000000001 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 72.329999999999998 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 70.109999999999999 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.420000000000002 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.329999999999998 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 71.150000000000006 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 64.109999999999999 110.818 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.544 ' HB3' HG23 ' A' ' 87' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.540000000000006 111.912 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.010000000000005 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.675 HG23 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 61.539999999999999 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.449 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.350000000000001 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.299999999999997 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.430000000000007 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.430000000000007 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.150000000000006 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.310000000000002 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.239999999999995 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.209999999999994 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.530000000000001 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.340000000000003 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.409999999999997 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.140000000000001 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.399999999999999 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.019999999999996 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.439999999999998 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.329999999999998 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.299999999999997 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 73.439999999999998 111.612 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 73.319999999999993 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' HG13 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.519999999999996 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 73.099999999999994 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.497 ' HB3' HD23 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.319999999999993 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.230000000000004 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 63.409999999999997 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.010000000000005 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.439999999999998 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.310000000000002 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.140000000000001 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.549999999999997 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.6 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.219999999999999 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.15 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.230000000000004 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.099999999999994 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.510000000000005 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 62.240000000000002 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.608 HG23 HG11 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.120000000000005 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 65.540000000000006 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.219999999999999 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.544 HG23 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 61.229999999999997 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.299999999999997 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 74.430000000000007 110.644 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.099999999999994 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.675 ' HB ' HG23 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.230000000000004 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 83' ' ' ALA . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 74.239999999999995 112.377 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.049999999999997 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 73.120000000000005 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.150000000000006 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 72.010000000000005 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.120000000000005 110.536 176.435 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.400000000000006 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 54.329999999999998 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 71.340000000000003 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.299999999999997 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 61.140000000000001 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.540000000000006 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 65.5 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.439999999999998 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 73.019999999999996 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.030000000000001 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.519999999999996 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.019999999999996 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.340000000000003 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.433 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 73.030000000000001 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 62.200000000000003 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.040000000000006 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 75.409999999999997 112.247 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.209999999999994 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.349999999999994 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 72.530000000000001 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.519999999999996 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 52.409999999999997 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.329999999999998 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.439999999999998 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.439999999999998 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.219999999999999 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HB3' HD23 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.409999999999997 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' NZ ' ' OH ' ' A' ' 45' ' ' TYR . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 70.120000000000005 111.544 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.140000000000001 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.433 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.119999999999997 113.736 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.530000000000001 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 74.239999999999995 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.230000000000004 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.219999999999999 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.120000000000005 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.430000000000007 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.430000000000007 110.391 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.340000000000003 114.503 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.230000000000004 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 45.329999999999998 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.129999999999995 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.239999999999995 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.510000000000005 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 74.129999999999995 112.29 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.219999999999999 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.210000000000001 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.430000000000007 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.430000000000007 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.530000000000001 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 75.420000000000002 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.430000000000007 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.230000000000004 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.519999999999996 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.414 ' O ' HD11 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.430000000000007 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.439999999999998 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 74.299999999999997 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 74.519999999999996 112.743 -171.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.743 0.306 . . . . 74.329999999999998 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 71.239999999999995 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.030000000000001 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HZ2' ' HG2' ' A' ' 44' ' ' GLU . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.210000000000001 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 74.140000000000001 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HZ2' ' A' ' 42' ' ' LYS . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.450000000000003 111.591 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.420000000000002 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.586 HG13 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.530000000000001 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.530000000000001 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.329999999999998 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.409999999999997 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.200000000000003 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.586 ' CA ' HG13 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.149999999999999 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 73.219999999999999 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.120000000000005 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 74.439999999999998 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 63.210000000000001 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.319999999999993 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 74.519999999999996 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.230000000000004 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.450000000000003 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.420000000000002 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 111.206 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.019999999999996 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.239999999999995 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.340000000000003 109.848 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.329999999999998 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 73.239999999999995 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 74.219999999999999 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.109999999999999 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.200000000000003 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.329999999999998 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.465 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.209999999999994 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.450000000000003 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.239999999999995 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 75.219999999999999 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.219999999999999 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 72.200000000000003 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.329999999999998 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 37.579999999999998 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.049999999999997 111.312 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 37.579999999999998 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 72.299999999999997 111.425 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.519999999999996 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 73.329999999999998 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.140000000000001 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.119999999999997 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.656 ' HB ' HG23 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.019999999999996 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.540000000000006 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.150000000000006 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.150000000000006 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.329999999999998 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.465 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 71.120000000000005 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 51.130000000000003 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.340000000000003 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.088 -175.781 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB3' HG23 ' A' ' 87' ' ' ILE . 33.2 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.219999999999999 111.55 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.129999999999995 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.120000000000005 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.530000000000001 111.535 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.567 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.219999999999999 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.450000000000003 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.109999999999999 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.420000000000002 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.540000000000006 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 63.340000000000003 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 61.25 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.129999999999995 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 73.519999999999996 112.358 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 71.140000000000001 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.530000000000001 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 60.109999999999999 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.140000000000001 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.150000000000006 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 74.129999999999995 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.209999999999994 110.762 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.569 HG12 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.230000000000004 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.530000000000001 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 64.530000000000001 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.130000000000003 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.409999999999997 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 70.299999999999997 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.099999999999994 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.019999999999996 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.109999999999999 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.400000000000006 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB2' HD13 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.129999999999995 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.510000000000005 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.530000000000001 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.439999999999998 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.329999999999998 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.310000000000002 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.509999999999998 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.219999999999999 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.140000000000001 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.049999999999997 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.310000000000002 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.530000000000001 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 70.540000000000006 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.694 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.340000000000003 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 73.239999999999995 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.530000000000001 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD3' HG23 ' A' ' 46' ' ' VAL . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.010000000000005 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.329999999999998 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.340000000000003 112.741 -168.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.219999999999999 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.581 HG23 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.349999999999994 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.530000000000001 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.099999999999994 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.329999999999998 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 74.209999999999994 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 70.299999999999997 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.450000000000003 110.37 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.329999999999998 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.540000000000006 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.210000000000001 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.239999999999995 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.319999999999993 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 73.219999999999999 111.668 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 72.109999999999999 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.350000000000001 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.350000000000001 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.319999999999993 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.009999999999998 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.420000000000002 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.299999999999997 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 73.409999999999997 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.466 HG11 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.209999999999994 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 73.030000000000001 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.420000000000002 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.430000000000007 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.439999999999998 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.239999999999995 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 41.240000000000002 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 55.240000000000002 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.140000000000001 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.448 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.200000000000003 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.439999999999998 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.652 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.409999999999997 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.652 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.219999999999999 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.540000000000006 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 73.319999999999993 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.209999999999994 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG21 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.109999999999999 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 64.219999999999999 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.466 HG22 HG11 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 75.010000000000005 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.520000000000003 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.020000000000003 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.219999999999999 110.884 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.239999999999995 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.540000000000006 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.319999999999993 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 37.5 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HB ' HG23 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 75.530000000000001 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.109999999999999 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.129999999999995 112.446 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 71.409999999999997 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.508 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 75.340000000000003 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.448 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 112.062 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.319999999999993 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 73.420000000000002 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.439999999999998 111.025 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' A' ' 87' ' ' ILE . 40.7 m-85 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.219999999999999 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.409999999999997 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.644 HG23 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 73.329999999999998 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.678 ' HZ1' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.510000000000005 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.129999999999995 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.299999999999997 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 75.5 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 75.120000000000005 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 63.229999999999997 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.439999999999998 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.299999999999997 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.219999999999999 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 74.239999999999995 112.192 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 53.509999999999998 111.546 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.200000000000003 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.530000000000001 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 54.420000000000002 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.420000000000002 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.310000000000002 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.129999999999995 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 73.439999999999998 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.120000000000005 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.209999999999994 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.530000000000001 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.420000000000002 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.319999999999993 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.099999999999994 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.219999999999999 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.129999999999995 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.576 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.319999999999993 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HB2' HD13 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 75.430000000000007 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.140000000000001 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 61.450000000000003 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.219999999999999 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 64.219999999999999 109.645 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.520000000000003 113.168 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.420000000000002 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.349999999999994 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.329999999999998 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.299999999999997 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.409999999999997 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.539 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.399999999999999 110.143 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.129999999999995 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.329999999999998 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.450000000000003 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.020000000000003 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.644 ' HB ' HG23 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.150000000000006 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.109999999999999 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.230000000000004 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.239999999999995 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.109999999999999 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 70.109999999999999 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.430000000000007 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 73.450000000000003 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 65.0 110.995 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.381 0.61 . . . . 74.340000000000003 112.495 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.150000000000006 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.763 HG23 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.549999999999997 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.200000000000003 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.340000000000003 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.120000000000005 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.319999999999993 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 71.420000000000002 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 72.439999999999998 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.329999999999998 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.520000000000003 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.711 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.239999999999995 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 72.420000000000002 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 73.400000000000006 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.450000000000003 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 64.109999999999999 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.399999999999999 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.099999999999994 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.310000000000002 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.010000000000005 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.219999999999999 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 74.120000000000005 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 73.5 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 61.450000000000003 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 64.510000000000005 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 65.409999999999997 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.230000000000004 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.399999999999999 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.450000000000003 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.240000000000002 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.049999999999997 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.010000000000005 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.299999999999997 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 65.409999999999997 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.129999999999995 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.230000000000004 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.420000000000002 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.140000000000001 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 75.219999999999999 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 37.670000000000002 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.129999999999995 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.5 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.519999999999996 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.230000000000004 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.100000000000001 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.763 ' HB ' HG23 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 62.130000000000003 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.239999999999995 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.009999999999998 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.209999999999994 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.219999999999999 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.240000000000002 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 65.329999999999998 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 71.120000000000005 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 74.010000000000005 111.96 -171.81 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.179 0.514 . . . . 73.349999999999994 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.219999999999999 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.75 HG23 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.340000000000003 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 74.150000000000006 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.219999999999999 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 74.150000000000006 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.798 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 73.219999999999999 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.240000000000002 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 65.329999999999998 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 37.990000000000002 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.430000000000007 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.099999999999994 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 HD12 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.439999999999998 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 72.030000000000001 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.109999999999999 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.487 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.530000000000001 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 71.230000000000004 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.239999999999995 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 75.030000000000001 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.530000000000001 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.120000000000005 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.140000000000001 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.519999999999996 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.129999999999995 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.209999999999994 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.450000000000003 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 74.120000000000005 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.430000000000007 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.100000000000001 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 74.049999999999997 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 74.439999999999998 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.219999999999999 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.400000000000006 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.239999999999995 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.329999999999998 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 72.310000000000002 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 70.120000000000005 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 74.420000000000002 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.549999999999997 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.009999999999998 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.349999999999994 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.119999999999997 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.540000000000006 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.039999999999999 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 61.350000000000001 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.75 ' HB ' HG23 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.140000000000001 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.519999999999996 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.319999999999993 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HD3' HG22 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 72.530000000000001 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.340000000000003 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 74.140000000000001 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 74.349999999999994 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.200000000000003 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.149999999999999 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 75.150000000000006 109.968 175.116 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.471 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.240000000000002 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.120000000000005 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.439999999999998 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.229999999999997 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 60.229999999999997 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.329999999999998 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.219999999999999 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.120000000000005 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.766 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.340000000000003 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 72.430000000000007 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.010000000000005 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.519999999999996 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 75.019999999999996 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.430000000000007 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.240000000000002 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 111.101 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.230000000000004 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CG ' HG23 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.310000000000002 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.340000000000003 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.129999999999995 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HB3' HD21 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.430000000000007 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.109999999999999 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.439999999999998 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.129999999999995 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.519999999999996 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.120000000000005 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 74.040000000000006 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 74.310000000000002 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.239999999999995 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.448 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.399999999999999 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.420000000000002 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.129999999999995 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 74.049999999999997 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.010000000000005 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 74.129999999999995 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.439999999999998 111.17 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 70.010000000000005 110.912 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.140000000000001 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.430000000000007 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 71.25 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.099999999999994 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.400000000000006 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 72.519999999999996 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.230000000000004 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.319999999999993 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.229999999999997 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.209999999999994 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.100000000000001 111.605 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.695 0.283 . . . . 74.329999999999998 111.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.030000000000001 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.439999999999998 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.688 ' HZ2' ' HG2' ' A' ' 44' ' ' GLU . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.450000000000003 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.688 ' HG2' ' HZ2' ' A' ' 42' ' ' LYS . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.310000000000002 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.409999999999997 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.150000000000006 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.549999999999997 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.400000000000006 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.209999999999994 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 63.0 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.219999999999999 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 62.119999999999997 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 73.109999999999999 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.549999999999997 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.230000000000004 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.130000000000003 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 73.549999999999997 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 74.299999999999997 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.450000000000003 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.549999999999997 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.049999999999997 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.439999999999998 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.530000000000001 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 72.400000000000006 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.400000000000006 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.409999999999997 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.450000000000003 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.030000000000001 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 72.540000000000006 113.284 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.510000000000005 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.239999999999995 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 72.439999999999998 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.549 ' HD3' HG23 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 75.409999999999997 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 74.329999999999998 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 HD11 HD23 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 72.129999999999995 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.340000000000003 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.140000000000001 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.350000000000001 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HH ' ' A' ' 96' ' ' TYR . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.030000000000001 112.401 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.67 HG23 HG11 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.239999999999995 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.520000000000003 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.230000000000004 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.140000000000001 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.109999999999999 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.519999999999996 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.239999999999995 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.210000000000001 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 72.230000000000004 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.120000000000005 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.340000000000003 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.43 ' HH ' ' HB3' ' A' ' 83' ' ' ALA . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.420000000000002 110.408 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.150000000000006 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.209999999999994 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 61.539999999999999 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.109999999999999 111.758 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.013 0.435 . . . . 64.400000000000006 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.040000000000006 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 74.0 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.699 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.310000000000002 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.210000000000001 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HD1' ' HH ' ' A' ' 98' ' ' TYR . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.549999999999997 109.587 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.209999999999994 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.530000000000001 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.030000000000001 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.510000000000005 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.219999999999999 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.040000000000006 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG13 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.340000000000003 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.010000000000005 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.240000000000002 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.420000000000002 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 45.210000000000001 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.109999999999999 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 64.230000000000004 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.219999999999999 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.240000000000002 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.299999999999997 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.405 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.329999999999998 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 60.43 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.209999999999994 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.230000000000004 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.049999999999997 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.120000000000005 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.219999999999999 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.540000000000006 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.540000000000006 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.319999999999993 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.430000000000007 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.400000000000006 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.049999999999997 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.099999999999994 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.230000000000004 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 71.319999999999993 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 72.310000000000002 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 94' ' ' VAL . 9.3 t30 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.540000000000006 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CG1' ' A' ' 94' ' ' VAL . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 64.430000000000007 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.319999999999993 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.449 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.219999999999999 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 70.530000000000001 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.150000000000006 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.039999999999999 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.400000000000006 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.239999999999995 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 73.439999999999998 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HD3' HG23 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.450000000000003 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.439999999999998 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.430000000000007 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.488 ' HH ' ' HD1' ' A' ' 45' ' ' TYR . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.140000000000001 112.304 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.430000000000007 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.219999999999999 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 62.200000000000003 110.438 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.200000000000003 110.0 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 71.200000000000003 111.642 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.119999999999997 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.340000000000003 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.430000000000007 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.230000000000004 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 72.219999999999999 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.549999999999997 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.129999999999995 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.329999999999998 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.329999999999998 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.140000000000001 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.239999999999995 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.240000000000002 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.109999999999999 111.71 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.219999999999999 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.519999999999996 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.109999999999999 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.310000000000002 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.439999999999998 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 72.010000000000005 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.439999999999998 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.409999999999997 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.129999999999995 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 71.530000000000001 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.540000000000006 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.310000000000002 110.94 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.299999999999997 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.510000000000005 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 73.349999999999994 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 61.210000000000001 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 75.0 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.150000000000006 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.030000000000001 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.621 HD21 HG22 ' A' ' 88' ' ' THR . 0.9 OUTLIER -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.219999999999999 111.359 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.030000000000001 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.621 HG22 HD21 ' A' ' 86' ' ' ASN . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 74.329999999999998 111.087 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.299999999999997 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.230000000000004 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.614 ' HB ' HG21 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.530000000000001 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.030000000000001 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.340000000000003 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.439999999999998 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.219999999999999 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.1 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.541 -179.151 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.540000000000006 110.887 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 74.099999999999994 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 63.210000000000001 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.310000000000002 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.019999999999996 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 65.239999999999995 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.400000000000006 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.400000000000006 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 73.150000000000006 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.109999999999999 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.407 HG13 HD12 ' A' ' 71' ' ' ILE . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.129999999999995 111.759 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.030000000000001 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.530000000000001 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 75.219999999999999 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 74.420000000000002 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 75.120000000000005 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.450000000000003 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.230000000000004 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.528 ' CD1' HG22 ' A' ' 41' ' ' VAL . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.439999999999998 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.530000000000001 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 73.140000000000001 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.120000000000005 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.019999999999996 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.407 HD12 HG13 ' A' ' 53' ' ' ILE . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.129999999999995 110.932 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.019999999999996 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 73.200000000000003 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 70.430000000000007 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.109999999999999 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 72.239999999999995 111.821 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.439999999999998 112.19 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.109999999999999 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.120000000000005 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.129999999999995 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.329999999999998 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 74.109999999999999 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.109999999999999 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.219999999999999 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.219999999999999 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.458 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.120000000000005 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.430000000000007 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.340000000000003 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.450000000000003 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 73.230000000000004 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.340000000000003 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 74.25 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.200000000000003 111.653 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 73.129999999999995 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 74.420000000000002 110.255 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.340000000000003 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.310000000000002 111.071 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.053 -0.351 . . . . 74.519999999999996 110.053 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 62.009999999999998 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.299999999999997 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.299999999999997 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.409999999999997 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 70.209999999999994 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.200000000000003 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.049999999999997 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.109999999999999 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.319999999999993 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.340000000000003 112.483 -173.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.209999999999994 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.329999999999998 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.58 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.099999999999994 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.409999999999997 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.010000000000005 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.400000000000006 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.329999999999998 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.329999999999998 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 74.150000000000006 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.150000000000006 110.347 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.209999999999994 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.509999999999998 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 73.5 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.420000000000002 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.530000000000001 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.230000000000004 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 62.149999999999999 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 63.140000000000001 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 75.219999999999999 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 73.430000000000007 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.239999999999995 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 73.400000000000006 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.219999999999999 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.510000000000005 113.148 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 74.310000000000002 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.3 t30 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.420000000000002 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 51.420000000000002 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.407 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.399999999999999 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.310000000000002 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.129999999999995 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 75.239999999999995 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.120000000000005 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 65.109999999999999 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.549999999999997 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.150000000000006 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 71.230000000000004 112.346 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.140000000000001 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.049999999999997 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.409999999999997 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.209999999999994 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 72.329999999999998 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.295 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 87' ' ' ILE . 70.1 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.899 0.38 . . . . 74.310000000000002 111.537 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.219999999999999 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.130000000000003 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 73.310000000000002 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.340000000000003 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.419 ' HD2' ' HH ' ' A' ' 98' ' ' TYR . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.510000000000005 109.337 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.420000000000002 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.409999999999997 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.340000000000003 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.349999999999994 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.200000000000003 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 70.349999999999994 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 74.040000000000006 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.409999999999997 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.120000000000005 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 72.540000000000006 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.129999999999995 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 75.319999999999993 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.120000000000005 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.420000000000002 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.413 ' CD1' HG23 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.129999999999995 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.310000000000002 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 64.319999999999993 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 63.119999999999997 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.109999999999999 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.310000000000002 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.409999999999997 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.010000000000005 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 61.140000000000001 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 73.040000000000006 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.329999999999998 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.109999999999999 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.230000000000004 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 74.120000000000005 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 75.120000000000005 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.4 ' O ' HG21 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.439999999999998 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 62.350000000000001 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.030000000000001 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 72.540000000000006 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.230000000000004 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.209999999999994 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.010000000000005 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 72.140000000000001 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.430000000000007 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.573 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.310000000000002 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.140000000000001 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.450000000000003 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 72.450000000000003 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.019999999999996 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.419 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.239999999999995 111.231 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.530000000000001 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.239999999999995 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.209999999999994 112.189 -173.646 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB3' HG22 ' A' ' 87' ' ' ILE . 84.6 m-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.979 0.419 . . . . 65.109999999999999 111.649 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.409999999999997 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HZ3' ' HG2' ' A' ' 44' ' ' GLU . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.409999999999997 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 71.25 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 71.349999999999994 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 71.120000000000005 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.200000000000003 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.400000000000006 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.099999999999994 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.099999999999994 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.109999999999999 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.329999999999998 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.109999999999999 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.419 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.299999999999997 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.020000000000003 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 75.439999999999998 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 71.319999999999993 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.420000000000002 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.049999999999997 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.099999999999994 110.174 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.219999999999999 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.319999999999993 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.450000000000003 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.240000000000002 112.261 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.420000000000002 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 73.120000000000005 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.130000000000003 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 74.409999999999997 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.140000000000001 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.510000000000005 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.409999999999997 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.120000000000005 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.430000000000007 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.450000000000003 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.420000000000002 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.120000000000005 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.409999999999997 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.420000000000002 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.329999999999998 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.130000000000003 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.010000000000005 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.200000000000003 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.409999999999997 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.520000000000003 110.567 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.129999999999995 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 74.019999999999996 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.230000000000004 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.420000000000002 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.230000000000004 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.7 mt . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 111.22 -174.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.009 0.433 . . . . 73.040000000000006 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 74.540000000000006 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.685 HG23 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.239999999999995 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.539999999999999 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 74.329999999999998 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.539999999999999 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.519999999999996 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.420000000000002 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.399999999999999 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 75.239999999999995 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.430000000000007 112.306 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.019999999999996 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.129999999999995 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.510000000000005 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.25 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.040000000000006 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 72.420000000000002 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 73.329999999999998 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.209999999999994 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.400000000000006 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.310000000000002 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.299999999999997 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.109999999999999 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.310000000000002 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.409999999999997 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 65.129999999999995 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.510000000000005 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.129999999999995 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.400000000000006 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.319999999999993 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.349999999999994 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.539999999999999 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.439999999999998 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.349999999999994 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 74.519999999999996 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.109999999999999 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.310000000000002 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.109999999999999 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.230000000000004 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.319999999999993 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 72.120000000000005 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.462 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.319999999999993 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 73.340000000000003 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.039999999999999 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 63.229999999999997 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 75.329999999999998 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.685 ' HB ' HG23 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.129999999999995 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.430000000000007 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 63.25 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.109999999999999 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.420000000000002 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.549999999999997 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.483 ' SD ' ' N ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.739 0.304 . . . . 70.310000000000002 111.268 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -86.5 -41.76 14.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.385 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -68.6 -45.82 70.94 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.321 -0.4 . . . . 64.109999999999999 111.949 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 60.83 24.27 14.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.318 0.58 . . . . 74.439999999999998 111.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.53 37.24 19.71 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.43 -0.805 . . . . 74.439999999999998 112.664 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -72.88 87.13 1.3 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.727 -0.608 . . . . 72.319999999999993 110.101 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.533 HG21 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 74.230000000000004 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.727 HG23 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.484 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.439999999999998 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG21 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.120000000000005 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 74.420000000000002 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.310000000000002 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.140000000000001 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.520000000000003 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.439999999999998 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 54.409999999999997 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.420000000000002 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.542 HG13 HD11 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 73.430000000000007 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.049999999999997 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.299999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 74.030000000000001 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.533 ' HA ' HG21 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.450000000000003 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 63.0 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.240000000000002 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.402 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.120000000000005 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.450000000000003 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 63.329999999999998 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 64.530000000000001 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.129999999999995 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.530000000000001 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.542 HD11 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 71.120000000000005 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 75.230000000000004 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HB2' HD13 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.310000000000002 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.140000000000001 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.319999999999993 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.549999999999997 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.329999999999998 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 74.040000000000006 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.299999999999997 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.449 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.120000000000005 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 75.340000000000003 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.430000000000007 110.542 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.549999999999997 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.540000000000006 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 74.219999999999999 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.727 ' HB ' HG23 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.510000000000005 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' HB ' HG21 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.510000000000005 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.439999999999998 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 74.219999999999999 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.340000000000003 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.409999999999997 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.230000000000004 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.645 HD13 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -78.77 113.86 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.310000000000002 111.504 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mm -90.49 93.62 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.017 0.437 . . . . 75.120000000000005 110.342 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t70 66.97 156.7 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.269 -0.878 . . . . 73.230000000000004 111.813 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 104' ' ' VAL . 10.1 t -80.75 4.39 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 116.088 -0.505 . . . . 65.129999999999995 111.968 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m 65.4 21.84 11.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.457 0.646 . . . . 74.030000000000001 109.739 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -107.34 50.94 0.76 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.417 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' C ' ' H ' ' A' ' 109' ' ' GLU . 32.3 m -97.17 -25.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.383 0.611 . . . . 65.219999999999999 110.686 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 63.96 -10.95 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.261 1.024 . . . . 75.109999999999999 113.449 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 107' ' ' VAL . 13.8 tp10 -74.7 -49.4 21.35 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.296 0.569 . . . . 73.109999999999999 110.362 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.2 p -96.99 93.97 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.72 -0.673 . . . . 61.520000000000003 111.57 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 56.53 -122.48 28.35 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.003 -0.544 . . . . 64.540000000000006 114.002 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -168.31 -65.19 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.086 0.47 . . . . 74.040000000000006 110.886 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -103.82 102.17 11.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.167 0.508 . . . . 65.049999999999997 110.24 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.5 mt -112.71 -12.3 13.4 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 71.400000000000006 112.884 -170.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.26 136.37 95.2 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 111.913 0.338 . . . . 63.350000000000001 111.913 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.27 170.3 2.4 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.916 2.411 . . . . 63.200000000000003 113.823 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.18 167.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.527 0.565 . . . . 71.510000000000005 112.527 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.2 96.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.518 0.675 . . . . 61.100000000000001 111.754 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.73 132.08 56.52 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.996 -0.547 . . . . 73.140000000000001 109.694 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.75 109.73 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 113.501 0.926 . . . . 70.239999999999995 113.501 -169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -102.47 -178.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 116.063 -0.517 . . . . 60.200000000000003 111.231 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 65.32 -163.35 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.054 0.39 . . . . 72.109999999999999 112.054 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.7 m 69.9 150.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.523 0.678 . . . . 72.430000000000007 112.688 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 56.21 16.17 2.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.337 -0.847 . . . . 75.420000000000002 112.724 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.7 -3.87 57.03 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.47 0.652 . . . . 73.530000000000001 110.125 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.56 90.05 2.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.119 -0.946 . . . . 72.219999999999999 110.387 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.6 m -111.17 -37.28 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.819 0.674 . . . . 63.340000000000003 112.819 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 65.1 tp 73.81 -48.56 0.67 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 75.099999999999994 114.261 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.8 119.28 1.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.936 1.087 . . . . 75.340000000000003 113.936 -167.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.01 145.84 30.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.617 -0.72 . . . . 65.230000000000004 110.546 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -147.18 107.66 4.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.58 0.585 . . . . 75.140000000000001 112.58 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -82.32 136.51 35.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.677 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -98.32 127.26 44.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.893 0.377 . . . . 75.439999999999998 111.052 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -53.13 -50.43 64.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 111.937 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.815 -0.612 . . . . 74.239999999999995 111.499 176.308 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.861 0.362 . . . . 74.430000000000007 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.29 -81.7 0.45 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.701 0.286 . . . . 70.150000000000006 110.547 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 79.1 p -104.54 70.27 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.401 0.62 . . . . 73.209999999999994 109.759 171.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER 72.17 -69.28 0.19 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.419 -0.809 . . . . 64.239999999999995 110.856 -172.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m120 42.6 77.98 0.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.758 0.423 . . . . 73.310000000000002 111.879 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -55.05 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 72.040000000000006 112.061 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.530000000000001 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG23 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 54.520000000000003 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.661 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.209999999999994 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 66' ' ' SER . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 72.109999999999999 110.656 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.647 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.450000000000003 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HD2' ' HH ' ' A' ' 98' ' ' TYR . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.319999999999993 108.974 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 75.510000000000005 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.140000000000001 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.420000000000002 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 53.0 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.420000000000002 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.329999999999998 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.439999999999998 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.240000000000002 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.020000000000003 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 71.319999999999993 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 72.140000000000001 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 72.340000000000003 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.329999999999998 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.020000000000003 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 74.109999999999999 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.516 HG12 HG23 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 75.120000000000005 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.696 ' HG ' HG12 ' A' ' 43' ' ' VAL . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 72.329999999999998 112.825 -174.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.020000000000003 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 71.310000000000002 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.239999999999995 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.439999999999998 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.239999999999995 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' HA2' HG12 ' A' ' 104' ' ' VAL . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 71.040000000000006 113.853 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.340000000000003 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 74.310000000000002 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.120000000000005 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.129999999999995 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.310000000000002 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.430000000000007 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.43 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.329999999999998 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.019999999999996 112.046 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 73.230000000000004 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 74.099999999999994 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.230000000000004 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.239999999999995 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.140000000000001 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 73.349999999999994 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.430000000000007 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 54.140000000000001 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.329999999999998 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 83' ' ' ALA . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 75.340000000000003 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 71.510000000000005 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.452 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.299999999999997 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.428 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.530000000000001 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.230000000000004 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.230000000000004 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt -75.07 123.64 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.549999999999997 110.53 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.5 -49.36 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 74.340000000000003 112.193 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.28 97.2 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.357 0.599 . . . . 71.219999999999999 110.972 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 HG13 ' CD1' ' A' ' 106' ' ' TYR . 9.3 p -168.83 29.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.245 -0.888 . . . . 64.299999999999997 110.956 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.5 m 69.92 11.18 7.69 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.474 0.71 . . . . 74.129999999999995 111.933 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' A' ' 104' ' ' VAL . 11.5 m-85 -103.95 135.38 45.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.261 0.553 . . . . 74.030000000000001 109.868 175.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.13 148.78 4.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.67 -0.695 . . . . 55.039999999999999 111.768 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.88 116.09 14.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 112.147 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.51 -52.74 42.68 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.515 0.674 . . . . 75.439999999999998 109.621 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -170.65 -160.59 0.21 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.94 -1.027 . . . . 71.010000000000005 109.565 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.01 65.51 1.18 Allowed Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.799 -0.715 . . . . 72.239999999999995 113.532 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.4 mptp? -124.35 -168.25 1.77 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.798 0.439 . . . . 64.340000000000003 110.096 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 21.1 t70 70.63 -70.61 0.15 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.717 0.294 . . . . 75.540000000000006 110.722 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.8 mt 54.93 -169.24 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.189 0.811 . . . . 74.420000000000002 113.189 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 tp -164.07 129.56 2.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.804 -0.635 . . . . 73.219999999999999 111.571 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.4 133.38 9.58 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.575 2.183 . . . . 53.409999999999997 112.27 172.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.41 119.06 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.19 0.519 . . . . 74.129999999999995 111.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.81 123.15 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.881 0.372 . . . . 75.230000000000004 111.304 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' HG2' HD12 ' A' ' 120' ' ' ILE . 27.1 tt0 -161.32 152.56 18.69 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.641 -0.254 . . . . 70.400000000000006 110.829 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.504 HD12 ' HG2' ' A' ' 119' ' ' GLU . 1.7 mp 62.45 125.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.479 0.918 . . . . 70.129999999999995 113.479 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.33 165.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 111.1 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 33.4 t-20 -105.26 153.03 22.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.124 0.488 . . . . 65.109999999999999 111.805 -174.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.6 m -84.16 22.56 1.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.082 -0.508 . . . . 74.209999999999994 111.187 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.491 ' HG2' ' HB3' ' A' ' 122' ' ' ASN . 9.8 pt-20 -66.78 177.38 1.66 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.141 0.577 . . . . 62.439999999999998 112.392 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 74.32 -37.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.84 0.681 . . . . 65.200000000000003 112.84 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.53 -16.4 63.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.122 0.416 . . . . 74.299999999999997 112.122 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.15 99.65 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.832 0.348 . . . . 63.340000000000003 111.392 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' H ' HD21 ' A' ' 128' ' ' LEU . 1.6 pt? -129.67 101.23 5.81 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.298 0.57 . . . . 61.229999999999997 110.792 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.79 126.38 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 112.112 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -146.66 139.58 25.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 110.78 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -85.5 136.01 33.6 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -91.58 96.6 10.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.255 0.55 . . . . 75.510000000000005 110.467 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -68.27 143.24 55.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.842 -0.617 . . . . 65.310000000000002 112.494 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -95.47 161.03 14.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.263 0.554 . . . . 63.229999999999997 111.912 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.67 -0.681 . . . . 64.299999999999997 111.248 178.764 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.537 0.208 . . . . 53.520000000000003 111.11 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.14 112.91 3.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.888 0.375 . . . . 53.439999999999998 110.822 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.2 p -141.24 -53.6 0.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.489 0.551 . . . . 74.239999999999995 112.489 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 59.78 34.63 21.96 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.273 0.559 . . . . 64.109999999999999 110.735 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -58.71 111.21 1.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.744 -0.662 . . . . 73.109999999999999 111.771 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.754 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 -64.68 88.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 72.219999999999999 110.915 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 75.109999999999999 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.664 HG21 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 61.340000000000003 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.129999999999995 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 73.5 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.340000000000003 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.540000000000006 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.668 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.329999999999998 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.450000000000003 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 72.140000000000001 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.310000000000002 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 74.450000000000003 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.439999999999998 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.049999999999997 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.417 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.530000000000001 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.019999999999996 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.120000000000005 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 71.099999999999994 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.310000000000002 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.409999999999997 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 73.109999999999999 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 75.25 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.150000000000006 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.420000000000002 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.540000000000006 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 74.310000000000002 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.557 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.009999999999998 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.019999999999996 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.400000000000006 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.140000000000001 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.329999999999998 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.409999999999997 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.25 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 74.310000000000002 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HB2' HD13 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 73.129999999999995 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 64.420000000000002 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.209999999999994 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.540000000000006 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.468 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.439999999999998 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.010000000000005 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.230000000000004 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.519999999999996 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.557 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 71.109999999999999 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.439999999999998 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.120000000000005 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.150000000000006 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.329999999999998 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.109999999999999 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.119999999999997 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.664 ' HB ' HG21 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.400000000000006 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.140000000000001 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 65.530000000000001 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 72.329999999999998 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 70.109999999999999 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.420000000000002 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 75.239999999999995 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.329999999999998 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 71.150000000000006 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt -77.14 104.69 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 64.109999999999999 110.818 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 102' ' ' ILE . 30.4 mt -97.5 14.4 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.868 0.842 . . . . 71.519999999999996 110.559 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -87.26 -154.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.857 -0.611 . . . . 70.209999999999994 110.394 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.3 -26.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.749 0.648 . . . . 71.439999999999998 112.749 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.7 t 61.19 -82.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.83 -0.623 . . . . 70.239999999999995 111.768 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 47.9 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.925 1.083 . . . . 72.310000000000002 113.925 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.6 t 63.07 75.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.17 -0.923 . . . . 74.010000000000005 109.93 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.74 22.13 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.269 -0.878 . . . . 74.340000000000003 112.65 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.97 105.09 12.83 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 112.1 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.7 p -77.43 140.21 39.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.984 -0.553 . . . . 73.120000000000005 110.811 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.53 132.73 1.64 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.44 -0.886 . . . . 72.439999999999998 113.161 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 64.12 15.23 9.15 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.272 0.558 . . . . 75.299999999999997 111.633 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.15 17.75 13.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.123 -0.49 . . . . 73.120000000000005 111.738 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mt -95.7 115.48 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 75.319999999999993 111.22 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 mp -139.48 134.05 16.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 72.340000000000003 112.575 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 115' ' ' LEU . 15.6 Cg_exo -71.42 176.37 8.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.31 2.673 . . . . 73.319999999999993 112.654 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.3 t 69.01 126.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.715 0.769 . . . . 63.310000000000002 112.603 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.84 153.31 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.668 -0.697 . . . . 74.019999999999996 111.036 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -85.01 105.63 15.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.055 0.455 . . . . 71.540000000000006 110.626 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.44 102.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.991 0.424 . . . . 60.219999999999999 111.232 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.91 152.94 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.905 0.383 . . . . 75.140000000000001 111.969 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -131.14 128.93 41.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.152 -0.477 . . . . 72.109999999999999 110.035 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 33.1 t -163.58 -155.84 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.099 0.159 . . . . 74.400000000000006 110.79 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 127' ' ' VAL . 38.8 tt0 76.24 -52.53 0.61 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.264 0.626 . . . . 74.439999999999998 112.628 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.52 -29.49 10.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.504 0.927 . . . . 63.409999999999997 113.504 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.99 35.11 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.282 0.475 . . . . 42.210000000000001 112.282 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 124' ' ' GLU . 9.3 p -92.25 152.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.003 0.43 . . . . 74.409999999999997 111.655 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mp -100.68 107.24 18.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 110.542 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -63.63 105.4 0.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.819 0.342 . . . . 63.439999999999998 111.378 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -70.55 92.39 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.297 0.57 . . . . 73.450000000000003 110.528 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -106.64 39.74 1.78 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.819 -0.628 . . . . 72.239999999999995 111.547 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -72.94 126.73 30.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.2 0.524 . . . . 72.219999999999999 111.866 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.96 145.88 32.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.251 0.548 . . . . 74.420000000000002 111.837 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -94.84 115.63 27.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.065 -0.516 . . . . 65.099999999999994 110.384 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.829 -0.605 . . . . 72.430000000000007 111.538 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 111.791 0.293 . . . . 71.409999999999997 111.791 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.6 -13.01 60.1 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.017 0.436 . . . . 74.010000000000005 112.007 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -98.3 173.28 7.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.287 -0.415 . . . . 64.239999999999995 111.558 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.95 90.79 0.19 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 72.219999999999999 111.374 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -85.16 103.55 14.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.806 0.336 . . . . 75.420000000000002 111.018 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.544 ' HB3' HG23 ' A' ' 87' ' ' ILE . 91.5 m-85 -82.71 94.79 7.67 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.540000000000006 111.912 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.010000000000005 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.675 HG23 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 61.539999999999999 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.350000000000001 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.299999999999997 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.430000000000007 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.430000000000007 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.150000000000006 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.310000000000002 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.239999999999995 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.209999999999994 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.530000000000001 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.340000000000003 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.409999999999997 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.140000000000001 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.399999999999999 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.019999999999996 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.439999999999998 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.329999999999998 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.299999999999997 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 73.439999999999998 111.612 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.608 HG11 HG23 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 73.319999999999993 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' HG13 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.519999999999996 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 73.099999999999994 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.497 ' HB3' HD23 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.319999999999993 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.230000000000004 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 63.409999999999997 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.010000000000005 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.439999999999998 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.310000000000002 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.140000000000001 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.549999999999997 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.6 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.219999999999999 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.15 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.533 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.230000000000004 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.099999999999994 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.510000000000005 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 62.240000000000002 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.608 HG23 HG11 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.120000000000005 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 65.540000000000006 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.219999999999999 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.544 HG23 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 61.229999999999997 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.299999999999997 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 124' ' ' GLU . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 74.430000000000007 110.644 173.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.099999999999994 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.675 ' HB ' HG23 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.230000000000004 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 83' ' ' ALA . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 74.239999999999995 112.377 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.049999999999997 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 73.120000000000005 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.150000000000006 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 72.010000000000005 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.8 120.41 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.120000000000005 110.536 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.55 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.227 0.537 . . . . 71.329999999999998 110.849 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.37 -167.29 2.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.736 -0.665 . . . . 54.25 111.227 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.41 ' O ' HG12 ' A' ' 104' ' ' VAL . 10.7 t -115.22 39.98 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.093 0.473 . . . . 74.200000000000003 111.642 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.2 t -54.1 -44.12 70.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.226 0.536 . . . . 72.109999999999999 110.158 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 63.61 63.62 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.249 -0.887 . . . . 65.239999999999995 112.401 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.45 88.34 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.568 0.699 . . . . 70.200000000000003 110.688 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.91 -19.13 64.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.78 -0.645 . . . . 75.329999999999998 112.569 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.38 105.34 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.484 0.659 . . . . 73.209999999999994 111.57 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t -59.74 159.99 8.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.94 -1.027 . . . . 74.239999999999995 112.689 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 82.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.07 -0.514 . . . . 73.200000000000003 112.651 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -121.18 144.1 48.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.137 0.421 . . . . 61.340000000000003 112.137 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.78 87.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.658 -0.701 . . . . 73.549999999999997 112.484 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.93 5.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.158 0.799 . . . . 71.340000000000003 113.158 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.439 HD12 ' HD2' ' A' ' 116' ' ' PRO . 18.1 tp -72.0 131.33 85.61 Favored Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 121.947 -0.47 . . . . 74.109999999999999 111.522 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' HD12 ' A' ' 115' ' ' LEU . 73.0 Cg_endo -77.85 106.35 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.451 2.101 . . . . 75.019999999999996 112.919 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.9 p -77.15 -25.38 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.348 0.594 . . . . 72.209999999999994 111.289 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.3 m 37.17 -161.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 114.302 -1.317 . . . . 72.519999999999996 113.849 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -99.51 115.43 29.31 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.277 -0.419 . . . . 70.349999999999994 110.151 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -62.48 123.03 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.114 0.413 . . . . 71.5 112.114 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.506 ' O ' HD11 ' A' ' 121' ' ' ILE . 1.6 pp -125.78 124.25 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 N-CA-C 112.8 0.667 . . . . 74.400000000000006 112.8 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -144.6 139.99 28.46 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.91 -0.586 . . . . 74.129999999999995 110.091 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -162.85 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.617 0.969 . . . . 75.109999999999999 113.617 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 29.9 mt-10 -78.3 -0.41 28.7 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.35 0.87 . . . . 61.049999999999997 113.35 -164.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.03 -9.81 58.68 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.112 0.412 . . . . 70.25 112.112 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.92 175.68 9.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.759 0.314 . . . . 72.239999999999995 111.822 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.3 t 63.6 101.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.283 0.563 . . . . 75.120000000000005 111.968 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 tp -79.85 81.28 6.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.266 0.555 . . . . 73.239999999999995 111.173 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.39 109.24 6.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.32 0.581 . . . . 73.430000000000007 110.785 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -55.8 106.98 0.3 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 112.185 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -86.52 118.74 26.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 75.219999999999999 111.324 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -73.49 91.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.285 0.564 . . . . 75.150000000000006 111.328 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -80.36 149.62 30.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.665 -0.698 . . . . 74.430000000000007 111.62 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -106.02 169.64 8.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 72.209999999999994 112.764 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 115.669 -0.696 . . . . 72.519999999999996 111.102 173.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.58 ' SD ' ' N ' ' A' ' 34' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 111.958 0.355 . . . . 73.450000000000003 111.958 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.99 134.93 55.95 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 112.093 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 36.5 p -130.18 121.9 27.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.17 0.51 . . . . 71.430000000000007 111.686 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.37 84.21 1.94 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.069 0.461 . . . . 71.430000000000007 111.387 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.55 103.95 13.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.046 0.45 . . . . 74.209999999999994 111.136 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.81 92.89 3.64 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.400000000000006 111.426 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 54.329999999999998 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.579 HG23 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 71.340000000000003 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.299999999999997 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 61.140000000000001 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 73.540000000000006 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 65.5 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.439999999999998 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 73.019999999999996 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.030000000000001 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.519999999999996 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.019999999999996 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.340000000000003 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.433 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 73.030000000000001 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 62.200000000000003 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.040000000000006 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 75.409999999999997 112.247 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.209999999999994 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.349999999999994 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 72.530000000000001 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.519999999999996 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 52.409999999999997 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.329999999999998 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.439999999999998 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.439999999999998 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.219999999999999 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HB3' HD23 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.409999999999997 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' NZ ' ' OH ' ' A' ' 45' ' ' TYR . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 70.120000000000005 111.544 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.140000000000001 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.433 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.119999999999997 113.736 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.530000000000001 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 74.239999999999995 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HG3' HD13 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.230000000000004 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.219999999999999 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.120000000000005 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.430000000000007 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.430000000000007 110.391 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.340000000000003 114.503 -173.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.230000000000004 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 45.329999999999998 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.129999999999995 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.239999999999995 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.510000000000005 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 74.129999999999995 112.29 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.219999999999999 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.210000000000001 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.430000000000007 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.430000000000007 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.579 ' HB ' HG23 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.530000000000001 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 75.420000000000002 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.430000000000007 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.230000000000004 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.519999999999996 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.414 ' O ' HD11 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.430000000000007 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.439999999999998 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 74.299999999999997 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.526 HD13 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt -54.73 109.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 74.519999999999996 112.743 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.66 52.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.394 1.092 . . . . 74.219999999999999 110.026 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.7 -155.31 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.486 -1.234 . . . . 70.510000000000005 109.164 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.1 81.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.064 0.935 . . . . 74.439999999999998 112.154 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.4 m -89.83 41.5 1.05 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.863 -1.062 . . . . 75.219999999999999 110.189 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.38 22.48 0.68 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.818 0.673 . . . . 74.299999999999997 112.818 -169.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 108' ' ' ASP . 12.5 p -167.18 159.85 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.237 0.458 . . . . 72.230000000000004 112.237 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.413 ' O ' ' HB3' ' A' ' 72' ' ' PRO . 28.5 t0 77.57 115.94 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.194 0.998 . . . . 53.200000000000003 111.783 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.27 24.71 1.76 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.726 -0.67 . . . . 73.230000000000004 111.371 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.6 t -56.22 101.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.619 0.723 . . . . 64.430000000000007 112.084 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.27 179.49 39.08 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.61 -0.723 . . . . 55.149999999999999 112.249 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -174.08 -6.78 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.919 0.39 . . . . 75.340000000000003 111.377 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 64.51 92.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.488 0.661 . . . . 70.510000000000005 112.116 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 pp -144.91 151.71 39.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.487 -0.779 . . . . 75.409999999999997 110.647 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.3 mp -103.0 147.84 34.71 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 112.648 0.61 . . . . 71.140000000000001 112.648 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HB2' HG23 ' A' ' 118' ' ' VAL . 23.4 Cg_exo -68.66 139.72 45.08 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.607 2.871 . . . . 75.510000000000005 113.344 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.13 10.38 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.994 0.902 . . . . 72.510000000000005 111.458 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 116' ' ' PRO . 27.9 m -77.22 18.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.874 1.064 . . . . 72.129999999999995 113.874 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.25 61.93 5.71 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.755 -0.591 . . . . 65.519999999999996 111.862 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.1 mp -108.08 99.69 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.898 0.38 . . . . 65.129999999999995 110.409 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.82 109.41 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 111.273 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.14 155.07 24.48 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.182 0.515 . . . . 74.150000000000006 111.347 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -132.56 3.74 3.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.354 0.597 . . . . 73.319999999999993 110.286 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 124' ' ' GLU . 8.4 mp0 -88.13 141.21 28.75 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.531 -0.758 . . . . 70.140000000000001 111.109 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.03 -153.76 0.35 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.352 -0.386 . . . . 65.430000000000007 112.033 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 74.99 -28.18 0.19 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.476 0.917 . . . . 63.119999999999997 113.476 175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.12 98.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.759 0.314 . . . . 75.209999999999994 111.835 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -169.87 113.59 0.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.891 0.377 . . . . 73.450000000000003 110.911 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.82 -50.39 0.6 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 111.504 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.8 m170 66.35 179.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.487 0.661 . . . . 74.409999999999997 112.377 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -105.42 165.44 11.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.855 -0.611 . . . . 73.120000000000005 110.72 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 60.58 89.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.617 0.599 . . . . 74.319999999999993 112.617 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -85.49 169.39 13.65 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.784 0.326 . . . . 74.219999999999999 111.027 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -137.29 149.49 47.13 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.637 0.236 . . . . 65.510000000000005 111.637 -173.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.983 -0.532 . . . . 73.209999999999994 111.257 175.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.409 ' SD ' ' HB2' ' A' ' 39' ' ' PHE . 32.6 mmt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.546 -0.168 . . . . 65.239999999999995 110.546 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 71.18 -58.96 0.56 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.071 1.137 . . . . 74.129999999999995 114.071 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -52.99 -71.63 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.14 0.792 . . . . 75.340000000000003 113.14 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.92 11.4 35.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 111.576 0.213 . . . . 74.510000000000005 111.576 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 52.24 62.29 2.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.187 0.518 . . . . 74.420000000000002 111.029 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.409 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 89.2 m-85 -63.36 96.06 0.1 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.294 -0.412 . . . . 74.329999999999998 111.756 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 71.239999999999995 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.030000000000001 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HZ2' ' HG2' ' A' ' 44' ' ' GLU . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.210000000000001 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 74.140000000000001 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HZ2' ' A' ' 42' ' ' LYS . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.450000000000003 111.591 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.420000000000002 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.586 HG13 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.530000000000001 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.530000000000001 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.329999999999998 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.409999999999997 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.200000000000003 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.586 ' CA ' HG13 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.149999999999999 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 73.219999999999999 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.120000000000005 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 74.439999999999998 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 63.210000000000001 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.319999999999993 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 74.519999999999996 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.230000000000004 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.450000000000003 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.420000000000002 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 111.206 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.019999999999996 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HB2' HD11 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.239999999999995 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.340000000000003 109.848 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.329999999999998 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 73.239999999999995 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 74.219999999999999 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.109999999999999 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.200000000000003 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.329999999999998 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.465 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.209999999999994 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.450000000000003 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.239999999999995 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 75.219999999999999 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.219999999999999 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 72.200000000000003 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.329999999999998 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 37.579999999999998 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.049999999999997 111.312 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 37.579999999999998 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 72.299999999999997 111.425 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.519999999999996 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 73.329999999999998 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.140000000000001 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.119999999999997 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.656 ' HB ' HG23 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.019999999999996 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.540000000000006 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.150000000000006 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.150000000000006 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.329999999999998 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.465 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 71.120000000000005 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 51.130000000000003 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.340000000000003 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt -69.36 103.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.088 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.2 mm -73.85 -20.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.22 0.533 . . . . 74.450000000000003 110.48 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 70.9 86.96 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.142 -0.936 . . . . 74.099999999999994 111.528 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.86 3.74 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.163 -0.471 . . . . 65.230000000000004 111.299 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m 70.06 -53.9 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.429 0.691 . . . . 74.319999999999993 111.452 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.38 102.33 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.413 0.625 . . . . 74.420000000000002 111.821 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.95 103.17 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.789 -0.641 . . . . 62.43 110.497 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -77.83 83.38 4.17 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.706 0.765 . . . . 73.239999999999995 111.598 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.15 14.82 18.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.529 -0.76 . . . . 60.100000000000001 111.568 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -101.24 97.12 7.67 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.905 0.383 . . . . 73.420000000000002 111.729 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.38 165.55 24.69 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.928 -0.653 . . . . 43.439999999999998 113.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.459 ' HG2' ' N ' ' A' ' 113' ' ' ASP . 87.7 tttt -157.15 163.63 38.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.516 0.326 . . . . 71.430000000000007 110.649 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 10.9 m-20 -59.19 -37.21 76.85 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.106 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 97.6 mt 65.43 -177.17 0.18 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.858 0.837 . . . . 73.319999999999993 112.944 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -147.69 174.15 3.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 111.181 175.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 115' ' ' LEU . 31.2 Cg_exo -62.33 19.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 122.929 2.419 . . . . 71.109999999999999 115.343 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 115' ' ' LEU . 46.5 t 64.27 122.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.695 0.798 . . . . 74.109999999999999 112.797 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.3 p -161.43 113.28 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.829 -0.623 . . . . 71.409999999999997 111.049 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.97 180.0 4.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.208 0.528 . . . . 72.340000000000003 111.688 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mm -82.61 109.2 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.35 -0.386 . . . . 75.049999999999997 111.647 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.46 -41.37 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.961 0.41 . . . . 73.340000000000003 111.991 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.08 120.18 41.14 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.77 0.319 . . . . 74.200000000000003 111.311 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.3 t -153.71 170.24 21.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 74.329999999999998 110.733 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 62.03 174.97 0.13 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 111.146 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.88 -174.63 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.821 -0.172 . . . . 71.439999999999998 110.841 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.71 -155.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.77 0.319 . . . . 73.519999999999996 111.761 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.6 t 56.81 80.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.545 0.688 . . . . 73.340000000000003 112.141 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 128' ' ' LEU . 6.9 mp -89.53 77.44 7.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.419 0.628 . . . . 62.219999999999999 110.813 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.28 139.82 50.12 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.025 -0.534 . . . . 73.430000000000007 111.343 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -131.42 103.69 6.57 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.97 0.359 . . . . 73.319999999999993 111.97 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -79.84 72.83 6.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.372 -0.603 . . . . 64.030000000000001 109.372 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 63.16 170.9 0.15 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.024 -0.534 . . . . 75.099999999999994 109.888 -169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -70.09 77.97 0.5 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.385 -0.822 . . . . 64.140000000000001 110.112 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.9 145.64 55.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.348 -0.842 . . . . 74.340000000000003 112.446 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.706 -0.664 . . . . 72.450000000000003 111.817 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.632 0.254 . . . . 73.140000000000001 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.18 -155.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.95 0.5 . . . . 71.439999999999998 112.303 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -72.76 122.75 22.03 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 63.439999999999998 111.265 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -80.91 37.73 0.44 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.597 0.592 . . . . 74.230000000000004 112.597 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.03 61.32 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.094 0.474 . . . . 73.540000000000006 111.172 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB3' HG23 ' A' ' 87' ' ' ILE . 33.2 m-85 -59.69 100.66 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.219999999999999 111.55 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.129999999999995 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.120000000000005 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.530000000000001 111.535 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.567 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.219999999999999 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.672 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.450000000000003 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.109999999999999 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.420000000000002 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.540000000000006 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 63.340000000000003 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 61.25 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.129999999999995 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 73.519999999999996 112.358 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 71.140000000000001 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.530000000000001 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 60.109999999999999 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.140000000000001 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.150000000000006 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 74.129999999999995 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.209999999999994 110.762 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG12 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.230000000000004 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.530000000000001 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 64.530000000000001 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.130000000000003 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.409999999999997 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 70.299999999999997 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.099999999999994 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.019999999999996 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.109999999999999 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.400000000000006 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB2' HD13 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.129999999999995 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.510000000000005 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.530000000000001 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.439999999999998 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.329999999999998 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.310000000000002 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.509999999999998 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.219999999999999 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.569 HG22 HG12 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.140000000000001 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.049999999999997 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.310000000000002 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 HG23 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.530000000000001 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 70.540000000000006 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.694 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.340000000000003 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 73.239999999999995 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.530000000000001 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD3' HG23 ' A' ' 46' ' ' VAL . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.010000000000005 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.329999999999998 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -68.42 106.83 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.340000000000003 112.741 -168.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -80.11 78.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.959 0.885 . . . . 74.519999999999996 110.144 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -148.24 -26.04 0.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.963 -1.017 . . . . 70.040000000000006 111.311 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 m -76.47 81.67 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.027 -0.988 . . . . 71.439999999999998 110.621 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 t -60.67 82.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.258 -0.883 . . . . 62.329999999999998 111.968 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -125.38 108.93 12.16 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.718 -0.674 . . . . 75.239999999999995 111.276 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.97 100.43 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.989 0.423 . . . . 52.32 110.371 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -147.86 152.59 37.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.89 0.376 . . . . 75.209999999999994 112.009 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.11 -2.7 7.62 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.28 -0.418 . . . . 74.420000000000002 111.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -76.48 -12.87 60.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.162 0.43 . . . . 74.109999999999999 112.162 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.19 174.35 16.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.305 -0.474 . . . . 53.350000000000001 113.152 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -175.27 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.244 -0.65 . . . . 73.349999999999994 109.244 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -170.68 123.12 0.63 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 109.661 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD21 ' N ' ' A' ' 114' ' ' LEU . 2.7 mm? -114.73 149.07 37.44 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.926 -174.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.76 158.68 72.9 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.286 0.476 . . . . 73.439999999999998 112.286 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.4 -177.89 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.06 2.507 . . . . 72.219999999999999 112.914 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 117' ' ' VAL . 16.3 m -80.27 98.9 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.461 0.648 . . . . 65.049999999999997 111.248 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 m -75.82 120.38 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 71.239999999999995 111.736 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -149.32 137.7 20.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.982 -0.554 . . . . 74.049999999999997 111.151 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 122' ' ' ASN . 48.2 mm -91.58 131.22 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.547 ' H ' HD11 ' A' ' 121' ' ' ILE . 0.2 OUTLIER -81.85 -17.0 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 112.679 0.622 . . . . 54.43 112.679 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.462 ' H ' HG22 ' A' ' 120' ' ' ILE . 3.8 t-20 72.29 116.88 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.079 0.552 . . . . 74.129999999999995 112.087 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -106.08 -75.81 0.62 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.427 0.529 . . . . 74.409999999999997 112.427 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.91 85.44 1.26 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.364 0.602 . . . . 71.219999999999999 111.813 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -165.87 -66.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.531 -0.758 . . . . 74.109999999999999 110.511 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.81 47.08 1.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.253 0.549 . . . . 73.409999999999997 111.265 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 33.1 m -106.46 13.44 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.868 0.692 . . . . 74.420000000000002 112.868 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.7 tp -76.96 -31.63 56.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.854 0.359 . . . . 71.439999999999998 111.589 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.02 113.77 12.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.244 0.545 . . . . 74.099999999999994 112.307 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 127' ' ' VAL . 27.8 m80 -144.98 10.23 1.32 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.059 -0.519 . . . . 75.329999999999998 110.82 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 61.16 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.681 0.393 . . . . 63.399999999999999 110.731 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -68.79 72.56 0.24 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.096 0.406 . . . . 75.25 112.096 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.6 p80 173.84 127.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.844 0.858 . . . . 74.349999999999994 110.384 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -65.07 98.89 0.32 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.448 . . . . 73.099999999999994 110.779 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.747 -0.66 . . . . 75.120000000000005 112.35 -174.654 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.945 0.402 . . . . 74.340000000000003 111.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.08 -23.37 17.36 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.577 -0.283 . . . . 74.329999999999998 111.467 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.5 p -54.08 137.33 40.33 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.289 0.477 . . . . 72.200000000000003 112.289 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.93 -39.33 90.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.382 0.512 . . . . 65.230000000000004 112.382 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 65.13 65.45 0.58 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.076 0.465 . . . . 74.349999999999994 111.992 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -65.65 88.6 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.101 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.219999999999999 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.581 HG23 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.349999999999994 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.530000000000001 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.099999999999994 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.329999999999998 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 74.209999999999994 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 70.299999999999997 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.450000000000003 110.37 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.329999999999998 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.540000000000006 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.210000000000001 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.239999999999995 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.319999999999993 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 73.219999999999999 111.668 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 72.109999999999999 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.350000000000001 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.350000000000001 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.319999999999993 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.009999999999998 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.420000000000002 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.299999999999997 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 73.409999999999997 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 HG11 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.209999999999994 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 73.030000000000001 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.420000000000002 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.430000000000007 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.439999999999998 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.239999999999995 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 41.240000000000002 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 55.240000000000002 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.140000000000001 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.448 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.200000000000003 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.439999999999998 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.652 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.409999999999997 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.652 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.219999999999999 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.540000000000006 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 73.319999999999993 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.209999999999994 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG21 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.109999999999999 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 64.219999999999999 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.466 HG22 HG11 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 75.010000000000005 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.520000000000003 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.020000000000003 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.219999999999999 110.884 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.239999999999995 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.540000000000006 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.319999999999993 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 37.5 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.581 ' HB ' HG23 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 75.530000000000001 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.109999999999999 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.129999999999995 112.446 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 71.409999999999997 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.508 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 75.340000000000003 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.448 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 112.062 -178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.463 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.319999999999993 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 73.420000000000002 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.448 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt -74.11 104.75 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.439999999999998 111.025 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.6 mm -69.07 -31.16 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.272 0.558 . . . . 73.349999999999994 110.541 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.3 t70 68.66 167.54 0.27 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.185 -0.916 . . . . 71.109999999999999 112.704 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.6 m -84.56 4.43 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.404 -0.816 . . . . 74.409999999999997 112.046 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 m 71.45 -62.93 0.44 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.199 0.599 . . . . 72.530000000000001 110.507 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 t80 73.06 -22.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.594 0.961 . . . . 73.409999999999997 113.594 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -93.66 178.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 122.706 0.402 . . . . 74.540000000000006 112.067 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.99 -68.57 0.41 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.372 0.606 . . . . 71.329999999999998 111.119 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.73 88.99 4.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 74.109999999999999 110.643 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.8 p -72.51 75.83 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.017 -0.538 . . . . 75.099999999999994 111.759 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.68 125.55 1.58 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.316 -0.469 . . . . 75.209999999999994 113.067 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -168.76 -72.64 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.956 0.502 . . . . 73.439999999999998 109.869 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -157.0 115.27 3.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 109.994 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 114' ' ' LEU . 2.0 mp -115.27 170.56 8.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 110.98 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.416 HD13 ' HD2' ' A' ' 116' ' ' PRO . 26.3 tp -160.83 134.22 4.81 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.955 -0.566 . . . . 73.409999999999997 110.517 175.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' A' ' 115' ' ' LEU . 71.9 Cg_exo -51.31 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.379 2.052 . . . . 64.219999999999999 112.095 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.13 119.47 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.594 0.712 . . . . 72.209999999999994 111.619 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.89 145.57 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.387 -0.824 . . . . 73.109999999999999 112.237 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.06 147.08 43.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.206 0.527 . . . . 63.240000000000002 111.16 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.65 122.13 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.353 -0.385 . . . . 72.109999999999999 111.757 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.07 121.61 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.884 -0.413 . . . . 74.409999999999997 109.884 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -64.1 125.16 23.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.911 0.338 . . . . 74.5 111.911 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -53.21 128.09 26.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 70.030000000000001 110.084 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.04 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.755 0.659 . . . . 74.349999999999994 112.52 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.77 1.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.588 0.959 . . . . 55.329999999999998 113.588 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.47 -2.86 57.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.932 0.396 . . . . 53.299999999999997 111.859 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -71.78 100.96 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.419 0.628 . . . . 75.319999999999993 112.074 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.66 94.16 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.485 0.66 . . . . 75.340000000000003 111.416 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -71.33 164.4 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.183 0.516 . . . . 71.340000000000003 111.677 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -133.53 95.01 3.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.069 -0.514 . . . . 73.230000000000004 110.964 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -144.25 115.71 8.08 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.421 -0.354 . . . . 71.209999999999994 111.034 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -116.32 129.83 56.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.203 0.525 . . . . 71.120000000000005 111.619 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -98.5 95.6 7.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.154 -0.476 . . . . 75.109999999999999 111.155 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -101.59 120.68 40.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.536 -0.302 . . . . 74.340000000000003 110.674 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.6 t60 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 123.175 0.59 . . . . 73.030000000000001 111.994 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.893 0.378 . . . . 65.25 110.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.73 -26.17 24.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 65.439999999999998 111.415 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 p -90.72 176.83 6.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.23 0.538 . . . . 73.430000000000007 112.273 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -119.74 24.6 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 111.154 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.57 104.03 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.967 0.729 . . . . 71.019999999999996 112.967 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' A' ' 87' ' ' ILE . 40.7 m-85 -75.93 86.93 2.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.219999999999999 110.47 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.409999999999997 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.644 HG23 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 73.329999999999998 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.678 ' HB2' ' HZ1' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.510000000000005 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.129999999999995 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.299999999999997 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 75.5 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 75.120000000000005 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 63.229999999999997 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.439999999999998 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.299999999999997 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.219999999999999 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 74.239999999999995 112.192 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 53.509999999999998 111.546 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.200000000000003 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.530000000000001 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 54.420000000000002 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.420000000000002 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.310000000000002 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.129999999999995 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 73.439999999999998 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.120000000000005 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.209999999999994 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.530000000000001 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.420000000000002 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.319999999999993 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.099999999999994 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.219999999999999 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.129999999999995 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.576 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.319999999999993 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.408 ' HB2' HD13 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 75.430000000000007 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.140000000000001 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 61.450000000000003 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.219999999999999 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 64.219999999999999 109.645 170.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.520000000000003 113.168 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.420000000000002 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.349999999999994 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.329999999999998 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.299999999999997 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.409999999999997 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.539 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.0 OUTLIER -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.399999999999999 110.143 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.129999999999995 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.329999999999998 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.450000000000003 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.020000000000003 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.644 ' HB ' HG23 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.150000000000006 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.592 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.109999999999999 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.230000000000004 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.239999999999995 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.109999999999999 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.41 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 70.109999999999999 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.430000000000007 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 73.450000000000003 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt -79.26 104.85 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 65.0 110.995 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.29 -22.49 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.105 0.409 . . . . 75.439999999999998 112.105 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.33 -1.33 6.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.843 0.683 . . . . 75.430000000000007 112.843 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.63 19.24 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.247 0.546 . . . . 74.219999999999999 110.214 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.8 m 70.15 2.23 3.87 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.229 0.612 . . . . 71.430000000000007 112.216 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -79.63 85.07 5.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.067 0.461 . . . . 75.409999999999997 111.946 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.89 170.87 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 110.822 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.29 153.55 42.29 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.159 0.504 . . . . 75.010000000000005 112.024 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -129.57 -60.43 1.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 71.219999999999999 110.645 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -154.56 134.44 12.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.113 -0.494 . . . . 71.25 110.911 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.02 144.9 6.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.984 -0.627 . . . . 74.450000000000003 113.039 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.645 ' HD3' HD23 ' A' ' 114' ' ' LEU . 85.7 tttt -161.68 140.01 9.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.917 0.389 . . . . 75.230000000000004 111.335 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -73.87 75.79 1.63 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.488 0.661 . . . . 71.530000000000001 111.171 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.645 HD23 ' HD3' ' A' ' 112' ' ' LYS . 1.1 pp -122.75 7.48 9.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.376 0.51 . . . . 75.549999999999997 112.376 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD13 HD12 ' A' ' 114' ' ' LEU . 6.1 mp -81.49 148.83 63.52 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.261 0.467 . . . . 51.409999999999997 112.261 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.4 116.14 2.97 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.027 2.485 . . . . 64.439999999999998 112.869 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.34 171.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.116 0.484 . . . . 73.420000000000002 112.173 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.9 p -143.19 152.73 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.225 -0.443 . . . . 44.130000000000003 111.259 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.42 122.37 26.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.927 0.394 . . . . 71.439999999999998 112.059 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 120' ' ' ILE . 2.0 mp -79.1 122.31 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.823 0.344 . . . . 52.130000000000003 110.207 174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.72 99.2 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 121.569 0.7 . . . . 72.129999999999995 112.596 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -127.11 93.12 3.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 109.769 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.5 p -116.35 143.38 45.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.595 0.591 . . . . 61.240000000000002 112.595 -172.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' O ' HG11 ' A' ' 127' ' ' VAL . 35.2 mt-10 55.45 29.46 13.29 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.128 0.49 . . . . 75.319999999999993 111.084 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.478 ' HB3' HG11 ' A' ' 127' ' ' VAL . . . 61.67 4.56 1.08 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.484 -0.78 . . . . 65.150000000000006 111.892 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.54 31.88 21.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.525 0.679 . . . . 62.329999999999998 111.149 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 125' ' ' ALA . 7.6 p -113.72 149.22 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.695 -0.684 . . . . 74.010000000000005 111.876 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.32 104.81 16.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.969 0.414 . . . . 74.329999999999998 110.261 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -90.22 -62.9 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 112.164 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -89.39 88.74 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.908 0.385 . . . . 63.229999999999997 111.551 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -96.97 114.28 25.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.299 -0.41 . . . . 73.140000000000001 111.356 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -165.81 89.84 0.44 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.139 0.495 . . . . 75.439999999999998 111.215 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -119.95 118.95 32.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 72.239999999999995 110.597 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -87.84 151.08 23.13 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.433 0.158 . . . . 70.340000000000003 110.66 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.564 -0.731 . . . . 72.510000000000005 111.213 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.747 0.308 . . . . 75.319999999999993 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.18 129.49 50.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.399 -0.364 . . . . 75.140000000000001 110.631 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.1 m 71.27 111.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.343 0.497 . . . . 74.049999999999997 112.343 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -66.54 85.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.422 0.63 . . . . 70.400000000000006 112.141 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.09 87.74 2.99 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 110.42 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 -46.57 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.784 -0.644 . . . . 74.340000000000003 112.495 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.150000000000006 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.763 HG23 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.549999999999997 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.200000000000003 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.340000000000003 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.120000000000005 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.711 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.319999999999993 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 71.420000000000002 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 72.439999999999998 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.329999999999998 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.520000000000003 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.711 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.239999999999995 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 72.420000000000002 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 73.400000000000006 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.450000000000003 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 64.109999999999999 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.399999999999999 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.099999999999994 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.310000000000002 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.010000000000005 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.219999999999999 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.426 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 74.120000000000005 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 73.5 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 61.450000000000003 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 64.510000000000005 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 65.409999999999997 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.230000000000004 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.399999999999999 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.450000000000003 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.240000000000002 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.049999999999997 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.010000000000005 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.299999999999997 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 65.409999999999997 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.129999999999995 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.230000000000004 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.420000000000002 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.140000000000001 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 75.219999999999999 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 37.670000000000002 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.129999999999995 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.5 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.519999999999996 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.230000000000004 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.100000000000001 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.763 ' HB ' HG23 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 62.130000000000003 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.239999999999995 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.009999999999998 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.209999999999994 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.219999999999999 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.240000000000002 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 65.329999999999998 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 71.120000000000005 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt -68.15 104.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 74.010000000000005 111.96 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.83 -26.93 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.414 0.626 . . . . 75.340000000000003 110.76 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -101.37 106.9 18.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.439 -0.801 . . . . 75.420000000000002 111.351 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.06 93.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.649 0.738 . . . . 75.510000000000005 112.027 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -63.88 -23.91 67.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.566 -0.743 . . . . 64.510000000000005 109.95 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.92 101.78 0.16 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.031 -0.986 . . . . 74.040000000000006 111.308 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.87 153.64 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.916 -0.583 . . . . 73.150000000000006 111.699 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.29 104.29 3.66 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.456 0.539 . . . . 70.329999999999998 112.456 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -156.14 -57.42 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.906 -0.588 . . . . 54.420000000000002 110.154 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 t -153.14 151.09 29.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.85 -0.614 . . . . 74.430000000000007 111.219 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.19 -148.91 6.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.389 -0.434 . . . . 72.329999999999998 112.134 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -67.25 144.67 55.81 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.195 0.521 . . . . 75.329999999999998 111.108 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.88 104.39 2.05 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.534 0.683 . . . . 75.140000000000001 112.427 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.94 133.0 33.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.044 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.79 153.25 83.13 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.376 0.51 . . . . 73.25 112.376 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.87 88.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.881 2.388 . . . . 74.219999999999999 113.114 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.13 127.12 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.125 0.488 . . . . 72.540000000000006 111.53 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.24 116.26 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.569 0.699 . . . . 74.129999999999995 111.835 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' HB3' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -133.66 -160.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.953 -0.567 . . . . 72.230000000000004 110.175 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.537 HD11 ' HB3' ' A' ' 119' ' ' GLU . 3.4 mp 52.64 42.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 122.394 1.092 . . . . 74.319999999999993 109.764 -172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.4 pt -81.6 57.51 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.185 -0.916 . . . . 70.120000000000005 111.662 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.79 162.98 26.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.877 -0.601 . . . . 71.329999999999998 111.887 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.7 m -77.2 160.38 28.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.956 -0.566 . . . . 73.420000000000002 110.02 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -50.22 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.004 0.431 . . . . 72.219999999999999 111.964 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.69 11.34 3.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.872 -0.604 . . . . 74.340000000000003 112.532 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 47.31 76.49 0.11 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.152 0.581 . . . . 64.109999999999999 112.38 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.9 111.5 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.436 -0.347 . . . . 64.420000000000002 111.111 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.48 133.97 20.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.303 0.483 . . . . 61.140000000000001 112.303 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -176.7 147.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.458 -0.792 . . . . 55.32 109.718 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -135.0 137.15 42.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.419 0.525 . . . . 75.219999999999999 112.419 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -141.05 162.55 35.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.043 -0.526 . . . . 73.409999999999997 110.59 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.73 127.82 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 74.239999999999995 111.357 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.11 95.43 0.56 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.885 -0.598 . . . . 75.420000000000002 111.846 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -160.73 143.38 12.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.577 -0.283 . . . . 73.239999999999995 111.428 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.928 -0.558 . . . . 71.140000000000001 111.743 178.12 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.543 ' SD ' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 120.928 0.395 . . . . 71.120000000000005 111.296 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.12 104.2 16.17 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.388 0.613 . . . . 71.120000000000005 111.736 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -120.55 42.31 3.03 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.296 0.57 . . . . 73.109999999999999 111.206 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.01 40.57 0.41 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.183 0.809 . . . . 74.319999999999993 113.183 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 40.15 70.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.578 0.704 . . . . 64.109999999999999 111.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -65.25 90.71 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 73.349999999999994 112.139 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.219999999999999 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.75 HG23 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.340000000000003 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 74.150000000000006 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.219999999999999 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 74.150000000000006 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.798 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 73.219999999999999 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.240000000000002 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 65.329999999999998 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 37.990000000000002 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.430000000000007 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.798 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.099999999999994 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG13 HD12 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.439999999999998 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 72.030000000000001 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.109999999999999 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.487 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.530000000000001 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 71.230000000000004 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.497 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.239999999999995 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 75.030000000000001 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.530000000000001 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.120000000000005 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.140000000000001 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.519999999999996 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.129999999999995 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.209999999999994 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.450000000000003 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.447 HD12 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 74.120000000000005 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.430000000000007 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.100000000000001 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 74.049999999999997 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 74.439999999999998 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.219999999999999 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.400000000000006 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.239999999999995 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.329999999999998 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 72.310000000000002 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 70.120000000000005 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 74.420000000000002 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.549999999999997 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.009999999999998 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.349999999999994 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.119999999999997 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.540000000000006 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.039999999999999 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 61.350000000000001 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.75 ' HB ' HG23 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.140000000000001 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.519999999999996 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.319999999999993 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HD3' HG22 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 72.530000000000001 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.340000000000003 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 74.140000000000001 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 74.349999999999994 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.200000000000003 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.149999999999999 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt -76.39 103.63 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 75.150000000000006 109.968 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 102' ' ' ILE . 33.0 mt -90.01 45.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 122.535 1.159 . . . . 75.209999999999994 111.02 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.5 -167.24 0.37 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.97 -1.468 . . . . 73.420000000000002 110.378 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 25.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.489 0.551 . . . . 64.400000000000006 112.489 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 m 58.94 46.59 13.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.98 0.895 . . . . 72.439999999999998 108.758 -168.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 108' ' ' ASP . 35.4 t80 -66.26 94.58 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.163 -1.38 . . . . 75.230000000000004 112.243 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t -86.82 83.93 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.689 0.757 . . . . 72.219999999999999 111.328 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 39.1 t70 -150.37 60.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.29 -0.868 . . . . 64.319999999999993 109.301 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 56.68 -84.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.256 -0.884 . . . . 53.43 111.954 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.1 p 43.83 32.63 0.62 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.103 0.478 . . . . 71.409999999999997 112.192 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.402 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 108.01 55.34 0.61 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.13 -0.486 . . . . 70.230000000000004 112.085 -171.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.12 -40.74 82.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.181 0.515 . . . . 44.219999999999999 111.156 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.56 94.6 4.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.889 -0.596 . . . . 72.329999999999998 109.969 174.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 78.4 mt -95.73 -168.1 1.71 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.556 0.576 . . . . 64.310000000000002 112.556 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.9 mt 69.64 119.33 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.675 -0.693 . . . . 71.450000000000003 111.763 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.93 52.25 3.71 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.835 2.357 . . . . 74.420000000000002 112.436 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -57.27 103.84 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.718 0.77 . . . . 64.140000000000001 112.338 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.09 149.01 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.882 -0.599 . . . . 63.409999999999997 111.852 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 120' ' ' ILE . 39.7 tt0 -151.0 165.56 33.37 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.669 -0.696 . . . . 74.400000000000006 109.587 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.476 ' N ' ' HG2' ' A' ' 119' ' ' GLU . 45.3 mm -54.89 94.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.346 0.593 . . . . 71.310000000000002 111.237 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.86 -26.25 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.8 -0.637 . . . . 75.310000000000002 111.696 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.94 -62.74 0.44 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.128 0.571 . . . . 71.510000000000005 111.933 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 t -44.01 -51.78 7.54 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.323 0.86 . . . . 63.420000000000002 113.323 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.86 -21.81 65.0 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.499 0.555 . . . . 64.239999999999995 112.499 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.66 -16.63 50.72 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.845 0.313 . . . . 63.109999999999999 111.845 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.54 7.75 34.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.626 0.602 . . . . 62.030000000000001 112.626 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.48 154.58 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 122.191 -0.318 . . . . 74.340000000000003 111.343 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.36 119.18 11.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.827 0.346 . . . . 70.519999999999996 111.772 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -134.37 139.51 45.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.719 0.295 . . . . 72.219999999999999 110.623 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -130.94 89.33 2.73 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.115 0.483 . . . . 71.349999999999994 111.755 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.56 62.03 4.43 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.99 -0.444 . . . . 74.209999999999994 112.058 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -169.31 62.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 110.889 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -87.67 178.65 6.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.236 0.541 . . . . 75.439999999999998 112.184 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -103.87 -162.11 0.88 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 109.996 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.699 -0.667 . . . . 72.230000000000004 111.921 178.84 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.324 0.107 . . . . 74.319999999999993 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 54.91 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.7 1.0 . . . . 74.200000000000003 113.7 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -59.15 101.75 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 75.439999999999998 112.697 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -82.7 21.15 1.03 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.714 -0.676 . . . . 63.329999999999998 111.262 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 t30 56.18 63.72 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.658 0.742 . . . . 74.409999999999997 110.15 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -60.5 104.02 0.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.143 -0.935 . . . . 72.530000000000001 111.471 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.240000000000002 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.120000000000005 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.439999999999998 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.229999999999997 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 60.229999999999997 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.329999999999998 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.219999999999999 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.120000000000005 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.766 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.340000000000003 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 72.430000000000007 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB1' HD11 ' A' ' 71' ' ' ILE . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.010000000000005 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.519999999999996 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 75.019999999999996 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.430000000000007 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.240000000000002 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 111.101 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.230000000000004 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' CG ' HG23 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.310000000000002 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.340000000000003 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.129999999999995 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HB3' HD21 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.430000000000007 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.454 HD11 ' HB1' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.109999999999999 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.439999999999998 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.129999999999995 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.519999999999996 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.120000000000005 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 74.040000000000006 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 74.310000000000002 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.239999999999995 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.448 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.399999999999999 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.420000000000002 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.448 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.129999999999995 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 74.049999999999997 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.010000000000005 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 74.129999999999995 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.439999999999998 111.17 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 70.010000000000005 110.912 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.140000000000001 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.430000000000007 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 71.25 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.099999999999994 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.400000000000006 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 72.519999999999996 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.230000000000004 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.319999999999993 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.229999999999997 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.209999999999994 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt -66.98 123.61 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.100000000000001 111.605 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.7 mm -95.14 96.99 6.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.026 0.441 . . . . 75.230000000000004 111.341 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 71.26 149.13 0.09 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.626 0.973 . . . . 73.349999999999994 113.626 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.3 -1.1 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.528 -0.76 . . . . 72.310000000000002 111.972 177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.5 m 69.98 11.47 7.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.79 0.663 . . . . 72.209999999999994 112.79 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -97.82 10.3 40.49 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.116 0.413 . . . . 74.219999999999999 112.116 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.71 150.2 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.559 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -82.4 27.47 0.5 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.375 0.509 . . . . 53.420000000000002 112.375 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -119.04 -20.25 8.15 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.162 0.43 . . . . 65.230000000000004 112.162 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.8 p -76.26 -68.51 0.58 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.931 0.396 . . . . 75.430000000000007 111.877 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.54 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . -179.65 -84.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.781 0 C-N-CA 121.394 -0.431 . . . . 72.420000000000002 112.146 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 50.69 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.503 0.927 . . . . 73.129999999999995 113.503 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t70 -131.61 18.58 4.74 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.398 0.618 . . . . 71.219999999999999 111.952 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 0.7 OUTLIER -104.78 -161.64 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.535 . . . . 72.239999999999995 110.694 -179.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.3 mt -94.45 112.67 58.59 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.12 -0.491 . . . . 64.540000000000006 110.937 168.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.95 105.67 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.174 1.916 . . . . 73.519999999999996 111.674 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.7 t -69.24 79.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.811 0.815 . . . . 72.439999999999998 111.448 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.28 -167.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.995 -1.002 . . . . 74.239999999999995 110.247 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.54 84.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.772 0.796 . . . . 75.219999999999999 111.746 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mt -92.13 47.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.028 0.918 . . . . 75.230000000000004 109.472 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 39.3 pt -68.5 -41.66 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.162 -0.926 . . . . 74.239999999999995 112.881 -172.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.512 ' HB2' ' HB1' ' A' ' 126' ' ' ALA . 37.7 m-80 54.41 -165.93 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.898 0.38 . . . . 74.049999999999997 111.837 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 t -143.06 -71.25 0.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 71.099999999999994 112.334 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.64 -64.82 0.78 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.118 0.414 . . . . 53.340000000000003 112.118 -173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.27 9.63 5.49 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.614 0.598 . . . . 74.400000000000006 112.614 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB1' ' HB2' ' A' ' 122' ' ' ASN . . . -83.97 2.33 39.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.641 0.608 . . . . 74.349999999999994 112.641 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.64 18.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 112.861 0.689 . . . . 64.400000000000006 112.861 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.76 -39.69 21.52 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.483 0.549 . . . . 74.230000000000004 112.483 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.642 ' HG2' ' H ' ' A' ' 131' ' ' HIS . 30.6 tt0 65.73 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.276 0.63 . . . . 75.140000000000001 111.282 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -77.83 1.57 19.91 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.864 0.69 . . . . 71.109999999999999 112.864 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.642 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 72.9 m80 48.3 58.68 4.92 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 74.409999999999997 112.519 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -78.13 -72.4 0.37 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.858 -0.526 . . . . 72.25 110.674 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -123.63 87.74 2.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.077 0.465 . . . . 73.409999999999997 110.694 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -86.6 110.86 20.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.639 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.187 -0.911 . . . . 75.040000000000006 111.764 -176.54 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.482 0.182 . . . . 71.019999999999996 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -162.37 174.49 12.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.846 0.355 . . . . 75.030000000000001 111.573 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.3 m -128.39 110.08 12.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.731 0.301 . . . . 74.439999999999998 111.738 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -85.02 106.84 16.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.843 0.354 . . . . 72.150000000000006 110.822 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.84 101.29 5.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.994 0.426 . . . . 63.140000000000001 111.299 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.53 105.14 11.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.524 -0.307 . . . . 74.329999999999998 111.094 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.030000000000001 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG21 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.439999999999998 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.688 ' HZ2' ' HG2' ' A' ' 44' ' ' GLU . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.450000000000003 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.688 ' HG2' ' HZ2' ' A' ' 42' ' ' LYS . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.310000000000002 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.409999999999997 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.627 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.150000000000006 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB3' HG23 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.549999999999997 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.400000000000006 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.209999999999994 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 63.0 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.219999999999999 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG23 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 62.119999999999997 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 73.109999999999999 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.549999999999997 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.230000000000004 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.130000000000003 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 73.549999999999997 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 74.299999999999997 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.450000000000003 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.549999999999997 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.049999999999997 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.439999999999998 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.67 HG11 HG23 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.530000000000001 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 72.400000000000006 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.400000000000006 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.409999999999997 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.450000000000003 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.030000000000001 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.471 ' HA2' HG12 ' A' ' 104' ' ' VAL . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 72.540000000000006 113.284 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.510000000000005 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.636 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.239999999999995 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 72.439999999999998 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' HD3' HG23 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 75.409999999999997 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 74.329999999999998 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 HD11 HD23 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 72.129999999999995 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.340000000000003 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.140000000000001 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.350000000000001 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HH ' ' A' ' 96' ' ' TYR . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.030000000000001 112.401 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.67 HG23 HG11 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.239999999999995 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.520000000000003 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.230000000000004 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.140000000000001 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.109999999999999 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.519999999999996 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.239999999999995 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.210000000000001 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.62 ' HB ' HG21 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 72.230000000000004 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.120000000000005 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.340000000000003 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.43 ' HH ' ' HB3' ' A' ' 83' ' ' ALA . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.420000000000002 110.408 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.150000000000006 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.209999999999994 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 61.539999999999999 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt -79.12 123.52 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.109999999999999 111.758 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.7 mm -85.92 -22.29 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.309 0.576 . . . . 75.340000000000003 110.888 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.15 63.06 3.7 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.588 0.709 . . . . 70.329999999999998 111.697 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.471 HG12 ' HA2' ' A' ' 73' ' ' GLY . 30.0 m -140.33 28.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 74.420000000000002 110.237 176.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.2 t -70.98 78.12 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.482 0.658 . . . . 72.510000000000005 112.669 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.3 5.5 9.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 109.406 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.7 t -100.35 86.3 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.314 -0.857 . . . . 73.0 111.433 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.17 73.83 8.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.639 0.733 . . . . 75.329999999999998 110.778 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.75 -86.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.468 -0.787 . . . . 72.420000000000002 109.602 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -150.48 -175.99 5.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.663 0.385 . . . . 72.010000000000005 110.558 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 66.68 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.24 -0.505 . . . . 70.329999999999998 112.203 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -88.44 -72.67 0.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.131 0.419 . . . . 64.319999999999993 112.131 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.67 -68.32 0.9 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.412 0.523 . . . . 72.340000000000003 112.412 -174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mp 55.76 29.93 14.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.618 0.723 . . . . 74.519999999999996 110.157 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.454 HD22 ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -79.3 126.61 81.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.909 -1.041 . . . . 73.310000000000002 111.125 -170.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' HD2' HD22 ' A' ' 115' ' ' LEU . 57.2 Cg_endo -69.69 165.51 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.753 2.302 . . . . 71.319999999999993 113.031 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.02 123.14 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.52 0.676 . . . . 75.099999999999994 112.691 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -156.55 142.3 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.815 -0.63 . . . . 64.219999999999999 110.699 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -151.35 90.12 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.781 0.289 . . . . 71.400000000000006 111.781 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.8 mt 57.3 110.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 112.771 0.656 . . . . 73.530000000000001 112.771 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.507 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.1 pp -124.88 133.52 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 113.46 0.911 . . . . 75.010000000000005 113.46 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -157.63 90.95 1.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.317 -0.856 . . . . 71.409999999999997 110.238 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.5 m -91.29 -33.12 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.629 0.603 . . . . 74.209999999999994 112.629 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.01 90.93 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.125 0.488 . . . . 72.430000000000007 110.789 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.03 -55.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.966 -0.561 . . . . 64.140000000000001 111.074 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.63 90.3 2.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.086 0.469 . . . . 73.129999999999995 111.86 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.41 96.24 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 71.409999999999997 111.881 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.28 97.72 9.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.282 -0.636 . . . . 72.010000000000005 109.282 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.7 131.07 49.17 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.056 0.455 . . . . 75.510000000000005 111.91 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -110.3 161.95 15.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.323 -0.399 . . . . 73.209999999999994 111.766 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -162.21 112.27 1.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.013 0.435 . . . . 65.25 111.996 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -137.83 123.3 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.813 0.34 . . . . 75.230000000000004 110.977 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -88.27 139.75 30.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 62.32 111.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -137.02 175.84 9.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.929 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.302 -0.863 . . . . 73.0 110.319 177.371 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.609 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.754 0.312 . . . . 65.409999999999997 111.511 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.36 101.79 0.61 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.659 0.266 . . . . 73.219999999999999 110.878 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m 63.19 96.26 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 60.350000000000001 111.148 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 87.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 72.450000000000003 110.768 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -66.76 105.99 1.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.261 -0.882 . . . . 65.420000000000002 111.672 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 -74.04 93.43 2.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.74 -0.663 . . . . 64.400000000000006 111.128 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.040000000000006 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.784 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 74.0 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.699 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.310000000000002 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.210000000000001 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.488 ' HD1' ' HH ' ' A' ' 98' ' ' TYR . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.549999999999997 109.587 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.209999999999994 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.530000000000001 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.030000000000001 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.510000000000005 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.219999999999999 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.040000000000006 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG13 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.340000000000003 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.010000000000005 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.240000000000002 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.420000000000002 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 45.210000000000001 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.109999999999999 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 64.230000000000004 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.219999999999999 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.240000000000002 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.299999999999997 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.405 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.329999999999998 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 60.43 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.209999999999994 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.230000000000004 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.049999999999997 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.120000000000005 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.219999999999999 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.540000000000006 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.540000000000006 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.319999999999993 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.430000000000007 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD12 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.400000000000006 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.049999999999997 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.099999999999994 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.230000000000004 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 71.319999999999993 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 72.310000000000002 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.43 ' O ' HG22 ' A' ' 94' ' ' VAL . 9.3 t30 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.540000000000006 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HA ' ' CG1' ' A' ' 94' ' ' VAL . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 64.430000000000007 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.319999999999993 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.449 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.219999999999999 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 70.530000000000001 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.150000000000006 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.039999999999999 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.400000000000006 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.784 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.239999999999995 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 73.439999999999998 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HD3' HG23 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.450000000000003 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.439999999999998 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.430000000000007 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.488 ' HH ' ' HD1' ' A' ' 45' ' ' TYR . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.140000000000001 112.304 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.430000000000007 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.219999999999999 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt -85.79 102.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 62.200000000000003 110.438 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.473 HG21 ' O ' ' A' ' 102' ' ' ILE . 36.3 mt -114.54 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.739 0.78 . . . . 75.109999999999999 110.235 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.72 170.89 2.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.23 -1.396 . . . . 74.420000000000002 107.23 -174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 104' ' ' VAL . 6.7 p -77.64 77.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 122.643 1.211 . . . . 72.200000000000003 112.615 -171.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.6 m 61.59 15.85 7.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.583 -1.189 . . . . 75.200000000000003 112.286 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.14 96.69 3.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.155 0.502 . . . . 72.540000000000006 111.916 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.45 131.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.131 -0.486 . . . . 63.140000000000001 110.912 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.66 -43.76 95.76 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.618 0.599 . . . . 70.430000000000007 112.618 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 69.92 -51.16 0.64 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.685 0.794 . . . . 75.510000000000005 112.255 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p 53.82 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.944 0.897 . . . . 74.140000000000001 113.367 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.82 -112.76 4.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.123 -0.561 . . . . 71.329999999999998 112.762 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -148.67 -43.13 0.15 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.277 0.561 . . . . 75.540000000000006 110.668 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.82 90.07 2.9 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.674 -0.694 . . . . 72.540000000000006 112.031 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -169.93 165.53 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.409999999999997 112.361 174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.3 mt -124.69 106.7 29.37 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.854 -0.612 . . . . 61.130000000000003 111.15 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.49 -167.7 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.995 2.463 . . . . 71.299999999999997 112.79 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.13 136.43 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.9 0.381 . . . . 73.439999999999998 111.489 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -72.4 114.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.496 -0.32 . . . . 73.219999999999999 111.164 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.04 179.8 0.15 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.175 0.59 . . . . 75.310000000000002 112.248 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mm 64.34 117.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.184 0.516 . . . . 74.310000000000002 111.072 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.409 HG13 ' OD1' ' A' ' 122' ' ' ASN . 26.1 pt -80.03 175.15 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.768 0.318 . . . . 44.030000000000001 111.247 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.409 ' OD1' HG13 ' A' ' 121' ' ' ILE . 15.0 m120 72.53 -61.83 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.31 0.644 . . . . 75.019999999999996 111.823 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.4 t 66.75 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.034 0.534 . . . . 74.019999999999996 112.144 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.93 118.08 6.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.235 0.54 . . . . 75.340000000000003 112.017 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.23 6.26 0.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.221 0.823 . . . . 74.340000000000003 113.221 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 49.33 60.86 3.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 71.239999999999995 112.158 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.86 80.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.143 0.497 . . . . 70.010000000000005 111.414 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.71 101.48 3.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.454 0.538 . . . . 62.5 112.454 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.61 104.21 16.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.877 -0.416 . . . . 74.409999999999997 109.877 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -96.36 118.81 33.66 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 74.519999999999996 111.479 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -78.43 150.99 32.95 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.169 0.433 . . . . 72.340000000000003 112.169 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.67 -166.09 1.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.71 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -148.66 133.73 18.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.973 0.416 . . . . 71.120000000000005 111.597 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -128.02 108.18 10.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.279 0.561 . . . . 73.200000000000003 111.174 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.954 -0.546 . . . . 75.409999999999997 111.611 -179.525 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.439 ' HG2' ' N ' ' A' ' 35' ' ' ASP . 56.0 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.509 0.195 . . . . 73.049999999999997 111.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 34' ' ' MET . 24.8 t70 79.91 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.019 0.928 . . . . 73.450000000000003 111.819 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.5 m -160.26 136.72 8.84 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.189 -0.319 . . . . 74.230000000000004 111.294 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -87.88 88.55 7.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.214 0.531 . . . . 73.219999999999999 110.038 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.98 104.43 8.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 74.200000000000003 111.937 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.58 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 -76.76 88.2 3.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.200000000000003 110.0 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 71.200000000000003 111.642 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.614 HG21 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.119999999999997 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.340000000000003 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.430000000000007 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.230000000000004 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 72.219999999999999 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.549999999999997 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.129999999999995 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.771 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.329999999999998 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.329999999999998 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.140000000000001 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.239999999999995 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.240000000000002 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.109999999999999 111.71 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.219999999999999 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.519999999999996 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.109999999999999 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.310000000000002 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.439999999999998 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 75.409999999999997 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 72.010000000000005 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.439999999999998 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.409999999999997 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.129999999999995 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 71.530000000000001 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.540000000000006 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.310000000000002 110.94 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.299999999999997 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.510000000000005 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 73.349999999999994 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 61.210000000000001 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 75.0 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.150000000000006 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.030000000000001 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.621 HD21 HG22 ' A' ' 88' ' ' THR . 0.9 OUTLIER -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.219999999999999 111.359 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.030000000000001 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.621 HG22 HD21 ' A' ' 86' ' ' ASN . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 74.329999999999998 111.087 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.299999999999997 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.230000000000004 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.614 ' HB ' HG21 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.530000000000001 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.030000000000001 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.340000000000003 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.439999999999998 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.219999999999999 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.1 mt -70.82 107.62 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.541 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.3 mm -89.84 -37.21 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 73.219999999999999 110.638 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.5 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.311 -0.859 . . . . 62.299999999999997 110.954 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.65 1.84 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.413 0.523 . . . . 74.230000000000004 112.413 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.3 t 64.45 -72.32 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.727 0.411 . . . . 72.329999999999998 111.494 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.9 t80 64.49 19.25 11.74 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.006 0.522 . . . . 75.329999999999998 111.602 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 109' ' ' GLU . 83.8 t -73.73 136.7 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.923 0.392 . . . . 72.430000000000007 111.053 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -55.03 -30.59 59.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.8 0.667 . . . . 74.349999999999994 112.8 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' H ' HG12 ' A' ' 107' ' ' VAL . 46.7 mt-10 -56.42 -37.96 70.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 111.358 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.639 HG23 ' H ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -103.96 -69.45 0.8 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.439 -0.346 . . . . 73.109999999999999 111.414 176.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.639 ' H ' HG23 ' A' ' 110' ' ' THR . . . 53.93 15.65 5.17 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.15 0.42 . . . . 64.329999999999998 114.15 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -96.95 -6.26 36.0 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 117.392 0.596 . . . . 71.230000000000004 111.627 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -100.36 91.46 4.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.605 -0.27 . . . . 51.310000000000002 110.784 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -127.73 -165.01 1.42 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.001 0.429 . . . . 73.0 111.361 -178.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.1 mt 71.22 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.73 . . . . 73.310000000000002 112.855 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 105.14 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.626 2.217 . . . . 75.010000000000005 112.68 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.04 96.64 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.409 0.623 . . . . 73.109999999999999 111.483 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.66 145.52 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.169 0.433 . . . . 72.040000000000006 112.169 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.18 107.54 9.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.264 -0.425 . . . . 74.109999999999999 110.765 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.3 mt -90.9 95.4 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.128 0.489 . . . . 64.25 111.461 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.0 pt -95.16 145.78 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.851 -0.613 . . . . 75.409999999999997 110.944 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.74 -172.92 4.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.284 0.564 . . . . 70.140000000000001 111.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -76.69 -175.1 3.25 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.253 -0.43 . . . . 64.549999999999997 110.48 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.43 109.79 0.75 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.042 0.448 . . . . 63.340000000000003 110.71 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.92 7.34 1.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.043 -0.526 . . . . 71.340000000000003 112.328 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.62 25.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.931 0.396 . . . . 71.120000000000005 111.372 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.2 m -51.56 134.19 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.654 0.612 . . . . 54.210000000000001 112.654 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 25.9 tp -132.6 15.23 4.43 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.888 -0.596 . . . . 64.430000000000007 110.772 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.04 94.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.312 0.577 . . . . 62.340000000000003 112.343 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -103.08 113.29 26.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 110.93 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -129.91 170.39 14.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.053 0.454 . . . . 64.319999999999993 111.412 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -103.57 174.34 5.91 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.001 0.429 . . . . 62.409999999999997 111.026 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -85.6 -171.62 3.7 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.47 -0.332 . . . . 72.219999999999999 111.578 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.946 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.532 -0.747 . . . . 65.299999999999997 111.458 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.718 0.294 . . . . 75.530000000000001 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.81 -63.0 1.5 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.104 0.478 . . . . 62.130000000000003 111.484 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -70.96 120.79 17.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.211 -0.45 . . . . 74.400000000000006 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.38 -64.62 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.402 0.281 . . . . 73.129999999999995 111.722 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 51.33 72.99 0.33 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.98 0.512 . . . . 63.509999999999998 112.368 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -59.8 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.540000000000006 110.887 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 74.099999999999994 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.571 HG21 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 63.210000000000001 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.310000000000002 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.019999999999996 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.65 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 74.319999999999993 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 65.239999999999995 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.400000000000006 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.400000000000006 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 73.150000000000006 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.682 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.109999999999999 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.407 HG13 HD12 ' A' ' 71' ' ' ILE . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.129999999999995 111.759 -174.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.030000000000001 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.530000000000001 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 75.219999999999999 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 74.420000000000002 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 75.120000000000005 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.450000000000003 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.230000000000004 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 73.209999999999994 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.528 ' CD1' HG22 ' A' ' 41' ' ' VAL . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.439999999999998 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.541 HG12 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.530000000000001 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 65.140000000000001 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 73.140000000000001 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.120000000000005 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.019999999999996 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 HD12 HG13 ' A' ' 53' ' ' ILE . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.129999999999995 110.932 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.019999999999996 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 73.200000000000003 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 70.430000000000007 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.109999999999999 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 72.239999999999995 111.821 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.439999999999998 112.19 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.109999999999999 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.120000000000005 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.129999999999995 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.466 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.329999999999998 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 74.109999999999999 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.541 HG22 HG12 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.109999999999999 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.219999999999999 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.219999999999999 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.458 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.120000000000005 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.430000000000007 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.340000000000003 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.571 ' HB ' HG21 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.450000000000003 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 73.230000000000004 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.340000000000003 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 74.25 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.200000000000003 111.653 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.426 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 73.129999999999995 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 74.420000000000002 110.255 169.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.340000000000003 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 103' ' ' ASP . 57.5 mt -72.48 122.46 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.310000000000002 111.071 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.67 -24.21 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.235 0.54 . . . . 74.209999999999994 110.705 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 101' ' ' ILE . 17.4 t70 78.28 163.27 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.193 -0.912 . . . . 74.400000000000006 111.365 170.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 104' ' ' VAL . 2.7 p -116.9 49.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.857 0.837 . . . . 74.129999999999995 112.995 -168.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 m 79.88 16.73 0.78 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.036 -0.984 . . . . 73.099999999999994 112.338 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.01 2.33 32.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.049999999999997 112.391 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.06 148.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.928 0.394 . . . . 75.299999999999997 111.821 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.51 151.22 21.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.974 0.416 . . . . 74.239999999999995 111.54 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.42 -58.11 8.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.21 -0.45 . . . . 75.030000000000001 111.963 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.481 ' HB ' HD22 ' A' ' 114' ' ' LEU . 47.8 p -87.33 -77.17 0.34 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.583 -0.28 . . . . 74.420000000000002 111.091 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 50.25 -87.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.833 0.693 . . . . 62.340000000000003 114.833 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.09 -56.79 15.37 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.267 0.469 . . . . 45.030000000000001 112.267 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.79 -67.85 0.53 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.735 0.643 . . . . 62.200000000000003 112.735 -169.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.481 HD22 ' HB ' ' A' ' 110' ' ' THR . 60.7 mt 67.02 -167.93 0.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.297 0.57 . . . . 75.349999999999994 112.105 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD13 ' HD2' ' A' ' 116' ' ' PRO . 16.9 tp -141.89 134.33 13.81 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.178 -0.464 . . . . 74.219999999999999 111.807 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.434 ' HD2' HD13 ' A' ' 115' ' ' LEU . 84.0 Cg_endo -82.1 169.38 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.709 2.273 . . . . 53.509999999999998 113.274 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.88 117.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.299 0.571 . . . . 60.229999999999997 111.303 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -163.76 122.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.057 -0.52 . . . . 74.140000000000001 111.763 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -171.2 99.15 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.302 -0.408 . . . . 70.439999999999998 111.174 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 71.1 mt -139.98 122.97 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.03 0.443 . . . . 75.040000000000006 111.672 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.7 mt -129.76 108.41 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.382 -0.372 . . . . 75.400000000000006 110.57 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -138.28 96.56 3.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.416 0.627 . . . . 70.030000000000001 111.538 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.7 p -127.15 148.59 50.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.737 -0.665 . . . . 71.5 110.386 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.1 29.23 18.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.031 0.443 . . . . 74.230000000000004 111.177 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 67.43 5.71 4.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.57 0.748 . . . . 74.510000000000005 112.514 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 52.66 87.11 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.164 0.506 . . . . 61.119999999999997 112.19 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.8 t -72.84 95.57 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.88 0.371 . . . . 74.549999999999997 110.331 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.7 tp -138.01 22.72 2.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.16 0.505 . . . . 74.209999999999994 111.908 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.58 71.14 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.193 0.52 . . . . 75.519999999999996 110.252 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -90.68 43.87 1.17 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.824 0.676 . . . . 74.5 112.824 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -61.31 105.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.125 0.488 . . . . 75.510000000000005 111.144 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.54 127.26 31.89 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.018 -0.537 . . . . 71.019999999999996 110.942 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -136.82 147.79 46.78 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.957 0.354 . . . . 72.400000000000006 111.957 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m170 63.2 -178.42 0.15 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.992 0.517 . . . . 71.040000000000006 111.449 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 119.257 -0.402 . . . . 74.200000000000003 111.538 177.956 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.814 0.301 . . . . 63.200000000000003 111.814 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -72.21 -75.22 0.14 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.998 0.428 . . . . 72.439999999999998 111.276 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -81.16 138.3 35.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 111.068 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -57.19 108.77 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.291 0.567 . . . . 73.329999999999998 110.754 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -54.89 91.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.54 -0.755 . . . . 40.420000000000002 112.988 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 -87.42 150.27 23.9 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 74.519999999999996 110.053 171.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 62.009999999999998 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.299999999999997 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.299999999999997 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.409999999999997 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 70.209999999999994 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.200000000000003 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.049999999999997 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.109999999999999 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.319999999999993 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.340000000000003 112.483 -173.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.209999999999994 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.329999999999998 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.58 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.099999999999994 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.409999999999997 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.010000000000005 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.400000000000006 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.329999999999998 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.329999999999998 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 74.150000000000006 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.150000000000006 110.347 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.209999999999994 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.509999999999998 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 73.5 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.420000000000002 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.530000000000001 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.230000000000004 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 62.149999999999999 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 63.140000000000001 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 75.219999999999999 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.481 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 73.430000000000007 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.239999999999995 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 73.400000000000006 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.219999999999999 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.510000000000005 113.148 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 74.310000000000002 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 94' ' ' VAL . 8.3 t30 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.420000000000002 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 51.420000000000002 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.407 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.399999999999999 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.310000000000002 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.129999999999995 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 75.239999999999995 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.120000000000005 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 65.109999999999999 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.549999999999997 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.150000000000006 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 71.230000000000004 112.346 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.140000000000001 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.049999999999997 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.409999999999997 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.209999999999994 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 72.329999999999998 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt -84.52 104.37 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.295 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.0 mm -84.05 -13.5 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 110.404 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.41 -1.13 9.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.642 -0.708 . . . . 75.439999999999998 112.046 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.66 -4.48 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.71 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.4 m 69.48 -50.55 0.61 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.139 0.575 . . . . 71.319999999999993 111.304 -172.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 t80 60.5 26.86 16.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.579 0.704 . . . . 75.409999999999997 111.284 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 108' ' ' ASP . 8.4 p -166.86 169.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.521 -0.763 . . . . 71.310000000000002 110.346 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.483 ' N ' HG23 ' A' ' 107' ' ' VAL . 31.1 t70 79.5 159.63 0.18 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.716 0.806 . . . . 74.329999999999998 112.126 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.38 -20.79 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.689 -0.687 . . . . 72.400000000000006 111.643 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.4 p -142.87 45.7 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.829 0.347 . . . . 63.229999999999997 110.947 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -48.01 -59.35 6.3 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.121 0.808 . . . . 75.409999999999997 115.121 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.37 -79.23 0.59 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.391 0.595 . . . . 74.430000000000007 111.69 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -142.21 99.5 3.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 71.099999999999994 110.499 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 114' ' ' LEU . 1.9 pt? -176.35 144.73 0.56 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 111.776 -174.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 mt -127.39 91.39 46.21 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.439999999999998 110.822 171.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.04 126.74 8.86 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.905 2.404 . . . . 44.229999999999997 113.437 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.82 113.29 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.095 0.474 . . . . 61.329999999999998 110.694 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.84 175.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 111.891 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.75 127.86 38.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 111.22 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 120' ' ' ILE . 3.0 mp -98.89 100.51 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.126 0.489 . . . . 73.200000000000003 110.463 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 58.0 mt -98.93 116.94 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.067 0.46 . . . . 71.430000000000007 111.79 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -141.97 105.86 4.73 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 70.519999999999996 110.319 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 30.9 t -122.16 -172.37 2.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.165 0.186 . . . . 50.43 111.12 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 123' ' ' SER . 45.7 tt0 74.97 -46.21 0.59 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.828 0.677 . . . . 74.519999999999996 112.828 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.85 -4.2 6.37 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.105 0.78 . . . . 75.239999999999995 113.105 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.33 0.63 55.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.606 0.595 . . . . 53.149999999999999 112.606 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.71 89.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.928 0.394 . . . . 74.319999999999993 111.873 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.08 117.49 29.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.776 0.322 . . . . 65.439999999999998 110.481 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.19 146.75 31.6 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 73.329999999999998 112.046 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -130.85 77.33 1.78 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.097 0.475 . . . . 71.5 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -85.01 77.43 10.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.083 0.468 . . . . 73.109999999999999 112.152 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.1 p80 176.56 151.44 0.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 72.420000000000002 110.057 173.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -63.85 98.72 0.21 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.094 0.474 . . . . 74.420000000000002 111.928 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -78.49 103.05 8.17 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.258 0.551 . . . . 73.019999999999996 110.098 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.1 t60 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.687 -0.673 . . . . 75.209999999999994 111.735 -174.459 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.669 0.271 . . . . 74.129999999999995 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.36 107.93 8.96 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.998 0.428 . . . . 73.400000000000006 110.692 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -162.86 150.37 13.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.873 0.368 . . . . 73.420000000000002 111.591 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -80.92 69.19 7.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.057 0.456 . . . . 74.230000000000004 111.444 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -84.29 109.47 17.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 111.187 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB3' HG23 ' A' ' 87' ' ' ILE . 70.1 m-85 -75.63 98.77 4.12 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.885 -0.598 . . . . 74.310000000000002 111.537 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.219999999999999 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.130000000000003 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 73.310000000000002 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.340000000000003 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' HD2' ' HH ' ' A' ' 98' ' ' TYR . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.510000000000005 109.337 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.420000000000002 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.409999999999997 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.340000000000003 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.349999999999994 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.200000000000003 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 70.349999999999994 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 74.040000000000006 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.409999999999997 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.120000000000005 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 72.540000000000006 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.129999999999995 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 75.319999999999993 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.120000000000005 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.420000000000002 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.413 ' CD1' HG23 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.129999999999995 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.310000000000002 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 64.319999999999993 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 63.119999999999997 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.109999999999999 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.310000000000002 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.409999999999997 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.010000000000005 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 61.140000000000001 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 73.040000000000006 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.329999999999998 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.109999999999999 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.230000000000004 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 74.120000000000005 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 75.120000000000005 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.4 ' O ' HG21 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.439999999999998 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 62.350000000000001 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.030000000000001 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 72.540000000000006 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.488 HG23 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.230000000000004 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.209999999999994 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.010000000000005 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 72.140000000000001 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.430000000000007 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.573 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.310000000000002 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.140000000000001 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.450000000000003 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 72.450000000000003 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.019999999999996 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' HH ' ' HD2' ' A' ' 45' ' ' TYR . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.239999999999995 111.231 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.530000000000001 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.239999999999995 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt -85.26 115.61 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.209999999999994 112.189 -173.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 102' ' ' ILE . 4.0 mp -82.32 -37.11 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.101 -0.5 . . . . 75.400000000000006 109.999 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 70.5 152.79 0.11 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.099 -0.955 . . . . 74.510000000000005 111.685 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.4 m -86.65 35.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.604 . . . . 75.420000000000002 111.92 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.6 t -80.86 38.12 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.533 . . . . 74.230000000000004 111.479 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.88 90.29 5.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.934 0.397 . . . . 73.510000000000005 111.887 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.14 137.01 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.315 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -104.71 31.62 4.63 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.871 0.367 . . . . 74.239999999999995 111.726 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 110' ' ' THR . 10.0 pt-20 -73.94 -37.07 64.67 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.787 0.662 . . . . 72.239999999999995 112.787 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.488 HG22 ' HG3' ' A' ' 109' ' ' GLU . 19.5 p -91.72 144.7 25.24 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.081 -0.387 . . . . 75.430000000000007 111.945 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.6 72.09 2.44 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.304 -0.474 . . . . 62.409999999999997 112.512 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.89 -56.93 3.32 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.938 0.399 . . . . 74.209999999999994 111.85 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -136.36 100.88 4.5 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.252 0.548 . . . . 52.030000000000001 111.412 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.629 HD11 ' N ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -131.3 68.75 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.83 0.824 . . . . 53.32 111.478 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.2 tp -103.23 131.98 21.57 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.773 -0.649 . . . . 72.340000000000003 110.963 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.72 108.2 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.59 2.194 . . . . 74.340000000000003 112.875 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -85.65 131.12 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.22 0.534 . . . . 72.310000000000002 112.188 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.06 93.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.225 0.536 . . . . 73.010000000000005 111.344 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -144.37 151.68 39.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.111 -0.495 . . . . 72.310000000000002 110.71 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.5 mp -79.61 90.11 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.323 0.582 . . . . 71.150000000000006 111.336 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.2 pt -76.1 130.74 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.428 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -133.9 147.98 51.18 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.398 0.518 . . . . 72.230000000000004 112.398 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.7 t -163.72 -162.97 0.75 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.774 -0.648 . . . . 64.510000000000005 110.045 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 75.8 -57.42 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.149 0.796 . . . . 64.430000000000007 113.149 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.49 -9.41 41.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.434 0.902 . . . . 61.039999999999999 113.434 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.15 27.89 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.791 0.663 . . . . 73.310000000000002 112.791 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.23 137.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.691 0.626 . . . . 72.219999999999999 112.691 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.13 97.35 7.46 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.314 0.578 . . . . 73.230000000000004 110.855 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.48 179.64 2.9 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.731 -0.668 . . . . 51.25 111.953 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -154.93 -175.39 5.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.637 -0.256 . . . . 73.400000000000006 110.976 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -133.11 156.52 47.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.487 0.184 . . . . 71.040000000000006 110.746 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -98.51 164.42 12.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.192 0.52 . . . . 74.120000000000005 112.273 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -132.51 147.84 52.37 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 75.430000000000007 111.514 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 31.2 m170 -120.18 113.8 20.98 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.627 -0.508 . . . . 73.349999999999994 109.627 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 76.2 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 123.61 0.764 . . . . 74.030000000000001 110.886 -168.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.812 0.339 . . . . 61.539999999999999 110.966 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.96 91.13 0.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 73.219999999999999 111.386 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.1 m -156.74 -61.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.823 0.344 . . . . 74.510000000000005 111.919 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -122.17 16.92 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.833 0.309 . . . . 74.409999999999997 111.833 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 48.57 65.72 1.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.112 0.482 . . . . 73.510000000000005 111.236 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB3' HG22 ' A' ' 87' ' ' ILE . 84.6 m-85 -63.83 104.21 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 65.109999999999999 111.649 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.409999999999997 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HZ3' ' HG2' ' A' ' 44' ' ' GLU . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.409999999999997 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 71.25 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 71.349999999999994 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.425 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 71.120000000000005 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.200000000000003 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.400000000000006 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.099999999999994 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.099999999999994 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.109999999999999 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.329999999999998 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.109999999999999 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.419 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.299999999999997 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.020000000000003 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 62.310000000000002 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 75.439999999999998 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 71.319999999999993 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.420000000000002 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.049999999999997 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.099999999999994 110.174 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.219999999999999 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.319999999999993 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.450000000000003 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.240000000000002 112.261 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.420000000000002 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 73.120000000000005 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.130000000000003 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 74.409999999999997 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.140000000000001 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.510000000000005 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.409999999999997 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.488 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.120000000000005 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.430000000000007 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' HB1' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.450000000000003 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.420000000000002 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.120000000000005 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.409999999999997 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.420000000000002 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.329999999999998 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.130000000000003 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.010000000000005 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.200000000000003 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.409999999999997 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.520000000000003 110.567 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.129999999999995 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 74.019999999999996 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.230000000000004 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.420000000000002 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.230000000000004 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 103' ' ' ASP . 51.7 mt -77.19 125.46 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 111.22 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 102' ' ' ILE . 24.0 mm -76.55 14.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.333 0.587 . . . . 61.329999999999998 112.284 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' H ' HG22 ' A' ' 101' ' ' ILE . 30.5 t70 -73.32 13.82 0.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.34 0.591 . . . . 74.530000000000001 112.362 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.5 m -112.95 28.08 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 122.156 -0.34 . . . . 72.129999999999995 111.339 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m 70.12 -69.18 0.18 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.045 0.538 . . . . 74.150000000000006 110.366 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 67.14 2.99 2.99 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.351 0.871 . . . . 73.040000000000006 113.351 168.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -133.94 122.99 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.199 0.523 . . . . 70.129999999999995 112.404 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.02 -34.28 0.81 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.356 0.598 . . . . 65.409999999999997 110.616 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -75.04 -70.76 0.4 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.666 -0.697 . . . . 63.149999999999999 109.975 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.7 p -157.56 167.58 29.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.973 0.509 . . . . 71.310000000000002 110.908 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.56 -166.41 38.61 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.086 -0.578 . . . . 62.310000000000002 112.812 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.67 ' HB2' ' HZ2' ' A' ' 112' ' ' LYS . 3.9 ttmp? -148.68 -174.59 4.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.977 -0.379 . . . . 72.120000000000005 109.977 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.649 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 6.2 m-20 -59.74 88.49 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.279 0.561 . . . . 60.350000000000001 112.069 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 pp -173.65 154.65 2.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.305 -0.861 . . . . 70.439999999999998 110.024 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -97.81 165.2 15.91 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.161 0.43 . . . . 74.319999999999993 112.161 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.54 97.15 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.279 1.986 . . . . 71.409999999999997 112.518 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.52 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.902 0.858 . . . . 74.420000000000002 111.548 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.37 109.63 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.799 -0.637 . . . . 75.310000000000002 111.92 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.96 118.1 33.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.301 -0.409 . . . . 73.5 109.985 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.775 HG23 HD12 ' A' ' 121' ' ' ILE . 7.7 mt -84.51 157.97 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.029 0.381 . . . . 74.400000000000006 112.029 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.775 HD12 HG23 ' A' ' 120' ' ' ILE . 3.6 mp 55.2 65.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.919 0.866 . . . . 73.140000000000001 110.382 -170.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -142.43 12.86 1.95 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.757 -0.656 . . . . 71.25 111.373 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -80.25 163.19 24.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.052 0.454 . . . . 74.400000000000006 111.779 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 63.22 14.07 7.45 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.916 -0.584 . . . . 75.319999999999993 112.469 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.56 50.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.99 0.424 . . . . 72.450000000000003 111.203 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.71 88.75 2.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.19 -0.459 . . . . 70.340000000000003 111.583 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.04 103.76 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.261 0.553 . . . . 61.140000000000001 111.251 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.09 24.09 8.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.054 0.454 . . . . 73.439999999999998 111.599 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.07 13.15 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.824 0.676 . . . . 73.450000000000003 112.824 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -89.64 141.72 28.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.881 0.372 . . . . 75.329999999999998 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.95 130.93 50.18 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.706 0.632 . . . . 63.219999999999999 112.706 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -162.48 121.65 2.27 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.041 0.386 . . . . 74.319999999999993 112.041 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -92.98 133.43 36.13 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.354 -0.385 . . . . 73.209999999999994 111.019 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.5 m80 59.63 -172.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.014 0.435 . . . . 74.430000000000007 111.497 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.597 -0.716 . . . . 73.230000000000004 111.029 172.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.521 0.2 . . . . 64.230000000000004 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 61.72 14.98 6.56 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.589 0.589 . . . . 72.230000000000004 112.589 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.6 m -117.62 144.78 44.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.96 -0.462 . . . . 70.420000000000002 111.595 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.11 -64.59 1.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.558 -0.292 . . . . 72.209999999999994 111.132 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 45.33 79.86 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.099 0.777 . . . . 65.030000000000001 113.099 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 -61.41 95.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.009 0.433 . . . . 73.040000000000006 110.679 172.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 74.540000000000006 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.685 HG23 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.239999999999995 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.539999999999999 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 74.329999999999998 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 75.140000000000001 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.681 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.539999999999999 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.519999999999996 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.420000000000002 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.399999999999999 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.681 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 75.239999999999995 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.430000000000007 112.306 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.019999999999996 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.129999999999995 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.510000000000005 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.25 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.040000000000006 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 72.420000000000002 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 73.329999999999998 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.209999999999994 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.400000000000006 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.310000000000002 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.299999999999997 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.109999999999999 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.310000000000002 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.409999999999997 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 65.129999999999995 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.510000000000005 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.129999999999995 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.400000000000006 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.319999999999993 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.349999999999994 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.539999999999999 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.439999999999998 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.349999999999994 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.535 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 74.519999999999996 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.109999999999999 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.411 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.310000000000002 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.109999999999999 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.230000000000004 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.319999999999993 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 72.120000000000005 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.462 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.319999999999993 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 73.340000000000003 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.039999999999999 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 63.229999999999997 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 75.329999999999998 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.685 ' HB ' HG23 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.129999999999995 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.430000000000007 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 63.25 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.109999999999999 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.420000000000002 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.549999999999997 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -65.39 118.63 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.76 82.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.909 0.861 . . . . 70.25 110.284 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -138.86 5.87 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.892 -1.049 . . . . 72.310000000000002 110.469 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.84 0.89 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.154 -0.93 . . . . 73.239999999999995 111.762 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.6 m 69.23 -13.0 0.38 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.262 0.838 . . . . 63.299999999999997 113.262 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -75.67 86.08 2.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 73.400000000000006 112.003 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.72 -166.82 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.936 -0.574 . . . . 71.219999999999999 110.758 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.58 158.17 31.37 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.003 0.43 . . . . 75.140000000000001 111.584 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.19 5.76 5.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.822 0.675 . . . . 75.140000000000001 112.822 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -143.52 -55.7 0.39 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.803 1.038 . . . . 75.319999999999993 113.803 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.04 57.91 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.607 -0.806 . . . . 65.099999999999994 113.395 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.47 -68.67 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 110.208 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -155.66 94.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.46 0.648 . . . . 65.219999999999999 110.139 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -115.65 149.94 37.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.844 -0.616 . . . . 64.430000000000007 111.213 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -90.68 165.12 23.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.146 0.424 . . . . 71.439999999999998 112.146 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.88 114.55 2.21 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.932 2.421 . . . . 74.540000000000006 113.173 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.51 112.23 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.514 0.673 . . . . 72.230000000000004 110.795 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.26 -170.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.6 -0.727 . . . . 74.349999999999994 112.21 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.57 107.21 2.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.167 0.508 . . . . 64.340000000000003 111.64 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.45 153.57 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.259 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -73.73 81.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.581 0.705 . . . . 72.129999999999995 110.307 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -170.05 -174.06 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.001 -1.0 . . . . 54.520000000000003 110.06 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.9 p -140.09 164.46 29.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.019 0.378 . . . . 72.409999999999997 112.019 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 60.55 23.61 13.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.302 0.572 . . . . 53.439999999999998 111.006 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.4 9.85 3.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.937 -0.574 . . . . 60.530000000000001 111.957 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.46 29.46 18.34 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.516 0.561 . . . . 54.409999999999997 112.516 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.83 163.02 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.708 0.633 . . . . 74.5 112.708 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 mt -110.44 33.67 4.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.077 -0.511 . . . . 61.32 112.109 -173.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.69 84.45 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.458 0.647 . . . . 75.510000000000005 112.549 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.48 141.54 37.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.762 -0.654 . . . . 74.219999999999999 110.168 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.91 131.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.977 0.417 . . . . 75.150000000000006 111.326 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.431 ' O ' ' HB2' ' A' ' 133' ' ' HIS . 56.0 t60 -143.79 -39.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.194 0.812 . . . . 72.329999999999998 113.194 -173.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 132' ' ' HIS . 88.4 m-70 71.04 148.11 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.054 0.542 . . . . 74.209999999999994 112.153 -173.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -169.15 133.68 1.46 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.069 -0.514 . . . . 71.200000000000003 110.853 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.76 -0.638 . . . . 75.5 111.964 -177.159 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.561 . . . . 72.299999999999997 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 64.0 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.439999999999998 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 62.509999999999998 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.120000000000005 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 ' CA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 64.140000000000001 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.310000000000002 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.140000000000001 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.520000000000003 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.439999999999998 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 52.219999999999999 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG12 ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.420000000000002 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 54.210000000000001 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.049999999999997 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.299999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.019999999999996 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 51.130000000000003 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.240000000000002 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.120000000000005 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.450000000000003 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 43.109999999999999 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 34.109999999999999 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.129999999999995 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.530000000000001 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 65.5 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 63.43 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.310000000000002 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.140000000000001 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.319999999999993 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.549999999999997 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.329999999999998 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 61.329999999999998 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.405 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.299999999999997 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.120000000000005 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 72.420000000000002 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' THR . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.430000000000007 110.542 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.549999999999997 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.540000000000006 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 53.240000000000002 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.510000000000005 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.340000000000003 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.439999999999998 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.340000000000003 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.409999999999997 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.230000000000004 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.310000000000002 111.504 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 60.210000000000001 112.061 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.530000000000001 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 41.229999999999997 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.701 ' HZ3' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.209999999999994 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 62.240000000000002 110.656 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.450000000000003 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.319999999999993 108.974 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 43.210000000000001 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.140000000000001 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.420000000000002 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 42.530000000000001 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.420000000000002 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.329999999999998 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.439999999999998 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.240000000000002 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.020000000000003 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 70.019999999999996 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 64.209999999999994 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 70.329999999999998 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.329999999999998 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.020000000000003 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 73.030000000000001 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 70.129999999999995 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 73.329999999999998 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 51.32 112.825 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.020000000000003 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 64.310000000000002 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.239999999999995 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.439999999999998 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.239999999999995 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 54.200000000000003 113.853 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.340000000000003 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 72.120000000000005 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.120000000000005 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.129999999999995 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.310000000000002 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.430000000000007 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.109999999999999 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.019999999999996 112.046 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.537 HG22 HG13 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 55.25 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 34.229999999999997 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.230000000000004 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.239999999999995 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.140000000000001 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 70.120000000000005 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.430000000000007 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 44.310000000000002 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.329999999999998 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 64.310000000000002 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 65.409999999999997 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.466 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.299999999999997 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.530000000000001 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.230000000000004 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.230000000000004 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.549999999999997 110.53 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 65.299999999999997 110.915 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 74.329999999999998 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 60.210000000000001 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.129999999999995 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 65.430000000000007 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.340000000000003 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.540000000000006 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.329999999999998 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.450000000000003 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 42.329999999999998 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.310000000000002 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 63.130000000000003 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.439999999999998 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.049999999999997 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.530000000000001 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.019999999999996 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.120000000000005 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 64.25 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.310000000000002 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.409999999999997 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 70.349999999999994 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 71.349999999999994 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.150000000000006 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.420000000000002 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.540000000000006 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 70.150000000000006 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.009999999999998 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.019999999999996 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.400000000000006 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.140000000000001 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.329999999999998 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.409999999999997 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.229999999999997 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 64.219999999999999 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 65.219999999999999 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 60.009999999999998 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.209999999999994 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.540000000000006 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.439999999999998 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.010000000000005 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.230000000000004 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.519999999999996 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.607 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 70.019999999999996 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.439999999999998 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.120000000000005 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.150000000000006 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.329999999999998 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.762 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.109999999999999 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.119999999999997 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.674 ' HB ' HG22 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.400000000000006 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.140000000000001 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 63.229999999999997 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 53.399999999999999 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 64.019999999999996 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.420000000000002 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 65.430000000000007 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.329999999999998 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 64.239999999999995 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 45.32 110.818 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' HG21 ' A' ' 87' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.540000000000006 111.912 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.010000000000005 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 54.399999999999999 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.350000000000001 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.299999999999997 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.430000000000007 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.430000000000007 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.150000000000006 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.310000000000002 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.239999999999995 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.209999999999994 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.530000000000001 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.340000000000003 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.409999999999997 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.140000000000001 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.399999999999999 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.019999999999996 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.439999999999998 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.129999999999995 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.299999999999997 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 41' ' ' VAL . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 65.540000000000006 111.612 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 64.209999999999994 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' OG ' HG11 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.519999999999996 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 63.530000000000001 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.319999999999993 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.230000000000004 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 42.5 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.010000000000005 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.439999999999998 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.310000000000002 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.140000000000001 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.549999999999997 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.61 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.219999999999999 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.15 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.230000000000004 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.099999999999994 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.510000000000005 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 51.25 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.120000000000005 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 61.340000000000003 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.219999999999999 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.559 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 52.310000000000002 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.299999999999997 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 54.43 110.644 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.099999999999994 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.230000000000004 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.436 HG11 ' OG ' ' A' ' 66' ' ' SER . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 62.520000000000003 112.377 -172.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.049999999999997 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 72.310000000000002 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.150000000000006 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 64.329999999999998 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.120000000000005 110.536 176.435 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.400000000000006 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 53.009999999999998 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.299999999999997 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 44.030000000000001 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 64.549999999999997 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 64.430000000000007 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.439999999999998 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 62.109999999999999 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.030000000000001 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.519999999999996 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.019999999999996 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.340000000000003 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 61.100000000000001 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 51.530000000000001 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.040000000000006 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 53.130000000000003 112.247 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.209999999999994 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.349999999999994 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 63.32 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.519999999999996 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 51.509999999999998 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.329999999999998 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.439999999999998 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.439999999999998 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.219999999999999 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.598 ' HB3' HD22 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.409999999999997 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 64.239999999999995 111.544 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.140000000000001 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.119999999999997 113.736 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.530000000000001 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 73.319999999999993 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HG3' HD11 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.230000000000004 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.219999999999999 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.120000000000005 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.430000000000007 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.430000000000007 110.391 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.340000000000003 114.503 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.049999999999997 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 41.32 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.129999999999995 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.239999999999995 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.510000000000005 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 6.6 p30 -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 61.25 112.29 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.219999999999999 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.210000000000001 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.430000000000007 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.430000000000007 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.6 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.530000000000001 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 51.509999999999998 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.430000000000007 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.230000000000004 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.519999999999996 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.430000000000007 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.439999999999998 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 64.409999999999997 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 40.530000000000001 112.743 -171.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.743 0.306 . . . . 74.329999999999998 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 53.5 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.030000000000001 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.210000000000001 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 61.130000000000003 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.450000000000003 111.591 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.420000000000002 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.595 HG12 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.530000000000001 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.530000000000001 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.329999999999998 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.409999999999997 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.200000000000003 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.595 ' CA ' HG12 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.149999999999999 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 63.329999999999998 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.120000000000005 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 61.039999999999999 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 50.039999999999999 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.319999999999993 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 63.520000000000003 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.230000000000004 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.450000000000003 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.400000000000006 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 111.206 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.019999999999996 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HB2' HD12 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.239999999999995 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 84' ' ' THR . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.340000000000003 109.848 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.329999999999998 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 71.530000000000001 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 53.009999999999998 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.109999999999999 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.200000000000003 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.329999999999998 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.209999999999994 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 72.120000000000005 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.450000000000003 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.239999999999995 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 74.5 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.219999999999999 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 71.120000000000005 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.329999999999998 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 33.310000000000002 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.049999999999997 111.312 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 33.409999999999997 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 63.119999999999997 111.425 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.519999999999996 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 54.539999999999999 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.140000000000001 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.119999999999997 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.019999999999996 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.540000000000006 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.150000000000006 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.150000000000006 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.040000000000006 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.329999999999998 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 44.409999999999997 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.340000000000003 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 62.539999999999999 111.088 -175.781 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 87' ' ' ILE . 33.2 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.219999999999999 111.55 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.129999999999995 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.120000000000005 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.530000000000001 111.535 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.219999999999999 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.450000000000003 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.109999999999999 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.420000000000002 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.540000000000006 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 25.350000000000001 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 31.34 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.129999999999995 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 64.109999999999999 112.358 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 54.420000000000002 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.239999999999995 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 53.520000000000003 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.140000000000001 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.150000000000006 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 70.219999999999999 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.209999999999994 110.762 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.230000000000004 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.409999999999997 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 50.119999999999997 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.130000000000003 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.409999999999997 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 64.25 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.099999999999994 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.019999999999996 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.109999999999999 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.400000000000006 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.129999999999995 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.510000000000005 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.530000000000001 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.439999999999998 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.329999999999998 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.310000000000002 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.509999999999998 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.219999999999999 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.566 HG22 HG13 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.140000000000001 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.049999999999997 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.109999999999999 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.530000000000001 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 60.439999999999998 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 54.539999999999999 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.340000000000003 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 55.219999999999999 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.329999999999998 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.010000000000005 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.329999999999998 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.340000000000003 112.741 -168.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' ILE . 96.8 m-85 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.219999999999999 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.349999999999994 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.530000000000001 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.099999999999994 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.329999999999998 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 73.150000000000006 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.781 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 64.530000000000001 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HG21 ' A' ' 53' ' ' ILE . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.450000000000003 110.37 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.329999999999998 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.540000000000006 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.210000000000001 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.239999999999995 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.319999999999993 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 47' ' ' ASP . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 65.239999999999995 111.668 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 63.520000000000003 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.350000000000001 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.350000000000001 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.319999999999993 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.009999999999998 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.420000000000002 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.299999999999997 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 62.229999999999997 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.209999999999994 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 72.450000000000003 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.420000000000002 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.430000000000007 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.439999999999998 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.239999999999995 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 32.219999999999999 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 52.109999999999999 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.140000000000001 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.200000000000003 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.430000000000007 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.409999999999997 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.219999999999999 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.540000000000006 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 71.049999999999997 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.209999999999994 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.109999999999999 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 60.229999999999997 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 73.430000000000007 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.520000000000003 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.020000000000003 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.219999999999999 110.884 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.239999999999995 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.540000000000006 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.319999999999993 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 35.299999999999997 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' HG22 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 64.150000000000006 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.109999999999999 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.129999999999995 112.446 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 65.319999999999993 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 64.5 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 112.062 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.319999999999993 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 62.009999999999998 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.439999999999998 111.025 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HB3' HG21 ' A' ' 87' ' ' ILE . 40.7 m-85 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.219999999999999 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.409999999999997 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 64.230000000000004 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.510000000000005 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.129999999999995 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.030000000000001 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 74.25 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 65.340000000000003 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 53.43 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.439999999999998 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.299999999999997 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.219999999999999 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 71.120000000000005 112.192 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 35.25 111.546 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.200000000000003 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.530000000000001 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 51.340000000000003 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.420000000000002 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.310000000000002 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.129999999999995 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 72.230000000000004 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.120000000000005 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.209999999999994 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.530000000000001 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.420000000000002 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.319999999999993 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.099999999999994 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.219999999999999 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.129999999999995 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.319999999999993 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 65.430000000000007 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.140000000000001 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 54.350000000000001 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.219999999999999 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 109.645 170.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.520000000000003 113.168 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.420000000000002 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.349999999999994 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.329999999999998 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.299999999999997 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.409999999999997 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 19.4 p-10 -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.399999999999999 110.143 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.129999999999995 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.329999999999998 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.450000000000003 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.020000000000003 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.150000000000006 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.609 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.109999999999999 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.230000000000004 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.239999999999995 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.109999999999999 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.430000000000007 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 71.109999999999999 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 64.299999999999997 110.995 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.381 0.61 . . . . 74.340000000000003 112.495 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.150000000000006 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.781 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.549999999999997 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.200000000000003 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.340000000000003 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.120000000000005 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.319999999999993 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 55.140000000000001 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 61.229999999999997 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.329999999999998 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.520000000000003 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.239999999999995 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 63.420000000000002 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 71.040000000000006 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.450000000000003 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 55.240000000000002 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.399999999999999 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.099999999999994 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.310000000000002 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.010000000000005 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.219999999999999 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 72.319999999999993 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 60.020000000000003 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 60.509999999999998 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 54.310000000000002 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 61.030000000000001 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.230000000000004 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.399999999999999 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.450000000000003 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.240000000000002 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.049999999999997 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.010000000000005 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.299999999999997 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 63.299999999999997 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.129999999999995 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.230000000000004 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.420000000000002 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.140000000000001 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 61.409999999999997 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 25.420000000000002 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.129999999999995 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.519999999999996 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.230000000000004 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.100000000000001 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 61.310000000000002 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.239999999999995 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.009999999999998 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.209999999999994 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.219999999999999 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.240000000000002 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 64.310000000000002 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 64.409999999999997 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 72.319999999999993 111.96 -171.81 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.179 0.514 . . . . 73.349999999999994 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.219999999999999 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.340000000000003 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 62.310000000000002 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.219999999999999 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 70.319999999999993 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 70.150000000000006 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.240000000000002 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 44.030000000000001 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 24.34 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.430000000000007 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.099999999999994 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.439999999999998 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 51.520000000000003 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.109999999999999 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.530000000000001 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 53.439999999999998 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.239999999999995 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 73.430000000000007 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.530000000000001 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.120000000000005 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.140000000000001 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.519999999999996 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.129999999999995 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.209999999999994 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.450000000000003 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 44.210000000000001 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.430000000000007 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.100000000000001 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 52.130000000000003 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 70.209999999999994 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.219999999999999 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.400000000000006 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.239999999999995 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.329999999999998 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 63.049999999999997 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 54.149999999999999 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.544 HG22 HG13 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 64.120000000000005 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.549999999999997 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.009999999999998 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.349999999999994 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.119999999999997 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.540000000000006 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.039999999999999 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 41.340000000000003 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.140000000000001 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.519999999999996 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.319999999999993 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 63.100000000000001 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.340000000000003 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 73.329999999999998 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 73.510000000000005 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.200000000000003 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.149999999999999 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 64.519999999999996 109.968 175.116 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.944 0.402 . . . . 72.530000000000001 111.471 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.240000000000002 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.120000000000005 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.439999999999998 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.229999999999997 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.230000000000004 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 53.5 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.329999999999998 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.219999999999999 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.120000000000005 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.340000000000003 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 64.420000000000002 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.010000000000005 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.519999999999996 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 64.430000000000007 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.430000000000007 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.240000000000002 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 111.101 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.230000000000004 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.310000000000002 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.340000000000003 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.129999999999995 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.430000000000007 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.109999999999999 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.439999999999998 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.129999999999995 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.519999999999996 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.120000000000005 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 71.319999999999993 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 64.420000000000002 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.239999999999995 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.399999999999999 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.420000000000002 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.129999999999995 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 45.149999999999999 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.010000000000005 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 73.349999999999994 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.439999999999998 111.17 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 62' ' ' TYR . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 64.230000000000004 110.912 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.140000000000001 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.430000000000007 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 61.520000000000003 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.099999999999994 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.400000000000006 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 64.120000000000005 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.230000000000004 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.319999999999993 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.229999999999997 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.209999999999994 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.100000000000001 111.605 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.695 0.283 . . . . 74.329999999999998 111.094 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.030000000000001 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.439999999999998 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.450000000000003 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.310000000000002 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.409999999999997 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.150000000000006 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.549999999999997 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.400000000000006 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.209999999999994 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 45.299999999999997 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.219999999999999 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG21 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 44.009999999999998 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 52.100000000000001 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.549999999999997 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.230000000000004 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.130000000000003 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 64.450000000000003 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 60.340000000000003 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.450000000000003 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.549999999999997 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.049999999999997 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CD2' HG11 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.439999999999998 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.530000000000001 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 64.430000000000007 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.400000000000006 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.409999999999997 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.450000000000003 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.030000000000001 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 70.299999999999997 113.284 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.510000000000005 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.654 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.239999999999995 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 70.540000000000006 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' HD3' HG22 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 74.450000000000003 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 52.310000000000002 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 70.340000000000003 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.340000000000003 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.140000000000001 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.350000000000001 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.030000000000001 112.401 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.706 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.239999999999995 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.520000000000003 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.230000000000004 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.140000000000001 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.109999999999999 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.519999999999996 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.239999999999995 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.210000000000001 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 63.549999999999997 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.120000000000005 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.340000000000003 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.349999999999994 110.408 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.526 HG22 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.150000000000006 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.209999999999994 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 53.439999999999998 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.109999999999999 111.758 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.013 0.435 . . . . 64.400000000000006 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.040000000000006 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 62.299999999999997 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.310000000000002 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.210000000000001 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.549999999999997 109.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG12 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.209999999999994 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.530000000000001 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.030000000000001 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.510000000000005 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.219999999999999 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.040000000000006 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.594 ' CA ' HG12 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.340000000000003 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.010000000000005 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.240000000000002 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.420000000000002 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 24.030000000000001 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.109999999999999 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 54.240000000000002 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.219999999999999 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.240000000000002 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.299999999999997 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.329999999999998 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 50.439999999999998 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.209999999999994 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.230000000000004 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.049999999999997 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.120000000000005 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.219999999999999 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.540000000000006 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.540000000000006 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.319999999999993 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.430000000000007 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.400000000000006 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.049999999999997 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.099999999999994 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.230000000000004 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 65.109999999999999 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 35.409999999999997 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 94' ' ' VAL . 28.9 t-20 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.540000000000006 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 61.329999999999998 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.319999999999993 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.219999999999999 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 65.209999999999994 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.150000000000006 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.039999999999999 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.400000000000006 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.802 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.239999999999995 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 72.010000000000005 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.434 ' HD3' HG21 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.450000000000003 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.439999999999998 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.430000000000007 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.140000000000001 112.304 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.430000000000007 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.219999999999999 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 60.549999999999997 110.438 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.589 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.129999999999995 110.0 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 60' ' ' THR . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 62.340000000000003 111.642 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.119999999999997 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.340000000000003 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.430000000000007 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.230000000000004 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 65.420000000000002 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.549999999999997 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.129999999999995 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.329999999999998 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.329999999999998 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.140000000000001 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.239999999999995 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.240000000000002 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.109999999999999 111.71 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.219999999999999 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.519999999999996 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.109999999999999 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.310000000000002 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.439999999999998 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 74.099999999999994 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 61.210000000000001 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.439999999999998 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.409999999999997 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.129999999999995 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 30.41 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.540000000000006 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.310000000000002 110.94 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.299999999999997 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.510000000000005 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 44.25 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 73.340000000000003 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.150000000000006 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.030000000000001 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 1.1 p30 -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.219999999999999 111.359 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.030000000000001 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 62.299999999999997 111.087 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.299999999999997 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.230000000000004 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.635 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.530000000000001 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.030000000000001 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.340000000000003 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.439999999999998 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.219999999999999 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 75' ' ' LYS . 64.1 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.541 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.540000000000006 110.887 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 72.019999999999996 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 43.420000000000002 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.310000000000002 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.019999999999996 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 64.420000000000002 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.200000000000003 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.400000000000006 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 64.099999999999994 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.109999999999999 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.129999999999995 111.759 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.030000000000001 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.530000000000001 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 61.450000000000003 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 55.340000000000003 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.450000000000003 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.230000000000004 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 63.100000000000001 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' LEU . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.439999999999998 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.530000000000001 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 41.450000000000003 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 43.450000000000003 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.120000000000005 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.019999999999996 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.129999999999995 110.932 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.019999999999996 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 65.150000000000006 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 65.0 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.109999999999999 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.416 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 62.310000000000002 111.821 -178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.439999999999998 112.19 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.109999999999999 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.120000000000005 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.129999999999995 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.329999999999998 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 72.319999999999993 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.109999999999999 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.219999999999999 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.219999999999999 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.120000000000005 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.430000000000007 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.340000000000003 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.450000000000003 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 71.340000000000003 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.340000000000003 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 72.109999999999999 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 77' ' ' ARG . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.200000000000003 111.653 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 63.210000000000001 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 77' ' ' ARG . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 70.519999999999996 110.255 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.340000000000003 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.310000000000002 111.071 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.053 -0.351 . . . . 73.310000000000002 110.053 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 32.219999999999999 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.299999999999997 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.299999999999997 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.409999999999997 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 65.150000000000006 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.200000000000003 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.049999999999997 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.109999999999999 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.319999999999993 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 53' ' ' ILE . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.340000000000003 112.483 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.209999999999994 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.329999999999998 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.099999999999994 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.409999999999997 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.010000000000005 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.400000000000006 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.329999999999998 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.329999999999998 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 53.25 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.150000000000006 110.347 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.209999999999994 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.350000000000001 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 53.219999999999999 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.420000000000002 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.530000000000001 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.230000000000004 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 55.32 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 60.409999999999997 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 73.319999999999993 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.49 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 70.420000000000002 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.239999999999995 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 63.43 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.219999999999999 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.510000000000005 113.148 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 70.420000000000002 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.528 HD22 HG23 ' A' ' 92' ' ' ILE . 25.1 t-20 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.420000000000002 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 45.329999999999998 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.458 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.399999999999999 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.310000000000002 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.129999999999995 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 74.049999999999997 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.120000000000005 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 63.310000000000002 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.549999999999997 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.150000000000006 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 42' ' ' LYS . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 63.399999999999999 112.346 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.621 HG13 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.140000000000001 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.049999999999997 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.299999999999997 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.209999999999994 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 63.420000000000002 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.295 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' HB3' HG21 ' A' ' 87' ' ' ILE . 70.1 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.899 0.38 . . . . 72.25 111.537 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.219999999999999 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.130000000000003 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 63.43 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.340000000000003 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.510000000000005 109.337 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.420000000000002 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.409999999999997 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.340000000000003 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.349999999999994 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.200000000000003 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 61.130000000000003 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 63.200000000000003 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.409999999999997 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.120000000000005 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 61.329999999999998 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.129999999999995 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 74.129999999999995 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.120000000000005 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.129999999999995 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.129999999999995 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.310000000000002 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 51.210000000000001 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 31.510000000000002 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.109999999999999 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.310000000000002 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.409999999999997 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.010000000000005 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 54.310000000000002 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 72.129999999999995 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.329999999999998 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.109999999999999 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.230000000000004 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 61.450000000000003 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 65.420000000000002 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.439999999999998 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 53.030000000000001 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.030000000000001 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 61.340000000000003 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.230000000000004 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.209999999999994 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.010000000000005 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 65.420000000000002 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.430000000000007 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.310000000000002 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.140000000000001 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.450000000000003 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 71.25 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.019999999999996 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.219999999999999 111.231 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.530000000000001 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.239999999999995 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.209999999999994 112.189 -173.646 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' HG21 ' A' ' 87' ' ' ILE . 84.6 m-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.979 0.419 . . . . 65.109999999999999 111.649 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.409999999999997 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 56' ' ' SER . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.409999999999997 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 64.439999999999998 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 60.439999999999998 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.200000000000003 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.400000000000006 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.099999999999994 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.099999999999994 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.109999999999999 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.329999999999998 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.109999999999999 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.44 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.299999999999997 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.020000000000003 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 61.219999999999999 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 62.329999999999998 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 65.409999999999997 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.420000000000002 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.049999999999997 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD2' HG11 ' A' ' 41' ' ' VAL . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.099999999999994 110.174 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.219999999999999 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.319999999999993 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.450000000000003 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 76' ' ' LEU . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.240000000000002 112.261 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.420000000000002 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 72.439999999999998 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.130000000000003 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 64.519999999999996 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.140000000000001 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' PRO . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.510000000000005 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.409999999999997 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.120000000000005 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.430000000000007 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 94' ' ' VAL . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.450000000000003 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.420000000000002 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.120000000000005 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.409999999999997 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.420000000000002 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.329999999999998 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.130000000000003 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.010000000000005 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.200000000000003 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.409999999999997 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 82' ' ' ASN . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.520000000000003 110.567 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.129999999999995 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 73.120000000000005 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.230000000000004 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.420000000000002 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.230000000000004 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.7 mt . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 70.219999999999999 111.22 -174.688 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.009 0.433 . . . . 54.420000000000002 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 53.409999999999997 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.239999999999995 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.539999999999999 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 72.230000000000004 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 74.140000000000001 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.109999999999999 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.519999999999996 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.420000000000002 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.399999999999999 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 72.530000000000001 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 53' ' ' ILE . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.430000000000007 112.306 -177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.019999999999996 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.129999999999995 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.510000000000005 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.209999999999994 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.040000000000006 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 44.420000000000002 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 71.409999999999997 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.209999999999994 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.400000000000006 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.310000000000002 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.299999999999997 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.109999999999999 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.310000000000002 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.409999999999997 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 62.43 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.510000000000005 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.129999999999995 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.400000000000006 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.319999999999993 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.349999999999994 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.539999999999999 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.439999999999998 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.349999999999994 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 73.140000000000001 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.109999999999999 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.310000000000002 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.109999999999999 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.230000000000004 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.030000000000001 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 64.329999999999998 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.319999999999993 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 64.049999999999997 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.039999999999999 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 41.100000000000001 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 33.229999999999997 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.129999999999995 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.430000000000007 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 62.409999999999997 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.109999999999999 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.420000000000002 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.549999999999997 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.739 0.304 . . . . 65.430000000000007 111.268 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -86.5 -41.76 14.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.385 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -68.6 -45.82 70.94 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.321 -0.4 . . . . 64.109999999999999 111.949 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 60.83 24.27 14.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.318 0.58 . . . . 74.439999999999998 111.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.53 37.24 19.71 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.43 -0.805 . . . . 74.439999999999998 112.664 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -72.88 87.13 1.3 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.727 -0.608 . . . . 72.299999999999997 110.101 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 64.0 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.310000000000002 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.439999999999998 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 62.509999999999998 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.120000000000005 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 ' CA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 64.140000000000001 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.310000000000002 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.140000000000001 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.520000000000003 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.439999999999998 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 52.219999999999999 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG12 ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.420000000000002 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 54.210000000000001 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.049999999999997 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.299999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.140000000000001 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 64.150000000000006 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.019999999999996 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 51.130000000000003 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.240000000000002 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.120000000000005 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.450000000000003 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 43.109999999999999 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 34.109999999999999 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.129999999999995 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.239999999999995 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.530000000000001 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 65.5 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 63.43 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.310000000000002 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.140000000000001 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.319999999999993 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.549999999999997 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.329999999999998 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.329999999999998 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 61.329999999999998 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.405 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.299999999999997 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.120000000000005 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 72.420000000000002 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' THR . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.430000000000007 110.542 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.549999999999997 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.540000000000006 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 53.240000000000002 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.239999999999995 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.510000000000005 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.340000000000003 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.439999999999998 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 72.430000000000007 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.340000000000003 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.409999999999997 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.230000000000004 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -78.77 113.86 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.310000000000002 111.504 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mm -90.49 93.62 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.017 0.437 . . . . 75.120000000000005 110.342 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t70 66.97 156.7 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.269 -0.878 . . . . 73.230000000000004 111.813 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 104' ' ' VAL . 10.1 t -80.75 4.39 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 116.088 -0.505 . . . . 65.129999999999995 111.968 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m 65.4 21.84 11.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.457 0.646 . . . . 74.030000000000001 109.739 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -107.34 50.94 0.76 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.419 -0.81 . . . . 75.409999999999997 111.417 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 109' ' ' GLU . 32.3 m -97.17 -25.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.383 0.611 . . . . 65.219999999999999 110.686 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 63.96 -10.95 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.261 1.024 . . . . 64.409999999999997 113.449 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 107' ' ' VAL . 13.8 tp10 -74.7 -49.4 21.35 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.296 0.569 . . . . 73.109999999999999 110.362 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.2 p -96.99 93.97 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.72 -0.673 . . . . 61.520000000000003 111.57 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 56.53 -122.48 28.35 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.003 -0.544 . . . . 64.540000000000006 114.002 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -168.31 -65.19 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.086 0.47 . . . . 52.299999999999997 110.886 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -103.82 102.17 11.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.167 0.508 . . . . 65.049999999999997 110.24 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.5 mt -112.71 -12.3 13.4 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 71.400000000000006 112.884 -170.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.26 136.37 95.2 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 111.913 0.338 . . . . 63.350000000000001 111.913 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.27 170.3 2.4 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.916 2.411 . . . . 51.43 113.823 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.18 167.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.527 0.565 . . . . 71.510000000000005 112.527 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.2 96.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.518 0.675 . . . . 54.509999999999998 111.754 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.73 132.08 56.52 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.996 -0.547 . . . . 73.140000000000001 109.694 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.75 109.73 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 113.501 0.926 . . . . 70.239999999999995 113.501 -169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -102.47 -178.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 116.063 -0.517 . . . . 60.200000000000003 111.231 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 65.32 -163.35 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.054 0.39 . . . . 72.109999999999999 112.054 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.7 m 69.9 150.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.523 0.678 . . . . 72.430000000000007 112.688 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 56.21 16.17 2.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.337 -0.847 . . . . 75.420000000000002 112.724 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.7 -3.87 57.03 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.47 0.652 . . . . 73.530000000000001 110.125 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.56 90.05 2.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.119 -0.946 . . . . 72.219999999999999 110.387 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.6 m -111.17 -37.28 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.819 0.674 . . . . 63.340000000000003 112.819 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 65.1 tp 73.81 -48.56 0.67 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 75.099999999999994 114.261 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.8 119.28 1.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.936 1.087 . . . . 75.340000000000003 113.936 -167.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.01 145.84 30.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.617 -0.72 . . . . 53.509999999999998 110.546 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -147.18 107.66 4.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.58 0.585 . . . . 75.140000000000001 112.58 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -82.32 136.51 35.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.282 -0.417 . . . . 72.150000000000006 110.677 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -98.32 127.26 44.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.893 0.377 . . . . 74.140000000000001 111.052 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -53.13 -50.43 64.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.163 -0.471 . . . . 74.540000000000006 111.937 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.815 -0.612 . . . . 74.239999999999995 111.499 176.308 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.861 0.362 . . . . 74.430000000000007 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.29 -81.7 0.45 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.701 0.286 . . . . 70.150000000000006 110.547 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 79.1 p -104.54 70.27 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.401 0.62 . . . . 70.310000000000002 109.759 171.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 36' ' ' THR . 3.9 m-20 72.17 -69.28 0.19 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.419 -0.809 . . . . 64.239999999999995 110.856 -172.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m120 42.6 77.98 0.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.758 0.423 . . . . 73.310000000000002 111.879 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -55.05 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 60.210000000000001 112.061 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.530000000000001 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 41.229999999999997 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.701 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.209999999999994 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 62.240000000000002 110.656 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.450000000000003 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.319999999999993 108.974 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 43.210000000000001 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.140000000000001 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.420000000000002 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 42.530000000000001 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.030000000000001 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.420000000000002 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.329999999999998 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.439999999999998 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.240000000000002 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.020000000000003 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 70.019999999999996 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 64.209999999999994 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 70.329999999999998 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.329999999999998 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.020000000000003 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 73.030000000000001 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 70.129999999999995 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 73.329999999999998 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 51.32 112.825 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.020000000000003 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 64.310000000000002 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.310000000000002 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.239999999999995 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.439999999999998 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.239999999999995 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA2' HG11 ' A' ' 104' ' ' VAL . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 54.200000000000003 113.853 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.340000000000003 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 72.120000000000005 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.120000000000005 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.129999999999995 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.310000000000002 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.430000000000007 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.109999999999999 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.019999999999996 112.046 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.537 HG22 HG13 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 55.25 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 34.229999999999997 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.230000000000004 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.239999999999995 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.140000000000001 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 70.120000000000005 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.430000000000007 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 44.310000000000002 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.329999999999998 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 64.310000000000002 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 65.409999999999997 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.466 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.299999999999997 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.530000000000001 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.230000000000004 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.230000000000004 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt -75.07 123.64 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.549999999999997 110.53 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.5 -49.36 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 74.340000000000003 112.193 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.28 97.2 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.357 0.599 . . . . 71.219999999999999 110.972 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG13 ' CD1' ' A' ' 106' ' ' TYR . 9.3 p -168.83 29.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.245 -0.888 . . . . 61.25 110.956 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.5 m 69.92 11.18 7.69 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.474 0.71 . . . . 65.409999999999997 111.933 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' CD1' HG13 ' A' ' 104' ' ' VAL . 11.5 m-85 -103.95 135.38 45.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.261 0.553 . . . . 74.030000000000001 109.868 175.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.13 148.78 4.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.67 -0.695 . . . . 55.039999999999999 111.768 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.88 116.09 14.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 112.147 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.51 -52.74 42.68 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.515 0.674 . . . . 65.230000000000004 109.621 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -170.65 -160.59 0.21 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.94 -1.027 . . . . 34.340000000000003 109.565 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.01 65.51 1.18 Allowed Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.799 -0.715 . . . . 30.199999999999999 113.532 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.4 mptp? -124.35 -168.25 1.77 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.798 0.439 . . . . 64.340000000000003 110.096 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 21.1 t70 70.63 -70.61 0.15 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.717 0.294 . . . . 75.540000000000006 110.722 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.8 mt 54.93 -169.24 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.189 0.811 . . . . 74.420000000000002 113.189 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' A' ' 116' ' ' PRO . 16.4 tp -164.07 129.56 2.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.804 -0.635 . . . . 73.219999999999999 111.571 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' HD12 ' A' ' 115' ' ' LEU . 92.5 Cg_endo -80.4 133.38 9.58 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.575 2.183 . . . . 53.409999999999997 112.27 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.41 119.06 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.19 0.519 . . . . 74.129999999999995 111.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.81 123.15 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.881 0.372 . . . . 75.230000000000004 111.304 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 120' ' ' ILE . 27.1 tt0 -161.32 152.56 18.69 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.641 -0.254 . . . . 70.400000000000006 110.829 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.548 HD12 ' HG2' ' A' ' 119' ' ' GLU . 1.7 mp 62.45 125.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.479 0.918 . . . . 63.520000000000003 113.479 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.33 165.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 111.1 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 33.4 t-20 -105.26 153.03 22.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.124 0.488 . . . . 65.109999999999999 111.805 -174.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.6 m -84.16 22.56 1.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.082 -0.508 . . . . 74.209999999999994 111.187 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' A' ' 122' ' ' ASN . 9.8 pt-20 -66.78 177.38 1.66 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.141 0.577 . . . . 61.049999999999997 112.392 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 74.32 -37.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.84 0.681 . . . . 65.200000000000003 112.84 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.53 -16.4 63.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.122 0.416 . . . . 54.130000000000003 112.122 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.15 99.65 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.832 0.348 . . . . 50.420000000000002 111.392 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 128' ' ' LEU . 1.6 pt? -129.67 101.23 5.81 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.298 0.57 . . . . 52.450000000000003 110.792 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.79 126.38 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 112.112 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -146.66 139.58 25.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 110.78 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -85.5 136.01 33.6 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.279 0.474 . . . . 74.239999999999995 112.279 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -91.58 96.6 10.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.255 0.55 . . . . 70.209999999999994 110.467 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -68.27 143.24 55.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.842 -0.617 . . . . 65.310000000000002 112.494 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -95.47 161.03 14.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.263 0.554 . . . . 61.32 111.912 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.67 -0.681 . . . . 64.299999999999997 111.248 178.764 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.537 0.208 . . . . 52.109999999999999 111.11 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.14 112.91 3.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.888 0.375 . . . . 53.439999999999998 110.822 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.2 p -141.24 -53.6 0.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.489 0.551 . . . . 74.239999999999995 112.489 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 59.78 34.63 21.96 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.273 0.559 . . . . 64.109999999999999 110.735 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -58.71 111.21 1.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.744 -0.662 . . . . 73.109999999999999 111.771 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 -64.68 88.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 65.299999999999997 110.915 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 74.329999999999998 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 60.210000000000001 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.129999999999995 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 65.430000000000007 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.340000000000003 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.540000000000006 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.329999999999998 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.450000000000003 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 42.329999999999998 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.310000000000002 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 63.130000000000003 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.439999999999998 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.049999999999997 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.530000000000001 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.019999999999996 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.120000000000005 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 64.25 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.310000000000002 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.409999999999997 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 70.349999999999994 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 71.349999999999994 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.150000000000006 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.420000000000002 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.540000000000006 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 70.150000000000006 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.310000000000002 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.009999999999998 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.019999999999996 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.400000000000006 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.140000000000001 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.010000000000005 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.329999999999998 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.409999999999997 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.229999999999997 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 64.219999999999999 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 65.219999999999999 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 60.009999999999998 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.209999999999994 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.540000000000006 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.439999999999998 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.010000000000005 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.230000000000004 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.519999999999996 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.607 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 70.019999999999996 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.439999999999998 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.120000000000005 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.150000000000006 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.329999999999998 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.762 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.109999999999999 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.119999999999997 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.674 ' HB ' HG22 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.400000000000006 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.140000000000001 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 63.229999999999997 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 53.399999999999999 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 64.019999999999996 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.420000000000002 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 65.430000000000007 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.329999999999998 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 64.239999999999995 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt -77.14 104.69 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 45.32 110.818 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 102' ' ' ILE . 30.4 mt -97.5 14.4 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.868 0.842 . . . . 65.230000000000004 110.559 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -87.26 -154.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.857 -0.611 . . . . 70.209999999999994 110.394 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.3 -26.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.749 0.648 . . . . 71.439999999999998 112.749 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.7 t 61.19 -82.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.83 -0.623 . . . . 70.239999999999995 111.768 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 47.9 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.925 1.083 . . . . 64.340000000000003 113.925 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.6 t 63.07 75.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.17 -0.923 . . . . 64.129999999999995 109.93 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.74 22.13 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.269 -0.878 . . . . 74.340000000000003 112.65 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.97 105.09 12.83 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.148 0.499 . . . . 75.439999999999998 112.1 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.7 p -77.43 140.21 39.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.984 -0.553 . . . . 61.509999999999998 110.811 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.53 132.73 1.64 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.44 -0.886 . . . . 72.439999999999998 113.161 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 64.12 15.23 9.15 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.272 0.558 . . . . 75.299999999999997 111.633 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.15 17.75 13.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.123 -0.49 . . . . 64.109999999999999 111.738 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mt -95.7 115.48 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 75.319999999999993 111.22 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 mp -139.48 134.05 16.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 72.340000000000003 112.575 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 115' ' ' LEU . 15.6 Cg_exo -71.42 176.37 8.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.31 2.673 . . . . 73.319999999999993 112.654 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.3 t 69.01 126.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.715 0.769 . . . . 63.310000000000002 112.603 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.84 153.31 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.668 -0.697 . . . . 74.019999999999996 111.036 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -85.01 105.63 15.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.055 0.455 . . . . 71.540000000000006 110.626 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.44 102.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.991 0.424 . . . . 60.219999999999999 111.232 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.91 152.94 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.905 0.383 . . . . 75.140000000000001 111.969 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -131.14 128.93 41.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.152 -0.477 . . . . 72.109999999999999 110.035 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 33.1 t -163.58 -155.84 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.099 0.159 . . . . 74.400000000000006 110.79 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 127' ' ' VAL . 38.8 tt0 76.24 -52.53 0.61 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.264 0.626 . . . . 74.439999999999998 112.628 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.52 -29.49 10.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.504 0.927 . . . . 63.409999999999997 113.504 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.99 35.11 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.282 0.475 . . . . 42.210000000000001 112.282 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 124' ' ' GLU . 9.3 p -92.25 152.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.003 0.43 . . . . 74.409999999999997 111.655 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mp -100.68 107.24 18.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 110.542 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -63.63 105.4 0.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.819 0.342 . . . . 63.439999999999998 111.378 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -70.55 92.39 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.297 0.57 . . . . 73.450000000000003 110.528 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -106.64 39.74 1.78 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.819 -0.628 . . . . 72.239999999999995 111.547 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -72.94 126.73 30.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.2 0.524 . . . . 72.219999999999999 111.866 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.96 145.88 32.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.251 0.548 . . . . 74.420000000000002 111.837 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -94.84 115.63 27.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.065 -0.516 . . . . 65.099999999999994 110.384 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.829 -0.605 . . . . 72.430000000000007 111.538 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 111.791 0.293 . . . . 71.409999999999997 111.791 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.6 -13.01 60.1 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.017 0.436 . . . . 74.010000000000005 112.007 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -98.3 173.28 7.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.287 -0.415 . . . . 62.420000000000002 111.558 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.95 90.79 0.19 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 72.219999999999999 111.374 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -85.16 103.55 14.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.806 0.336 . . . . 75.420000000000002 111.018 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' HG21 ' A' ' 87' ' ' ILE . 91.5 m-85 -82.71 94.79 7.67 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.540000000000006 111.912 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.010000000000005 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 54.399999999999999 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.350000000000001 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.319999999999993 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.299999999999997 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.430000000000007 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.329999999999998 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.430000000000007 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.150000000000006 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.310000000000002 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.239999999999995 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.209999999999994 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.530000000000001 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.340000000000003 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.409999999999997 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.140000000000001 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.399999999999999 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.019999999999996 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.439999999999998 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.129999999999995 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.299999999999997 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.430000000000007 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.299999999999997 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 41' ' ' VAL . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 65.540000000000006 111.612 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 64.209999999999994 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' OG ' HG11 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.519999999999996 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 63.530000000000001 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.319999999999993 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.230000000000004 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 42.5 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.010000000000005 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.439999999999998 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.310000000000002 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.140000000000001 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.549999999999997 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.61 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.219999999999999 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.299999999999997 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.510000000000005 111.15 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.230000000000004 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.099999999999994 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.510000000000005 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 51.25 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.120000000000005 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 61.340000000000003 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.219999999999999 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.559 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 52.310000000000002 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.299999999999997 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 124' ' ' GLU . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 54.43 110.644 173.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.099999999999994 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.230000000000004 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.230000000000004 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.436 HG11 ' OG ' ' A' ' 66' ' ' SER . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 62.520000000000003 112.377 -172.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.049999999999997 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 72.310000000000002 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.150000000000006 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 64.329999999999998 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.8 120.41 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.120000000000005 110.536 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.55 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.227 0.537 . . . . 65.019999999999996 110.849 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.37 -167.29 2.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.736 -0.665 . . . . 53.009999999999998 111.227 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 104' ' ' VAL . 10.7 t -115.22 39.98 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.093 0.473 . . . . 45.039999999999999 111.642 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.2 t -54.1 -44.12 70.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.226 0.536 . . . . 71.129999999999995 110.158 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 63.61 63.62 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.249 -0.887 . . . . 43.329999999999998 112.401 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.45 88.34 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.568 0.699 . . . . 70.200000000000003 110.688 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.91 -19.13 64.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.78 -0.645 . . . . 74.549999999999997 112.569 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.38 105.34 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.484 0.659 . . . . 73.209999999999994 111.57 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t -59.74 159.99 8.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.94 -1.027 . . . . 74.019999999999996 112.689 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 82.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.07 -0.514 . . . . 73.200000000000003 112.651 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -121.18 144.1 48.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.137 0.421 . . . . 54.450000000000003 112.137 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.78 87.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.658 -0.701 . . . . 73.549999999999997 112.484 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.93 5.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.158 0.799 . . . . 71.340000000000003 113.158 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 116' ' ' PRO . 18.1 tp -72.0 131.33 85.61 Favored Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 121.947 -0.47 . . . . 74.109999999999999 111.522 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 115' ' ' LEU . 73.0 Cg_endo -77.85 106.35 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.451 2.101 . . . . 64.549999999999997 112.919 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.9 p -77.15 -25.38 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.348 0.594 . . . . 72.209999999999994 111.289 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.3 m 37.17 -161.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 114.302 -1.317 . . . . 72.519999999999996 113.849 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -99.51 115.43 29.31 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.277 -0.419 . . . . 70.349999999999994 110.151 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -62.48 123.03 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.114 0.413 . . . . 61.149999999999999 112.114 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 121' ' ' ILE . 1.6 pp -125.78 124.25 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 N-CA-C 112.8 0.667 . . . . 74.400000000000006 112.8 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -144.6 139.99 28.46 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.91 -0.586 . . . . 60.32 110.091 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -162.85 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.617 0.969 . . . . 75.109999999999999 113.617 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 29.9 mt-10 -78.3 -0.41 28.7 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.35 0.87 . . . . 61.049999999999997 113.35 -164.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.03 -9.81 58.68 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.112 0.412 . . . . 70.25 112.112 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.92 175.68 9.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.759 0.314 . . . . 72.239999999999995 111.822 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.3 t 63.6 101.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.283 0.563 . . . . 75.120000000000005 111.968 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 tp -79.85 81.28 6.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.266 0.555 . . . . 73.239999999999995 111.173 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.39 109.24 6.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.32 0.581 . . . . 73.430000000000007 110.785 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -55.8 106.98 0.3 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.116 -0.493 . . . . 74.329999999999998 112.185 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -86.52 118.74 26.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 75.219999999999999 111.324 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -73.49 91.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.285 0.564 . . . . 75.150000000000006 111.328 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -80.36 149.62 30.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.665 -0.698 . . . . 74.430000000000007 111.62 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -106.02 169.64 8.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 72.209999999999994 112.764 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 115.669 -0.696 . . . . 63.409999999999997 111.102 173.508 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 111.958 0.355 . . . . 73.450000000000003 111.958 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.99 134.93 55.95 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 112.093 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 36.5 p -130.18 121.9 27.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.17 0.51 . . . . 61.119999999999997 111.686 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.37 84.21 1.94 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.069 0.461 . . . . 71.430000000000007 111.387 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.55 103.95 13.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.046 0.45 . . . . 74.209999999999994 111.136 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.81 92.89 3.64 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.400000000000006 111.426 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 53.009999999999998 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.299999999999997 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 44.030000000000001 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 64.549999999999997 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 64.430000000000007 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.439999999999998 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 62.109999999999999 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.030000000000001 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.519999999999996 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.019999999999996 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.340000000000003 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 61.100000000000001 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 51.530000000000001 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.040000000000006 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 53.130000000000003 112.247 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.209999999999994 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.349999999999994 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 63.32 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.519999999999996 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 51.509999999999998 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.329999999999998 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.439999999999998 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.439999999999998 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.219999999999999 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.598 ' HB3' HD22 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.409999999999997 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 64.239999999999995 111.544 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.140000000000001 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.119999999999997 113.736 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.530000000000001 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 73.319999999999993 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HG3' HD11 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.230000000000004 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.219999999999999 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.120000000000005 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.430000000000007 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.430000000000007 110.391 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.340000000000003 114.503 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.049999999999997 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 41.32 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.129999999999995 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.239999999999995 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.510000000000005 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 6.6 p30 -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 61.25 112.29 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.219999999999999 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.210000000000001 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.430000000000007 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.430000000000007 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.6 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.530000000000001 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 51.509999999999998 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.430000000000007 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.230000000000004 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.519999999999996 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.430000000000007 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.439999999999998 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 64.409999999999997 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt -54.73 109.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 40.530000000000001 112.743 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.66 52.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.394 1.092 . . . . 74.219999999999999 110.026 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.7 -155.31 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.486 -1.234 . . . . 70.510000000000005 109.164 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.1 81.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.064 0.935 . . . . 74.439999999999998 112.154 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.4 m -89.83 41.5 1.05 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.863 -1.062 . . . . 75.219999999999999 110.189 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.38 22.48 0.68 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.818 0.673 . . . . 74.299999999999997 112.818 -169.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 108' ' ' ASP . 12.5 p -167.18 159.85 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.237 0.458 . . . . 72.109999999999999 112.237 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 107' ' ' VAL . 28.5 t0 77.57 115.94 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.194 0.998 . . . . 53.200000000000003 111.783 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.27 24.71 1.76 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.726 -0.67 . . . . 73.230000000000004 111.371 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.6 t -56.22 101.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.619 0.723 . . . . 64.430000000000007 112.084 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.27 179.49 39.08 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.61 -0.723 . . . . 55.149999999999999 112.249 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 113' ' ' ASP . 85.3 tttt -174.08 -6.78 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.919 0.39 . . . . 75.340000000000003 111.377 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.405 ' H ' ' H ' ' A' ' 112' ' ' LYS . 18.2 m-20 64.51 92.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.488 0.661 . . . . 53.039999999999999 112.116 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.5 pp -144.91 151.71 39.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.487 -0.779 . . . . 73.109999999999999 110.647 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.3 mp -103.0 147.84 34.71 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 112.648 0.61 . . . . 71.140000000000001 112.648 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HB2' HG22 ' A' ' 118' ' ' VAL . 23.4 Cg_exo -68.66 139.72 45.08 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.607 2.871 . . . . 75.510000000000005 113.344 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.13 10.38 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.994 0.902 . . . . 72.510000000000005 111.458 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 116' ' ' PRO . 27.9 m -77.22 18.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.874 1.064 . . . . 72.129999999999995 113.874 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.25 61.93 5.71 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.755 -0.591 . . . . 43.520000000000003 111.862 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.1 mp -108.08 99.69 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.898 0.38 . . . . 54.229999999999997 110.409 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.82 109.41 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 111.273 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -160.14 155.07 24.48 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.182 0.515 . . . . 74.150000000000006 111.347 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -132.56 3.74 3.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.354 0.597 . . . . 71.430000000000007 110.286 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 124' ' ' GLU . 8.4 mp0 -88.13 141.21 28.75 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.531 -0.758 . . . . 54.210000000000001 111.109 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.03 -153.76 0.35 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.352 -0.386 . . . . 65.430000000000007 112.033 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' THR . . . 74.99 -28.18 0.19 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.476 0.917 . . . . 62.130000000000003 113.476 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.12 98.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.759 0.314 . . . . 71.349999999999994 111.835 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -169.87 113.59 0.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.891 0.377 . . . . 73.450000000000003 110.911 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.82 -50.39 0.6 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 111.504 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.8 m170 66.35 179.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.487 0.661 . . . . 74.409999999999997 112.377 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -105.42 165.44 11.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.855 -0.611 . . . . 73.120000000000005 110.72 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 60.58 89.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.617 0.599 . . . . 74.319999999999993 112.617 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -85.49 169.39 13.65 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.784 0.326 . . . . 74.219999999999999 111.027 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -137.29 149.49 47.13 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.637 0.236 . . . . 65.510000000000005 111.637 -173.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.983 -0.532 . . . . 71.319999999999993 111.257 175.624 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 39' ' ' PHE . 32.6 mmt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.546 -0.168 . . . . 65.239999999999995 110.546 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 71.18 -58.96 0.56 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.071 1.137 . . . . 74.129999999999995 114.071 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -52.99 -71.63 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.14 0.792 . . . . 75.140000000000001 113.14 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.92 11.4 35.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 111.576 0.213 . . . . 74.510000000000005 111.576 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 52.24 62.29 2.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.187 0.518 . . . . 74.420000000000002 111.029 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 89.2 m-85 -63.36 96.06 0.1 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.294 -0.412 . . . . 74.329999999999998 111.756 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 53.5 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.030000000000001 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.210000000000001 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 61.130000000000003 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.450000000000003 111.591 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.420000000000002 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.595 HG12 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.530000000000001 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.530000000000001 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.329999999999998 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.409999999999997 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.200000000000003 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.595 ' CA ' HG12 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.149999999999999 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 63.329999999999998 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.120000000000005 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 61.039999999999999 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 50.039999999999999 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.319999999999993 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 63.520000000000003 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.230000000000004 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.450000000000003 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.400000000000006 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.239999999999995 111.206 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.019999999999996 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HB2' HD12 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.239999999999995 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 84' ' ' THR . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.340000000000003 109.848 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.329999999999998 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 71.530000000000001 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 53.009999999999998 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.109999999999999 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.540000000000006 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.200000000000003 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.329999999999998 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.510000000000005 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.209999999999994 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 72.120000000000005 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.450000000000003 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.239999999999995 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 74.5 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.219999999999999 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 71.120000000000005 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.329999999999998 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 33.310000000000002 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.049999999999997 111.312 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 33.409999999999997 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 63.119999999999997 111.425 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.519999999999996 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 54.539999999999999 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.329999999999998 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.140000000000001 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.119999999999997 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.019999999999996 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.540000000000006 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.150000000000006 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.150000000000006 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.040000000000006 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.329999999999998 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 70.129999999999995 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 44.409999999999997 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.340000000000003 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt -69.36 103.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 62.539999999999999 111.088 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.2 mm -73.85 -20.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.22 0.533 . . . . 74.450000000000003 110.48 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 70.9 86.96 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.142 -0.936 . . . . 74.099999999999994 111.528 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.86 3.74 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.163 -0.471 . . . . 51.219999999999999 111.299 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m 70.06 -53.9 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.429 0.691 . . . . 74.319999999999993 111.452 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.38 102.33 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.413 0.625 . . . . 74.420000000000002 111.821 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.95 103.17 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.789 -0.641 . . . . 62.43 110.497 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -77.83 83.38 4.17 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.706 0.765 . . . . 73.239999999999995 111.598 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.15 14.82 18.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.529 -0.76 . . . . 60.100000000000001 111.568 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -101.24 97.12 7.67 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.905 0.383 . . . . 73.349999999999994 111.729 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.38 165.55 24.69 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.928 -0.653 . . . . 43.439999999999998 113.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 113' ' ' ASP . 87.7 tttt -157.15 163.63 38.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.516 0.326 . . . . 71.430000000000007 110.649 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.47 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 10.9 m-20 -59.19 -37.21 76.85 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.106 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.437 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 97.6 mt 65.43 -177.17 0.18 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.858 0.837 . . . . 71.040000000000006 112.944 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -147.69 174.15 3.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 111.181 175.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 115' ' ' LEU . 31.2 Cg_exo -62.33 19.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 122.929 2.419 . . . . 71.109999999999999 115.343 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 115' ' ' LEU . 46.5 t 64.27 122.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.695 0.798 . . . . 52.520000000000003 112.797 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.3 p -161.43 113.28 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.829 -0.623 . . . . 71.409999999999997 111.049 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.97 180.0 4.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.208 0.528 . . . . 72.340000000000003 111.688 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mm -82.61 109.2 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.35 -0.386 . . . . 75.049999999999997 111.647 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.46 -41.37 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.961 0.41 . . . . 73.340000000000003 111.991 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -106.08 120.18 41.14 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.77 0.319 . . . . 74.200000000000003 111.311 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.3 t -153.71 170.24 21.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 74.140000000000001 110.733 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 62.03 174.97 0.13 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 72.319999999999993 111.146 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.88 -174.63 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.821 -0.172 . . . . 71.439999999999998 110.841 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.71 -155.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.77 0.319 . . . . 73.519999999999996 111.761 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.6 t 56.81 80.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.545 0.688 . . . . 73.340000000000003 112.141 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 128' ' ' LEU . 6.9 mp -89.53 77.44 7.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.419 0.628 . . . . 53.539999999999999 110.813 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.28 139.82 50.12 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.025 -0.534 . . . . 73.430000000000007 111.343 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -131.42 103.69 6.57 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.97 0.359 . . . . 73.319999999999993 111.97 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -79.84 72.83 6.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.372 -0.603 . . . . 64.030000000000001 109.372 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 63.16 170.9 0.15 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.024 -0.534 . . . . 74.140000000000001 109.888 -169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -70.09 77.97 0.5 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.385 -0.822 . . . . 64.140000000000001 110.112 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.9 145.64 55.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.348 -0.842 . . . . 73.340000000000003 112.446 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.706 -0.664 . . . . 71.310000000000002 111.817 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.632 0.254 . . . . 73.140000000000001 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.18 -155.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.95 0.5 . . . . 71.439999999999998 112.303 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -72.76 122.75 22.03 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 22.510000000000002 111.265 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -80.91 37.73 0.44 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.597 0.592 . . . . 74.230000000000004 112.597 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.03 61.32 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.094 0.474 . . . . 63.409999999999997 111.172 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 87' ' ' ILE . 33.2 m-85 -59.69 100.66 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.219999999999999 111.55 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.129999999999995 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.430000000000007 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.120000000000005 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.530000000000001 111.535 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.219999999999999 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.450000000000003 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.109999999999999 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.420000000000002 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.540000000000006 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 25.350000000000001 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 31.34 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.129999999999995 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 64.109999999999999 112.358 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 54.420000000000002 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.239999999999995 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 53.520000000000003 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.140000000000001 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.439999999999998 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.219999999999999 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.150000000000006 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 70.219999999999999 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.209999999999994 110.762 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.230000000000004 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.409999999999997 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 50.119999999999997 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.130000000000003 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.409999999999997 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 64.25 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.099999999999994 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.019999999999996 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.109999999999999 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.400000000000006 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.129999999999995 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.510000000000005 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.439999999999998 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.530000000000001 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.439999999999998 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.329999999999998 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.310000000000002 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.509999999999998 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.219999999999999 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.566 HG22 HG13 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.140000000000001 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.049999999999997 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.109999999999999 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.530000000000001 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 60.439999999999998 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.430000000000007 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.099999999999994 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 54.539999999999999 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.340000000000003 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 55.219999999999999 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.329999999999998 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.409999999999997 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.420000000000002 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.439999999999998 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.010000000000005 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.329999999999998 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -68.42 106.83 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.340000000000003 112.741 -168.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -80.11 78.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.959 0.885 . . . . 73.019999999999996 110.144 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -148.24 -26.04 0.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.963 -1.017 . . . . 70.040000000000006 111.311 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 m -76.47 81.67 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.027 -0.988 . . . . 71.439999999999998 110.621 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 t -60.67 82.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.258 -0.883 . . . . 62.329999999999998 111.968 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -125.38 108.93 12.16 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.718 -0.674 . . . . 73.129999999999995 111.276 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.97 100.43 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.989 0.423 . . . . 52.32 110.371 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -147.86 152.59 37.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.89 0.376 . . . . 75.209999999999994 112.009 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.11 -2.7 7.62 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.28 -0.418 . . . . 74.420000000000002 111.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -76.48 -12.87 60.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.162 0.43 . . . . 65.310000000000002 112.162 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.19 174.35 16.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.305 -0.474 . . . . 53.350000000000001 113.152 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -175.27 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.244 -0.65 . . . . 73.349999999999994 109.244 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -170.68 123.12 0.63 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.597 -0.728 . . . . 74.319999999999993 109.661 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.434 ' N ' HD22 ' A' ' 114' ' ' LEU . 2.7 mm? -114.73 149.07 37.44 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 111.926 -174.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.76 158.68 72.9 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.286 0.476 . . . . 73.439999999999998 112.286 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.4 -177.89 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.06 2.507 . . . . 63.109999999999999 112.914 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 117' ' ' VAL . 16.3 m -80.27 98.9 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.461 0.648 . . . . 65.049999999999997 111.248 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 m -75.82 120.38 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 71.239999999999995 111.736 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -149.32 137.7 20.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.982 -0.554 . . . . 74.049999999999997 111.151 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 122' ' ' ASN . 48.2 mm -91.58 131.22 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 111.969 0.359 . . . . 71.439999999999998 111.969 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -81.85 -17.0 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 112.679 0.622 . . . . 50.43 112.679 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.501 ' H ' HG22 ' A' ' 120' ' ' ILE . 3.8 t-20 72.29 116.88 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.079 0.552 . . . . 74.129999999999995 112.087 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -106.08 -75.81 0.62 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.427 0.529 . . . . 74.340000000000003 112.427 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.91 85.44 1.26 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.364 0.602 . . . . 71.219999999999999 111.813 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -165.87 -66.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.531 -0.758 . . . . 74.109999999999999 110.511 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.81 47.08 1.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.253 0.549 . . . . 52.25 111.265 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -106.46 13.44 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.868 0.692 . . . . 73.430000000000007 112.868 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.7 tp -76.96 -31.63 56.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.854 0.359 . . . . 62.109999999999999 111.589 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.02 113.77 12.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.244 0.545 . . . . 61.109999999999999 112.307 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -144.98 10.23 1.32 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.059 -0.519 . . . . 75.329999999999998 110.82 173.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 61.16 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.681 0.393 . . . . 63.350000000000001 110.731 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -68.79 72.56 0.24 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.096 0.406 . . . . 75.25 112.096 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.6 p80 173.84 127.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.844 0.858 . . . . 74.349999999999994 110.384 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -65.07 98.89 0.32 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.448 . . . . 62.240000000000002 110.779 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.747 -0.66 . . . . 75.120000000000005 112.35 -174.654 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.945 0.402 . . . . 74.340000000000003 111.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.08 -23.37 17.36 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.577 -0.283 . . . . 72.030000000000001 111.467 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.5 p -54.08 137.33 40.33 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.289 0.477 . . . . 65.519999999999996 112.289 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.93 -39.33 90.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.382 0.512 . . . . 65.230000000000004 112.382 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 65.13 65.45 0.58 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.076 0.465 . . . . 72.239999999999995 111.992 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' ILE . 96.8 m-85 -65.65 88.6 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.439999999999998 111.101 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.219999999999999 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.349999999999994 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.530000000000001 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.099999999999994 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.329999999999998 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 73.150000000000006 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.781 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 64.530000000000001 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HG21 ' A' ' 53' ' ' ILE . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.450000000000003 110.37 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.329999999999998 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.540000000000006 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.210000000000001 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.239999999999995 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.319999999999993 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 47' ' ' ASP . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 65.239999999999995 111.668 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 63.520000000000003 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.350000000000001 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.400000000000006 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.350000000000001 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.530000000000001 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.319999999999993 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.009999999999998 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.420000000000002 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.299999999999997 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 62.229999999999997 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.209999999999994 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 72.450000000000003 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.420000000000002 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.430000000000007 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.439999999999998 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.239999999999995 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 32.219999999999999 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 52.109999999999999 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.140000000000001 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.200000000000003 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.430000000000007 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.409999999999997 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.219999999999999 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.540000000000006 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 71.049999999999997 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.209999999999994 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.109999999999999 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 60.229999999999997 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 73.430000000000007 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.520000000000003 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.020000000000003 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.219999999999999 110.884 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.239999999999995 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.540000000000006 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.319999999999993 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 35.299999999999997 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' HG22 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 64.150000000000006 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.109999999999999 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.129999999999995 112.446 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 65.319999999999993 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 64.5 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 112.062 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.319999999999993 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 62.009999999999998 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt -74.11 104.75 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.439999999999998 111.025 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.6 mm -69.07 -31.16 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.272 0.558 . . . . 61.310000000000002 110.541 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.3 t70 68.66 167.54 0.27 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.185 -0.916 . . . . 71.109999999999999 112.704 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 104' ' ' VAL . 12.6 m -84.56 4.43 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.404 -0.816 . . . . 74.409999999999997 112.046 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 m 71.45 -62.93 0.44 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.199 0.599 . . . . 50.409999999999997 110.507 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 t80 73.06 -22.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.594 0.961 . . . . 71.519999999999996 113.594 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -93.66 178.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 122.706 0.402 . . . . 74.540000000000006 112.067 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.99 -68.57 0.41 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.372 0.606 . . . . 71.329999999999998 111.119 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.73 88.99 4.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 74.109999999999999 110.643 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.8 p -72.51 75.83 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.017 -0.538 . . . . 61.210000000000001 111.759 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.68 125.55 1.58 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.316 -0.469 . . . . 75.209999999999994 113.067 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -168.76 -72.64 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.956 0.502 . . . . 73.439999999999998 109.869 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -157.0 115.27 3.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 65.340000000000003 109.994 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 114' ' ' LEU . 2.0 mp -115.27 170.56 8.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 110.98 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HD2' ' A' ' 116' ' ' PRO . 26.3 tp -160.83 134.22 4.81 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.955 -0.566 . . . . 73.120000000000005 110.517 175.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 115' ' ' LEU . 71.9 Cg_exo -51.31 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.379 2.052 . . . . 64.219999999999999 112.095 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.13 119.47 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.594 0.712 . . . . 72.209999999999994 111.619 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.89 145.57 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.387 -0.824 . . . . 73.109999999999999 112.237 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.06 147.08 43.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.206 0.527 . . . . 53.539999999999999 111.16 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.65 122.13 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.353 -0.385 . . . . 72.109999999999999 111.757 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.07 121.61 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.884 -0.413 . . . . 74.409999999999997 109.884 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -64.1 125.16 23.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.911 0.338 . . . . 74.5 111.911 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -53.21 128.09 26.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 42.450000000000003 110.084 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.04 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.755 0.659 . . . . 71.439999999999998 112.52 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.77 1.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.588 0.959 . . . . 55.329999999999998 113.588 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.47 -2.86 57.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.932 0.396 . . . . 52.009999999999998 111.859 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -71.78 100.96 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.419 0.628 . . . . 75.319999999999993 112.074 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.66 94.16 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.485 0.66 . . . . 75.340000000000003 111.416 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -71.33 164.4 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.183 0.516 . . . . 62.32 111.677 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -133.53 95.01 3.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.069 -0.514 . . . . 73.230000000000004 110.964 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -144.25 115.71 8.08 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.421 -0.354 . . . . 71.209999999999994 111.034 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -116.32 129.83 56.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.203 0.525 . . . . 71.120000000000005 111.619 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -98.5 95.6 7.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.154 -0.476 . . . . 73.409999999999997 111.155 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -101.59 120.68 40.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.536 -0.302 . . . . 74.340000000000003 110.674 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.6 t60 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 123.175 0.59 . . . . 73.030000000000001 111.994 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.893 0.378 . . . . 65.25 110.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.73 -26.17 24.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 65.439999999999998 111.415 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 p -90.72 176.83 6.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.23 0.538 . . . . 64.519999999999996 112.273 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -119.74 24.6 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 111.154 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.57 104.03 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.967 0.729 . . . . 71.019999999999996 112.967 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HB3' HG21 ' A' ' 87' ' ' ILE . 40.7 m-85 -75.93 86.93 2.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.219999999999999 110.47 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.409999999999997 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 64.230000000000004 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.510000000000005 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.129999999999995 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.030000000000001 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 74.25 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 65.340000000000003 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 53.43 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.439999999999998 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.299999999999997 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.219999999999999 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 71.120000000000005 112.192 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 35.25 111.546 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.200000000000003 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.530000000000001 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 51.340000000000003 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.420000000000002 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.310000000000002 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.129999999999995 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 72.230000000000004 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.120000000000005 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.209999999999994 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.530000000000001 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.420000000000002 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.319999999999993 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.099999999999994 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.219999999999999 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.129999999999995 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.319999999999993 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 65.430000000000007 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.140000000000001 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 54.350000000000001 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.219999999999999 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 109.645 170.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.520000000000003 113.168 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.420000000000002 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.349999999999994 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.329999999999998 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.299999999999997 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.409999999999997 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 19.4 p-10 -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.399999999999999 110.143 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.230000000000004 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.129999999999995 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.329999999999998 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.450000000000003 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.020000000000003 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.150000000000006 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.609 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.109999999999999 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.230000000000004 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.239999999999995 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.109999999999999 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 64.019999999999996 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.430000000000007 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 71.109999999999999 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.109999999999999 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt -79.26 104.85 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 64.299999999999997 110.995 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.29 -22.49 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.105 0.409 . . . . 75.439999999999998 112.105 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.33 -1.33 6.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.843 0.683 . . . . 75.430000000000007 112.843 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 104' ' ' VAL . 5.8 t -108.63 19.24 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.247 0.546 . . . . 74.219999999999999 110.214 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.8 m 70.15 2.23 3.87 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.229 0.612 . . . . 71.430000000000007 112.216 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -79.63 85.07 5.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.067 0.461 . . . . 72.439999999999998 111.946 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.89 170.87 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 110.822 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.29 153.55 42.29 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.159 0.504 . . . . 75.010000000000005 112.024 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -129.57 -60.43 1.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 71.219999999999999 110.645 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -154.56 134.44 12.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.113 -0.494 . . . . 71.25 110.911 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.02 144.9 6.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.984 -0.627 . . . . 74.450000000000003 113.039 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.665 ' HD3' HD23 ' A' ' 114' ' ' LEU . 85.7 tttt -161.68 140.01 9.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.917 0.389 . . . . 75.230000000000004 111.335 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -73.87 75.79 1.63 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.488 0.661 . . . . 71.109999999999999 111.171 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.665 HD23 ' HD3' ' A' ' 112' ' ' LYS . 1.1 pp -122.75 7.48 9.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.376 0.51 . . . . 75.549999999999997 112.376 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 114' ' ' LEU . 6.1 mp -81.49 148.83 63.52 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.261 0.467 . . . . 51.32 112.261 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.4 116.14 2.97 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.027 2.485 . . . . 64.439999999999998 112.869 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.34 171.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.116 0.484 . . . . 55.210000000000001 112.173 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.9 p -143.19 152.73 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.225 -0.443 . . . . 44.130000000000003 111.259 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.42 122.37 26.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.927 0.394 . . . . 71.439999999999998 112.059 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.0 mp -79.1 122.31 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.823 0.344 . . . . 51.039999999999999 110.207 174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.72 99.2 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 121.569 0.7 . . . . 72.129999999999995 112.596 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -127.11 93.12 3.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.051 -0.522 . . . . 71.239999999999995 109.769 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.5 p -116.35 143.38 45.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.595 0.591 . . . . 42.310000000000002 112.595 -172.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 127' ' ' VAL . 35.2 mt-10 55.45 29.46 13.29 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.128 0.49 . . . . 70.319999999999993 111.084 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 127' ' ' VAL . . . 61.67 4.56 1.08 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.484 -0.78 . . . . 55.439999999999998 111.892 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.54 31.88 21.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.525 0.679 . . . . 62.329999999999998 111.149 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 125' ' ' ALA . 7.6 p -113.72 149.22 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.695 -0.684 . . . . 74.010000000000005 111.876 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.32 104.81 16.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.969 0.414 . . . . 73.209999999999994 110.261 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -90.22 -62.9 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 112.164 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -89.39 88.74 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.908 0.385 . . . . 63.229999999999997 111.551 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -96.97 114.28 25.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.299 -0.41 . . . . 73.140000000000001 111.356 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -165.81 89.84 0.44 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.139 0.495 . . . . 64.310000000000002 111.215 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -119.95 118.95 32.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 72.239999999999995 110.597 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -87.84 151.08 23.13 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.433 0.158 . . . . 70.340000000000003 110.66 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.564 -0.731 . . . . 72.510000000000005 111.213 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.747 0.308 . . . . 75.319999999999993 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.18 129.49 50.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.399 -0.364 . . . . 61.43 110.631 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.1 m 71.27 111.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.343 0.497 . . . . 72.099999999999994 112.343 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -66.54 85.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.422 0.63 . . . . 70.400000000000006 112.141 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.09 87.74 2.99 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 110.42 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 -46.57 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.784 -0.644 . . . . 74.340000000000003 112.495 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.150000000000006 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.781 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.549999999999997 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.200000000000003 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.340000000000003 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.120000000000005 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.319999999999993 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 55.140000000000001 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 61.229999999999997 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.329999999999998 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.520000000000003 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.239999999999995 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 63.420000000000002 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 71.040000000000006 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.450000000000003 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 55.240000000000002 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.399999999999999 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.099999999999994 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.310000000000002 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.010000000000005 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.010000000000005 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.310000000000002 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.219999999999999 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 72.319999999999993 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 60.020000000000003 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 60.509999999999998 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 54.310000000000002 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 61.030000000000001 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.230000000000004 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.399999999999999 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.450000000000003 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.240000000000002 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.049999999999997 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.010000000000005 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.299999999999997 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.400000000000006 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 63.299999999999997 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.129999999999995 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.230000000000004 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.420000000000002 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.140000000000001 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 61.409999999999997 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 25.420000000000002 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.129999999999995 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.420000000000002 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.519999999999996 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.230000000000004 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.100000000000001 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 61.310000000000002 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.239999999999995 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.009999999999998 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.209999999999994 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.219999999999999 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.240000000000002 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 64.310000000000002 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 64.409999999999997 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt -68.15 104.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 72.319999999999993 111.96 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.83 -26.93 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.414 0.626 . . . . 75.340000000000003 110.76 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -101.37 106.9 18.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.439 -0.801 . . . . 75.420000000000002 111.351 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.06 93.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.649 0.738 . . . . 75.510000000000005 112.027 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -63.88 -23.91 67.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.566 -0.743 . . . . 64.510000000000005 109.95 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.92 101.78 0.16 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.031 -0.986 . . . . 74.040000000000006 111.308 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.87 153.64 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.916 -0.583 . . . . 73.150000000000006 111.699 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.29 104.29 3.66 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.456 0.539 . . . . 70.329999999999998 112.456 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -156.14 -57.42 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.906 -0.588 . . . . 54.420000000000002 110.154 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 t -153.14 151.09 29.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.85 -0.614 . . . . 74.430000000000007 111.219 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.19 -148.91 6.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.389 -0.434 . . . . 72.329999999999998 112.134 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -67.25 144.67 55.81 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.195 0.521 . . . . 75.329999999999998 111.108 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.88 104.39 2.05 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.534 0.683 . . . . 75.140000000000001 112.427 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.94 133.0 33.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.044 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.79 153.25 83.13 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.376 0.51 . . . . 73.140000000000001 112.376 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.87 88.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.881 2.388 . . . . 74.219999999999999 113.114 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.13 127.12 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.125 0.488 . . . . 72.540000000000006 111.53 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.24 116.26 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.569 0.699 . . . . 63.119999999999997 111.835 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.554 ' HB3' HD12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -133.66 -160.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.953 -0.567 . . . . 65.120000000000005 110.175 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 119' ' ' GLU . 3.4 mp 52.64 42.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 122.394 1.092 . . . . 74.319999999999993 109.764 -172.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.4 pt -81.6 57.51 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.185 -0.916 . . . . 33.229999999999997 111.662 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.79 162.98 26.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.877 -0.601 . . . . 71.329999999999998 111.887 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.7 m -77.2 160.38 28.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.956 -0.566 . . . . 73.420000000000002 110.02 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -50.22 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.004 0.431 . . . . 72.219999999999999 111.964 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.69 11.34 3.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.872 -0.604 . . . . 74.340000000000003 112.532 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 47.31 76.49 0.11 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.152 0.581 . . . . 64.109999999999999 112.38 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.9 111.5 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.436 -0.347 . . . . 50.340000000000003 111.111 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.48 133.97 20.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.303 0.483 . . . . 54.299999999999997 112.303 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -176.7 147.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.458 -0.792 . . . . 55.32 109.718 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -135.0 137.15 42.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.419 0.525 . . . . 75.219999999999999 112.419 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -141.05 162.55 35.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.043 -0.526 . . . . 73.409999999999997 110.59 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.73 127.82 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 72.329999999999998 111.357 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.11 95.43 0.56 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.885 -0.598 . . . . 75.420000000000002 111.846 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -160.73 143.38 12.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.577 -0.283 . . . . 73.239999999999995 111.428 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.928 -0.558 . . . . 52.439999999999998 111.743 178.12 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 120.928 0.395 . . . . 71.120000000000005 111.296 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.12 104.2 16.17 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.388 0.613 . . . . 71.120000000000005 111.736 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -120.55 42.31 3.03 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.296 0.57 . . . . 73.109999999999999 111.206 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.01 40.57 0.41 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.183 0.809 . . . . 74.319999999999993 113.183 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 40.15 70.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.578 0.704 . . . . 64.109999999999999 111.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -65.25 90.71 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 73.349999999999994 112.139 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.219999999999999 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.340000000000003 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 62.310000000000002 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.219999999999999 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 70.319999999999993 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 70.150000000000006 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.240000000000002 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 44.030000000000001 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 24.34 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.430000000000007 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.099999999999994 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.439999999999998 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 51.520000000000003 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.109999999999999 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.530000000000001 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.030000000000001 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 53.439999999999998 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.239999999999995 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.209999999999994 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 73.430000000000007 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.530000000000001 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.120000000000005 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.140000000000001 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.519999999999996 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.129999999999995 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.209999999999994 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.450000000000003 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 44.210000000000001 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.430000000000007 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.100000000000001 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 52.130000000000003 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 70.209999999999994 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.219999999999999 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.400000000000006 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 72.519999999999996 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.239999999999995 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.329999999999998 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 63.049999999999997 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 54.149999999999999 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.544 HG22 HG13 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 64.120000000000005 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.549999999999997 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.009999999999998 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.349999999999994 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.119999999999997 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.540000000000006 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.039999999999999 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 41.340000000000003 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.140000000000001 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.519999999999996 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.319999999999993 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 63.100000000000001 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.340000000000003 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 73.329999999999998 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 73.510000000000005 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.200000000000003 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.149999999999999 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt -76.39 103.63 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 64.519999999999996 109.968 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 102' ' ' ILE . 33.0 mt -90.01 45.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 122.535 1.159 . . . . 75.209999999999994 111.02 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.5 -167.24 0.37 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.97 -1.468 . . . . 73.420000000000002 110.378 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 25.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.489 0.551 . . . . 64.400000000000006 112.489 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 m 58.94 46.59 13.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.98 0.895 . . . . 72.439999999999998 108.758 -168.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 108' ' ' ASP . 35.4 t80 -66.26 94.58 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.163 -1.38 . . . . 75.230000000000004 112.243 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t -86.82 83.93 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.689 0.757 . . . . 72.219999999999999 111.328 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 39.1 t70 -150.37 60.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.29 -0.868 . . . . 64.319999999999993 109.301 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 56.68 -84.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.256 -0.884 . . . . 53.43 111.954 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 106' ' ' TYR . 54.1 p 43.83 32.63 0.62 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.103 0.478 . . . . 71.329999999999998 112.192 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 108.01 55.34 0.61 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.13 -0.486 . . . . 70.230000000000004 112.085 -171.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.12 -40.74 82.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.181 0.515 . . . . 44.219999999999999 111.156 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.56 94.6 4.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.889 -0.596 . . . . 72.329999999999998 109.969 174.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 78.4 mt -95.73 -168.1 1.71 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.556 0.576 . . . . 64.310000000000002 112.556 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.9 mt 69.64 119.33 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.675 -0.693 . . . . 71.450000000000003 111.763 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.93 52.25 3.71 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.835 2.357 . . . . 74.420000000000002 112.436 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -57.27 103.84 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.718 0.77 . . . . 64.140000000000001 112.338 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.09 149.01 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.882 -0.599 . . . . 62.240000000000002 111.852 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 120' ' ' ILE . 39.7 tt0 -151.0 165.56 33.37 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.669 -0.696 . . . . 74.400000000000006 109.587 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.488 ' N ' ' HG2' ' A' ' 119' ' ' GLU . 45.3 mm -54.89 94.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.346 0.593 . . . . 71.310000000000002 111.237 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.86 -26.25 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.8 -0.637 . . . . 72.409999999999997 111.696 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.94 -62.74 0.44 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.128 0.571 . . . . 71.510000000000005 111.933 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 t -44.01 -51.78 7.54 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.323 0.86 . . . . 44.210000000000001 113.323 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.86 -21.81 65.0 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.499 0.555 . . . . 64.239999999999995 112.499 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.66 -16.63 50.72 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.845 0.313 . . . . 63.109999999999999 111.845 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.54 7.75 34.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.626 0.602 . . . . 62.030000000000001 112.626 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.48 154.58 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 122.191 -0.318 . . . . 74.340000000000003 111.343 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.36 119.18 11.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.827 0.346 . . . . 53.130000000000003 111.772 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -134.37 139.51 45.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.719 0.295 . . . . 72.219999999999999 110.623 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -130.94 89.33 2.73 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.115 0.483 . . . . 71.349999999999994 111.755 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.56 62.03 4.43 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.99 -0.444 . . . . 70.109999999999999 112.058 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -169.31 62.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.366 0.603 . . . . 75.310000000000002 110.889 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -87.67 178.65 6.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.236 0.541 . . . . 75.439999999999998 112.184 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -103.87 -162.11 0.88 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.964 -0.562 . . . . 72.329999999999998 109.996 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.699 -0.667 . . . . 72.230000000000004 111.921 178.84 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.324 0.107 . . . . 74.319999999999993 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 54.91 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.7 1.0 . . . . 74.200000000000003 113.7 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -59.15 101.75 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 72.040000000000006 112.697 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -82.7 21.15 1.03 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.714 -0.676 . . . . 63.329999999999998 111.262 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 t30 56.18 63.72 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.658 0.742 . . . . 74.409999999999997 110.15 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -60.5 104.02 0.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.143 -0.935 . . . . 72.530000000000001 111.471 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.240000000000002 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.120000000000005 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.439999999999998 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.229999999999997 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.230000000000004 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 53.5 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.329999999999998 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.219999999999999 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.120000000000005 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.340000000000003 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 64.420000000000002 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.010000000000005 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.519999999999996 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 64.430000000000007 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.430000000000007 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.219999999999999 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.010000000000005 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.240000000000002 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.420000000000002 111.101 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.230000000000004 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.310000000000002 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.340000000000003 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.239999999999995 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.129999999999995 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.430000000000007 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.109999999999999 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.439999999999998 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.129999999999995 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.519999999999996 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.120000000000005 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 71.319999999999993 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 64.420000000000002 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.239999999999995 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.129999999999995 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.399999999999999 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.420000000000002 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.129999999999995 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 45.149999999999999 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.010000000000005 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 73.349999999999994 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.439999999999998 111.17 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 62' ' ' TYR . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 64.230000000000004 110.912 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.140000000000001 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.430000000000007 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 61.520000000000003 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.209999999999994 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.099999999999994 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.400000000000006 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 64.120000000000005 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.230000000000004 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.319999999999993 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.229999999999997 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.209999999999994 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt -66.98 123.61 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.100000000000001 111.605 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.7 mm -95.14 96.99 6.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.026 0.441 . . . . 75.230000000000004 111.341 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 105' ' ' SER . 20.4 t0 71.26 149.13 0.09 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.626 0.973 . . . . 73.349999999999994 113.626 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 106' ' ' TYR . 26.8 m -106.3 -1.1 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.528 -0.76 . . . . 72.310000000000002 111.972 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 49.5 m 69.98 11.47 7.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.79 0.663 . . . . 72.209999999999994 112.79 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' H ' HG23 ' A' ' 104' ' ' VAL . 25.1 m-85 -97.82 10.3 40.49 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.116 0.413 . . . . 74.219999999999999 112.116 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.71 150.2 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.559 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -82.4 27.47 0.5 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.375 0.509 . . . . 53.420000000000002 112.375 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -119.04 -20.25 8.15 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.162 0.43 . . . . 65.230000000000004 112.162 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.8 p -76.26 -68.51 0.58 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.931 0.396 . . . . 71.109999999999999 111.877 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . -179.65 -84.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.781 0 C-N-CA 121.394 -0.431 . . . . 61.130000000000003 112.146 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 50.69 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.503 0.927 . . . . 73.129999999999995 113.503 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t70 -131.61 18.58 4.74 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.398 0.618 . . . . 71.209999999999994 111.952 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 0.7 OUTLIER -104.78 -161.64 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.535 . . . . 72.239999999999995 110.694 -179.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.3 mt -94.45 112.67 58.59 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.12 -0.491 . . . . 64.540000000000006 110.937 168.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.95 105.67 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.174 1.916 . . . . 73.519999999999996 111.674 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.7 t -69.24 79.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.811 0.815 . . . . 72.439999999999998 111.448 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.28 -167.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.995 -1.002 . . . . 61.25 110.247 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.54 84.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.772 0.796 . . . . 75.219999999999999 111.746 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mt -92.13 47.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.028 0.918 . . . . 63.310000000000002 109.472 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 122' ' ' ASN . 39.3 pt -68.5 -41.66 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.162 -0.926 . . . . 74.239999999999995 112.881 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 37.7 m-80 54.41 -165.93 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.898 0.38 . . . . 53.229999999999997 111.837 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 t -143.06 -71.25 0.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 63.399999999999999 112.334 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.64 -64.82 0.78 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.118 0.414 . . . . 45.140000000000001 112.118 -173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.27 9.63 5.49 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.614 0.598 . . . . 74.400000000000006 112.614 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . . . -83.97 2.33 39.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.641 0.608 . . . . 74.349999999999994 112.641 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.64 18.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 112.861 0.689 . . . . 64.400000000000006 112.861 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.76 -39.69 21.52 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.483 0.549 . . . . 74.230000000000004 112.483 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.723 ' HG2' ' H ' ' A' ' 131' ' ' HIS . 30.6 tt0 65.73 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.276 0.63 . . . . 75.140000000000001 111.282 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -77.83 1.57 19.91 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.864 0.69 . . . . 71.109999999999999 112.864 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.723 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 72.9 m80 48.3 58.68 4.92 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 74.409999999999997 112.519 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -78.13 -72.4 0.37 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.858 -0.526 . . . . 72.25 110.674 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -123.63 87.74 2.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.077 0.465 . . . . 73.409999999999997 110.694 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -86.6 110.86 20.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.398 -0.365 . . . . 74.319999999999993 110.639 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.187 -0.911 . . . . 71.450000000000003 111.764 -176.54 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.482 0.182 . . . . 71.019999999999996 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -162.37 174.49 12.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.846 0.355 . . . . 75.030000000000001 111.573 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.3 m -128.39 110.08 12.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.731 0.301 . . . . 74.049999999999997 111.738 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -85.02 106.84 16.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.843 0.354 . . . . 72.150000000000006 110.822 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.84 101.29 5.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.994 0.426 . . . . 63.140000000000001 111.299 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.53 105.14 11.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.524 -0.307 . . . . 74.329999999999998 111.094 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.030000000000001 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.439999999999998 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.450000000000003 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.109999999999999 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.310000000000002 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.409999999999997 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.150000000000006 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.549999999999997 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.400000000000006 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.230000000000004 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.209999999999994 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 45.299999999999997 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.219999999999999 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG21 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 44.009999999999998 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 52.100000000000001 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.549999999999997 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.230000000000004 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.130000000000003 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 64.450000000000003 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 60.340000000000003 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.450000000000003 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.549999999999997 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.049999999999997 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CD2' HG11 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.439999999999998 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.530000000000001 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 64.430000000000007 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.400000000000006 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.409999999999997 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.450000000000003 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.030000000000001 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 104' ' ' VAL . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 70.299999999999997 113.284 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.510000000000005 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.654 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.239999999999995 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 70.540000000000006 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' HD3' HG22 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 74.450000000000003 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 52.310000000000002 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 70.340000000000003 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.340000000000003 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.140000000000001 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.350000000000001 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.030000000000001 112.401 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.706 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.239999999999995 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.520000000000003 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.230000000000004 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.140000000000001 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.109999999999999 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.519999999999996 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.239999999999995 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.210000000000001 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 63.549999999999997 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.140000000000001 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.120000000000005 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.340000000000003 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.349999999999994 110.408 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.526 HG22 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.150000000000006 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.209999999999994 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.049999999999997 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 53.439999999999998 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt -79.12 123.52 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.109999999999999 111.758 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.7 mm -85.92 -22.29 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.309 0.576 . . . . 75.340000000000003 110.888 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.15 63.06 3.7 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.588 0.709 . . . . 70.329999999999998 111.697 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 73' ' ' GLY . 30.0 m -140.33 28.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 74.420000000000002 110.237 176.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.2 t -70.98 78.12 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.482 0.658 . . . . 72.510000000000005 112.669 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.3 5.5 9.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.567 0.699 . . . . 74.450000000000003 109.406 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.7 t -100.35 86.3 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.314 -0.857 . . . . 73.0 111.433 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.17 73.83 8.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.639 0.733 . . . . 55.340000000000003 110.778 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.75 -86.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.468 -0.787 . . . . 72.420000000000002 109.602 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -150.48 -175.99 5.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.663 0.385 . . . . 72.010000000000005 110.558 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 66.68 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.24 -0.505 . . . . 70.329999999999998 112.203 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -88.44 -72.67 0.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.131 0.419 . . . . 64.319999999999993 112.131 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.67 -68.32 0.9 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.412 0.523 . . . . 72.340000000000003 112.412 -174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mp 55.76 29.93 14.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.618 0.723 . . . . 74.519999999999996 110.157 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -79.3 126.61 81.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.909 -1.041 . . . . 73.310000000000002 111.125 -170.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 115' ' ' LEU . 57.2 Cg_endo -69.69 165.51 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.753 2.302 . . . . 71.319999999999993 113.031 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.02 123.14 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.52 0.676 . . . . 75.099999999999994 112.691 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -156.55 142.3 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.815 -0.63 . . . . 64.219999999999999 110.699 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -151.35 90.12 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.781 0.289 . . . . 71.400000000000006 111.781 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.8 mt 57.3 110.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 112.771 0.656 . . . . 73.530000000000001 112.771 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 121' ' ' ILE . 2.1 pp -124.88 133.52 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 113.46 0.911 . . . . 75.010000000000005 113.46 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -157.63 90.95 1.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.317 -0.856 . . . . 71.409999999999997 110.238 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.5 m -91.29 -33.12 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.629 0.603 . . . . 74.209999999999994 112.629 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.01 90.93 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.125 0.488 . . . . 71.150000000000006 110.789 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.03 -55.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.966 -0.561 . . . . 64.140000000000001 111.074 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.63 90.3 2.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.086 0.469 . . . . 72.519999999999996 111.86 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.41 96.24 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 61.399999999999999 111.881 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.28 97.72 9.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.282 -0.636 . . . . 70.030000000000001 109.282 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.7 131.07 49.17 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.056 0.455 . . . . 75.510000000000005 111.91 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -110.3 161.95 15.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.323 -0.399 . . . . 72.430000000000007 111.766 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -162.21 112.27 1.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.013 0.435 . . . . 65.25 111.996 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -137.83 123.3 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.813 0.34 . . . . 75.230000000000004 110.977 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -88.27 139.75 30.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 62.130000000000003 111.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -137.02 175.84 9.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.222 0.534 . . . . 74.319999999999993 111.929 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.302 -0.863 . . . . 73.0 110.319 177.371 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.609 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.754 0.312 . . . . 62.240000000000002 111.511 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.36 101.79 0.61 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.659 0.266 . . . . 73.219999999999999 110.878 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m 63.19 96.26 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 44.310000000000002 111.148 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 87.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 72.450000000000003 110.768 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -66.76 105.99 1.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.261 -0.882 . . . . 65.420000000000002 111.672 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 -74.04 93.43 2.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.74 -0.663 . . . . 64.400000000000006 111.128 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.040000000000006 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 62.299999999999997 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.209999999999994 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.310000000000002 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.210000000000001 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.549999999999997 109.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG12 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.209999999999994 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.530000000000001 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.030000000000001 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.510000000000005 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.219999999999999 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.040000000000006 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.594 ' CA ' HG12 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.340000000000003 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.010000000000005 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.240000000000002 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.420000000000002 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 24.030000000000001 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.109999999999999 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 54.240000000000002 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.219999999999999 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.240000000000002 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.299999999999997 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.329999999999998 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 50.439999999999998 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.209999999999994 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.540000000000006 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.230000000000004 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.049999999999997 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.120000000000005 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.219999999999999 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.540000000000006 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.540000000000006 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.319999999999993 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.430000000000007 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.400000000000006 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.049999999999997 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.099999999999994 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.230000000000004 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 65.109999999999999 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 35.409999999999997 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 94' ' ' VAL . 28.9 t-20 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.540000000000006 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 61.329999999999998 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.319999999999993 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.219999999999999 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 65.209999999999994 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.150000000000006 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.039999999999999 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.400000000000006 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.802 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.239999999999995 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 72.010000000000005 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.434 ' HD3' HG21 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.450000000000003 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.439999999999998 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.430000000000007 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.140000000000001 112.304 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.430000000000007 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.219999999999999 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt -85.79 102.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 60.549999999999997 110.438 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 102' ' ' ILE . 36.3 mt -114.54 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.739 0.78 . . . . 71.109999999999999 110.235 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.72 170.89 2.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.23 -1.396 . . . . 73.230000000000004 107.23 -174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 104' ' ' VAL . 6.7 p -77.64 77.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 122.643 1.211 . . . . 72.200000000000003 112.615 -171.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.6 m 61.59 15.85 7.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.583 -1.189 . . . . 72.109999999999999 112.286 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.14 96.69 3.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.155 0.502 . . . . 72.540000000000006 111.916 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.45 131.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.131 -0.486 . . . . 63.140000000000001 110.912 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.66 -43.76 95.76 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.618 0.599 . . . . 63.119999999999997 112.618 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 69.92 -51.16 0.64 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.685 0.794 . . . . 75.510000000000005 112.255 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p 53.82 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.944 0.897 . . . . 74.140000000000001 113.367 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.82 -112.76 4.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.123 -0.561 . . . . 71.329999999999998 112.762 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -148.67 -43.13 0.15 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.277 0.561 . . . . 75.540000000000006 110.668 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.82 90.07 2.9 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.674 -0.694 . . . . 64.200000000000003 112.031 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -169.93 165.53 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.409999999999997 112.361 174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.3 mt -124.69 106.7 29.37 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.854 -0.612 . . . . 61.130000000000003 111.15 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.49 -167.7 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.995 2.463 . . . . 71.299999999999997 112.79 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.13 136.43 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.9 0.381 . . . . 70.140000000000001 111.489 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -72.4 114.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.496 -0.32 . . . . 73.219999999999999 111.164 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.04 179.8 0.15 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.175 0.59 . . . . 75.310000000000002 112.248 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mm 64.34 117.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.184 0.516 . . . . 74.310000000000002 111.072 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.411 HG13 ' OD1' ' A' ' 122' ' ' ASN . 26.1 pt -80.03 175.15 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.768 0.318 . . . . 32.409999999999997 111.247 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 121' ' ' ILE . 15.0 m120 72.53 -61.83 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.31 0.644 . . . . 75.019999999999996 111.823 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.4 t 66.75 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.034 0.534 . . . . 74.019999999999996 112.144 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.93 118.08 6.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.235 0.54 . . . . 75.340000000000003 112.017 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.23 6.26 0.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.221 0.823 . . . . 72.409999999999997 113.221 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 49.33 60.86 3.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 71.239999999999995 112.158 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.86 80.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.143 0.497 . . . . 70.010000000000005 111.414 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.71 101.48 3.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.454 0.538 . . . . 62.5 112.454 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.61 104.21 16.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.877 -0.416 . . . . 74.409999999999997 109.877 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -96.36 118.81 33.66 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 74.519999999999996 111.479 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -78.43 150.99 32.95 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.169 0.433 . . . . 72.340000000000003 112.169 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.67 -166.09 1.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.263 -0.426 . . . . 73.439999999999998 110.71 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -148.66 133.73 18.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.973 0.416 . . . . 71.120000000000005 111.597 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -128.02 108.18 10.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.279 0.561 . . . . 73.200000000000003 111.174 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.954 -0.546 . . . . 72.25 111.611 -179.525 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.451 ' HG2' ' N ' ' A' ' 35' ' ' ASP . 56.0 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.509 0.195 . . . . 73.049999999999997 111.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.451 ' N ' ' HG2' ' A' ' 34' ' ' MET . 24.8 t70 79.91 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.019 0.928 . . . . 73.450000000000003 111.819 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.5 m -160.26 136.72 8.84 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.189 -0.319 . . . . 72.510000000000005 111.294 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -87.88 88.55 7.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.214 0.531 . . . . 73.219999999999999 110.038 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.98 104.43 8.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 74.200000000000003 111.937 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.589 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 -76.76 88.2 3.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.129999999999995 110.0 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 60' ' ' THR . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 62.340000000000003 111.642 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.119999999999997 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.340000000000003 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.430000000000007 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.230000000000004 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 65.420000000000002 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.549999999999997 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.319999999999993 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.230000000000004 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.129999999999995 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.329999999999998 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.329999999999998 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.140000000000001 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.439999999999998 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.239999999999995 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.240000000000002 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.310000000000002 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.109999999999999 111.71 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.219999999999999 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.519999999999996 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.109999999999999 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.310000000000002 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.439999999999998 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 74.099999999999994 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 61.210000000000001 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.439999999999998 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.409999999999997 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.129999999999995 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 30.41 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.540000000000006 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.310000000000002 110.94 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.299999999999997 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.510000000000005 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 44.25 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 73.340000000000003 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.150000000000006 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.030000000000001 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 1.1 p30 -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.219999999999999 111.359 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.030000000000001 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 62.299999999999997 111.087 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.299999999999997 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.129999999999995 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.230000000000004 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.635 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.530000000000001 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.030000000000001 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.340000000000003 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.140000000000001 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.439999999999998 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.430000000000007 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.219999999999999 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 75' ' ' LYS . 64.1 mt -70.82 107.62 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.219999999999999 111.541 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.3 mm -89.84 -37.21 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 73.219999999999999 110.638 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.5 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.311 -0.859 . . . . 62.299999999999997 110.954 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.65 1.84 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.413 0.523 . . . . 44.420000000000002 112.413 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.3 t 64.45 -72.32 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.727 0.411 . . . . 72.329999999999998 111.494 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.9 t80 64.49 19.25 11.74 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.006 0.522 . . . . 75.329999999999998 111.602 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 109' ' ' GLU . 83.8 t -73.73 136.7 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.923 0.392 . . . . 72.430000000000007 111.053 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -55.03 -30.59 59.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.8 0.667 . . . . 74.349999999999994 112.8 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.5 ' H ' HG12 ' A' ' 107' ' ' VAL . 46.7 mt-10 -56.42 -37.96 70.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.291 -0.413 . . . . 74.530000000000001 111.358 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -103.96 -69.45 0.8 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.439 -0.346 . . . . 65.540000000000006 111.414 176.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 110' ' ' THR . . . 53.93 15.65 5.17 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.15 0.42 . . . . 64.329999999999998 114.15 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -96.95 -6.26 36.0 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 117.392 0.596 . . . . 65.230000000000004 111.627 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -100.36 91.46 4.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.605 -0.27 . . . . 51.310000000000002 110.784 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -127.73 -165.01 1.42 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.001 0.429 . . . . 73.0 111.361 -178.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.1 mt 71.22 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.73 . . . . 73.310000000000002 112.855 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 105.14 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.626 2.217 . . . . 75.010000000000005 112.68 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.04 96.64 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.409 0.623 . . . . 73.109999999999999 111.483 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.66 145.52 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.169 0.433 . . . . 72.040000000000006 112.169 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.18 107.54 9.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.264 -0.425 . . . . 74.109999999999999 110.765 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.3 mt -90.9 95.4 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.128 0.489 . . . . 64.25 111.461 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.0 pt -95.16 145.78 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.851 -0.613 . . . . 75.409999999999997 110.944 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.74 -172.92 4.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.284 0.564 . . . . 70.140000000000001 111.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -76.69 -175.1 3.25 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.253 -0.43 . . . . 64.549999999999997 110.48 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.43 109.79 0.75 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.042 0.448 . . . . 63.340000000000003 110.71 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.92 7.34 1.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.043 -0.526 . . . . 71.340000000000003 112.328 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.62 25.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.931 0.396 . . . . 71.120000000000005 111.372 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.2 m -51.56 134.19 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.654 0.612 . . . . 54.210000000000001 112.654 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 25.9 tp -132.6 15.23 4.43 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.888 -0.596 . . . . 64.230000000000004 110.772 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.04 94.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.312 0.577 . . . . 62.340000000000003 112.343 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -103.08 113.29 26.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 110.93 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -129.91 170.39 14.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.053 0.454 . . . . 64.319999999999993 111.412 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -103.57 174.34 5.91 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.001 0.429 . . . . 62.409999999999997 111.026 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -85.6 -171.62 3.7 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.47 -0.332 . . . . 72.140000000000001 111.578 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.946 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.532 -0.747 . . . . 65.299999999999997 111.458 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.718 0.294 . . . . 75.530000000000001 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.81 -63.0 1.5 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.104 0.478 . . . . 62.130000000000003 111.484 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -70.96 120.79 17.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.211 -0.45 . . . . 74.400000000000006 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.38 -64.62 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.402 0.281 . . . . 73.129999999999995 111.722 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 m120 51.33 72.99 0.33 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.98 0.512 . . . . 63.509999999999998 112.368 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -59.8 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.540000000000006 110.887 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 72.019999999999996 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 43.420000000000002 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.310000000000002 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.019999999999996 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 64.420000000000002 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.299999999999997 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.200000000000003 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.400000000000006 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 64.099999999999994 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.109999999999999 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.129999999999995 111.759 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.030000000000001 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.530000000000001 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 61.450000000000003 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.439999999999998 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 55.340000000000003 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 74.109999999999999 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.450000000000003 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.230000000000004 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 63.100000000000001 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' LEU . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.439999999999998 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.530000000000001 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 41.450000000000003 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 43.450000000000003 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.120000000000005 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.019999999999996 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.299999999999997 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.129999999999995 110.932 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.019999999999996 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.209999999999994 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 65.150000000000006 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 65.0 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.109999999999999 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.416 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 62.310000000000002 111.821 -178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.439999999999998 112.19 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.109999999999999 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.120000000000005 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.129999999999995 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.329999999999998 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 72.319999999999993 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.109999999999999 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.219999999999999 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.219999999999999 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.120000000000005 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.430000000000007 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.430000000000007 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.340000000000003 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.450000000000003 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 71.340000000000003 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.340000000000003 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 72.109999999999999 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 77' ' ' ARG . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.200000000000003 111.653 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 63.210000000000001 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 77' ' ' ARG . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 70.519999999999996 110.255 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.340000000000003 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 103' ' ' ASP . 57.5 mt -72.48 122.46 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.310000000000002 111.071 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.67 -24.21 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.235 0.54 . . . . 71.409999999999997 110.705 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 101' ' ' ILE . 17.4 t70 78.28 163.27 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.193 -0.912 . . . . 74.400000000000006 111.365 170.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 104' ' ' VAL . 2.7 p -116.9 49.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.857 0.837 . . . . 74.129999999999995 112.995 -168.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 m 79.88 16.73 0.78 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.036 -0.984 . . . . 73.099999999999994 112.338 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.01 2.33 32.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.049999999999997 112.391 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.06 148.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.928 0.394 . . . . 75.299999999999997 111.821 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.51 151.22 21.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.974 0.416 . . . . 74.239999999999995 111.54 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.42 -58.11 8.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.21 -0.45 . . . . 75.030000000000001 111.963 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 114' ' ' LEU . 47.8 p -87.33 -77.17 0.34 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.583 -0.28 . . . . 74.420000000000002 111.091 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 50.25 -87.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.833 0.693 . . . . 62.340000000000003 114.833 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.09 -56.79 15.37 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.267 0.469 . . . . 45.030000000000001 112.267 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.79 -67.85 0.53 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.735 0.643 . . . . 62.200000000000003 112.735 -169.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HB ' ' A' ' 110' ' ' THR . 60.7 mt 67.02 -167.93 0.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.297 0.57 . . . . 74.409999999999997 112.105 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD12 ' HD2' ' A' ' 116' ' ' PRO . 16.9 tp -141.89 134.33 13.81 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.178 -0.464 . . . . 74.219999999999999 111.807 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD2' HD12 ' A' ' 115' ' ' LEU . 84.0 Cg_endo -82.1 169.38 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.709 2.273 . . . . 53.509999999999998 113.274 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.88 117.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.299 0.571 . . . . 60.229999999999997 111.303 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -163.76 122.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.057 -0.52 . . . . 65.109999999999999 111.763 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -171.2 99.15 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.302 -0.408 . . . . 70.439999999999998 111.174 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 71.1 mt -139.98 122.97 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.03 0.443 . . . . 71.340000000000003 111.672 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.7 mt -129.76 108.41 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.382 -0.372 . . . . 72.329999999999998 110.57 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -138.28 96.56 3.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.416 0.627 . . . . 70.030000000000001 111.538 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.7 p -127.15 148.59 50.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.737 -0.665 . . . . 71.5 110.386 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.1 29.23 18.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.031 0.443 . . . . 74.230000000000004 111.177 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 67.43 5.71 4.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.57 0.748 . . . . 74.510000000000005 112.514 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 52.66 87.11 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.164 0.506 . . . . 61.119999999999997 112.19 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.8 t -72.84 95.57 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.88 0.371 . . . . 74.549999999999997 110.331 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.7 tp -138.01 22.72 2.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.16 0.505 . . . . 74.209999999999994 111.908 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.58 71.14 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.193 0.52 . . . . 75.519999999999996 110.252 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -90.68 43.87 1.17 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.824 0.676 . . . . 74.5 112.824 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -61.31 105.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.125 0.488 . . . . 75.510000000000005 111.144 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.54 127.26 31.89 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.018 -0.537 . . . . 71.019999999999996 110.942 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -136.82 147.79 46.78 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.957 0.354 . . . . 72.400000000000006 111.957 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m170 63.2 -178.42 0.15 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.992 0.517 . . . . 71.040000000000006 111.449 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 119.257 -0.402 . . . . 71.109999999999999 111.538 177.956 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.814 0.301 . . . . 63.200000000000003 111.814 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -72.21 -75.22 0.14 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.998 0.428 . . . . 72.439999999999998 111.276 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -81.16 138.3 35.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 111.068 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -57.19 108.77 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.291 0.567 . . . . 73.329999999999998 110.754 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -54.89 91.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.54 -0.755 . . . . 40.420000000000002 112.988 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 -87.42 150.27 23.9 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 110.053 171.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 32.219999999999999 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.299999999999997 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.299999999999997 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.140000000000001 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.409999999999997 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 65.150000000000006 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.200000000000003 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.049999999999997 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.109999999999999 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.319999999999993 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 53' ' ' ILE . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.340000000000003 112.483 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.209999999999994 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.329999999999998 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.099999999999994 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.409999999999997 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.010000000000005 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.400000000000006 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.329999999999998 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.329999999999998 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 53.25 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.150000000000006 110.347 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.209999999999994 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.350000000000001 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.329999999999998 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 53.219999999999999 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.420000000000002 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.530000000000001 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.230000000000004 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 55.32 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 60.409999999999997 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 73.319999999999993 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.49 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 70.420000000000002 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.239999999999995 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 63.43 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.219999999999999 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.510000000000005 113.148 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 70.420000000000002 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.528 HD22 HG23 ' A' ' 92' ' ' ILE . 25.1 t-20 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.420000000000002 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 45.329999999999998 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.458 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.319999999999993 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.399999999999999 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.310000000000002 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.129999999999995 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 74.049999999999997 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.120000000000005 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 63.310000000000002 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.549999999999997 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.150000000000006 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 42' ' ' LYS . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 63.399999999999999 112.346 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.621 HG13 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.140000000000001 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.049999999999997 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.299999999999997 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.209999999999994 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 63.420000000000002 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.230000000000004 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt -84.52 104.37 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.329999999999998 111.295 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.0 mm -84.05 -13.5 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 110.404 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.41 -1.13 9.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.642 -0.708 . . . . 75.439999999999998 112.046 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.66 -4.48 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.258 -0.428 . . . . 74.109999999999999 111.71 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.4 m 69.48 -50.55 0.61 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.139 0.575 . . . . 71.319999999999993 111.304 -172.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 t80 60.5 26.86 16.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.579 0.704 . . . . 75.409999999999997 111.284 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 108' ' ' ASP . 8.4 p -166.86 169.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.521 -0.763 . . . . 71.310000000000002 110.346 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 107' ' ' VAL . 31.1 t70 79.5 159.63 0.18 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.716 0.806 . . . . 74.010000000000005 112.126 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.38 -20.79 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.689 -0.687 . . . . 72.400000000000006 111.643 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.4 p -142.87 45.7 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.829 0.347 . . . . 62.049999999999997 110.947 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -48.01 -59.35 6.3 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.121 0.808 . . . . 75.409999999999997 115.121 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.37 -79.23 0.59 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.391 0.595 . . . . 74.430000000000007 111.69 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -142.21 99.5 3.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 71.099999999999994 110.499 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 114' ' ' LEU . 1.9 pt? -176.35 144.73 0.56 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.99 0.424 . . . . 74.040000000000006 111.776 -174.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 mt -127.39 91.39 46.21 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.439999999999998 110.822 171.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.04 126.74 8.86 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.905 2.404 . . . . 44.229999999999997 113.437 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.82 113.29 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.095 0.474 . . . . 61.329999999999998 110.694 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.84 175.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 73.409999999999997 111.891 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.75 127.86 38.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 111.22 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.0 mp -98.89 100.51 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.126 0.489 . . . . 61.420000000000002 110.463 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 58.0 mt -98.93 116.94 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.067 0.46 . . . . 63.5 111.79 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -141.97 105.86 4.73 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 70.519999999999996 110.319 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 30.9 t -122.16 -172.37 2.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.165 0.186 . . . . 44.439999999999998 111.12 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 123' ' ' SER . 45.7 tt0 74.97 -46.21 0.59 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.828 0.677 . . . . 74.519999999999996 112.828 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.85 -4.2 6.37 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.105 0.78 . . . . 75.239999999999995 113.105 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.33 0.63 55.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.606 0.595 . . . . 53.149999999999999 112.606 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.71 89.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.928 0.394 . . . . 55.030000000000001 111.873 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.08 117.49 29.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.776 0.322 . . . . 65.439999999999998 110.481 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.19 146.75 31.6 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 73.329999999999998 112.046 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -130.85 77.33 1.78 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.097 0.475 . . . . 71.5 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -85.01 77.43 10.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.083 0.468 . . . . 73.109999999999999 112.152 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.1 p80 176.56 151.44 0.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 72.420000000000002 110.057 173.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -63.85 98.72 0.21 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.094 0.474 . . . . 74.129999999999995 111.928 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -78.49 103.05 8.17 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.258 0.551 . . . . 73.019999999999996 110.098 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.1 t60 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.687 -0.673 . . . . 74.140000000000001 111.735 -174.459 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.669 0.271 . . . . 74.129999999999995 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.36 107.93 8.96 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.998 0.428 . . . . 73.400000000000006 110.692 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -162.86 150.37 13.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.873 0.368 . . . . 71.310000000000002 111.591 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -80.92 69.19 7.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.057 0.456 . . . . 74.230000000000004 111.444 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -84.29 109.47 17.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.182 0.515 . . . . 72.430000000000007 111.187 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' HB3' HG21 ' A' ' 87' ' ' ILE . 70.1 m-85 -75.63 98.77 4.12 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.885 -0.598 . . . . 72.25 111.537 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.400000000000006 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.219999999999999 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.130000000000003 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 63.43 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.340000000000003 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.510000000000005 109.337 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.420000000000002 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.409999999999997 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.340000000000003 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.349999999999994 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.200000000000003 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 61.130000000000003 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 63.200000000000003 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.409999999999997 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.120000000000005 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 61.329999999999998 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.299999999999997 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.129999999999995 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 74.129999999999995 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.430000000000007 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.120000000000005 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.129999999999995 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.129999999999995 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.310000000000002 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 51.210000000000001 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 31.510000000000002 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.109999999999999 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.310000000000002 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.409999999999997 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.010000000000005 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 54.310000000000002 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 72.129999999999995 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.329999999999998 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.109999999999999 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.230000000000004 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.319999999999993 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.340000000000003 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 61.450000000000003 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 65.420000000000002 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.439999999999998 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 53.030000000000001 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.340000000000003 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.030000000000001 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 61.340000000000003 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.230000000000004 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.209999999999994 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.010000000000005 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 65.420000000000002 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.430000000000007 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.310000000000002 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.140000000000001 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.450000000000003 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 71.25 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.019999999999996 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.219999999999999 111.231 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.530000000000001 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.239999999999995 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt -85.26 115.61 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.209999999999994 112.189 -173.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 102' ' ' ILE . 4.0 mp -82.32 -37.11 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.101 -0.5 . . . . 75.400000000000006 109.999 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 70.5 152.79 0.11 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.099 -0.955 . . . . 74.510000000000005 111.685 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.4 m -86.65 35.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.604 . . . . 75.420000000000002 111.92 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.6 t -80.86 38.12 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.533 . . . . 23.039999999999999 111.479 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.88 90.29 5.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.934 0.397 . . . . 73.510000000000005 111.887 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.14 137.01 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.315 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -104.71 31.62 4.63 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.871 0.367 . . . . 74.239999999999995 111.726 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 110' ' ' THR . 10.0 pt-20 -73.94 -37.07 64.67 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.787 0.662 . . . . 72.239999999999995 112.787 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 109' ' ' GLU . 19.5 p -91.72 144.7 25.24 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.081 -0.387 . . . . 75.430000000000007 111.945 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.6 72.09 2.44 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.304 -0.474 . . . . 62.409999999999997 112.512 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.89 -56.93 3.32 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.938 0.399 . . . . 74.209999999999994 111.85 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -136.36 100.88 4.5 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.252 0.548 . . . . 52.030000000000001 111.412 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.657 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -131.3 68.75 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.83 0.824 . . . . 53.119999999999997 111.478 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.2 tp -103.23 131.98 21.57 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.773 -0.649 . . . . 72.340000000000003 110.963 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.72 108.2 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.59 2.194 . . . . 74.340000000000003 112.875 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -85.65 131.12 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.22 0.534 . . . . 61.310000000000002 112.188 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.06 93.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.225 0.536 . . . . 73.010000000000005 111.344 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -144.37 151.68 39.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.111 -0.495 . . . . 72.310000000000002 110.71 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.5 mp -79.61 90.11 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.323 0.582 . . . . 64.219999999999999 111.336 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.2 pt -76.1 130.74 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.077 -0.51 . . . . 72.430000000000007 110.428 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -133.9 147.98 51.18 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.398 0.518 . . . . 72.230000000000004 112.398 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.7 t -163.72 -162.97 0.75 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.045 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 75.8 -57.42 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.149 0.796 . . . . 64.430000000000007 113.149 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.49 -9.41 41.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.434 0.902 . . . . 61.039999999999999 113.434 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.15 27.89 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.791 0.663 . . . . 73.310000000000002 112.791 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.23 137.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.691 0.626 . . . . 72.219999999999999 112.691 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.13 97.35 7.46 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.314 0.578 . . . . 72.209999999999994 110.855 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.48 179.64 2.9 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.731 -0.668 . . . . 51.25 111.953 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -154.93 -175.39 5.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.637 -0.256 . . . . 73.400000000000006 110.976 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -133.11 156.52 47.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.487 0.184 . . . . 71.040000000000006 110.746 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -98.51 164.42 12.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.192 0.52 . . . . 63.109999999999999 112.273 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -132.51 147.84 52.37 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 75.430000000000007 111.514 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 31.2 m170 -120.18 113.8 20.98 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.627 -0.508 . . . . 73.349999999999994 109.627 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 76.2 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 123.61 0.764 . . . . 74.030000000000001 110.886 -168.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.812 0.339 . . . . 61.539999999999999 110.966 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.96 91.13 0.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 73.219999999999999 111.386 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.1 m -156.74 -61.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.823 0.344 . . . . 74.510000000000005 111.919 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -122.17 16.92 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.833 0.309 . . . . 74.409999999999997 111.833 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 48.57 65.72 1.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.112 0.482 . . . . 73.25 111.236 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' HG21 ' A' ' 87' ' ' ILE . 84.6 m-85 -63.83 104.21 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 65.109999999999999 111.649 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.409999999999997 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.430000000000007 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 56' ' ' SER . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.409999999999997 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 64.439999999999998 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 60.439999999999998 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 63.439999999999998 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.200000000000003 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.209999999999994 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.400000000000006 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.420000000000002 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.099999999999994 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.099999999999994 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.109999999999999 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.329999999999998 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.109999999999999 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.44 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.299999999999997 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.020000000000003 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 61.219999999999999 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 62.329999999999998 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 65.409999999999997 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.329999999999998 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.420000000000002 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.049999999999997 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD2' HG11 ' A' ' 41' ' ' VAL . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.099999999999994 110.174 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.219999999999999 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.319999999999993 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.450000000000003 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 76' ' ' LEU . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.240000000000002 112.261 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.420000000000002 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 72.439999999999998 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.130000000000003 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 64.519999999999996 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.140000000000001 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' PRO . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.329999999999998 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.510000000000005 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.409999999999997 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.120000000000005 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.430000000000007 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 94' ' ' VAL . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.450000000000003 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.420000000000002 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.120000000000005 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.409999999999997 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.420000000000002 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.329999999999998 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.130000000000003 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.010000000000005 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.200000000000003 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.409999999999997 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 82' ' ' ASN . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.520000000000003 110.567 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.129999999999995 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 73.120000000000005 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.230000000000004 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.340000000000003 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.420000000000002 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.230000000000004 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 103' ' ' ASP . 51.7 mt -77.19 125.46 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 70.219999999999999 111.22 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 102' ' ' ILE . 24.0 mm -76.55 14.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.333 0.587 . . . . 61.329999999999998 112.284 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 101' ' ' ILE . 30.5 t70 -73.32 13.82 0.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.34 0.591 . . . . 74.530000000000001 112.362 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.5 m -112.95 28.08 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 122.156 -0.34 . . . . 72.129999999999995 111.339 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m 70.12 -69.18 0.18 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.045 0.538 . . . . 62.340000000000003 110.366 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 67.14 2.99 2.99 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.351 0.871 . . . . 71.329999999999998 113.351 168.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -133.94 122.99 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.199 0.523 . . . . 70.129999999999995 112.404 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.02 -34.28 0.81 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.356 0.598 . . . . 65.409999999999997 110.616 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -75.04 -70.76 0.4 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.666 -0.697 . . . . 63.149999999999999 109.975 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.7 p -157.56 167.58 29.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.973 0.509 . . . . 71.310000000000002 110.908 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.56 -166.41 38.61 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.086 -0.578 . . . . 60.310000000000002 112.812 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.669 ' HG2' ' H ' ' A' ' 113' ' ' ASP . 3.9 ttmp? -148.68 -174.59 4.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.977 -0.379 . . . . 72.120000000000005 109.977 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 6.2 m-20 -59.74 88.49 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.279 0.561 . . . . 60.350000000000001 112.069 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 pp -173.65 154.65 2.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.305 -0.861 . . . . 70.439999999999998 110.024 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -97.81 165.2 15.91 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.161 0.43 . . . . 64.530000000000001 112.161 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.54 97.15 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.279 1.986 . . . . 71.409999999999997 112.518 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.52 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.902 0.858 . . . . 71.420000000000002 111.548 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.37 109.63 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.799 -0.637 . . . . 75.310000000000002 111.92 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.96 118.1 33.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.301 -0.409 . . . . 73.5 109.985 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.816 HG22 HD12 ' A' ' 121' ' ' ILE . 7.7 mt -84.51 157.97 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.029 0.381 . . . . 74.400000000000006 112.029 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 120' ' ' ILE . 3.6 mp 55.2 65.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.919 0.866 . . . . 73.140000000000001 110.382 -170.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -142.43 12.86 1.95 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.757 -0.656 . . . . 71.25 111.373 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -80.25 163.19 24.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.052 0.454 . . . . 73.310000000000002 111.779 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 63.22 14.07 7.45 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.916 -0.584 . . . . 75.319999999999993 112.469 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.56 50.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.99 0.424 . . . . 64.120000000000005 111.203 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.71 88.75 2.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.19 -0.459 . . . . 70.340000000000003 111.583 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.04 103.76 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.261 0.553 . . . . 61.140000000000001 111.251 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.09 24.09 8.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.054 0.454 . . . . 73.439999999999998 111.599 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.07 13.15 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.824 0.676 . . . . 62.420000000000002 112.824 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -89.64 141.72 28.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.881 0.372 . . . . 75.329999999999998 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.95 130.93 50.18 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.706 0.632 . . . . 63.219999999999999 112.706 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -162.48 121.65 2.27 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.041 0.386 . . . . 74.319999999999993 112.041 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -92.98 133.43 36.13 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.354 -0.385 . . . . 70.420000000000002 111.019 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.5 m80 59.63 -172.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.014 0.435 . . . . 74.430000000000007 111.497 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.597 -0.716 . . . . 73.230000000000004 111.029 172.734 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.521 0.2 . . . . 64.230000000000004 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 61.72 14.98 6.56 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.589 0.589 . . . . 72.230000000000004 112.589 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.6 m -117.62 144.78 44.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.96 -0.462 . . . . 61.25 111.595 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.11 -64.59 1.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.558 -0.292 . . . . 72.209999999999994 111.132 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 45.33 79.86 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.099 0.777 . . . . 65.030000000000001 113.099 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 -61.41 95.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.009 0.433 . . . . 54.420000000000002 110.679 172.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 53.409999999999997 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.319999999999993 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.239999999999995 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.539999999999999 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 72.230000000000004 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 74.140000000000001 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.409999999999997 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.109999999999999 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.519999999999996 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.420000000000002 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.399999999999999 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 72.530000000000001 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 53' ' ' ILE . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.430000000000007 112.306 -177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.019999999999996 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.129999999999995 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.510000000000005 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.209999999999994 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.040000000000006 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 44.420000000000002 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 71.409999999999997 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.209999999999994 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.400000000000006 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.310000000000002 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.299999999999997 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.109999999999999 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.319999999999993 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.310000000000002 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.409999999999997 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 62.43 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.109999999999999 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.510000000000005 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.129999999999995 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.400000000000006 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.319999999999993 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.349999999999994 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.539999999999999 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.439999999999998 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.349999999999994 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 73.140000000000001 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.109999999999999 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.310000000000002 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.109999999999999 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.230000000000004 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.030000000000001 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 64.329999999999998 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.319999999999993 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 64.049999999999997 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.039999999999999 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 41.100000000000001 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 33.229999999999997 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.129999999999995 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.430000000000007 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 62.409999999999997 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.109999999999999 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.420000000000002 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.549999999999997 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -65.39 118.63 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.76 82.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.909 0.861 . . . . 70.25 110.284 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -138.86 5.87 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.892 -1.049 . . . . 65.129999999999995 110.469 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 106' ' ' TYR . 30.0 m -93.84 0.89 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.154 -0.93 . . . . 73.239999999999995 111.762 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.6 m 69.23 -13.0 0.38 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.262 0.838 . . . . 63.299999999999997 113.262 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.428 ' H ' HG23 ' A' ' 104' ' ' VAL . 71.0 m-85 -75.67 86.08 2.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 73.400000000000006 112.003 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.72 -166.82 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.936 -0.574 . . . . 71.219999999999999 110.758 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.58 158.17 31.37 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.003 0.43 . . . . 75.140000000000001 111.584 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.19 5.76 5.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.822 0.675 . . . . 75.140000000000001 112.822 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -143.52 -55.7 0.39 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.803 1.038 . . . . 72.409999999999997 113.803 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.04 57.91 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.607 -0.806 . . . . 65.099999999999994 113.395 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.47 -68.67 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.175 0.512 . . . . 74.319999999999993 110.208 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -155.66 94.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.46 0.648 . . . . 65.219999999999999 110.139 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.4 pp -115.65 149.94 37.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.844 -0.616 . . . . 64.430000000000007 111.213 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -90.68 165.12 23.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.146 0.424 . . . . 71.439999999999998 112.146 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.88 114.55 2.21 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.932 2.421 . . . . 74.540000000000006 113.173 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.51 112.23 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.514 0.673 . . . . 72.230000000000004 110.795 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.26 -170.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.6 -0.727 . . . . 74.349999999999994 112.21 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.57 107.21 2.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.167 0.508 . . . . 64.340000000000003 111.64 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.45 153.57 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 111.259 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.9 mp -73.73 81.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.581 0.705 . . . . 63.539999999999999 110.307 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -170.05 -174.06 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.001 -1.0 . . . . 54.520000000000003 110.06 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.9 p -140.09 164.46 29.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.019 0.378 . . . . 72.409999999999997 112.019 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 60.55 23.61 13.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.302 0.572 . . . . 53.439999999999998 111.006 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.4 9.85 3.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.937 -0.574 . . . . 60.530000000000001 111.957 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.46 29.46 18.34 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.516 0.561 . . . . 30.050000000000001 112.516 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.83 163.02 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.708 0.633 . . . . 74.5 112.708 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 mt -110.44 33.67 4.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.077 -0.511 . . . . 61.32 112.109 -173.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.69 84.45 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.458 0.647 . . . . 75.510000000000005 112.549 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.48 141.54 37.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.762 -0.654 . . . . 74.219999999999999 110.168 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.8 t60 67.91 131.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.977 0.417 . . . . 62.240000000000002 111.326 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 133' ' ' HIS . 56.0 t60 -143.79 -39.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.194 0.812 . . . . 62.399999999999999 113.194 -173.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 132' ' ' HIS . 88.4 m-70 71.04 148.11 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.054 0.542 . . . . 71.140000000000001 112.153 -173.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -169.15 133.68 1.46 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.069 -0.514 . . . . 71.200000000000003 110.853 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.76 -0.638 . . . . 75.5 111.964 -177.159 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 121.279 0.561 . . . . 72.3 110.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 64.0 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.31 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.44 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 62.51 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.14 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.12 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 ' CA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 64.14 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.31 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.14 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.52 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.44 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 52.22 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG12 ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.42 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.23 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 54.21 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.05 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.3 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.14 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 64.15 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 73.42 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.02 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 51.13 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.24 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.3 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.12 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.45 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 43.11 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 34.11 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.13 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.24 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.53 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 65.5 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.53 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 63.43 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.31 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.14 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.32 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.55 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.33 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.33 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 61.33 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.405 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.3 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.12 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.03 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 72.42 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' THR . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.43 110.542 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.55 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.54 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 53.24 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.45 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.24 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.51 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.34 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.44 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 72.43 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.34 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.41 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.23 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.31 111.504 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 60.21 112.061 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.53 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 41.23 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.701 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.21 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 62.24 110.656 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.45 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.32 108.974 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 43.21 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.14 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.42 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 42.53 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.03 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.42 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.33 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.44 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.24 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.02 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 70.02 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 64.21 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 70.33 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.33 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.02 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 73.03 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 70.13 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.42 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 73.33 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 51.32 112.825 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.02 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 64.31 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.31 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.24 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.44 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.24 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 54.2 113.853 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.34 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 72.12 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.12 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.13 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.31 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.43 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.11 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.02 112.046 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.537 HG22 HG13 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 55.25 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 34.23 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.23 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.24 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.14 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 70.12 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.43 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 44.31 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.33 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 64.31 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 65.41 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.466 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.3 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.53 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.23 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.23 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.55 110.53 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 65.3 110.915 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 74.33 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 60.21 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.13 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 65.43 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.34 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.54 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.33 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.45 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 42.33 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.31 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 63.13 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.44 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.05 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.53 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.02 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.12 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 64.25 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.31 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.41 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 70.35 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 71.35 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.15 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.42 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.54 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 70.15 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.31 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.01 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.02 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.4 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.14 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.01 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.33 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.41 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.23 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 64.22 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 65.22 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 60.01 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.21 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.54 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.44 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.01 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.23 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.52 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.607 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 70.02 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.44 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.12 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.15 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.33 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.11 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.762 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.11 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.12 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.674 ' HB ' HG22 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.4 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.14 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 63.23 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 53.4 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 64.02 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.42 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 65.43 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.33 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 64.24 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 45.32 110.818 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' HG21 ' A' ' 87' ' ' ILE . 91.5 m-85 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.54 111.912 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.01 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 54.4 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.35 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.32 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.3 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.43 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.33 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.43 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.43 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.15 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.31 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.24 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.21 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.53 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.34 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.41 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.14 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.4 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.02 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.44 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.13 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.3 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.43 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.3 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 41' ' ' VAL . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 65.54 111.612 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 64.21 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' OG ' HG11 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.52 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 63.53 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.32 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.23 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 42.5 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.01 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.44 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.31 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.14 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.55 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.61 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.22 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.3 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.51 111.15 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.23 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.1 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.51 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 51.25 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.12 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 61.34 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.22 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.559 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 52.31 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.3 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 54.43 110.644 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.1 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.23 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.23 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.436 HG11 ' OG ' ' A' ' 66' ' ' SER . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.3 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 62.52 112.377 -172.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.05 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 72.31 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.15 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 64.33 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.12 110.536 176.435 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.4 111.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 53.01 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 64.41 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.3 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 44.03 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 64.55 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 64.43 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.44 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 62.11 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.03 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.52 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.02 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.34 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.44 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 61.1 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 51.53 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.04 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 53.13 112.247 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.21 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.35 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 63.32 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.51 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.52 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 51.51 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.13 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.33 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.44 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.44 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.22 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.598 ' HB3' HD22 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.41 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 64.24 111.544 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.14 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.11 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.12 113.736 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.53 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 73.32 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HG3' HD11 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.23 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.22 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.12 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.43 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.43 110.391 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.34 114.503 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.05 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 41.32 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.13 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.24 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.51 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 61.25 112.29 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.22 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.21 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.43 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.43 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.22 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.6 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.53 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 51.51 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.43 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.23 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.52 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.43 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.44 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 64.41 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 40.53 112.743 -171.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.743 0.306 . . . . 74.33 111.756 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 53.5 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.03 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.21 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 61.13 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.45 111.591 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.42 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.595 HG12 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.53 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.53 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.33 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.41 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.2 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.595 ' CA ' HG12 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.15 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 63.33 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.12 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 61.04 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 50.04 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.32 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 63.52 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.23 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.45 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.4 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.24 111.206 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.02 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HB2' HD12 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.24 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 84' ' ' THR . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.34 109.848 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.33 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.24 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 71.53 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 53.01 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.11 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.54 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.2 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.33 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.51 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.21 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 72.12 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.45 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.24 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 74.5 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.22 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 71.12 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.33 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 33.31 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.05 111.312 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 33.41 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 63.12 111.425 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.52 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 54.54 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.14 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.12 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.02 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.54 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.15 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.15 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.04 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.33 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 70.13 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 44.41 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.34 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 62.54 111.088 -175.781 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 87' ' ' ILE . 33.2 m-85 . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.22 111.55 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.13 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.43 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.44 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.12 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.53 111.535 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.22 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.45 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.11 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.42 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.54 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 25.35 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 31.34 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.13 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 64.11 112.358 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 54.42 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.24 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 53.52 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.52 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.14 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.44 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.44 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.15 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 70.22 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.21 110.762 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.23 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.41 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 50.12 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.13 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.41 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 64.25 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.1 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.02 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.11 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.4 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.13 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.51 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.44 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.53 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.44 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.33 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.31 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.51 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.22 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.566 HG22 HG13 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.14 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.05 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.11 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.53 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 60.44 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.43 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.1 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 54.54 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.34 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 55.22 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.33 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.42 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.44 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.41 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.01 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.33 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt . . . . . 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.34 112.741 -168.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' ILE . 96.8 m-85 . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.44 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.22 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.35 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.53 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.1 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.33 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 73.15 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.781 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 64.53 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HG21 ' A' ' 53' ' ' ILE . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.45 110.37 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.33 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.54 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.21 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.24 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.32 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 47' ' ' ASP . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 65.24 111.668 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 63.52 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.35 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.4 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.41 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.35 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.53 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.32 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.01 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.42 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.3 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 62.23 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.21 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 72.45 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.42 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.43 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.44 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 32.22 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 52.11 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.14 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.2 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.43 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.41 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.22 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.54 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 71.05 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.21 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.11 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 60.23 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 73.43 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.52 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.02 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.22 110.884 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.24 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.54 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.32 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 35.3 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' HG22 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 64.15 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.11 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.13 112.446 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 65.32 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 64.5 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.41 112.062 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.32 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 62.01 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.44 111.025 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HB3' HG21 ' A' ' 87' ' ' ILE . 40.7 m-85 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.22 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.41 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 64.23 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.51 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.13 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.03 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 74.25 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 65.34 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 53.43 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.44 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.3 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.22 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 71.12 112.192 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 35.25 111.546 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.2 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.44 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.53 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 51.34 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.42 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.31 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.13 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.43 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 72.23 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.12 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.21 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.53 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.42 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.32 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.1 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.22 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.13 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.32 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 65.43 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.14 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 54.35 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.22 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 61.45 109.645 170.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.52 113.168 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.42 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.35 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.33 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.3 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.41 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.567 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.4 110.143 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.23 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.13 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.33 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.45 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.02 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.15 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.609 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.11 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.23 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.24 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.11 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 64.02 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.43 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 71.11 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.11 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 64.3 110.995 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 . . . . . 0 N--CA 1.476 0.841 0 CA-C-O 121.381 0.61 . . . . 74.34 112.495 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.15 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.781 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.55 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.2 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.34 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.12 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.32 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 55.14 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 61.23 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.33 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.52 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.24 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 63.42 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 71.04 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.45 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 55.24 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.4 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.1 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.31 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.01 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.01 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.31 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.22 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 72.32 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 60.02 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 60.51 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 54.31 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 61.03 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.23 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.4 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.45 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.24 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.05 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.01 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.3 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.4 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 63.3 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.3 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.13 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.23 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.42 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.14 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 61.41 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 25.42 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.13 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.42 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.52 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.23 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.33 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.1 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 61.31 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.24 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.01 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.21 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.33 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.22 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.24 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 64.31 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 64.41 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 72.32 111.96 -171.81 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.179 0.514 . . . . 73.35 112.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.22 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.31 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.34 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 62.31 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.22 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 70.32 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 70.15 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.24 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 44.03 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 24.34 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.43 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.1 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.44 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 51.52 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.11 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.53 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.03 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 53.44 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.24 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.21 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 73.43 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.53 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.12 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.14 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.52 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.13 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.21 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.45 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 44.21 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.43 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.1 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 52.13 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 70.21 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.22 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.4 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 72.52 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.32 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.24 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.33 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 63.05 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 54.15 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.544 HG22 HG13 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 64.12 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.55 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.01 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.35 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.12 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.54 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.04 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 41.34 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.14 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.52 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.32 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 63.1 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.34 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 73.33 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 73.51 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.2 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.15 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 64.52 109.968 175.116 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 120.944 0.402 . . . . 72.53 111.471 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.24 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.12 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.44 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.23 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.23 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 53.5 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.33 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.22 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.12 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.34 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 64.42 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.01 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.52 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 64.43 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.43 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.01 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.24 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.42 111.101 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.23 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.31 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.34 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.24 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.13 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.43 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.11 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.44 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.13 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.52 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.12 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 71.32 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 64.42 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.24 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.4 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.42 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.13 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 45.15 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.01 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 73.35 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.44 111.17 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 62' ' ' TYR . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 64.23 110.912 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.14 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.43 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 61.52 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.21 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.1 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.4 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 64.12 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.23 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.32 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.23 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.21 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.1 111.605 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.695 0.283 . . . . 74.33 111.094 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.03 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.44 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.45 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.11 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.31 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.41 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.15 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.55 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.4 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.23 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.21 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 45.3 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.22 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 HG21 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 44.01 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 52.1 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.55 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.23 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.13 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 64.45 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.02 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 60.34 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.45 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.55 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.05 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CD2' HG11 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.44 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.23 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.53 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 64.43 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.4 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.41 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.45 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.03 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 70.3 113.284 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.51 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.654 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.24 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 70.54 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.526 ' HD3' HG22 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 74.45 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 52.31 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 70.34 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.34 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.14 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.35 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.03 112.401 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.706 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.24 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.52 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.23 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.14 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.11 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.52 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.24 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.21 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 63.55 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.14 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.12 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.34 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.35 110.408 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.526 HG22 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.15 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.21 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.05 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 53.44 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt . . . . . 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.11 111.758 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.013 0.435 . . . . 64.4 111.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.04 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.802 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 62.3 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.21 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.31 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.21 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.55 109.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG12 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.21 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.53 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.03 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.51 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.22 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.04 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.594 ' CA ' HG12 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.34 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.01 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.24 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.42 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 24.03 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.11 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 54.24 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.22 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.24 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.3 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.33 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 50.44 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.21 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.23 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.05 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.12 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.22 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.54 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.54 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.32 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.43 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.4 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.05 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.12 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.1 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.23 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 65.11 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 35.41 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 94' ' ' VAL . 9.3 t30 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.54 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 61.33 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.32 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.22 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 65.21 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.15 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.04 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.4 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.802 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.24 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 72.01 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.41 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.434 ' HD3' HG21 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.45 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.44 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.43 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.14 112.304 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.43 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.22 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 60.55 110.438 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.589 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 . . . . . 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.13 110.0 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 60' ' ' THR . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 62.34 111.642 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.12 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.34 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.43 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.23 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 65.42 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.55 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.32 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.23 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.13 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.33 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.33 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.34 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.14 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.44 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.24 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.24 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.31 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.11 111.71 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.22 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.52 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.11 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.31 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.44 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 74.1 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 61.21 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.44 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.45 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.41 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.13 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 30.41 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.54 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.31 110.94 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.3 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.51 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 72.24 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 44.25 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 73.34 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.15 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.03 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.667 HD22 HG23 ' A' ' 88' ' ' THR . 0.9 OUTLIER -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.22 111.359 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.03 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 HD22 ' A' ' 86' ' ' ASN . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 62.3 111.087 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.3 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.13 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.23 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.635 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.53 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.03 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.34 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.14 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.44 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.22 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 75' ' ' LYS . 64.1 mt . . . . . 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.22 111.541 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.54 110.887 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 72.02 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 43.42 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.15 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.31 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.02 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 73.22 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 64.42 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.3 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.2 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.4 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 64.1 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.11 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.13 111.759 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.03 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.53 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 61.45 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.44 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 55.34 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 74.11 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.45 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.23 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 63.1 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' LEU . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.44 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.53 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 41.45 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 43.45 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.12 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.02 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.3 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.13 110.932 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.02 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 65.15 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 65.0 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.11 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.416 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 62.31 111.821 -178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.44 112.19 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.11 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.12 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.13 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.33 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 72.32 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.11 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.22 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.22 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.12 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.43 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.43 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.34 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.22 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.45 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 71.34 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.24 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.34 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 72.11 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 77' ' ' ARG . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.2 111.653 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 63.21 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 77' ' ' ARG . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 70.52 110.255 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.34 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.31 111.071 179.815 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 110.053 -0.351 . . . . 73.31 110.053 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 32.22 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.3 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.3 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.14 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.41 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 65.15 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.2 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.44 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.05 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.11 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.32 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 53' ' ' ILE . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.34 112.483 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.21 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.33 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.1 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.41 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.01 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.4 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.33 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.33 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 53.25 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.15 110.347 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.21 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.35 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.33 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 53.22 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.42 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.53 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.23 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 55.32 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 60.41 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 73.32 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.49 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.31 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 70.42 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.24 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 63.43 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.22 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.51 113.148 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 70.42 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.529 HD21 HG22 ' A' ' 92' ' ' ILE . 8.3 t30 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.42 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 45.33 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.458 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.32 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.4 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.31 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.13 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 74.05 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.12 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 63.31 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.55 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.15 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 42' ' ' LYS . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 63.4 112.346 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.621 HG13 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.14 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.05 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.3 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.21 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 63.42 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.23 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.33 111.295 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' HB3' HG21 ' A' ' 87' ' ' ILE . 70.1 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.899 0.38 . . . . 72.25 111.537 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.4 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.22 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.13 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 63.43 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.34 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.51 109.337 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.42 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.41 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.34 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.35 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.2 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 61.13 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 63.2 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.41 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.12 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 61.33 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.3 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.13 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 74.13 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.43 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.12 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.13 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.13 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.31 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 51.21 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 31.51 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.11 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.31 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.41 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.01 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 54.31 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 72.13 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.33 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.11 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.23 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.32 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.34 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 61.45 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 65.42 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.44 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 53.03 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.34 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.03 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 61.34 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.23 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.21 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.01 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 65.42 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.43 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.31 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.14 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.45 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 71.25 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.34 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.02 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.22 111.231 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.53 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.24 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.21 112.189 -173.646 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' HG21 ' A' ' 87' ' ' ILE . 84.6 m-85 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 120.979 0.419 . . . . 65.11 111.649 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.41 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.767 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.43 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 56' ' ' SER . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.41 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 64.44 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 60.44 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 63.44 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.2 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.21 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.4 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.42 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.1 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.1 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.11 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.33 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.11 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.44 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.3 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.02 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 61.22 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 62.33 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 65.41 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.33 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.42 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.05 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD2' HG11 ' A' ' 41' ' ' VAL . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.1 110.174 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.22 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.32 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.45 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 76' ' ' LEU . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.24 112.261 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.42 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 72.44 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.13 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 64.52 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.14 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' PRO . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.51 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.41 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.12 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.43 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 94' ' ' VAL . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.45 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.42 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.12 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.41 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.42 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.33 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.13 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.01 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.2 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.41 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 82' ' ' ASN . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.52 110.567 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.13 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 73.12 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.34 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.42 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.23 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.7 mt . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 70.22 111.22 -174.688 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.009 0.433 . . . . 54.42 110.679 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 53.41 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.24 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.54 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 72.23 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 74.14 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.41 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.14 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.11 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.52 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.42 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.4 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 72.53 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 53' ' ' ILE . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.43 112.306 -177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.02 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.13 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.51 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.21 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.04 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 44.42 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 71.41 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.21 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.4 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.31 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.3 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.11 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.31 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.41 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 62.43 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.11 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.51 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.13 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.4 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.32 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.35 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.44 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.35 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 73.14 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.11 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.31 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.11 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.23 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.03 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 64.33 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.32 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 64.05 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.04 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 41.1 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 33.23 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.13 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.43 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 62.41 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.11 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.32 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.43 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.42 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.55 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.483 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.739 0.304 . . . . 65.43 111.268 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -86.5 -41.76 14.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.815 0.341 . . . . 74.11 111.385 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.8 p -68.6 -45.82 70.94 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.321 -0.4 . . . . 64.11 111.949 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 60.83 24.27 14.22 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.318 0.58 . . . . 74.44 111.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 t30 60.53 37.24 19.71 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.43 -0.805 . . . . 74.44 112.664 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -72.88 87.13 1.3 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.727 -0.608 . . . . 72.3 110.101 169.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 60' ' ' THR . 46.6 p -132.98 166.79 21.57 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.635 -0.712 . . . . 64.0 111.141 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.4 t -120.18 119.94 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.081 0.467 . . . . 74.31 111.459 178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HE2' ' HG2' ' A' ' 44' ' ' GLU . 2.0 tmtp? -93.91 122.7 36.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.292 0.568 . . . . 74.44 110.891 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG22 ' HB ' ' A' ' 94' ' ' VAL . 36.7 t -99.86 119.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.206 -0.452 . . . . 62.51 111.759 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.515 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 49.8 mt-10 -105.22 144.54 31.87 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.201 0.524 . . . . 74.14 111.063 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 49.8 m-85 -119.48 101.33 7.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.08 0.466 . . . . 74.12 110.678 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG12 ' CA ' ' A' ' 52' ' ' GLU . 21.1 m -120.55 165.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.086 0.47 . . . . 64.14 111.912 -172.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -92.53 -175.57 4.02 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.31 111.574 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.75 -2.74 21.54 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.972 0.415 . . . . 75.14 111.708 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -95.95 -9.49 31.06 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.49 -0.323 . . . . 62.52 111.374 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.06 36.8 10.64 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.532 -0.366 . . . . 72.44 113.634 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -134.98 128.1 31.79 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.651 -0.323 . . . . 52.22 110.669 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.589 ' CA ' HG12 ' A' ' 46' ' ' VAL . 13.4 pt-20 -62.89 110.65 1.84 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.264 1.031 . . . . 74.42 111.289 -177.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 HD13 ' A' ' 71' ' ' ILE . 13.2 pt -89.47 4.24 5.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.71 -1.132 . . . . 75.23 111.724 -177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.56 155.72 31.75 Favored Pre-proline 0 N--CA 1.468 0.442 0 CA-C-N 116.371 -0.377 . . . . 54.21 111.819 -172.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -59.29 135.75 67.61 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.523 2.149 . . . . 75.05 113.284 175.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.32 170.85 11.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.2 -0.909 . . . . 75.3 112.089 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -132.85 165.69 24.02 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.125 0.488 . . . . 74.14 111.647 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.4 m -128.64 103.94 7.38 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.206 -0.452 . . . . 64.15 110.596 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.43 105.55 12.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.022 0.439 . . . . 73.42 111.156 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.546 ' HA ' HG22 ' A' ' 40' ' ' THR . 12.9 t -90.92 2.07 56.51 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.087 0.47 . . . . 71.02 111.884 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -78.71 143.19 36.46 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.142 -0.481 . . . . 51.13 110.902 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -55.03 -38.25 67.71 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.94 0.4 . . . . 62.24 110.994 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -97.37 88.38 4.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 75.3 110.548 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 34.7 p90 -68.41 87.85 0.31 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.948 0.88 . . . . 74.12 110.154 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.43 110.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.527 -0.761 . . . . 70.45 110.107 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.8 p -100.15 166.78 10.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.33 0.586 . . . . 43.11 112.107 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.3 p -139.57 141.6 28.94 Favored Pre-proline 0 N--CA 1.47 0.566 0 CA-C-N 115.829 -0.623 . . . . 34.11 111.264 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.21 155.52 69.39 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.264 1.976 . . . . 75.13 112.338 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 99.0 mttt -116.18 149.21 39.45 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.203 0.525 . . . . 74.24 112.014 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -76.9 86.04 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.929 -0.578 . . . . 65.53 110.394 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.541 HD13 HG13 ' A' ' 53' ' ' ILE . 57.7 mt -88.94 124.6 64.82 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.109 -0.496 . . . . 65.5 111.328 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.2 106.77 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.691 2.261 . . . . 73.53 113.123 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.36 18.55 41.8 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.125 -0.559 . . . . 60.43 113.307 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 61.1 m-85 -139.24 141.66 37.84 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.476 0.655 . . . . 63.43 112.597 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.665 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.2 ttpt -120.54 144.18 48.19 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.689 -0.687 . . . . 74.31 110.712 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.8 tp -62.22 113.9 3.14 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.057 -0.402 . . . . 75.14 111.322 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -79.23 -45.29 20.11 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.091 0.472 . . . . 72.32 111.041 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -155.89 153.38 29.58 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.969 -0.56 . . . . 75.55 111.602 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 71.6 mt -95.41 116.24 66.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.305 -0.407 . . . . 73.33 110.09 170.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.9 Cg_endo -48.23 137.13 24.35 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.247 2.631 . . . . 64.33 113.848 -176.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -57.93 -8.38 0.98 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.138 0.792 . . . . 61.33 113.138 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.405 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.5 p-10 -124.52 26.87 7.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.72 0.408 . . . . 72.3 111.069 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -69.42 -32.94 72.22 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.178 0.807 . . . . 74.12 113.178 -174.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.4 p -136.57 139.04 41.89 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.757 0.313 . . . . 72.03 111.791 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.28 -158.59 31.49 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.768 -0.73 . . . . 63.43 113.564 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 131.58 44.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.688 0.395 . . . . 72.42 111.253 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' THR . 22.7 mt -67.17 94.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.526 0.679 . . . . 71.43 110.542 175.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.1 p -100.04 -16.94 17.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.507 -0.77 . . . . 75.55 111.455 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -137.9 166.8 23.14 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.346 -0.388 . . . . 73.54 111.551 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -103.45 153.5 20.45 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.99 0.424 . . . . 53.24 111.602 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.12 28.59 66.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.223 -0.444 . . . . 74.45 113.683 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.744 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.9 mt -82.69 139.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.763 0.316 . . . . 74.24 110.784 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 56.2 mt -123.5 122.56 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.207 0.527 . . . . 72.51 112.067 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.508 ' HB ' HG22 ' A' ' 43' ' ' VAL . 74.8 t -98.13 111.25 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.908 -0.587 . . . . 73.34 109.827 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 38.3 ttm180 -115.24 106.71 14.37 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.126 0.417 . . . . 61.43 112.126 -173.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -79.31 136.45 37.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.427 -0.351 . . . . 74.44 111.433 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -103.5 129.39 55.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.032 -0.531 . . . . 72.43 110.659 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.452 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 83.5 m-85 -118.24 141.07 48.89 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.905 0.383 . . . . 73.34 111.828 178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -87.95 137.02 32.7 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.819 -0.438 . . . . 74.41 109.819 174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -77.23 110.88 12.29 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.384 0.612 . . . . 74.23 112.063 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.665 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -78.77 113.86 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.501 -0.772 . . . . 73.31 111.504 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.5 mm -90.49 93.62 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.017 0.437 . . . . 75.12 110.342 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.6 t70 66.97 156.7 0.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.269 -0.878 . . . . 73.23 111.813 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 104' ' ' VAL . 10.1 t -80.75 4.39 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 CA-C-N 116.088 -0.505 . . . . 65.13 111.968 -175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.0 m 65.4 21.84 11.92 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.457 0.646 . . . . 74.03 109.739 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -107.34 50.94 0.76 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.419 -0.81 . . . . 75.41 111.417 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 109' ' ' GLU . 32.3 m -97.17 -25.59 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.383 0.611 . . . . 65.22 110.686 173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 63.96 -10.95 0.12 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.261 1.024 . . . . 64.41 113.449 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 107' ' ' VAL . 13.8 tp10 -74.7 -49.4 21.35 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.296 0.569 . . . . 73.11 110.362 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.2 p -96.99 93.97 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.72 -0.673 . . . . 61.52 111.57 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 56.53 -122.48 28.35 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.003 -0.544 . . . . 64.54 114.002 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -168.31 -65.19 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.086 0.47 . . . . 52.3 110.886 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -103.82 102.17 11.99 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.167 0.508 . . . . 65.05 110.24 177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 26.5 mt -112.71 -12.3 13.4 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.884 0.698 . . . . 71.4 112.884 -170.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.6 tp -66.26 136.37 95.2 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 111.913 0.338 . . . . 63.35 111.913 -171.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -58.27 170.3 2.4 Favored 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.916 2.411 . . . . 51.43 113.823 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.7 m -80.18 167.1 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 112.527 0.565 . . . . 71.51 112.527 -178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.2 96.1 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.518 0.675 . . . . 54.51 111.754 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -117.73 132.08 56.52 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.996 -0.547 . . . . 73.14 109.694 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.4 mm -68.75 109.73 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 113.501 0.926 . . . . 70.24 113.501 -169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -102.47 -178.16 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 116.063 -0.517 . . . . 60.2 111.231 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 65.32 -163.35 0.25 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.054 0.39 . . . . 72.11 112.054 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.7 m 69.9 150.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.523 0.678 . . . . 72.43 112.688 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 56.21 16.17 2.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.337 -0.847 . . . . 75.42 112.724 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -82.7 -3.87 57.03 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.47 0.652 . . . . 73.53 110.125 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -138.56 90.05 2.43 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.119 -0.946 . . . . 72.22 110.387 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.6 m -111.17 -37.28 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.819 0.674 . . . . 63.34 112.819 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 65.1 tp 73.81 -48.56 0.67 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 114.261 1.208 . . . . 75.1 114.261 173.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -41.8 119.28 1.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.936 1.087 . . . . 75.34 113.936 -167.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -146.01 145.84 30.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.617 -0.72 . . . . 53.51 110.546 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -147.18 107.66 4.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.58 0.585 . . . . 75.14 112.58 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -82.32 136.51 35.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.282 -0.417 . . . . 72.15 110.677 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -98.32 127.26 44.17 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.893 0.377 . . . . 74.14 111.052 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -53.13 -50.43 64.51 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.163 -0.471 . . . . 74.54 111.937 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.499 176.308 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 9.0 tmm? . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.861 0.362 . . . . 74.43 110.835 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -99.29 -81.7 0.45 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.701 0.286 . . . . 70.15 110.547 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' ASN . 79.1 p -104.54 70.27 0.94 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.401 0.62 . . . . 70.31 109.759 171.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 72.17 -69.28 0.19 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.419 -0.809 . . . . 64.24 110.856 -172.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m120 42.6 77.98 0.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 122.758 0.423 . . . . 73.31 111.879 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -55.05 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.488 0.661 . . . . 60.21 112.061 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.5 p -129.73 166.26 20.22 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.19 -0.914 . . . . 64.53 110.837 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.0 t -122.22 110.96 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 112.329 0.492 . . . . 41.23 112.329 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.701 ' HB2' ' HZ3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -75.04 135.64 41.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.145 -0.479 . . . . 75.21 110.758 174.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.6 t -119.36 115.54 48.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.825 0.345 . . . . 62.24 110.656 176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.676 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 56.5 mt-10 -104.63 138.08 41.51 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.254 0.55 . . . . 71.45 111.755 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -114.24 96.66 5.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.974 -0.75 . . . . 72.32 108.974 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.0 m -120.38 156.55 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 113.379 0.881 . . . . 43.21 113.379 -165.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -75.65 171.35 14.47 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.002 -0.999 . . . . 71.14 110.155 170.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -4.2 2.37 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.313 1.227 . . . . 74.42 114.313 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -92.83 -10.88 35.21 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.814 -0.554 . . . . 42.53 111.534 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.55 60.6 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.244 -0.435 . . . . 71.03 112.75 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.63 130.31 34.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 122.678 -0.307 . . . . 62.43 110.658 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -59.53 157.88 10.73 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.863 0.839 . . . . 73.42 112.504 -177.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 pt -132.83 0.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.205 -0.907 . . . . 71.33 110.835 174.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -160.54 149.4 13.59 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 115.873 -0.603 . . . . 74.44 111.497 -169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -43.12 122.48 2.85 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.358 2.705 . . . . 62.24 114.291 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.1 m -92.98 129.19 38.97 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.179 -0.919 . . . . 41.02 111.151 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 69' ' ' LYS . 58.0 m-20 -88.94 167.51 13.15 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.982 0.734 . . . . 70.02 112.982 -173.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -140.65 104.12 4.66 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.455 -0.793 . . . . 64.21 110.199 172.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -83.99 138.62 33.02 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.374 0.509 . . . . 70.33 112.374 -175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.4 t -102.23 -12.0 18.33 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.267 0.556 . . . . 71.33 111.312 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 130.59 42.49 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.84 -0.618 . . . . 55.02 112.014 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 81.6 t80 -51.86 -52.39 49.91 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.213 0.53 . . . . 73.03 111.215 177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.18 87.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.96 0.409 . . . . 70.13 110.003 173.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HE2' ' O ' ' A' ' 82' ' ' ASN . 55.5 p90 -77.23 116.97 18.3 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.468 0.652 . . . . 72.42 111.303 -177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 84' ' ' THR . 93.3 t -130.72 110.65 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.705 -0.679 . . . . 73.33 109.845 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.3 t -99.74 171.78 7.68 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.825 0.676 . . . . 51.32 112.825 -174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.6 p -133.39 132.79 22.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 CA-C-N 115.562 -0.744 . . . . 62.02 110.906 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.2 104.32 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.929 1.752 . . . . 64.31 112.149 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' HG13 ' A' ' 71' ' ' ILE . 53.1 mttp -53.07 127.3 23.57 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.033 0.444 . . . . 74.31 111.987 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.85 85.57 0.33 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.186 0.517 . . . . 73.24 110.212 176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 69' ' ' LYS . 61.0 mt -79.49 117.27 66.26 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.981 -0.554 . . . . 61.44 112.256 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.85 104.42 0.27 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.252 1.968 . . . . 74.24 112.325 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' HA2' HG11 ' A' ' 104' ' ' VAL . . . 109.58 -10.89 32.9 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.108 -0.568 . . . . 54.2 113.853 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 8.2 m-85 -124.5 140.19 53.18 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.448 0.642 . . . . 75.5 112.485 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.523 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.8 tttm -112.14 126.87 55.66 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.542 -0.754 . . . . 75.34 111.322 -175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.7 tp -63.09 122.92 17.27 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.736 0.303 . . . . 72.12 111.51 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HD3' ' CG2' ' A' ' 97' ' ' ILE . 15.5 ptm180 -92.49 -37.03 12.75 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.732 0.271 . . . . 74.12 111.732 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 13.2 pt-20 -163.93 161.71 23.05 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.219 0.533 . . . . 71.13 111.818 178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.8 mt -105.14 134.99 19.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.566 -0.743 . . . . 54.25 111.252 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.41 138.22 74.99 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.717 2.278 . . . . 73.31 112.798 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -62.07 -25.75 67.87 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.098 0.407 . . . . 75.43 112.098 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.433 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 3.0 p-10 -98.01 29.53 3.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.673 0.249 . . . . 74.11 111.673 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.34 -19.81 63.03 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.046 0.387 . . . . 74.02 112.046 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.537 HG22 HG13 ' A' ' 65' ' ' VAL . 74.7 p -140.36 129.87 24.1 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.27 -0.423 . . . . 55.25 111.156 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.37 -165.31 37.35 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.666 -0.778 . . . . 34.23 113.49 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 10.5 m-20 -98.41 138.32 35.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.405 0.282 . . . . 71.23 111.026 178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.1 mt -67.22 93.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.351 0.596 . . . . 72.24 109.669 172.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.3 p -107.23 -4.01 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.698 -0.683 . . . . 73.14 111.248 -177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -150.64 164.06 36.99 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.886 -0.597 . . . . 60.5 109.758 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.2 t -97.54 134.22 41.05 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.464 0.65 . . . . 70.12 112.742 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.22 36.63 17.21 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 115.709 -0.678 . . . . 73.43 113.782 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.5 mt -73.67 137.46 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 122.497 -0.414 . . . . 44.31 110.51 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 25.4 mt -120.9 119.37 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.434 0.635 . . . . 74.33 112.601 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 99.1 t -91.09 111.9 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.752 -0.658 . . . . 75.0 109.847 171.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.676 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 24.2 ttt180 -115.36 105.57 13.01 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.288 0.477 . . . . 64.31 112.288 -170.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -86.67 136.34 33.07 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.401 0.281 . . . . 65.41 111.357 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.466 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 8.6 mm -107.84 130.31 60.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 120.67 0.271 . . . . 74.3 111.182 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 70.4 m-85 -123.92 134.77 53.46 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.022 0.439 . . . . 74.53 112.161 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -95.06 128.89 42.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.956 -0.566 . . . . 73.23 110.36 173.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.72 128.63 38.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.023 0.44 . . . . 73.23 112.097 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HB2' ' A' ' 75' ' ' LYS . 47.8 mt -75.07 123.64 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.042 -0.526 . . . . 70.55 110.53 175.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mm -67.5 -49.36 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 74.34 112.193 -177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -100.28 97.2 8.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.357 0.599 . . . . 71.22 110.972 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.491 HG13 ' CD1' ' A' ' 106' ' ' TYR . 9.3 p -168.83 29.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 115.245 -0.888 . . . . 61.25 110.956 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.5 m 69.92 11.18 7.69 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.474 0.71 . . . . 65.41 111.933 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' CD1' HG13 ' A' ' 104' ' ' VAL . 11.5 m-85 -103.95 135.38 45.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.261 0.553 . . . . 74.03 109.868 175.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.13 148.78 4.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.67 -0.695 . . . . 55.04 111.768 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -134.88 116.09 14.36 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.129 -0.487 . . . . 74.42 112.147 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.51 -52.74 42.68 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.515 0.674 . . . . 65.23 109.621 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -170.65 -160.59 0.21 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.94 -1.027 . . . . 34.34 109.565 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.01 65.51 1.18 Allowed Glycine 0 CA--C 1.524 0.611 0 C-N-CA 120.799 -0.715 . . . . 30.2 113.532 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 2.4 mptp? -124.35 -168.25 1.77 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.798 0.439 . . . . 64.34 110.096 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.43 ' HB3' ' O ' ' A' ' 112' ' ' LYS . 21.1 t70 70.63 -70.61 0.15 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.717 0.294 . . . . 75.54 110.722 -177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 76.8 mt 54.93 -169.24 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.189 0.811 . . . . 74.42 113.189 172.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' A' ' 116' ' ' PRO . 16.4 tp -164.07 129.56 2.11 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.804 -0.635 . . . . 73.22 111.571 173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' HD12 ' A' ' 115' ' ' LEU . 92.5 Cg_endo -80.4 133.38 9.58 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.575 2.183 . . . . 53.41 112.27 172.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.6 m -94.41 119.06 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.19 0.519 . . . . 74.13 111.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.81 123.15 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.881 0.372 . . . . 75.23 111.304 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.548 ' HG2' HD12 ' A' ' 120' ' ' ILE . 27.1 tt0 -161.32 152.56 18.69 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.641 -0.254 . . . . 70.4 110.829 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.548 HD12 ' HG2' ' A' ' 119' ' ' GLU . 1.7 mp 62.45 125.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.479 0.918 . . . . 63.52 113.479 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.33 165.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.035 -0.53 . . . . 74.31 111.1 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.483 ' HB3' ' HG2' ' A' ' 124' ' ' GLU . 33.4 t-20 -105.26 153.03 22.14 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.124 0.488 . . . . 65.11 111.805 -174.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 50.6 m -84.16 22.56 1.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.082 -0.508 . . . . 74.21 111.187 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.483 ' HG2' ' HB3' ' A' ' 122' ' ' ASN . 9.8 pt-20 -66.78 177.38 1.66 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.141 0.577 . . . . 61.05 112.392 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 74.32 -37.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.84 0.681 . . . . 65.2 112.84 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.53 -16.4 63.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.122 0.416 . . . . 54.13 112.122 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.15 99.65 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.832 0.348 . . . . 50.42 111.392 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.6 pt? -129.67 101.23 5.81 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.298 0.57 . . . . 52.45 110.792 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -71.79 126.38 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.177 -0.465 . . . . 74.53 112.112 -175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.8 p-80 -146.66 139.58 25.35 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.454 -0.339 . . . . 73.23 110.78 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -85.5 136.01 33.6 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.279 0.474 . . . . 74.24 112.279 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -91.58 96.6 10.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.255 0.55 . . . . 70.21 110.467 175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -68.27 143.24 55.33 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.842 -0.617 . . . . 65.31 112.494 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -95.47 161.03 14.24 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.263 0.554 . . . . 61.32 111.912 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 14.4 p80 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.67 -0.681 . . . . 64.3 111.248 178.764 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 34' ' ' MET . 3.5 mpp? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.537 0.208 . . . . 52.11 111.11 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.14 112.91 3.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.888 0.375 . . . . 53.44 110.822 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.2 p -141.24 -53.6 0.47 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.489 0.551 . . . . 74.24 112.489 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 59.78 34.63 21.96 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.273 0.559 . . . . 64.11 110.735 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -58.71 111.21 1.19 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.744 -0.662 . . . . 73.11 111.771 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.762 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 76.2 m-85 -64.68 88.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.148 0.499 . . . . 65.3 110.915 172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -123.04 150.16 43.44 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.379 0.609 . . . . 74.33 112.318 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' A' ' 92' ' ' ILE . 90.0 t -115.19 120.14 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.594 -0.73 . . . . 60.21 111.355 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 10.5 tppt? -80.97 129.71 34.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.155 0.502 . . . . 73.13 110.606 175.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.3 t -111.88 112.61 41.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.854 0.359 . . . . 65.43 110.133 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 39.0 mt-10 -108.11 149.61 28.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.326 0.584 . . . . 72.34 111.047 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 56.2 m-85 -122.3 103.36 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.733 -0.469 . . . . 74.54 109.733 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.6 m -120.19 158.91 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.002 0.43 . . . . 73.33 112.027 -170.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.429 ' HB3' HD13 ' A' ' 53' ' ' ILE . 6.0 p30 -83.4 -177.2 6.65 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.283 0.564 . . . . 73.45 112.015 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.31 -8.44 53.69 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.768 0.655 . . . . 42.33 112.768 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -89.8 -26.34 20.62 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.122 0.487 . . . . 61.31 110.702 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 20.71 7.09 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 116.244 -0.434 . . . . 63.13 113.167 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.18 135.87 53.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.273 0.559 . . . . 75.44 110.956 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -69.32 137.07 52.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.611 0.72 . . . . 74.05 111.72 -178.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 47' ' ' ASP . 6.6 pt -124.59 -5.27 6.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.469 -0.787 . . . . 64.53 112.216 -173.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -137.53 150.09 67.24 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-N 116.66 -0.246 . . . . 65.02 110.906 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.59 129.92 28.31 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.327 2.018 . . . . 72.12 113.134 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.8 p -90.52 158.3 17.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.613 -0.721 . . . . 64.25 111.377 -175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 20.4 m-20 -114.04 165.11 12.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.187 0.518 . . . . 72.31 111.441 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -141.68 104.41 4.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.955 -0.566 . . . . 75.41 109.952 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.55 122.03 35.58 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.026 -0.534 . . . . 70.35 112.356 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 t -99.28 -6.45 27.98 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.372 0.606 . . . . 71.35 110.586 171.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.13 124.59 21.55 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.499 -0.773 . . . . 70.15 111.13 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -43.68 -50.13 7.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.292 0.478 . . . . 75.42 112.292 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -90.28 86.27 6.45 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.783 -0.573 . . . . 71.54 110.791 172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -69.97 90.2 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.986 0.898 . . . . 70.15 110.454 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 84' ' ' THR . 85.8 t -105.36 110.08 29.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.687 -0.688 . . . . 72.31 110.49 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 76.9 p -93.48 165.9 12.53 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.195 0.522 . . . . 61.01 111.931 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.4 p -134.96 134.42 21.78 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.094 -0.503 . . . . 74.02 111.583 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.51 126.44 16.18 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.433 2.089 . . . . 75.4 112.636 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' O ' HG13 ' A' ' 71' ' ' ILE . 96.6 mttt -96.06 112.54 24.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.353 -0.385 . . . . 74.14 110.853 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -70.16 101.0 1.76 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.239 0.542 . . . . 75.01 110.816 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 63.1 mt -89.06 128.51 51.57 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.779 -0.646 . . . . 74.33 111.995 -173.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.04 103.62 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.062 1.842 . . . . 74.41 111.734 174.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.82 -11.09 32.34 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.397 -0.43 . . . . 61.23 113.25 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.5 m-85 -132.09 140.03 48.69 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.369 0.604 . . . . 64.22 112.426 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.447 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.6 tttp -117.87 135.43 54.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.647 -0.706 . . . . 65.22 110.794 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -59.55 121.39 11.43 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.175 0.435 . . . . 60.01 112.175 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -80.04 -57.8 3.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.265 0.555 . . . . 73.21 111.275 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.88 152.44 29.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.246 0.546 . . . . 64.54 112.062 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.28 122.66 47.48 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.436 -0.802 . . . . 73.25 110.622 177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.481 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 30.1 Cg_endo -61.36 151.68 77.76 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.729 2.286 . . . . 72.44 113.867 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -64.37 -16.73 62.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.563 0.579 . . . . 73.01 112.563 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.481 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 23.4 p-10 -104.52 19.26 20.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.822 0.305 . . . . 72.23 111.822 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -64.12 -28.38 69.73 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.291 0.478 . . . . 72.52 112.291 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.607 HG22 HG13 ' A' ' 65' ' ' VAL . 65.4 p -137.1 134.18 36.17 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.425 -0.352 . . . . 70.02 110.713 178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.32 -161.82 35.39 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.985 -1.102 . . . . 75.44 114.419 177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -101.26 130.42 47.39 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.793 0.437 . . . . 75.12 111.398 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.44 94.83 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.345 0.593 . . . . 70.15 110.056 173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 72.1 p -95.56 -32.32 12.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.741 -0.663 . . . . 53.33 110.865 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -133.39 162.86 30.7 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.864 -0.607 . . . . 71.11 110.084 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.762 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 11.7 t -98.49 158.86 15.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.012 0.434 . . . . 75.11 111.591 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.64 14.35 76.03 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.281 -0.418 . . . . 54.12 113.604 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.674 ' HB ' HG22 ' A' ' 41' ' ' VAL . 74.7 mt -73.98 139.26 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 122.527 -0.396 . . . . 72.4 110.541 175.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 20.6 mt -124.59 126.99 72.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.565 0.697 . . . . 65.14 112.325 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 83' ' ' ALA . 55.3 t -104.84 109.3 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.511 -0.768 . . . . 63.23 110.37 176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 53.8 mtt180 -106.01 114.85 29.23 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.879 0.696 . . . . 53.4 112.879 -177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -86.49 125.8 33.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.749 -0.659 . . . . 64.02 110.399 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.6 mm -97.9 127.92 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.024 -0.534 . . . . 60.42 110.975 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 87.7 m-85 -118.33 130.98 56.33 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.141 0.496 . . . . 65.43 111.769 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -78.6 140.35 38.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.033 -0.531 . . . . 71.33 110.954 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -75.98 114.73 14.95 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.128 0.49 . . . . 64.24 111.911 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 75' ' ' LYS . 72.2 mt -77.14 104.69 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 121.278 0.561 . . . . 45.32 110.818 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 102' ' ' ILE . 30.4 mt -97.5 14.4 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.868 0.842 . . . . 65.23 110.559 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -87.26 -154.05 0.23 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.857 -0.611 . . . . 70.21 110.394 178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.3 -26.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.749 0.648 . . . . 71.44 112.749 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.7 t 61.19 -82.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.83 -0.623 . . . . 70.24 111.768 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 47.9 -89.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.925 1.083 . . . . 64.34 113.925 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.6 t 63.07 75.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.17 -0.923 . . . . 64.13 109.93 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.74 22.13 0.38 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.269 -0.878 . . . . 74.34 112.65 -174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -113.97 105.09 12.83 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.148 0.499 . . . . 75.44 112.1 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.7 p -77.43 140.21 39.82 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.984 -0.553 . . . . 61.51 110.811 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.53 132.73 1.64 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.44 -0.886 . . . . 72.44 113.161 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 78.8 tttt 64.12 15.23 9.15 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.272 0.558 . . . . 75.3 111.633 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -95.15 17.75 13.56 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.123 -0.49 . . . . 64.11 111.738 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mt -95.7 115.48 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.256 -0.429 . . . . 75.32 111.22 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 4.4 mp -139.48 134.05 16.17 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 72.34 112.575 173.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 115' ' ' LEU . 15.6 Cg_exo -71.42 176.37 8.09 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.31 2.673 . . . . 73.32 112.654 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.3 t 69.01 126.66 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.715 0.769 . . . . 63.31 112.603 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.84 153.31 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.668 -0.697 . . . . 74.02 111.036 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -85.01 105.63 15.91 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.055 0.455 . . . . 71.54 110.626 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.44 102.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.991 0.424 . . . . 60.22 111.232 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.91 152.94 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.905 0.383 . . . . 75.14 111.969 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -131.14 128.93 41.11 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.152 -0.477 . . . . 72.11 110.035 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 33.1 t -163.58 -155.84 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.099 0.159 . . . . 74.4 110.79 -175.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' HG12 ' A' ' 127' ' ' VAL . 38.8 tt0 76.24 -52.53 0.61 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.264 0.626 . . . . 74.44 112.628 175.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -50.52 -29.49 10.7 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.504 0.927 . . . . 63.41 113.504 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -129.99 35.11 4.17 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.282 0.475 . . . . 42.21 112.282 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 124' ' ' GLU . 9.3 p -92.25 152.71 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-O 121.003 0.43 . . . . 74.41 111.655 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mp -100.68 107.24 18.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.837 0.351 . . . . 73.02 110.542 173.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -63.63 105.4 0.79 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.819 0.342 . . . . 63.44 111.378 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -70.55 92.39 0.84 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.297 0.57 . . . . 73.45 110.528 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -106.64 39.74 1.78 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.819 -0.628 . . . . 72.24 111.547 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -72.94 126.73 30.63 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.2 0.524 . . . . 72.22 111.866 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -79.96 145.88 32.36 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.251 0.548 . . . . 74.42 111.837 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -94.84 115.63 27.73 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.065 -0.516 . . . . 65.1 110.384 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.829 -0.605 . . . . 72.43 111.538 179.495 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 111.791 0.293 . . . . 71.41 111.791 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.6 -13.01 60.1 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.017 0.436 . . . . 74.01 112.007 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.4 p -98.3 173.28 7.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.287 -0.415 . . . . 62.42 111.558 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -66.95 90.79 0.19 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 72.22 111.374 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -85.16 103.55 14.25 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.806 0.336 . . . . 75.42 111.018 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB3' HG21 ' A' ' 87' ' ' ILE . 91.5 m-85 -82.71 94.79 7.67 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.878 0.371 . . . . 74.54 111.912 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 78.1 p -134.44 147.03 50.35 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.291 0.567 . . . . 72.01 111.674 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 92' ' ' ILE . 86.0 t -114.51 105.79 19.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.9 -0.591 . . . . 54.4 110.97 176.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' CE ' ' HG2' ' A' ' 44' ' ' GLU . 28.0 tttt -82.2 129.94 34.96 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.606 -0.438 . . . . 61.35 110.809 175.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.53 113.6 38.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.476 -0.329 . . . . 74.32 110.298 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' ' CE ' ' A' ' 42' ' ' LYS . 29.5 mt-10 -100.25 121.31 41.26 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.553 0.692 . . . . 74.3 111.619 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -98.05 96.52 8.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.627 -0.715 . . . . 73.43 109.163 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 20.5 m -118.62 163.23 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.581 0.585 . . . . 74.33 112.581 -165.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.98 -172.56 3.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.192 0.52 . . . . 75.43 111.247 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -19.2 65.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.097 0.777 . . . . 74.43 113.097 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -93.22 -16.05 25.22 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.02 0.378 . . . . 74.15 112.02 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.95 39.54 3.09 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 120.978 -0.629 . . . . 74.31 113.847 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.74 125.58 44.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 122.659 -0.318 . . . . 75.24 110.499 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.1 pt-20 -63.93 113.32 3.38 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.379 1.085 . . . . 74.21 112.157 -172.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 25.0 pt -91.12 7.6 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.421 -1.263 . . . . 74.53 111.572 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.24 151.55 17.55 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 73.34 111.233 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.83 146.56 5.59 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.62 2.214 . . . . 61.41 113.335 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 p -113.17 156.53 23.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.419 -0.809 . . . . 62.14 112.228 -172.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -109.36 130.78 55.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.022 -0.535 . . . . 60.4 111.882 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.7 m -100.23 103.55 15.01 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.108 0.48 . . . . 72.02 110.374 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 89.6 mt -90.77 122.52 33.58 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.873 0.368 . . . . 74.44 111.636 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.8 t -100.53 -11.43 20.13 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.286 0.565 . . . . 72.13 111.048 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.08 131.91 46.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.857 -0.611 . . . . 73.3 111.651 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 67.7 t80 -54.26 -61.01 2.58 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.076 0.398 . . . . 74.43 112.076 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.34 73.74 9.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.104 0.478 . . . . 74.3 110.296 177.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 41' ' ' VAL . 49.3 p90 -71.29 125.44 26.98 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.793 0.806 . . . . 65.54 111.612 -176.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 84' ' ' THR . 98.5 t -128.9 109.68 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 115.601 -0.727 . . . . 64.21 109.819 177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' OG ' HG11 ' A' ' 94' ' ' VAL . 92.0 p -97.17 165.46 12.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.216 0.531 . . . . 71.52 112.201 -173.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.4 p -131.62 143.4 49.02 Favored Pre-proline 0 N--CA 1.471 0.598 0 CA-C-N 116.07 -0.514 . . . . 63.53 111.127 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' A' ' 76' ' ' LEU . 28.1 Cg_endo -65.14 168.61 13.68 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.031 1.821 . . . . 64.32 112.055 173.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.21 125.64 42.74 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.052 0.453 . . . . 75.23 111.604 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -67.63 83.1 0.18 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.382 0.61 . . . . 42.5 110.686 175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.7 mt -85.06 118.76 71.54 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 115.931 -0.577 . . . . 72.01 111.191 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.71 99.12 0.1 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.54 2.16 . . . . 75.44 112.789 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.7 6.96 28.24 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.252 -0.499 . . . . 75.31 113.707 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 42.9 m-85 -135.06 138.77 44.19 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.67 0.735 . . . . 71.14 112.684 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -113.62 127.02 55.9 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.433 -0.803 . . . . 75.25 111.44 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.544 HD22 ' HB3' ' A' ' 68' ' ' PRO . 45.0 tp -72.16 117.74 14.16 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 122.028 -0.42 . . . . 61.55 111.114 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.61 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 7.2 ptp180 -77.22 -37.89 52.44 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.876 0.324 . . . . 72.22 111.876 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.2 pt-20 -164.13 170.47 16.39 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.995 0.426 . . . . 73.3 111.657 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.406 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 69.2 mt -104.97 129.15 25.32 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.078 -0.51 . . . . 74.51 111.15 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.551 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 8.2 Cg_endo -50.23 145.18 21.18 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.658 2.905 . . . . 65.23 114.115 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.64 -5.83 4.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.394 0.887 . . . . 65.1 113.394 -176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -134.63 31.75 3.36 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 122.156 -0.34 . . . . 75.51 111.731 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -64.02 -31.4 72.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.082 0.467 . . . . 51.25 111.84 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.636 HG22 HG13 ' A' ' 65' ' ' VAL . 76.9 p -130.18 128.68 42.21 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.809 -0.632 . . . . 71.12 111.035 178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.66 -160.56 33.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.644 -0.789 . . . . 61.34 113.448 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.6 p-10 -109.41 148.88 30.38 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.767 0.318 . . . . 75.22 111.663 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.559 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.3 mt -67.2 95.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.647 0.737 . . . . 52.31 110.644 176.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 68.0 p -95.5 -37.66 10.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.292 -0.867 . . . . 62.3 111.426 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.529 ' HA ' ' HB2' ' A' ' 124' ' ' GLU . 2.0 m-20 -93.21 175.36 6.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.955 -0.566 . . . . 54.43 110.644 173.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.5 p -81.98 -32.79 30.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.268 0.556 . . . . 71.1 110.561 168.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -126.3 84.35 0.34 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.865 -0.607 . . . . 61.32 113.681 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.688 ' HB ' HG22 ' A' ' 41' ' ' VAL . 4.1 mp -93.95 145.69 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.411 -0.464 . . . . 73.23 110.42 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.1 mt -130.2 121.98 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 74.23 111.858 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.436 HG11 ' OG ' ' A' ' 66' ' ' SER . 70.3 t -98.93 108.04 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-N 115.831 -0.622 . . . . 74.3 109.993 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 27.0 ttm180 -113.43 106.57 14.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.377 0.51 . . . . 62.52 112.377 -172.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -85.3 135.0 34.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.037 -0.528 . . . . 74.05 111.112 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.6 mm -106.29 121.1 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 111.727 0.269 . . . . 72.31 111.727 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 78.1 m-85 -115.62 125.37 52.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.256 0.55 . . . . 74.15 112.351 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -85.69 122.75 30.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.066 -0.516 . . . . 64.33 110.116 169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -58.49 119.95 7.93 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.196 0.522 . . . . 72.25 111.684 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.8 120.41 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 115.903 -0.589 . . . . 71.12 110.536 176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -70.55 98.87 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.227 0.537 . . . . 65.02 110.849 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.37 -167.29 2.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.736 -0.665 . . . . 53.01 111.227 -177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 104' ' ' VAL . 10.7 t -115.22 39.98 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.093 0.473 . . . . 45.04 111.642 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.2 t -54.1 -44.12 70.97 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.226 0.536 . . . . 71.13 110.158 171.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 63.61 63.62 0.85 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.249 -0.887 . . . . 43.33 112.401 173.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.45 88.34 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.568 0.699 . . . . 70.2 110.688 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.91 -19.13 64.87 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.78 -0.645 . . . . 74.55 112.569 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.38 105.34 0.91 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.484 0.659 . . . . 73.21 111.57 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.8 t -59.74 159.99 8.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.94 -1.027 . . . . 74.02 112.689 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 175.44 82.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.07 -0.514 . . . . 73.2 112.651 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -121.18 144.1 48.76 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.137 0.421 . . . . 54.45 112.137 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.4 t70 57.78 87.03 0.07 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.658 -0.701 . . . . 73.55 112.484 173.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 pp -164.93 5.21 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.158 0.799 . . . . 71.34 113.158 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.488 HD12 ' HD2' ' A' ' 116' ' ' PRO . 18.1 tp -72.0 131.33 85.61 Favored Pre-proline 0 N--CA 1.469 0.515 0 O-C-N 121.947 -0.47 . . . . 74.11 111.522 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' HD12 ' A' ' 115' ' ' LEU . 73.0 Cg_endo -77.85 106.35 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.451 2.101 . . . . 64.55 112.919 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.9 p -77.15 -25.38 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 121.348 0.594 . . . . 72.21 111.289 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.3 m 37.17 -161.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 114.302 -1.317 . . . . 72.52 113.849 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -99.51 115.43 29.31 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.277 -0.419 . . . . 70.35 110.151 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 65.3 mt -62.48 123.03 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 112.114 0.413 . . . . 61.15 112.114 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.506 ' O ' HD12 ' A' ' 121' ' ' ILE . 1.6 pp -125.78 124.25 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 N-CA-C 112.8 0.667 . . . . 74.4 112.8 -178.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -144.6 139.99 28.46 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.91 -0.586 . . . . 60.32 110.091 175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 46.9 t -162.85 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.617 0.969 . . . . 75.11 113.617 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 89' ' ' ASP . 29.9 mt-10 -78.3 -0.41 28.7 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.35 0.87 . . . . 61.05 113.35 -164.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -71.03 -9.81 58.68 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.112 0.412 . . . . 70.25 112.112 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.92 175.68 9.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.759 0.314 . . . . 72.24 111.822 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.3 t 63.6 101.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.283 0.563 . . . . 75.12 111.968 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.5 tp -79.85 81.28 6.14 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.266 0.555 . . . . 73.24 111.173 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -73.39 109.24 6.76 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.32 0.581 . . . . 73.43 110.785 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -55.8 106.98 0.3 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.116 -0.493 . . . . 74.33 112.185 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -86.52 118.74 26.13 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 75.22 111.324 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -73.49 91.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.285 0.564 . . . . 75.15 111.328 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -80.36 149.62 30.16 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.665 -0.698 . . . . 74.43 111.62 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -106.02 169.64 8.37 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.764 0.653 . . . . 72.21 112.764 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.254 1.293 0 CA-C-N 115.669 -0.696 . . . . 63.41 111.102 173.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 34' ' ' MET . 2.8 mpp? . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 111.958 0.355 . . . . 73.45 111.958 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.99 134.93 55.95 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.053 0.454 . . . . 75.24 112.093 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 126' ' ' ALA . 36.5 p -130.18 121.9 27.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.17 0.51 . . . . 61.12 111.686 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -74.37 84.21 1.94 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.069 0.461 . . . . 71.43 111.387 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -83.55 103.95 13.3 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.046 0.45 . . . . 74.21 111.136 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -76.81 92.89 3.64 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.278 0.561 . . . . 72.4 111.426 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.2 p -139.03 161.42 37.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.869 -0.605 . . . . 53.01 111.107 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.9 t -113.0 129.62 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.196 -0.456 . . . . 64.41 111.705 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 21.4 tttt -96.38 131.5 42.87 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.884 0.374 . . . . 71.5 110.771 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.48 113.07 41.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.6 0.238 . . . . 64.3 110.662 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -100.66 121.15 41.14 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.098 0.475 . . . . 44.03 111.744 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' A' ' 52' ' ' GLU . 86.0 m-85 -90.74 98.35 11.72 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.355 -0.609 . . . . 64.55 109.355 171.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 22.4 m -118.41 152.07 20.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.06 0.457 . . . . 64.43 111.981 -167.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -71.63 -179.83 2.75 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.044 0.45 . . . . 74.44 111.178 175.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 -10.53 50.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.839 0.681 . . . . 62.11 112.839 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -92.85 -22.85 19.05 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.929 0.395 . . . . 70.03 111.177 177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.73 30.69 3.66 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.001 -0.619 . . . . 75.52 113.886 176.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.32 123.3 45.01 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 122.306 -0.526 . . . . 65.02 111.302 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.0 pt-20 -66.79 108.3 2.47 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.318 1.056 . . . . 54.34 111.639 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 HG13 HD13 ' A' ' 71' ' ' ILE . 10.1 pt -83.05 2.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 114.231 -1.35 . . . . 61.1 112.161 -176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -148.88 149.87 31.36 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.495 -0.321 . . . . 51.53 110.894 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -48.27 131.38 22.4 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.086 1.857 . . . . 72.04 112.672 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 44.8 p -96.72 149.38 21.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.598 -0.728 . . . . 53.13 112.247 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -93.93 165.45 12.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.51 0.672 . . . . 65.21 112.077 -174.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.6 m -134.5 104.12 5.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.529 -0.76 . . . . 71.35 109.999 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -89.5 125.5 35.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.283 -0.417 . . . . 63.32 111.429 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.7 t -105.68 -13.59 15.52 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.185 -0.461 . . . . 73.51 111.826 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.9 143.42 55.71 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.354 0.262 . . . . 74.52 111.656 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 88.8 t80 -54.56 -38.63 66.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.964 0.411 . . . . 51.51 111.171 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -100.17 86.78 3.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 74.13 110.444 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -71.23 95.06 1.23 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.844 0.83 . . . . 73.33 110.266 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.1 t -105.54 109.06 26.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.962 -0.563 . . . . 54.44 110.19 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -101.21 167.57 10.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.127 0.489 . . . . 63.44 112.056 -174.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -143.91 152.35 55.09 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.885 -0.598 . . . . 63.22 111.314 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.598 ' HB3' HD22 ' A' ' 76' ' ' LEU . 31.4 Cg_endo -65.61 176.27 3.65 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 122.434 2.089 . . . . 50.41 113.254 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -141.91 150.01 40.92 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.831 0.348 . . . . 64.24 111.544 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -73.55 92.15 1.89 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.17 0.51 . . . . 71.14 110.836 173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD13 HG13 ' A' ' 53' ' ' ILE . 61.9 mt -91.46 132.08 34.55 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.119 -0.491 . . . . 74.11 111.212 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 108' ' ' ASP . 74.9 Cg_exo -50.56 105.59 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.737 2.291 . . . . 63.12 113.736 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 77.6 19.35 76.15 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.346 -0.454 . . . . 75.53 114.137 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -134.91 147.37 49.8 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.45 0.625 . . . . 73.32 112.641 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.492 ' HG3' HD11 ' A' ' 101' ' ' ILE . 87.8 mttt -137.79 141.63 40.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.464 -0.789 . . . . 64.23 111.137 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 68' ' ' PRO . 41.9 tp -69.33 133.85 48.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.077 -0.51 . . . . 74.22 111.881 -174.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 3.7 ptm180 -98.17 -26.47 14.55 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.368 -0.378 . . . . 72.12 111.607 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -162.94 149.45 12.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.802 0.334 . . . . 73.43 111.367 -175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 61.8 mt -97.93 116.63 65.66 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.58 -0.282 . . . . 71.43 110.391 173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 11.9 Cg_endo -52.98 152.47 17.87 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.557 2.838 . . . . 73.34 114.503 -173.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -63.52 -3.29 2.03 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.208 0.818 . . . . 71.05 113.208 -177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -131.11 24.47 4.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.766 0.317 . . . . 41.32 111.795 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' A' ' 94' ' ' VAL . . . -67.41 -35.27 78.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.717 0.636 . . . . 70.13 112.717 -176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -131.6 133.4 44.94 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.617 -0.265 . . . . 71.24 111.278 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 172.57 -163.47 35.48 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.522 -0.847 . . . . 75.51 113.922 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -101.3 138.39 38.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.29 0.478 . . . . 61.25 112.29 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mt -72.28 95.22 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.479 0.656 . . . . 64.22 110.407 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 80.8 p -104.59 -13.45 15.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.713 -0.676 . . . . 63.21 111.055 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -146.82 178.51 8.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.811 -0.631 . . . . 75.43 109.675 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 t -114.65 172.97 6.71 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.044 0.45 . . . . 73.43 111.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.84 19.01 69.16 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.214 -0.517 . . . . 71.22 113.219 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.6 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.0 mt -70.66 127.83 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.919 0.39 . . . . 42.53 110.998 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.16 116.19 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.255 0.55 . . . . 51.51 111.726 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' A' ' 83' ' ' ALA . 59.7 t -101.28 107.5 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.826 -0.625 . . . . 73.43 110.132 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -100.01 106.61 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.861 0.689 . . . . 73.23 112.861 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -83.07 114.09 21.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 72.52 110.218 172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' O ' HD12 ' A' ' 76' ' ' LEU . 11.1 mm -88.28 116.8 30.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.81 0.338 . . . . 71.43 111.543 -175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -108.24 139.05 43.48 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.263 0.554 . . . . 64.44 111.901 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.0 137.45 34.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.252 -0.648 . . . . 64.41 109.252 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -67.68 122.82 18.89 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 75' ' ' LYS . 66.8 mt -54.73 109.6 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.743 0.645 . . . . 40.53 112.743 -171.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.8 mm -85.66 52.35 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 122.394 1.092 . . . . 74.22 110.026 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -148.7 -155.31 0.62 Allowed 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.486 -1.234 . . . . 70.51 109.164 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.1 81.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.064 0.935 . . . . 74.44 112.154 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 69.4 m -89.83 41.5 1.05 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.863 -1.062 . . . . 75.22 110.189 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.38 22.48 0.68 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.818 0.673 . . . . 74.3 112.818 -169.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 108' ' ' ASP . 12.5 p -167.18 159.85 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.237 0.458 . . . . 72.11 112.237 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.454 ' N ' HG22 ' A' ' 107' ' ' VAL . 28.5 t0 77.57 115.94 0.06 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.194 0.998 . . . . 53.2 111.783 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -143.27 24.71 1.76 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.726 -0.67 . . . . 73.23 111.371 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.6 t -56.22 101.3 0.05 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.619 0.723 . . . . 64.43 112.084 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -164.27 179.49 39.08 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.61 -0.723 . . . . 55.15 112.249 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.405 ' H ' ' H ' ' A' ' 113' ' ' ASP . 85.3 tttt -174.08 -6.78 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.919 0.39 . . . . 75.34 111.377 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.405 ' H ' ' H ' ' A' ' 112' ' ' LYS . 18.2 m-20 64.51 92.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.488 0.661 . . . . 53.04 112.116 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 114' ' ' LEU . 2.5 pp -144.91 151.71 39.1 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.487 -0.779 . . . . 73.11 110.647 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 7.3 mp -103.0 147.84 34.71 Favored Pre-proline 0 N--CA 1.471 0.615 0 N-CA-C 112.648 0.61 . . . . 71.14 112.648 -176.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.493 ' HB2' HG22 ' A' ' 118' ' ' VAL . 23.4 Cg_exo -68.66 139.72 45.08 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.607 2.871 . . . . 75.51 113.344 174.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.13 10.38 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.994 0.902 . . . . 72.51 111.458 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 116' ' ' PRO . 27.9 m -77.22 18.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 113.874 1.064 . . . . 72.13 113.874 -173.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.25 61.93 5.71 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.755 -0.591 . . . . 43.52 111.862 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 120' ' ' ILE . 3.1 mp -108.08 99.69 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 120.898 0.38 . . . . 54.23 110.409 176.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.82 109.41 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 120.858 0.361 . . . . 71.43 111.273 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -160.14 155.07 24.48 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.182 0.515 . . . . 74.15 111.347 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.3 t -132.56 3.74 3.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.354 0.597 . . . . 71.43 110.286 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 124' ' ' GLU . 8.4 mp0 -88.13 141.21 28.75 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.531 -0.758 . . . . 54.21 111.109 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.03 -153.76 0.35 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.352 -0.386 . . . . 65.43 112.033 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 36' ' ' THR . . . 74.99 -28.18 0.19 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.476 0.917 . . . . 62.13 113.476 175.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.9 t -65.12 98.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.759 0.314 . . . . 71.35 111.835 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -169.87 113.59 0.49 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.891 0.377 . . . . 73.45 110.911 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -137.82 -50.39 0.6 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.781 0.324 . . . . 75.13 111.504 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.8 m170 66.35 179.66 0.21 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.487 0.661 . . . . 74.41 112.377 -177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -105.42 165.44 11.13 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.855 -0.611 . . . . 73.12 110.72 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 60.58 89.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.617 0.599 . . . . 74.32 112.617 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -85.49 169.39 13.65 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.784 0.326 . . . . 74.22 111.027 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -137.29 149.49 47.13 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 111.637 0.236 . . . . 65.51 111.637 -173.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.983 -0.532 . . . . 71.32 111.257 175.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 39' ' ' PHE . 32.6 mmt . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.546 -0.168 . . . . 65.24 110.546 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 71.18 -58.96 0.56 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.071 1.137 . . . . 74.13 114.071 168.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.7 p -52.99 -71.63 0.07 Allowed 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.14 0.792 . . . . 75.14 113.14 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.92 11.4 35.58 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 111.576 0.213 . . . . 74.51 111.576 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 52.24 62.29 2.77 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.187 0.518 . . . . 74.42 111.029 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 89.2 m-85 -63.36 96.06 0.1 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.294 -0.412 . . . . 74.33 111.756 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.1 p -118.85 156.29 29.72 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.999 0.428 . . . . 53.5 111.291 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.4 t -117.66 126.8 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 116.338 -0.392 . . . . 73.03 111.32 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 11.5 tttt -96.85 127.92 43.3 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.085 0.469 . . . . 61.21 110.757 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 t -103.36 114.74 43.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.457 -0.338 . . . . 61.13 110.739 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -102.61 130.92 49.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.128 0.49 . . . . 65.45 111.591 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -104.05 98.42 8.25 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.92 -0.77 . . . . 74.42 108.92 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.595 HG12 ' CA ' ' A' ' 52' ' ' GLU . 17.3 m -119.45 168.18 12.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.61 0.596 . . . . 75.53 112.61 -166.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -91.28 -169.91 2.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 51.53 110.642 177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.91 -10.79 56.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.34 0.867 . . . . 74.25 113.34 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -94.4 -17.04 22.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.823 -0.548 . . . . 71.33 111.441 175.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.94 14.96 32.45 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.117 -0.563 . . . . 74.41 113.138 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.05 121.67 38.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.61 0.243 . . . . 60.2 110.73 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.595 ' CA ' HG12 ' A' ' 46' ' ' VAL . 14.6 pt-20 -67.96 103.66 1.54 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 122.397 1.094 . . . . 62.15 111.505 -174.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 17.3 pt -79.45 3.65 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 114.334 -1.303 . . . . 63.33 112.205 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.86 147.03 19.27 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.58 -0.282 . . . . 74.12 110.662 -174.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -49.06 129.5 21.82 Favored 'Trans proline' 0 C--O 1.238 0.512 0 C-N-CA 122.035 1.823 . . . . 61.04 113.109 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.8 p -95.69 167.55 11.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.293 -0.867 . . . . 50.04 112.004 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -124.48 142.83 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.078 -0.51 . . . . 70.32 112.329 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -105.68 104.14 13.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 63.52 110.326 172.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 64' ' ' TYR . 81.0 mt -81.48 112.42 18.71 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.08 0.467 . . . . 73.23 111.607 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.4 t -91.37 -6.14 53.41 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.293 0.568 . . . . 63.45 111.133 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.61 130.93 43.1 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.633 -0.712 . . . . 74.4 111.319 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 76.4 t80 -52.9 -44.23 66.78 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.062 0.458 . . . . 75.24 111.206 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -91.03 89.47 7.43 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.038 -0.414 . . . . 75.02 110.675 172.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HB2' HD12 ' A' ' 59' ' ' LEU . 27.3 p90 -73.09 90.46 1.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.98 0.895 . . . . 75.24 110.718 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 HG22 ' A' ' 84' ' ' THR . 96.7 t -105.4 109.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.72 -0.673 . . . . 74.34 109.848 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.1 p -98.54 163.15 12.79 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.617 0.599 . . . . 72.33 112.617 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.4 p -135.58 143.02 43.24 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.691 -0.686 . . . . 74.24 111.174 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.8 138.54 37.94 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.533 2.156 . . . . 71.53 112.836 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.43 140.97 30.3 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.781 0.8 . . . . 53.01 111.66 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -77.18 93.23 3.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.743 -1.117 . . . . 50.11 111.059 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 52.2 mt -93.64 116.67 66.78 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.904 -0.589 . . . . 71.54 111.283 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.37 118.68 5.6 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.652 2.234 . . . . 63.2 112.493 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.88 5.73 68.03 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.321 -0.466 . . . . 52.33 113.314 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.5 m-85 -130.82 147.29 52.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.367 0.603 . . . . 72.51 112.217 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -119.47 127.65 53.26 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.551 -0.75 . . . . 73.21 111.375 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.9 tp -65.07 111.74 3.04 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.955 0.407 . . . . 72.12 111.401 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -72.44 -58.6 3.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.394 0.616 . . . . 71.45 110.812 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -148.98 154.12 38.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.725 -0.67 . . . . 75.24 111.71 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.55 123.25 43.4 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.37 -0.832 . . . . 74.5 110.426 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 6.1 Cg_endo -48.26 132.52 23.84 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.234 2.623 . . . . 72.22 113.028 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.74 -22.64 24.91 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.265 0.469 . . . . 71.12 112.265 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -107.11 16.91 23.64 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.745 0.418 . . . . 72.33 112.127 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -58.79 -22.02 57.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.254 0.835 . . . . 33.31 113.254 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.43 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -132.12 135.71 46.6 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.716 0.294 . . . . 74.05 111.312 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.67 -166.21 36.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.944 -0.646 . . . . 33.41 113.156 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 18.2 p-10 -102.17 142.47 33.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.855 0.36 . . . . 63.12 111.425 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.5 mt -70.48 94.67 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 121.306 0.574 . . . . 74.52 110.433 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -99.21 -20.57 16.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.772 -0.649 . . . . 54.54 111.058 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.42 161.58 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.261 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -99.99 151.9 20.82 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 64.14 111.928 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.1 36.2 79.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.381 -0.438 . . . . 63.12 113.577 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.9 mt -83.96 137.69 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 122.482 -0.423 . . . . 64.02 110.917 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 43.5 mt -122.09 115.56 46.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 121.234 0.54 . . . . 73.54 111.913 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.75 103.54 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.016 -0.538 . . . . 73.15 109.961 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -108.34 107.36 17.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.663 0.616 . . . . 73.15 112.663 -171.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -83.36 139.32 33.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.04 111.298 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.8 mm -104.55 126.46 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 111.646 0.239 . . . . 64.33 111.646 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 53.4 m-85 -124.05 128.93 50.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.975 0.417 . . . . 70.13 111.819 177.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.13 132.98 34.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.16 -0.473 . . . . 44.41 110.611 171.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -73.75 114.24 11.79 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.193 -0.603 . . . . 71.34 110.585 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.8 mt -69.36 103.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.183 -0.462 . . . . 62.54 111.088 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 42.2 mm -73.85 -20.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.22 0.533 . . . . 74.45 110.48 175.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 70.9 86.96 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.142 -0.936 . . . . 74.1 111.528 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.86 3.74 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.163 -0.471 . . . . 51.22 111.299 175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 53.3 m 70.06 -53.9 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.429 0.691 . . . . 74.32 111.452 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.38 102.33 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.413 0.625 . . . . 74.42 111.821 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.1 m -131.95 103.17 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-N 115.789 -0.641 . . . . 62.43 110.497 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -77.83 83.38 4.17 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.706 0.765 . . . . 73.24 111.598 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -114.15 14.82 18.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.529 -0.76 . . . . 60.1 111.568 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.3 p -101.24 97.12 7.67 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.905 0.383 . . . . 73.35 111.729 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -135.38 165.55 24.69 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.928 -0.653 . . . . 43.44 113.224 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG2' ' N ' ' A' ' 113' ' ' ASP . 87.7 tttt -157.15 163.63 38.7 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 122.516 0.326 . . . . 71.43 110.649 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.47 ' N ' ' HG2' ' A' ' 112' ' ' LYS . 10.9 m-20 -59.19 -37.21 76.85 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.77 0.319 . . . . 74.33 111.106 173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.437 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 97.6 mt 65.43 -177.17 0.18 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.858 0.837 . . . . 71.04 112.944 174.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 117' ' ' VAL . 0.6 OUTLIER -147.69 174.15 3.64 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 73.32 111.181 175.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 115' ' ' LEU . 31.2 Cg_exo -62.33 19.71 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 122.929 2.419 . . . . 71.11 115.343 178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 115' ' ' LEU . 46.5 t 64.27 122.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.695 0.798 . . . . 52.52 112.797 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.3 p -161.43 113.28 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.829 -0.623 . . . . 71.41 111.049 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -122.97 180.0 4.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.208 0.528 . . . . 72.34 111.688 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mm -82.61 109.2 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.35 -0.386 . . . . 75.05 111.647 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.8 tt -84.46 -41.37 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.961 0.41 . . . . 73.34 111.991 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -106.08 120.18 41.14 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.77 0.319 . . . . 74.2 111.311 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.3 t -153.71 170.24 21.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.395 -0.366 . . . . 74.14 110.733 177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 62.03 174.97 0.13 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 72.32 111.146 -172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 58.88 -174.63 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.821 -0.172 . . . . 71.44 110.841 -175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.71 -155.65 0.25 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.77 0.319 . . . . 73.52 111.761 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.6 t 56.81 80.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.545 0.688 . . . . 73.34 112.141 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 128' ' ' LEU . 6.9 mp -89.53 77.44 7.25 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.419 0.628 . . . . 53.54 110.813 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.28 139.82 50.12 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.025 -0.534 . . . . 73.43 111.343 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -131.42 103.69 6.57 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 111.97 0.359 . . . . 73.32 111.97 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -79.84 72.83 6.59 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.372 -0.603 . . . . 64.03 109.372 170.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 63.16 170.9 0.15 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.024 -0.534 . . . . 74.14 109.888 -169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -70.09 77.97 0.5 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.385 -0.822 . . . . 64.14 110.112 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -63.9 145.64 55.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.348 -0.842 . . . . 73.34 112.446 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.706 -0.664 . . . . 71.31 111.817 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.632 0.254 . . . . 73.14 111.189 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 54.18 -155.82 0.23 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.95 0.5 . . . . 71.44 112.303 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 t -72.76 122.75 22.03 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 22.51 111.265 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -80.91 37.73 0.44 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.597 0.592 . . . . 74.23 112.597 -175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.3 t30 50.03 61.32 3.24 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.094 0.474 . . . . 63.41 111.172 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' HB3' HG21 ' A' ' 87' ' ' ILE . 33.2 m-85 -59.69 100.66 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.416 0.627 . . . . 72.22 111.55 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.6 p -139.5 153.87 47.59 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.372 -0.831 . . . . 71.13 110.865 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' HB ' ' A' ' 92' ' ' ILE . 96.2 t -118.29 115.75 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.311 -0.404 . . . . 74.43 111.702 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -82.73 133.98 35.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.789 0.328 . . . . 74.44 110.977 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.4 t -109.31 112.78 41.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.898 0.38 . . . . 75.12 110.594 175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 30.4 mt-10 -102.16 138.67 38.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.317 0.58 . . . . 71.53 111.535 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.627 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 52.1 m-85 -113.83 104.66 12.41 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.434 -0.58 . . . . 75.22 109.434 178.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -119.78 162.44 18.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.965 0.412 . . . . 63.45 111.933 -169.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -87.26 -171.92 3.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.186 0.517 . . . . 74.11 111.788 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.58 0.15 21.12 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.596 0.591 . . . . 73.42 112.596 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -104.99 -10.39 17.26 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.892 0.377 . . . . 64.54 111.294 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.14 13.5 36.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.189 -0.529 . . . . 25.35 113.681 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -110.13 134.17 52.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.278 0.561 . . . . 31.34 110.998 178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.677 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 1.3 pm0 -71.1 125.16 26.16 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.678 0.751 . . . . 64.13 111.624 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.0 pt -106.37 -7.99 10.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.198 -0.91 . . . . 64.11 112.358 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -134.58 148.5 67.67 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.661 -0.245 . . . . 54.42 111.309 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.08 140.19 25.14 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.731 2.287 . . . . 71.24 113.187 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 95.0 p -87.08 149.43 24.71 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.047 0.451 . . . . 53.52 111.957 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -109.22 154.62 22.14 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.151 -0.477 . . . . 73.52 111.206 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.5 m -123.75 104.54 9.04 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.097 0.475 . . . . 65.14 110.676 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.46 129.49 34.67 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.177 -0.465 . . . . 73.44 111.961 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -111.57 3.72 18.19 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.175 0.512 . . . . 71.44 111.315 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -77.85 138.61 39.03 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.565 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -55.04 -34.22 63.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.116 0.484 . . . . 74.15 110.779 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -101.24 93.3 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 70.22 110.524 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.6 p90 -71.29 86.04 0.8 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.936 0.875 . . . . 74.21 110.762 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG13 HG22 ' A' ' 84' ' ' THR . 55.1 t -104.91 108.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.537 -0.756 . . . . 74.23 109.825 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -103.89 168.07 9.37 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.387 0.613 . . . . 63.41 112.327 -174.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 77.0 p -138.5 143.49 38.58 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-N 115.768 -0.651 . . . . 50.12 111.0 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.21 166.21 28.91 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.45 2.1 . . . . 51.13 112.834 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.13 151.48 49.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.363 -0.38 . . . . 74.41 111.815 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.67 94.36 9.47 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.069 0.461 . . . . 64.25 110.162 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 59.2 mt -87.92 127.68 56.88 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.086 -0.506 . . . . 74.1 110.927 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.06 106.29 0.25 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.642 2.228 . . . . 70.02 112.914 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.48 57.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.289 -0.481 . . . . 75.11 113.28 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.3 m-85 -132.08 146.56 52.13 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.727 0.775 . . . . 72.4 112.893 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 101' ' ' ILE . 65.8 tttp -126.48 131.68 51.59 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.846 -1.07 . . . . 71.13 111.094 -177.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.08 121.44 14.17 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.007 0.432 . . . . 72.51 112.002 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' A' ' 99' ' ' ASP . 35.6 ttm180 -81.2 -58.54 3.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.034 0.445 . . . . 72.44 111.811 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -153.05 164.74 37.44 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.968 0.413 . . . . 75.53 111.812 -174.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.9 mt -107.71 127.22 28.15 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 116.029 -0.532 . . . . 54.44 111.272 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -56.0 155.96 21.61 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.276 2.651 . . . . 70.33 113.826 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.64 -9.71 21.51 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.867 -0.606 . . . . 71.31 112.624 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 94' ' ' VAL . 17.3 p-10 -131.5 41.36 3.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.921 0.341 . . . . 63.51 111.921 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.01 -26.19 48.38 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 122.148 -0.345 . . . . 70.22 111.698 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.566 HG22 HG13 ' A' ' 65' ' ' VAL . 70.0 p -136.97 129.8 30.57 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.486 -0.324 . . . . 74.14 111.262 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.33 -170.22 41.46 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.62 -0.8 . . . . 72.05 113.844 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -103.13 135.41 44.84 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.648 0.379 . . . . 64.11 111.681 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 39' ' ' PHE . 48.1 mt -66.64 96.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.21 0.529 . . . . 75.53 110.901 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.8 p -103.83 -12.21 17.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.133 -0.485 . . . . 60.44 112.178 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -137.27 169.07 18.41 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.939 0.4 . . . . 75.43 111.605 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.0 p -91.39 141.52 28.66 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.178 -0.465 . . . . 71.1 112.073 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.86 58.76 6.02 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.391 -0.433 . . . . 54.54 114.062 174.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.721 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -94.91 134.73 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.353 -0.498 . . . . 73.34 110.954 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 59.3 mt -116.99 114.95 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.096 0.475 . . . . 55.22 112.121 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 82' ' ' ASN . 47.4 t -92.73 106.3 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 62.33 109.96 172.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.406 ' HD3' HG21 ' A' ' 46' ' ' VAL . 22.1 ttm180 -112.76 111.2 21.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.176 0.436 . . . . 73.41 112.176 -174.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -88.54 138.15 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.373 -0.376 . . . . 75.42 111.446 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.6 mm -101.51 129.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.279 -0.418 . . . . 74.44 111.127 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 97.2 m-85 -122.92 128.42 50.27 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.216 0.531 . . . . 71.41 111.957 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 77' ' ' ARG . 6.6 m-20 -76.64 135.4 39.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.333 -0.394 . . . . 73.01 110.685 171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -75.69 111.29 10.88 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.095 0.474 . . . . 70.33 109.84 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 75' ' ' LYS . 58.0 mt -68.42 106.83 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 112.741 0.645 . . . . 72.34 112.741 -168.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -80.11 78.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.959 0.885 . . . . 73.02 110.144 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -148.24 -26.04 0.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.963 -1.017 . . . . 70.04 111.311 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.0 m -76.47 81.67 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.027 -0.988 . . . . 71.44 110.621 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.6 t -60.67 82.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.258 -0.883 . . . . 62.33 111.968 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -125.38 108.93 12.16 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.718 -0.674 . . . . 73.13 111.276 176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 45.2 t -84.97 100.43 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.989 0.423 . . . . 52.32 110.371 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -147.86 152.59 37.88 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.89 0.376 . . . . 75.21 112.009 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.11 -2.7 7.62 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 116.28 -0.418 . . . . 74.42 111.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 p -76.48 -12.87 60.11 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.162 0.43 . . . . 65.31 112.162 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -112.19 174.35 16.22 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.305 -0.474 . . . . 53.35 113.152 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -175.27 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.244 -0.65 . . . . 73.35 109.244 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -170.68 123.12 0.63 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.597 -0.728 . . . . 74.32 109.661 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 114' ' ' LEU . 2.7 mm? -114.73 149.07 37.44 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.862 0.363 . . . . 73.41 111.926 -174.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 mp -129.76 158.68 72.9 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.286 0.476 . . . . 73.44 112.286 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.4 -177.89 3.45 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.06 2.507 . . . . 63.11 112.914 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 117' ' ' VAL . 16.3 m -80.27 98.9 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.461 0.648 . . . . 65.05 111.248 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.5 m -75.82 120.38 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.316 0.579 . . . . 71.24 111.736 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -149.32 137.7 20.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.982 -0.554 . . . . 74.05 111.151 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 122' ' ' ASN . 48.2 mm -91.58 131.22 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 111.969 0.359 . . . . 71.44 111.969 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 121' ' ' ILE . 0.2 OUTLIER -81.85 -17.0 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 112.679 0.622 . . . . 50.43 112.679 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.501 ' H ' HG22 ' A' ' 120' ' ' ILE . 3.8 t-20 72.29 116.88 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.079 0.552 . . . . 74.13 112.087 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -106.08 -75.81 0.62 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.427 0.529 . . . . 74.34 112.427 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -72.91 85.44 1.26 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.364 0.602 . . . . 71.22 111.813 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -165.87 -66.82 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.531 -0.758 . . . . 74.11 110.511 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.81 47.08 1.05 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.253 0.549 . . . . 52.25 111.265 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.514 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 33.1 m -106.46 13.44 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.868 0.692 . . . . 73.43 112.868 -173.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.7 tp -76.96 -31.63 56.71 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.854 0.359 . . . . 62.11 111.589 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -134.02 113.77 12.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.244 0.545 . . . . 61.11 112.307 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 127' ' ' VAL . 27.8 m80 -144.98 10.23 1.32 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.059 -0.519 . . . . 75.33 110.82 173.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 61.16 101.53 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.681 0.393 . . . . 63.35 110.731 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -68.79 72.56 0.24 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.096 0.406 . . . . 75.25 112.096 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.6 p80 173.84 127.28 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.844 0.858 . . . . 74.35 110.384 177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -65.07 98.89 0.32 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.042 0.448 . . . . 62.24 110.779 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.3 p80 . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.747 -0.66 . . . . 75.12 112.35 -174.654 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 120.945 0.402 . . . . 74.34 111.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.08 -23.37 17.36 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.577 -0.283 . . . . 72.03 111.467 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.5 p -54.08 137.33 40.33 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.289 0.477 . . . . 65.52 112.289 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -65.93 -39.33 90.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.382 0.512 . . . . 65.23 112.382 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 65.13 65.45 0.58 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.076 0.465 . . . . 72.24 111.992 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 87' ' ' ILE . 96.8 m-85 -65.65 88.6 0.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.018 0.437 . . . . 73.44 111.101 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.2 p -126.41 146.38 50.1 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.361 -0.381 . . . . 64.22 111.64 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.601 HG22 ' HB ' ' A' ' 92' ' ' ILE . 98.3 t -107.35 114.76 47.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.429 . . . . 75.35 111.198 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -92.02 129.24 38.02 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 122.265 -0.272 . . . . 54.53 110.943 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 20.7 t -104.95 113.24 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 122.38 -0.2 . . . . 74.1 111.152 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.14 154.02 19.39 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.342 0.592 . . . . 71.33 111.773 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 46.1 m-85 -129.53 104.72 7.62 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.97 -0.559 . . . . 73.15 109.917 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.781 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.4 m -120.95 150.82 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.01 0.744 . . . . 64.53 113.01 -170.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HB2' HG21 ' A' ' 53' ' ' ILE . 11.2 t70 -70.53 166.03 21.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.696 -0.684 . . . . 62.45 110.37 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.2 -0.51 2.56 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.943 0.72 . . . . 74.33 112.943 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.11 -22.81 23.92 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.22 0.534 . . . . 75.54 110.609 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.78 33.87 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.081 -0.509 . . . . 63.21 113.375 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.62 133.42 43.98 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.687 -0.301 . . . . 75.24 110.765 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.781 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 11.8 pt-20 -69.87 148.32 49.18 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.916 0.865 . . . . 73.32 111.658 -176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 HG21 ' HB2' ' A' ' 47' ' ' ASP . 15.4 pt -124.69 4.51 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 114.899 -1.046 . . . . 65.24 111.668 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -157.8 156.5 28.53 Favored Pre-proline 0 C--O 1.236 0.374 0 N-CA-C 112.217 0.451 . . . . 63.52 112.217 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.3 146.87 70.17 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.433 2.089 . . . . 51.35 112.743 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.9 p -109.4 152.42 25.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.985 -0.552 . . . . 75.4 111.726 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -109.75 162.27 14.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.031 0.443 . . . . 71.41 111.546 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.5 m -130.26 103.38 6.67 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.038 0.447 . . . . 62.35 110.886 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.0 mt -85.41 137.71 32.75 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.934 0.397 . . . . 62.53 111.805 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -111.24 -7.45 14.43 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.042 0.448 . . . . 72.32 111.147 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.84 132.44 48.03 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.983 -0.553 . . . . 62.01 111.723 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -53.13 -48.91 67.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.443 . . . . 72.42 110.835 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -85.72 88.22 7.51 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 122.084 -0.385 . . . . 72.3 110.758 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -76.68 98.06 4.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.884 0.85 . . . . 62.23 110.405 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.464 HG13 HG22 ' A' ' 84' ' ' THR . 46.6 t -110.44 108.23 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 109.192 -0.67 . . . . 75.21 109.192 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.8 t -96.48 175.0 6.57 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.208 0.818 . . . . 72.45 113.208 -169.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.7 p -143.67 139.45 16.27 Favored Pre-proline 0 N--CA 1.473 0.717 0 CA-C-N 115.83 -0.623 . . . . 74.42 111.72 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.73 119.92 5.63 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.354 2.036 . . . . 64.25 112.421 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 63.4 mttm -72.43 142.27 48.65 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.902 0.334 . . . . 74.43 111.902 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -70.43 85.03 0.59 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.069 0.462 . . . . 63.44 110.479 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt -82.58 124.91 77.16 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.196 -0.456 . . . . 72.24 111.124 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -56.75 116.0 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.755 2.303 . . . . 32.22 113.286 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 16.89 72.67 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.25 -0.5 . . . . 52.11 113.673 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 49.4 m-85 -127.73 139.41 52.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.729 0.776 . . . . 75.14 112.939 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' HB2' HG12 ' A' ' 101' ' ' ILE . 27.9 tptp -115.45 120.31 39.13 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.639 -1.164 . . . . 74.2 111.464 -175.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.3 tp -68.05 125.99 28.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.953 -0.467 . . . . 64.43 110.906 176.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 ptm180 -95.66 -38.44 10.37 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.812 0.339 . . . . 73.41 111.842 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.666 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 10.3 pt-20 -154.66 136.94 14.87 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.132 0.491 . . . . 75.22 111.768 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.64 121.3 70.11 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.925 -0.58 . . . . 64.54 110.15 174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.22 149.38 54.95 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.207 2.605 . . . . 71.05 113.824 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -58.07 -26.13 62.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.432 0.634 . . . . 64.21 111.045 176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.423 ' O ' HG22 ' A' ' 94' ' ' VAL . 54.9 t30 -91.51 7.86 39.27 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.688 -0.687 . . . . 75.11 111.979 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.39 -34.69 75.76 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.163 0.801 . . . . 60.23 113.163 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.464 HG22 HG13 ' A' ' 65' ' ' VAL . 81.6 p -135.12 139.52 44.73 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.396 -0.19 . . . . 73.43 111.501 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 166.61 -171.92 41.68 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.735 -0.745 . . . . 52.52 113.779 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -104.87 145.58 30.2 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.654 0.264 . . . . 53.02 111.707 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.408 HG21 ' HB3' ' A' ' 39' ' ' PHE . 47.5 mt -73.06 94.8 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.399 0.619 . . . . 75.22 110.884 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.6 p -117.91 14.19 14.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.593 -0.73 . . . . 74.24 110.431 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -158.8 155.62 28.23 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.102 -0.954 . . . . 72.54 109.412 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.5 t -107.92 151.92 25.13 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.928 -0.482 . . . . 75.32 111.854 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.09 29.24 51.65 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.09 -0.576 . . . . 35.3 112.837 -174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' HG22 ' A' ' 41' ' ' VAL . 58.2 mt -77.57 122.89 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.886 0.374 . . . . 64.15 111.475 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.3 mt -118.49 113.26 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.363 0.505 . . . . 54.11 112.363 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 82' ' ' ASN . 61.5 t -89.48 102.53 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.315 -0.402 . . . . 63.43 110.409 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.3 ttm180 -109.91 118.73 37.25 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.446 0.535 . . . . 73.13 112.446 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -91.94 147.47 22.94 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.67 0.388 . . . . 65.32 111.649 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' A' ' 77' ' ' ARG . 7.3 mm -112.91 125.86 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.594 0.235 . . . . 64.5 111.187 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.64 130.68 53.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.936 0.398 . . . . 74.41 112.062 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' OD2' ' HD2' ' A' ' 77' ' ' ARG . 10.2 m-20 -85.54 134.12 34.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.599 -0.519 . . . . 64.32 109.599 170.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 5.6 ttmm -69.89 126.41 29.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.193 0.52 . . . . 62.01 110.74 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 75' ' ' LYS . 54.4 mt -74.11 104.75 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 72.44 111.025 -177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 44.6 mm -69.07 -31.16 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.272 0.558 . . . . 61.31 110.541 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.3 t70 68.66 167.54 0.27 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.185 -0.916 . . . . 71.11 112.704 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 104' ' ' VAL . 12.6 m -84.56 4.43 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.404 -0.816 . . . . 74.41 112.046 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.9 m 71.45 -62.93 0.44 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.199 0.599 . . . . 50.41 110.507 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.7 t80 73.06 -22.29 0.23 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.594 0.961 . . . . 71.52 113.594 168.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.8 m -93.66 178.76 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 122.706 0.402 . . . . 74.54 112.067 -175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -69.99 -68.57 0.41 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.372 0.606 . . . . 71.33 111.119 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -78.73 88.99 4.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.721 -0.672 . . . . 74.11 110.643 178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.8 p -72.51 75.83 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.017 -0.538 . . . . 61.21 111.759 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -157.68 125.55 1.58 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.316 -0.469 . . . . 75.21 113.067 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -168.76 -72.64 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.956 0.502 . . . . 73.44 109.869 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -157.0 115.27 3.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 65.34 109.994 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 114' ' ' LEU . 2.0 mp -115.27 170.56 8.29 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.211 0.529 . . . . 73.21 110.98 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HD2' ' A' ' 116' ' ' PRO . 26.3 tp -160.83 134.22 4.81 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.955 -0.566 . . . . 73.12 110.517 175.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 115' ' ' LEU . 71.9 Cg_exo -51.31 115.6 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.379 2.052 . . . . 64.22 112.095 173.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.7 p -55.13 119.47 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.594 0.712 . . . . 72.21 111.619 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.89 145.57 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.387 -0.824 . . . . 73.11 112.237 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -74.06 147.08 43.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.206 0.527 . . . . 53.54 111.16 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 58.5 mt -81.65 122.13 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.353 -0.385 . . . . 72.11 111.757 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.07 121.61 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 109.884 -0.413 . . . . 74.41 109.884 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -64.1 125.16 23.59 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 111.911 0.338 . . . . 74.5 111.911 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -53.21 128.09 26.75 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 42.45 110.084 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.04 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.755 0.659 . . . . 71.44 112.52 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.77 1.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.588 0.959 . . . . 55.33 113.588 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.47 -2.86 57.94 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.932 0.396 . . . . 52.01 111.859 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.8 m -71.78 100.96 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.419 0.628 . . . . 75.32 112.074 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.66 94.16 4.31 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.485 0.66 . . . . 75.34 111.416 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -71.33 164.4 25.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.183 0.516 . . . . 62.32 111.677 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -133.53 95.01 3.4 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.069 -0.514 . . . . 73.23 110.964 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -144.25 115.71 8.08 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.421 -0.354 . . . . 71.21 111.034 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 30.0 m170 -116.32 129.83 56.46 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.203 0.525 . . . . 71.12 111.619 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -98.5 95.6 7.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.154 -0.476 . . . . 73.41 111.155 176.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -101.59 120.68 40.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.536 -0.302 . . . . 74.34 110.674 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.6 t60 . . . . . 0 C--O 1.25 1.102 0 C-N-CA 123.175 0.59 . . . . 73.03 111.994 -179.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.893 0.378 . . . . 65.25 110.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -86.73 -26.17 24.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 65.44 111.415 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 p -90.72 176.83 6.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.23 0.538 . . . . 64.52 112.273 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -119.74 24.6 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.205 -0.452 . . . . 73.04 111.154 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -54.57 104.03 0.1 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.967 0.729 . . . . 71.02 112.967 -174.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.501 ' HB3' HG21 ' A' ' 87' ' ' ILE . 40.7 m-85 -75.93 86.93 2.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.176 0.512 . . . . 75.22 110.47 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.4 p -119.71 151.56 38.56 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.858 -0.61 . . . . 65.41 111.475 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.662 HG22 ' HB ' ' A' ' 92' ' ' ILE . 72.5 t -114.28 115.8 50.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.269 0.556 . . . . 64.23 111.544 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.609 ' HB3' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -82.73 129.43 34.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.875 -0.602 . . . . 74.25 110.91 177.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.4 t -116.36 113.33 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 122.127 -0.358 . . . . 71.51 110.653 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.9 mt-10 -115.57 145.86 42.28 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.036 0.446 . . . . 74.13 111.123 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.542 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 23.1 m-85 -117.97 104.44 10.89 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.096 0.474 . . . . 73.03 110.222 -173.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.4 m -120.23 160.62 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 115.929 -0.578 . . . . 74.25 112.082 -169.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.78 -169.51 2.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.079 0.466 . . . . 71.5 111.153 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.71 -16.58 61.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.526 0.936 . . . . 65.34 113.526 -177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.11 2.1 39.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.102 0.477 . . . . 53.43 111.457 177.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.49 18.44 62.15 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.07 -0.585 . . . . 74.44 113.541 177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.63 118.93 34.15 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.925 0.393 . . . . 74.3 110.695 178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 4.1 pt-20 -68.54 91.26 0.41 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.503 1.144 . . . . 75.22 111.504 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' H ' HG12 ' A' ' 53' ' ' ILE . 8.3 pt -66.39 -7.0 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 113.978 -1.465 . . . . 71.12 112.192 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -143.34 157.19 60.22 Favored Pre-proline 0 CA--C 1.537 0.479 0 O-C-N 122.26 -0.275 . . . . 35.25 111.546 -172.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.94 166.55 3.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.595 2.197 . . . . 71.2 113.361 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.0 p -124.89 147.45 48.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.611 . . . . 74.44 112.067 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 10.9 m-20 -98.57 164.54 12.21 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.335 0.588 . . . . 75.53 111.896 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -137.42 104.62 5.42 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.647 -0.706 . . . . 51.34 110.152 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.92 124.38 34.17 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.318 -0.401 . . . . 65.42 111.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -97.11 -10.41 26.07 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.971 0.415 . . . . 64.31 111.125 174.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.59 134.56 56.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.083 -0.508 . . . . 74.13 111.911 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 24.3 t80 -52.89 -50.94 62.86 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.026 0.441 . . . . 74.43 111.367 176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -84.43 84.35 7.68 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.405 . . . . 72.23 110.502 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CG ' HG21 ' A' ' 41' ' ' VAL . 16.7 p90 -68.44 90.48 0.37 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.101 0.953 . . . . 70.12 110.517 178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.1 t -104.72 108.34 24.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 72.21 109.014 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 t -92.2 169.35 10.68 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.878 0.696 . . . . 63.32 112.878 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -139.3 134.42 16.55 Favored Pre-proline 0 N--CA 1.471 0.601 0 CA-C-N 115.723 -0.671 . . . . 75.53 111.232 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.88 136.34 18.56 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.281 1.987 . . . . 75.25 112.337 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 62.9 mttm -89.87 143.59 26.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.807 0.336 . . . . 72.42 111.101 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -79.24 97.49 6.27 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.281 0.562 . . . . 65.32 110.527 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.51 127.64 53.91 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.027 -0.533 . . . . 64.1 111.404 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.53 112.29 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.591 2.194 . . . . 75.22 112.806 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.26 9.51 67.14 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.309 -0.472 . . . . 72.13 113.429 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 49.7 m-85 -133.3 143.0 48.76 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.487 0.66 . . . . 74.32 112.488 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' HB2' HD11 ' A' ' 101' ' ' ILE . 80.9 tttt -120.62 127.49 52.14 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.386 -0.825 . . . . 65.43 111.252 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.29 129.48 39.97 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.09 -0.381 . . . . 64.14 111.237 177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' ILE . 9.1 ptp180 -88.69 -43.4 11.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.793 0.33 . . . . 54.35 111.712 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 8.4 pt-20 -152.25 158.16 42.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.108 0.48 . . . . 70.22 111.806 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' PRO . 80.7 mt -101.3 116.16 64.14 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 115.953 -0.567 . . . . 61.45 109.645 170.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 7.0 Cg_endo -49.62 135.07 34.02 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.812 2.341 . . . . 60.52 113.168 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 -61.87 1.23 0.29 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.26 0.837 . . . . 71.42 113.26 -176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -123.93 27.08 7.36 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.281 -0.262 . . . . 64.35 111.163 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 -20.16 39.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.421 0.526 . . . . 64.33 112.421 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 32.0 p -130.36 146.99 52.02 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.779 0.324 . . . . 74.3 111.091 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 152.9 -142.28 9.14 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.851 -0.69 . . . . 52.41 113.238 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.567 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -132.26 133.3 43.95 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.143 -0.317 . . . . 62.4 110.143 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.501 HG21 ' HB3' ' A' ' 39' ' ' PHE . 36.7 mt -63.82 94.59 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 121.413 0.625 . . . . 72.23 111.342 -177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.4 p -103.94 -22.93 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.622 -0.717 . . . . 72.13 111.358 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -113.17 156.87 22.45 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.034 -0.53 . . . . 65.33 110.971 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -90.54 131.99 35.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.406 0.521 . . . . 55.45 112.406 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.66 57.77 6.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.16 -0.543 . . . . 63.02 113.6 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.662 ' HB ' HG22 ' A' ' 41' ' ' VAL . 63.3 mt -90.26 121.58 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.667 -0.313 . . . . 74.15 111.078 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.609 HG12 ' HB3' ' A' ' 42' ' ' LYS . 15.5 mt -107.29 116.07 50.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.399 0.618 . . . . 61.11 111.784 176.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.4 t -94.9 116.12 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.777 -0.647 . . . . 73.23 110.261 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 25.5 mtt180 -112.37 118.63 35.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.45 0.643 . . . . 74.24 112.493 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -89.72 130.72 35.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.381 -0.827 . . . . 74.11 110.391 174.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 11.6 mm -103.66 123.95 57.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.142 -0.481 . . . . 64.02 111.192 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.59 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 34.6 m-85 -115.34 129.54 56.63 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.162 0.506 . . . . 72.43 111.985 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -83.21 149.95 26.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.048 -0.523 . . . . 71.11 110.663 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -86.34 117.26 25.03 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.188 0.518 . . . . 74.11 111.732 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 75' ' ' LYS . 34.1 mt -79.26 104.85 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.09 -0.504 . . . . 64.3 110.995 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.1 mm -78.29 -22.49 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.105 0.409 . . . . 75.44 112.105 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.33 -1.33 6.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.843 0.683 . . . . 75.43 112.843 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 104' ' ' VAL . 5.8 t -108.63 19.24 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.247 0.546 . . . . 74.22 110.214 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.8 m 70.15 2.23 3.87 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.229 0.612 . . . . 71.43 112.216 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -79.63 85.07 5.39 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.067 0.461 . . . . 72.44 111.946 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.4 m -86.89 170.87 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.974 0.416 . . . . 74.42 110.822 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -66.29 153.55 42.29 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.159 0.504 . . . . 75.01 112.024 -177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -129.57 -60.43 1.05 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 71.22 110.645 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.3 t -154.56 134.44 12.97 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.113 -0.494 . . . . 71.25 110.911 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.02 144.9 6.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.984 -0.627 . . . . 74.45 113.039 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.665 ' HD3' HD23 ' A' ' 114' ' ' LEU . 85.7 tttt -161.68 140.01 9.33 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.917 0.389 . . . . 75.23 111.335 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -73.87 75.79 1.63 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.488 0.661 . . . . 71.11 111.171 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.665 HD23 ' HD3' ' A' ' 112' ' ' LYS . 1.1 pp -122.75 7.48 9.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.376 0.51 . . . . 75.55 112.376 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 114' ' ' LEU . 6.1 mp -81.49 148.83 63.52 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.261 0.467 . . . . 51.32 112.261 -175.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.4 116.14 2.97 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.027 2.485 . . . . 64.44 112.869 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.1 m -92.34 171.47 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.116 0.484 . . . . 55.21 112.173 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.9 p -143.19 152.73 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.225 -0.443 . . . . 44.13 111.259 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -79.42 122.37 26.32 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.927 0.394 . . . . 71.44 112.059 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 120' ' ' ILE . 2.0 mp -79.1 122.31 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.823 0.344 . . . . 51.04 110.207 174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.6 tt -80.72 99.2 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-O 121.569 0.7 . . . . 72.13 112.596 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -127.11 93.12 3.67 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.051 -0.522 . . . . 71.24 109.769 173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 96.5 p -116.35 143.38 45.63 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.595 0.591 . . . . 42.31 112.595 -172.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 127' ' ' VAL . 35.2 mt-10 55.45 29.46 13.29 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.128 0.49 . . . . 70.32 111.084 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.459 ' HB3' HG12 ' A' ' 127' ' ' VAL . . . 61.67 4.56 1.08 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.484 -0.78 . . . . 55.44 111.892 -176.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.54 31.88 21.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.525 0.679 . . . . 62.33 111.149 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 125' ' ' ALA . 7.6 p -113.72 149.22 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-N 115.695 -0.684 . . . . 74.01 111.876 -177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.6 mt -99.32 104.81 16.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.969 0.414 . . . . 73.21 110.261 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -90.22 -62.9 1.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.108 0.48 . . . . 72.04 112.164 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -89.39 88.74 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.908 0.385 . . . . 63.23 111.551 -175.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -96.97 114.28 25.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.299 -0.41 . . . . 73.14 111.356 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -165.81 89.84 0.44 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.139 0.495 . . . . 64.31 111.215 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -119.95 118.95 32.04 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 72.24 110.597 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -87.84 151.08 23.13 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.433 0.158 . . . . 70.34 110.66 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.564 -0.731 . . . . 72.51 111.213 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.747 0.308 . . . . 75.32 111.398 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.18 129.49 50.24 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.399 -0.364 . . . . 61.43 110.631 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.1 m 71.27 111.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.343 0.497 . . . . 72.1 112.343 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -66.54 85.33 0.11 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.422 0.63 . . . . 70.4 112.141 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.09 87.74 2.99 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.42 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 87' ' ' ILE . 57.8 m-85 -46.57 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.784 -0.644 . . . . 74.34 112.495 176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.2 p -138.59 161.33 37.38 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.787 -0.642 . . . . 70.15 111.161 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.781 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -123.24 126.61 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.112 -0.495 . . . . 72.55 111.326 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -92.25 137.68 32.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.701 -0.227 . . . . 74.2 110.791 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -115.27 112.98 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.867 0.365 . . . . 64.34 110.931 177.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 95' ' ' ARG . 35.6 mt-10 -104.02 154.83 19.22 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.325 0.583 . . . . 74.0 112.122 177.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 84.5 m-85 -125.36 104.38 8.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.944 -0.571 . . . . 73.12 109.655 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.699 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.6 m -123.27 153.79 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.901 0.704 . . . . 71.32 112.901 -170.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -72.63 163.92 27.3 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.506 -0.924 . . . . 53.32 108.506 170.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 1.81 0.47 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.379 0.881 . . . . 55.14 113.379 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -85.54 -22.3 28.18 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.326 0.584 . . . . 61.23 110.491 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.43 -4.05 40.26 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.756 -0.657 . . . . 63.33 112.586 -175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.96 134.41 36.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.481 0.312 . . . . 53.52 110.837 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.7 pt-20 -78.18 139.25 38.97 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 122.032 0.92 . . . . 73.24 112.123 -175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 pt -110.13 -0.09 9.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.1 -0.955 . . . . 63.42 111.459 -175.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -153.62 149.75 21.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 71.04 111.367 -172.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.82 146.48 11.46 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.852 2.368 . . . . 55.45 113.531 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -95.16 153.94 17.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.06 -0.518 . . . . 55.24 112.261 -175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -117.33 167.35 11.32 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.912 -0.585 . . . . 61.4 111.391 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 66.3 m -143.53 104.85 4.27 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.093 0.473 . . . . 74.1 111.451 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.24 118.5 23.67 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.11 -0.495 . . . . 62.31 111.445 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.4 t -94.19 -8.27 39.85 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.386 0.613 . . . . 74.01 110.657 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.08 136.47 57.3 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.499 -0.773 . . . . 73.01 111.907 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 83.1 t80 -54.38 -46.61 73.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.847 0.356 . . . . 71.31 110.953 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -89.61 83.31 6.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.016 0.436 . . . . 75.22 110.771 172.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CG ' HG21 ' A' ' 41' ' ' VAL . 15.1 p90 -73.21 91.4 1.66 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.138 0.971 . . . . 72.32 110.44 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.45 108.26 24.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.382 -0.826 . . . . 60.02 109.409 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.1 m -94.13 159.11 15.3 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.546 0.573 . . . . 60.51 112.546 -171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.9 p -134.66 136.16 24.91 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-N 115.831 -0.622 . . . . 54.31 111.661 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.0 120.27 6.93 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 122.686 2.257 . . . . 61.03 112.839 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -70.59 151.82 44.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.62 0.724 . . . . 70.23 112.262 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -83.1 89.16 6.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.239 -0.891 . . . . 61.4 110.697 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -87.18 116.78 67.25 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.135 -0.484 . . . . 71.45 111.075 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.84 107.86 0.82 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.639 2.226 . . . . 60.24 112.991 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.59 -1.13 42.52 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.27 -0.491 . . . . 70.05 113.242 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.57 150.91 40.96 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.63 0.729 . . . . 75.01 112.628 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -118.58 131.42 56.2 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.052 -0.976 . . . . 74.3 110.623 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.3 tp -67.12 108.35 2.63 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.11 0.481 . . . . 74.4 110.793 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -68.38 -50.99 49.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.381 . . . . 63.3 111.047 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -164.07 160.61 21.82 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.165 0.507 . . . . 64.3 111.686 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.4 mt -101.2 130.35 25.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 115.99 -0.55 . . . . 74.13 111.689 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.46 145.52 97.73 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.776 2.318 . . . . 75.23 113.518 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -60.64 -11.42 7.25 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.168 0.803 . . . . 75.42 113.168 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -117.36 24.41 11.15 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.196 -0.315 . . . . 75.14 111.765 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -30.26 71.16 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.693 0.627 . . . . 75.5 112.693 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 66.1 p -138.41 133.98 33.54 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.636 0.255 . . . . 61.41 111.504 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.71 -163.87 36.97 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.106 -0.568 . . . . 25.42 113.202 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 20.3 p-10 -105.76 138.61 41.66 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.558 -0.378 . . . . 73.13 111.133 176.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.503 HG21 ' HB3' ' A' ' 39' ' ' PHE . 41.8 mt -65.99 94.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-O 121.582 0.706 . . . . 75.42 110.728 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 82.4 p -97.48 -23.85 15.86 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.616 -0.72 . . . . 74.52 110.739 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -128.25 156.57 42.78 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.76 -0.654 . . . . 75.23 110.271 175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -93.39 158.86 15.52 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.841 0.353 . . . . 71.33 111.361 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.82 41.99 93.24 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.265 -0.493 . . . . 53.1 113.722 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 41' ' ' VAL . 67.0 mt -87.69 140.12 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.834 0.317 . . . . 61.31 110.717 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -123.16 110.0 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.076 0.465 . . . . 72.24 112.106 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 73.6 t -89.17 108.45 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.997 -0.547 . . . . 62.01 110.02 173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 44' ' ' GLU . 40.3 ttm180 -118.11 110.32 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.118 -0.364 . . . . 64.21 111.369 -174.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -82.15 139.06 34.56 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.888 0.375 . . . . 73.33 111.732 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.4 mm -102.48 124.84 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.883 -0.599 . . . . 70.22 111.068 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -120.4 159.65 24.65 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.747 0.784 . . . . 55.24 111.951 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -118.58 134.72 54.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.129 -0.941 . . . . 64.31 110.208 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -71.34 115.83 10.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.324 -0.55 . . . . 64.41 109.769 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.8 mt -68.15 104.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.099 0.475 . . . . 72.32 111.96 -171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.83 -26.93 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 121.414 0.626 . . . . 75.34 110.76 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -101.37 106.9 18.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.439 -0.801 . . . . 75.42 111.351 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 9.6 m -123.06 93.48 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.649 0.738 . . . . 75.51 112.027 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 49.7 m -63.88 -23.91 67.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.566 -0.743 . . . . 64.51 109.95 170.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -60.92 101.78 0.16 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.031 -0.986 . . . . 74.04 111.308 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -83.87 153.64 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 115.916 -0.583 . . . . 73.15 111.699 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.29 104.29 3.66 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.456 0.539 . . . . 70.33 112.456 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -156.14 -57.42 0.09 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.906 -0.588 . . . . 54.42 110.154 174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 t -153.14 151.09 29.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.85 -0.614 . . . . 74.43 111.219 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.19 -148.91 6.56 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.389 -0.434 . . . . 72.33 112.134 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -67.25 144.67 55.81 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.195 0.521 . . . . 75.33 111.108 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -68.88 104.39 2.05 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.534 0.683 . . . . 75.14 112.427 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.94 133.0 33.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.092 -0.504 . . . . 73.21 111.044 176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.79 153.25 83.13 Favored Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.376 0.51 . . . . 73.14 112.376 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -59.87 88.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.881 2.388 . . . . 74.22 113.114 176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p -133.13 127.12 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.125 0.488 . . . . 72.54 111.53 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.24 116.26 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.569 0.699 . . . . 63.12 111.835 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.554 ' HB3' HD12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -133.66 -160.55 1.06 Allowed 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.953 -0.567 . . . . 65.12 110.175 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 119' ' ' GLU . 3.4 mp 52.64 42.25 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 122.394 1.092 . . . . 74.32 109.764 -172.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 23.4 pt -81.6 57.51 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.185 -0.916 . . . . 33.23 111.662 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -69.79 162.98 26.78 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.877 -0.601 . . . . 71.33 111.887 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.7 m -77.2 160.38 28.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.956 -0.566 . . . . 73.42 110.02 173.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -50.22 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.004 0.431 . . . . 72.22 111.964 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.69 11.34 3.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.872 -0.604 . . . . 74.34 112.532 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 47.31 76.49 0.11 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.152 0.581 . . . . 64.11 112.38 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.9 111.5 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.436 -0.347 . . . . 50.34 111.111 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.48 133.97 20.86 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.303 0.483 . . . . 54.3 112.303 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -176.7 147.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.458 -0.792 . . . . 55.32 109.718 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -135.0 137.15 42.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.419 0.525 . . . . 75.22 112.419 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -141.05 162.55 35.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.043 -0.526 . . . . 73.41 110.59 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -148.73 127.82 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.111 0.482 . . . . 72.33 111.357 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -68.11 95.43 0.56 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.885 -0.598 . . . . 75.42 111.846 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -160.73 143.38 12.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.577 -0.283 . . . . 73.24 111.428 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.928 -0.558 . . . . 52.44 111.743 178.12 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.548 ' SD ' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 120.928 0.395 . . . . 71.12 111.296 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -99.12 104.2 16.17 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.388 0.613 . . . . 71.12 111.736 -175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.8 p -120.55 42.31 3.03 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.296 0.57 . . . . 73.11 111.206 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -79.01 40.57 0.41 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.183 0.809 . . . . 74.32 113.183 -175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 40.15 70.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.578 0.704 . . . . 64.11 111.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -65.25 90.71 0.1 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.648 -0.705 . . . . 73.35 112.139 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 60' ' ' THR . 23.6 p -126.73 156.95 40.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.817 -0.628 . . . . 74.22 111.391 175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.778 HG22 ' HB ' ' A' ' 92' ' ' ILE . 79.6 t -119.12 124.03 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 116.145 -0.48 . . . . 75.31 111.675 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 56' ' ' SER . 1.8 tmtp? -93.7 126.18 38.73 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.945 0.402 . . . . 52.34 111.016 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 57' ' ' ASP . 36.2 t -105.79 128.14 60.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 111.824 0.305 . . . . 62.31 111.824 -176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' HG2' ' HE2' ' A' ' 42' ' ' LYS . 44.7 mt-10 -112.96 149.23 33.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.001 0.429 . . . . 71.22 111.517 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -122.78 99.95 6.65 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.491 -0.559 . . . . 70.32 109.491 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 32.9 m -120.99 151.38 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 113.705 1.002 . . . . 70.15 113.705 -168.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.27 169.86 4.24 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.357 -0.838 . . . . 63.24 109.239 171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.62 -10.06 1.4 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.05 1.13 . . . . 44.03 114.05 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.03 8.75 36.65 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.51 0.559 . . . . 75.5 112.51 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.96 86.49 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.039 -0.601 . . . . 24.34 113.807 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.4 114.06 26.37 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.003 -0.369 . . . . 70.43 110.003 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.7 pt-20 -62.29 141.07 58.45 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 73.1 112.363 -173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG13 HD13 ' A' ' 71' ' ' ILE . 16.5 pt -115.92 1.4 8.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 114.675 -1.148 . . . . 70.44 110.935 -176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -155.97 155.95 29.9 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 115.907 -0.588 . . . . 51.52 111.067 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.05 146.53 22.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.812 2.342 . . . . 72.11 113.537 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HB2' ' HE3' ' A' ' 42' ' ' LYS . 47.9 p -97.23 141.22 30.61 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.118 -0.492 . . . . 61.53 111.911 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 43' ' ' VAL . 0.9 OUTLIER -97.91 166.73 11.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.133 -0.485 . . . . 53.03 111.864 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -139.48 104.58 4.98 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.635 174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.6 mt -84.32 120.97 26.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.146 0.498 . . . . 53.44 112.072 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.7 t -99.59 -18.26 17.43 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.308 -0.405 . . . . 73.24 111.765 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -60.17 137.85 58.03 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.255 -0.43 . . . . 73.21 112.051 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.26 -46.3 72.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.824 0.345 . . . . 75.0 111.031 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -86.13 84.62 7.45 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.067 -0.396 . . . . 73.43 110.245 171.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -74.03 88.41 1.89 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.314 1.054 . . . . 74.53 110.364 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.544 HG13 HG22 ' A' ' 84' ' ' THR . 58.0 t -105.02 107.93 23.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.22 -0.9 . . . . 75.12 109.162 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.1 p -95.26 167.14 11.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.159 0.504 . . . . 75.14 112.046 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.5 p -131.95 135.9 27.4 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 115.994 -0.548 . . . . 75.52 111.56 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -73.52 117.13 4.94 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.311 2.007 . . . . 73.13 112.415 173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.23 133.9 41.28 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.967 0.889 . . . . 65.21 112.031 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -72.53 77.87 1.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.398 -1.274 . . . . 74.45 111.441 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.443 HD13 HG13 ' A' ' 53' ' ' ILE . 62.8 mt -72.19 120.21 79.04 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.744 -0.662 . . . . 44.21 111.448 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -57.0 109.51 0.46 Allowed 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.563 2.176 . . . . 73.43 112.593 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.5 2.19 55.49 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.253 -0.498 . . . . 63.1 113.525 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -128.27 146.52 50.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.635 0.731 . . . . 52.13 112.446 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -114.72 135.3 54.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.062 -0.972 . . . . 70.21 110.684 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.76 108.97 1.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.829 0.347 . . . . 73.22 110.791 176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -71.14 -48.92 49.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.003 0.43 . . . . 71.4 111.254 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -162.4 154.63 19.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.174 -0.466 . . . . 72.52 111.323 -177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.1 mt -99.1 126.42 38.17 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.215 -0.448 . . . . 71.32 111.121 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 142.24 99.17 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.591 2.194 . . . . 74.24 113.333 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -47.11 -34.43 6.03 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.052 0.76 . . . . 72.33 113.052 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -102.2 27.3 6.8 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.451 0.537 . . . . 63.05 112.451 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.89 -31.24 72.07 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 112.547 0.573 . . . . 54.15 112.547 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.544 HG22 HG13 ' A' ' 65' ' ' VAL . 68.8 p -137.39 129.74 29.58 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.872 0.368 . . . . 64.12 111.805 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.32 -157.86 30.49 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.798 -0.715 . . . . 61.55 113.243 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.59 135.43 51.24 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.871 0.367 . . . . 61.01 111.27 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.2 mt -65.31 94.08 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.292 0.567 . . . . 72.35 110.588 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 p -93.8 -15.34 25.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.915 -0.584 . . . . 63.12 110.967 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -142.33 160.4 40.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.059 -0.519 . . . . 75.54 110.566 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -102.65 144.55 30.89 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.236 0.541 . . . . 63.04 112.287 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.93 27.9 36.3 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.796 -0.638 . . . . 41.34 113.28 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.778 ' HB ' HG22 ' A' ' 41' ' ' VAL . 60.4 mt -80.46 141.46 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 O-C-N 122.764 -0.256 . . . . 64.14 110.441 178.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 45.8 mt -123.23 120.97 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.185 0.517 . . . . 72.52 112.174 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.91 103.86 15.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.903 -0.59 . . . . 73.32 110.223 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD3' HG21 ' A' ' 46' ' ' VAL . 34.4 ttm180 -108.26 106.59 16.82 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.853 0.358 . . . . 63.1 111.734 -173.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -81.22 136.06 35.8 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.031 0.443 . . . . 75.34 111.646 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.5 mm -102.9 131.21 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.957 -0.565 . . . . 73.33 110.939 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -124.72 143.83 50.56 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.427 0.632 . . . . 73.51 112.395 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -97.75 134.42 40.95 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.438 -0.801 . . . . 75.2 110.243 169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -70.75 118.82 14.02 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.151 0.5 . . . . 62.15 111.646 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.8 mt -76.39 103.63 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.078 -0.51 . . . . 64.52 109.968 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 102' ' ' ILE . 33.0 mt -90.01 45.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 122.535 1.159 . . . . 75.21 111.02 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -173.5 -167.24 0.37 Allowed 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 113.97 -1.468 . . . . 73.42 110.378 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.75 25.41 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 112.489 0.551 . . . . 64.4 112.489 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 m 58.94 46.59 13.45 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.98 0.895 . . . . 72.44 108.758 -168.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 108' ' ' ASP . 35.4 t80 -66.26 94.58 0.26 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.163 -1.38 . . . . 75.23 112.243 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 50.7 t -86.82 83.93 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.689 0.757 . . . . 72.22 111.328 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.455 ' HB3' ' CE2' ' A' ' 106' ' ' TYR . 39.1 t70 -150.37 60.01 0.96 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.29 -0.868 . . . . 64.32 109.301 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 56.68 -84.55 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.256 -0.884 . . . . 53.43 111.954 -172.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.42 HG21 ' HD2' ' A' ' 106' ' ' TYR . 54.1 p 43.83 32.63 0.62 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.103 0.478 . . . . 71.33 112.192 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . 108.01 55.34 0.61 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 116.13 -0.486 . . . . 70.23 112.085 -171.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.12 -40.74 82.03 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.181 0.515 . . . . 44.22 111.156 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -123.56 94.6 4.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.889 -0.596 . . . . 72.33 109.969 174.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 78.4 mt -95.73 -168.1 1.71 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.556 0.576 . . . . 64.31 112.556 -177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.9 mt 69.64 119.33 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.675 -0.693 . . . . 71.45 111.763 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.93 52.25 3.71 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.835 2.357 . . . . 74.42 112.436 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -57.27 103.84 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.718 0.77 . . . . 64.14 112.338 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p -117.09 149.01 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.882 -0.599 . . . . 62.24 111.852 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 120' ' ' ILE . 39.7 tt0 -151.0 165.56 33.37 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.669 -0.696 . . . . 74.4 109.587 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.488 ' N ' ' HG2' ' A' ' 119' ' ' GLU . 45.3 mm -54.89 94.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.346 0.593 . . . . 71.31 111.237 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.86 -26.25 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.8 -0.637 . . . . 72.41 111.696 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 47.2 t30 70.94 -62.74 0.44 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.128 0.571 . . . . 71.51 111.933 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 26.0 t -44.01 -51.78 7.54 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.323 0.86 . . . . 44.21 113.323 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -61.86 -21.81 65.0 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.499 0.555 . . . . 64.24 112.499 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -81.66 -16.63 50.72 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 111.845 0.313 . . . . 63.11 111.845 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.54 7.75 34.66 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.626 0.602 . . . . 62.03 112.626 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.5 p -85.48 154.58 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 122.191 -0.318 . . . . 74.34 111.343 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.5 mt -66.36 119.18 11.14 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.827 0.346 . . . . 53.13 111.772 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -134.37 139.51 45.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.719 0.295 . . . . 72.22 110.623 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -130.94 89.33 2.73 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.115 0.483 . . . . 71.35 111.755 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -91.56 62.03 4.43 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.99 -0.444 . . . . 70.11 112.058 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -169.31 62.49 0.05 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.366 0.603 . . . . 75.31 110.889 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -87.67 178.65 6.7 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.236 0.541 . . . . 75.44 112.184 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -103.87 -162.11 0.88 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.964 -0.562 . . . . 72.33 109.996 173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 66.3 t60 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.699 -0.667 . . . . 72.23 111.921 178.84 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 120.324 0.107 . . . . 74.32 111.072 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 54.91 -79.18 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.7 1.0 . . . . 74.2 113.7 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.8 p -59.15 101.75 0.11 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.567 0.699 . . . . 72.04 112.697 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -82.7 21.15 1.03 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.714 -0.676 . . . . 63.33 111.262 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.3 t30 56.18 63.72 1.92 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.658 0.742 . . . . 74.41 110.15 -170.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -60.5 104.02 0.3 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.143 -0.935 . . . . 72.53 111.471 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.3 p -130.55 162.25 29.7 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.998 0.428 . . . . 62.24 111.228 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.1 t -120.66 106.59 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.369 0.604 . . . . 72.12 111.644 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.4 tptm -73.67 125.31 27.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.767 -0.651 . . . . 73.44 110.984 175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.72 112.1 39.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.214 -0.448 . . . . 61.23 110.277 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 55.7 mt-10 -104.22 141.73 35.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.278 0.561 . . . . 73.23 111.092 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 80.6 m-85 -115.28 101.75 9.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.201 0.524 . . . . 53.5 110.393 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 28.1 m -119.96 163.36 17.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.935 -0.575 . . . . 73.33 111.957 -169.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -84.66 -170.22 3.01 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.968 0.414 . . . . 71.22 111.1 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.19 -13.68 58.8 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.101 0.778 . . . . 63.25 113.101 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -106.34 7.68 31.35 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.039 0.385 . . . . 75.0 112.039 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.61 15.47 70.82 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.299 -0.477 . . . . 53.25 113.858 175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -101.75 118.8 37.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.745 -0.267 . . . . 74.12 110.831 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.6 pt-20 -62.3 106.68 0.78 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.174 0.988 . . . . 73.34 111.535 -176.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 53' ' ' ILE . 2.4 pp -94.07 22.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.315 -0.857 . . . . 64.42 110.784 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.446 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -161.22 150.05 13.26 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.863 -0.608 . . . . 73.01 111.655 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.14 125.55 19.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.586 2.19 . . . . 70.52 112.919 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -91.85 139.98 30.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.252 -0.885 . . . . 64.43 112.123 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -104.54 166.37 10.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.717 0.636 . . . . 72.43 112.717 -175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -128.74 104.64 7.75 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.202 -0.453 . . . . 74.22 110.801 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.69 129.75 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.034 0.445 . . . . 73.01 111.878 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -103.92 -13.49 16.34 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.053 -0.522 . . . . 62.24 111.861 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.26 134.78 54.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.64 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 86.6 t80 -53.59 -48.6 69.08 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.026 0.441 . . . . 74.42 111.101 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -85.42 90.92 8.07 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.05 -0.406 . . . . 75.23 110.443 170.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' CG ' HG21 ' A' ' 41' ' ' VAL . 35.8 p90 -72.59 87.9 1.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.76 0.79 . . . . 74.31 110.702 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.5 107.95 23.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.295 0.569 . . . . 74.34 109.651 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.1 p -99.35 163.45 12.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.149 0.5 . . . . 64.24 112.337 -171.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 70.8 p -134.0 146.07 58.38 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 115.814 -0.63 . . . . 64.13 111.299 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . 37.8 Cg_endo -67.4 108.3 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.253 1.969 . . . . 61.32 112.58 176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -66.83 144.32 56.36 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.071 0.939 . . . . 64.43 112.59 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -76.26 89.93 3.14 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.315 -1.312 . . . . 71.5 111.419 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.401 HD13 ' HB2' ' A' ' 54' ' ' ALA . 41.2 mt -87.96 114.77 60.68 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 115.959 -0.564 . . . . 72.11 111.105 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -58.22 101.5 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.543 2.162 . . . . 73.44 113.25 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.07 5.65 40.55 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.098 -0.572 . . . . 72.13 113.972 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -128.97 146.36 50.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.525 0.679 . . . . 75.52 112.763 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.577 ' HE2' HG12 ' A' ' 101' ' ' ILE . 34.7 mtmt -119.15 135.96 54.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.094 -0.957 . . . . 74.12 110.775 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 68' ' ' PRO . 53.8 tp -64.53 123.44 19.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.178 0.513 . . . . 71.32 112.297 -176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -83.58 -59.01 2.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.026 -0.533 . . . . 64.42 111.714 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.13 153.79 33.49 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.13 0.491 . . . . 74.24 112.202 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.6 mt -111.42 130.76 22.74 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.844 -0.616 . . . . 72.13 111.015 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.457 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 57.4 Cg_endo -69.23 141.01 46.13 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.491 2.128 . . . . 55.4 113.143 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -56.05 -23.83 35.79 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.64 0.607 . . . . 75.42 112.64 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 80' ' ' PRO . 19.7 p-10 -99.14 24.38 7.95 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.774 0.287 . . . . 72.13 111.774 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.24 -17.84 60.82 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.591 0.589 . . . . 45.15 112.591 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 64' ' ' TYR . 65.4 p -132.48 161.64 33.21 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.897 0.38 . . . . 75.01 111.155 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.34 -160.79 26.46 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.024 -0.607 . . . . 73.35 113.099 176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 21.6 p-10 -108.17 139.3 43.04 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.726 0.298 . . . . 72.44 111.17 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 62' ' ' TYR . 46.3 mt -69.88 95.21 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.329 0.585 . . . . 64.23 110.912 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.4 p -102.73 -1.61 29.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.859 -0.61 . . . . 74.14 111.703 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -148.84 158.21 44.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.799 0.333 . . . . 75.43 111.236 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.7 t -98.5 140.02 33.37 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.976 0.417 . . . . 61.52 112.104 -178.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.22 40.3 24.63 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 115.992 -0.549 . . . . 73.21 113.851 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.7 mt -84.36 133.21 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 O-C-N 122.376 -0.485 . . . . 73.1 110.682 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 21.3 mt -121.56 119.65 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.455 0.645 . . . . 72.0 111.944 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.34 121.36 49.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.556 -0.747 . . . . 74.4 110.363 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 44.6 mtt180 -112.69 116.05 29.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.202 0.815 . . . . 63.43 113.202 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -90.25 133.12 35.14 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.033 -0.53 . . . . 64.12 110.582 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.5 mm -102.66 128.45 55.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.269 -0.423 . . . . 72.23 111.273 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -123.63 156.49 35.74 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.444 0.64 . . . . 74.32 111.701 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -111.58 150.88 29.41 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.481 -0.781 . . . . 62.23 109.707 171.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -78.24 125.69 29.72 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.952 -0.467 . . . . 74.21 111.006 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HE2' ' A' ' 75' ' ' LYS . 49.4 mt -66.98 123.61 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.338 -0.392 . . . . 52.1 111.605 -177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 47.7 mm -95.14 96.99 6.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 121.026 0.441 . . . . 75.23 111.341 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 105' ' ' SER . 20.4 t0 71.26 149.13 0.09 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.626 0.973 . . . . 73.35 113.626 174.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 106' ' ' TYR . 26.8 m -106.3 -1.1 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.528 -0.76 . . . . 72.31 111.972 177.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 103' ' ' ASP . 49.5 m 69.98 11.47 7.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.79 0.663 . . . . 72.21 112.79 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.455 ' H ' HG23 ' A' ' 104' ' ' VAL . 25.1 m-85 -97.82 10.3 40.49 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.116 0.413 . . . . 74.22 112.116 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 34.5 m -92.71 150.2 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.094 0.473 . . . . 73.11 111.559 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -82.4 27.47 0.5 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.375 0.509 . . . . 53.42 112.375 -175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -119.04 -20.25 8.15 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.162 0.43 . . . . 65.23 112.162 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.8 p -76.26 -68.51 0.58 Allowed 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.931 0.396 . . . . 71.11 111.877 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 114' ' ' LEU . . . -179.65 -84.04 0.06 OUTLIER Glycine 0 C--O 1.219 -0.781 0 C-N-CA 121.394 -0.431 . . . . 61.13 112.146 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt 50.69 -78.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.503 0.927 . . . . 73.13 113.503 174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 111' ' ' GLY . 25.2 t70 -131.61 18.58 4.74 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.398 0.618 . . . . 71.21 111.952 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 111' ' ' GLY . 0.7 OUTLIER -104.78 -161.64 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.022 -0.535 . . . . 72.24 110.694 -179.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.3 mt -94.45 112.67 58.59 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.12 -0.491 . . . . 64.54 110.937 168.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.95 105.67 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.174 1.916 . . . . 73.52 111.674 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.7 t -69.24 79.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 121.811 0.815 . . . . 72.44 111.448 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.28 -167.03 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.995 -1.002 . . . . 61.25 110.247 176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -71.54 84.57 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.772 0.796 . . . . 75.22 111.746 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mt -92.13 47.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 122.028 0.918 . . . . 63.31 109.472 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 122' ' ' ASN . 39.3 pt -68.5 -41.66 83.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.162 -0.926 . . . . 74.24 112.881 -172.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.582 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 37.7 m-80 54.41 -165.93 0.09 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.898 0.38 . . . . 53.23 111.837 -177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.9 t -143.06 -71.25 0.31 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.334 0.494 . . . . 63.4 112.334 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.64 -64.82 0.78 Allowed 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.118 0.414 . . . . 45.14 112.118 -173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -80.27 9.63 5.49 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.614 0.598 . . . . 74.4 112.614 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' A' ' 122' ' ' ASN . . . -83.97 2.33 39.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.641 0.608 . . . . 74.35 112.641 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.64 18.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 112.861 0.689 . . . . 64.4 112.861 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.76 -39.69 21.52 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.483 0.549 . . . . 74.23 112.483 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.723 ' HG2' ' H ' ' A' ' 131' ' ' HIS . 30.6 tt0 65.73 122.19 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.276 0.63 . . . . 75.14 111.282 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -77.83 1.57 19.91 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.864 0.69 . . . . 71.11 112.864 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.723 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 72.9 m80 48.3 58.68 4.92 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 74.41 112.519 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -78.13 -72.4 0.37 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.858 -0.526 . . . . 72.25 110.674 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -123.63 87.74 2.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.077 0.465 . . . . 73.41 110.694 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -86.6 110.86 20.11 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.398 -0.365 . . . . 74.32 110.639 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.187 -0.911 . . . . 71.45 111.764 -176.54 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.482 0.182 . . . . 71.02 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -162.37 174.49 12.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.846 0.355 . . . . 75.03 111.573 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.3 m -128.39 110.08 12.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.731 0.301 . . . . 74.05 111.738 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -85.02 106.84 16.81 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.843 0.354 . . . . 72.15 110.822 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.84 101.29 5.83 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.994 0.426 . . . . 63.14 111.299 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.53 105.14 11.55 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.524 -0.307 . . . . 74.33 111.094 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.4 p -119.02 148.86 42.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.596 0.591 . . . . 74.03 112.596 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' A' ' 92' ' ' ILE . 76.5 t -113.86 129.71 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.92 -0.582 . . . . 71.44 110.881 174.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 9.9 tttt -100.57 130.82 46.69 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.108 0.48 . . . . 73.45 111.105 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.1 t -107.21 116.79 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.339 -0.391 . . . . 74.11 110.959 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HB2' ' HG2' ' A' ' 95' ' ' ARG . 45.3 mt-10 -102.57 133.9 46.8 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.318 0.58 . . . . 74.31 111.802 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' CZ ' ' HE2' ' A' ' 69' ' ' LYS . 57.0 m-85 -106.54 99.04 8.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.797 -0.638 . . . . 65.41 109.56 175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 26.9 m -119.82 157.75 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.54 0.571 . . . . 72.15 112.54 -166.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' HG21 ' A' ' 53' ' ' ILE . 5.3 p-10 -84.28 -170.13 2.95 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.115 0.483 . . . . 75.55 111.5 -179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.33 -15.63 63.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.209 0.818 . . . . 75.4 113.209 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -95.28 -3.44 47.43 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.952 0.406 . . . . 74.23 111.43 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.86 30.71 25.56 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 121.235 -0.507 . . . . 71.21 113.994 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -118.75 126.61 52.27 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.82 0.31 . . . . 45.3 110.355 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.0 pt-20 -60.52 122.78 15.5 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.952 0.882 . . . . 75.22 111.442 -174.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.447 HG21 ' HB3' ' A' ' 47' ' ' ASP . 10.9 pt -102.5 7.24 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.771 -1.104 . . . . 44.01 111.367 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -153.34 160.61 30.73 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.425 -0.352 . . . . 52.1 111.635 -172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.08 126.11 21.45 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.318 2.012 . . . . 55.55 112.456 174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.1 m -92.76 161.94 14.33 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.594 -0.73 . . . . 74.23 111.655 -176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -113.47 164.01 14.17 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.402 0.62 . . . . 55.13 111.458 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.7 m -140.11 103.6 4.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.028 -0.533 . . . . 64.45 110.094 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.1 mt -80.64 121.68 26.14 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.675 -0.693 . . . . 74.02 112.072 -173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.2 t -92.1 -10.46 38.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.789 -0.641 . . . . 60.34 110.533 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.74 132.45 48.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.433 -0.803 . . . . 44.45 112.076 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 38.1 t80 -50.95 -50.51 57.83 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.938 0.399 . . . . 75.55 111.529 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -85.43 85.05 7.46 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.823 -0.548 . . . . 64.05 110.434 172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CD2' HG11 ' A' ' 41' ' ' VAL . 18.3 p90 -70.8 96.53 1.26 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 122.054 0.93 . . . . 73.44 110.025 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 84' ' ' THR . 99.6 t -117.5 109.39 27.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 73.23 109.974 177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 p -103.14 170.14 8.14 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.457 0.646 . . . . 74.53 112.485 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.9 p -138.74 142.05 32.77 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.746 -0.661 . . . . 64.43 111.457 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.14 108.69 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.027 1.818 . . . . 71.4 112.865 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HE2' ' CZ ' ' A' ' 45' ' ' TYR . 67.5 mttm -63.77 145.25 56.12 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.998 0.904 . . . . 64.41 111.605 178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -86.74 86.35 7.32 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.518 -1.219 . . . . 74.45 111.128 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.3 mt -80.77 124.52 81.66 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.69 -0.686 . . . . 64.03 111.927 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.15 104.24 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.164 1.91 . . . . 71.25 112.242 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 104' ' ' VAL . . . 109.69 -2.06 30.53 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.276 -0.488 . . . . 70.3 113.284 -175.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 56.7 m-85 -138.05 148.3 44.93 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.304 0.573 . . . . 75.51 112.343 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.654 ' HB2' HD11 ' A' ' 101' ' ' ILE . 39.9 ttmt -126.37 141.0 52.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.775 -0.648 . . . . 73.24 111.357 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD21 HD11 ' A' ' 79' ' ' ILE . 26.9 tp -66.2 123.67 20.55 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.878 0.37 . . . . 70.54 111.442 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.526 ' HD3' HG22 ' A' ' 97' ' ' ILE . 11.6 ptm180 -100.07 -33.07 10.63 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.785 0.661 . . . . 74.45 112.785 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 11.6 pt-20 -159.53 154.77 25.26 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.935 0.398 . . . . 52.31 112.019 -176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.452 HD11 HD21 ' A' ' 76' ' ' LEU . 24.9 mm -107.19 134.34 19.95 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.017 -0.538 . . . . 70.34 112.192 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.74 147.02 49.8 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.896 2.397 . . . . 72.34 112.766 178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -60.5 -22.82 63.97 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.621 0.6 . . . . 64.14 112.621 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -104.74 29.02 6.54 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.373 0.508 . . . . 61.35 112.373 -177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.43 -26.76 68.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.401 0.519 . . . . 74.03 112.401 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.706 HG22 HG13 ' A' ' 65' ' ' VAL . 62.1 p -138.69 140.16 38.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.823 0.344 . . . . 71.24 111.393 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.43 -153.72 23.98 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.51 -0.852 . . . . 51.52 113.894 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 17.2 p-10 -123.14 138.66 54.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.78 0.432 . . . . 75.23 111.064 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.4 mt -67.12 95.39 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 121.536 0.684 . . . . 71.14 110.842 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.0 p -99.78 -20.18 16.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.623 -0.717 . . . . 74.11 110.901 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -137.43 158.52 44.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.727 -0.67 . . . . 73.52 110.56 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -99.4 150.19 22.41 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.051 0.453 . . . . 75.24 111.767 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.73 28.9 45.04 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.11 -0.495 . . . . 63.21 113.469 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 41' ' ' VAL . 68.1 mt -81.23 132.75 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 110.082 -0.34 . . . . 63.55 110.082 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 36.0 mt -115.09 118.96 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.309 0.576 . . . . 75.14 112.211 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.11 108.88 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.919 -0.582 . . . . 71.12 110.19 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.497 ' HG2' ' HB2' ' A' ' 44' ' ' GLU . 25.2 mtt180 -104.71 112.68 25.86 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.127 0.788 . . . . 63.34 113.127 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -89.81 126.08 35.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 73.35 110.408 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.526 HG22 ' HD3' ' A' ' 77' ' ' ARG . 6.5 mm -97.74 130.26 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 116.436 -0.347 . . . . 65.15 111.386 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 65.9 m-85 -118.73 134.67 54.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.148 0.499 . . . . 74.21 112.019 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.13 144.08 29.25 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.992 -0.549 . . . . 71.05 110.253 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -79.55 116.28 19.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.072 0.463 . . . . 53.44 111.26 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 75' ' ' LYS . 49.8 mt -79.12 123.52 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 116.045 -0.525 . . . . 73.11 111.758 -176.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 41.7 mm -85.92 -22.29 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.309 0.576 . . . . 75.34 110.888 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -79.15 63.06 3.7 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.588 0.709 . . . . 70.33 111.697 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 73' ' ' GLY . 30.0 m -140.33 28.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.571 -0.741 . . . . 74.42 110.237 176.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 48.2 t -70.98 78.12 0.65 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.482 0.658 . . . . 72.51 112.669 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.3 5.5 9.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.567 0.699 . . . . 74.45 109.406 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.7 t -100.35 86.3 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.314 -0.857 . . . . 73.0 111.433 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -89.17 73.83 8.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.639 0.733 . . . . 55.34 110.778 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.75 -86.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.468 -0.787 . . . . 72.42 109.602 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.1 p -150.48 -175.99 5.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.663 0.385 . . . . 72.01 110.558 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.09 66.68 0.01 OUTLIER Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.24 -0.505 . . . . 70.33 112.203 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -88.44 -72.67 0.53 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.131 0.419 . . . . 64.32 112.131 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -121.67 -68.32 0.9 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.412 0.523 . . . . 72.34 112.412 -174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mp 55.76 29.93 14.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.618 0.723 . . . . 74.52 110.157 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 ' HD2' ' A' ' 116' ' ' PRO . 0.7 OUTLIER -79.3 126.61 81.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.909 -1.041 . . . . 73.31 111.125 -170.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' HD22 ' A' ' 115' ' ' LEU . 57.2 Cg_endo -69.69 165.51 30.64 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.753 2.302 . . . . 71.32 113.031 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.02 123.14 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.52 0.676 . . . . 75.1 112.691 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.8 p -156.55 142.3 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.815 -0.63 . . . . 64.22 110.699 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -151.35 90.12 1.56 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.781 0.289 . . . . 71.4 111.781 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 62.8 mt 57.3 110.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 112.771 0.656 . . . . 73.53 112.771 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' O ' HD12 ' A' ' 121' ' ' ILE . 2.1 pp -124.88 133.52 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 113.46 0.911 . . . . 75.01 113.46 -176.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -157.63 90.95 1.11 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.317 -0.856 . . . . 71.41 110.238 174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.5 m -91.29 -33.12 15.46 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.629 0.603 . . . . 74.21 112.629 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -69.01 90.93 0.46 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.125 0.488 . . . . 71.15 110.789 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -162.03 -55.64 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.966 -0.561 . . . . 64.14 111.074 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.63 90.3 2.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.086 0.469 . . . . 72.52 111.86 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.41 96.24 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 61.4 111.881 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.28 97.72 9.07 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.282 -0.636 . . . . 70.03 109.282 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.7 131.07 49.17 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.056 0.455 . . . . 75.51 111.91 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -110.3 161.95 15.11 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.323 -0.399 . . . . 72.43 111.766 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -162.21 112.27 1.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.013 0.435 . . . . 65.25 111.996 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -137.83 123.3 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.813 0.34 . . . . 75.23 110.977 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -88.27 139.75 30.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.969 0.414 . . . . 62.13 111.372 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -137.02 175.84 9.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.222 0.534 . . . . 74.32 111.929 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.302 -0.863 . . . . 73.0 110.319 177.371 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.609 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.754 0.312 . . . . 62.24 111.511 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -65.36 101.79 0.61 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.659 0.266 . . . . 73.22 110.878 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 57.6 m 63.19 96.26 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.2 0.524 . . . . 44.31 111.148 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -71.51 87.51 0.9 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.516 0.674 . . . . 72.45 110.768 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -66.76 105.99 1.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.261 -0.882 . . . . 65.42 111.672 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 98.5 m-85 -74.04 93.43 2.25 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.74 -0.663 . . . . 64.4 111.128 176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 82.2 p -116.65 159.34 22.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.214 0.53 . . . . 72.04 112.135 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.802 HG22 ' HB ' ' A' ' 92' ' ' ILE . 81.8 t -124.05 115.93 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.087 -0.506 . . . . 62.3 111.973 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.708 ' HB3' HG12 ' A' ' 93' ' ' ILE . 4.0 tppt? -81.94 131.86 35.26 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.861 0.362 . . . . 72.21 110.994 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.3 t -110.87 114.56 47.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.727 0.299 . . . . 74.31 110.342 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -103.48 145.35 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.275 0.56 . . . . 55.21 111.507 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -122.04 97.63 5.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.826 -0.624 . . . . 72.55 109.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG12 ' CA ' ' A' ' 52' ' ' GLU . 23.3 m -120.38 154.55 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.383 0.883 . . . . 73.21 113.383 -166.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.14 169.99 15.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.46 -0.791 . . . . 73.53 110.407 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.82 -18.7 5.14 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.214 1.19 . . . . 75.03 114.214 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -83.79 -26.59 29.49 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.469 0.652 . . . . 73.51 110.485 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.99 5.34 15.35 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.433 -0.803 . . . . 51.22 113.792 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.95 122.87 33.37 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.438 -0.448 . . . . 73.04 111.68 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.594 ' CA ' HG12 ' A' ' 46' ' ' VAL . 12.5 pt-20 -67.22 99.44 0.69 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.573 1.177 . . . . 73.34 111.552 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.6 pt -76.03 1.38 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.473 -1.239 . . . . 72.01 112.378 -177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -154.92 155.9 30.76 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 111.617 0.229 . . . . 52.24 111.617 -174.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.87 138.37 34.36 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.553 2.169 . . . . 71.42 113.03 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.415 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 78.8 p -113.5 136.63 52.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.863 -0.608 . . . . 24.03 111.564 -174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 37.2 m-20 -90.74 166.22 13.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.276 0.56 . . . . 52.11 112.494 -172.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 61.2 m -131.63 104.02 6.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.067 -0.515 . . . . 54.24 110.622 171.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.2 mt -80.2 119.53 23.09 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.899 0.381 . . . . 71.22 111.515 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.1 t -96.49 -9.44 29.65 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.935 0.398 . . . . 63.24 111.16 176.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.63 133.7 55.26 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.15 -0.477 . . . . 51.3 111.356 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' O ' HG13 ' A' ' 87' ' ' ILE . 75.0 t80 -55.13 -47.28 75.26 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 111.895 0.331 . . . . 75.33 111.895 -178.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -87.52 85.43 7.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.985 0.422 . . . . 50.44 110.569 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -71.74 104.66 3.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.874 0.845 . . . . 72.21 110.699 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.8 t -118.16 108.94 25.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.197 -0.668 . . . . 73.54 109.197 174.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.0 p -94.44 166.6 11.98 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.466 0.65 . . . . 74.23 112.743 -171.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.8 p -126.79 133.22 24.8 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.699 -0.682 . . . . 73.05 111.715 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.2 125.09 9.5 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.495 2.13 . . . . 64.5 112.984 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' O ' HG13 ' A' ' 71' ' ' ILE . 67.3 mttm -90.13 109.17 20.24 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.649 -0.25 . . . . 71.12 111.123 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -72.18 88.39 1.13 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.176 -0.676 . . . . 63.22 109.176 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 72.8 mt -69.99 137.33 87.31 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.156 -0.929 . . . . 64.54 112.649 -171.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.38 108.59 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.276 1.984 . . . . 74.54 112.155 174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.1 -8.06 53.1 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.284 -0.484 . . . . 75.32 112.888 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 100' ' ' LYS . 34.5 m-85 -134.73 150.9 50.64 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.313 0.578 . . . . 74.43 112.082 178.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB2' HD11 ' A' ' 101' ' ' ILE . 8.0 ttmm -129.09 144.7 51.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.372 -0.376 . . . . 73.4 111.535 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.1 tp -64.76 119.57 10.85 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.715 0.635 . . . . 73.05 112.715 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -80.83 -51.45 8.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.885 0.374 . . . . 72.12 111.163 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -156.65 147.98 22.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.172 0.511 . . . . 74.1 112.368 -173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 62.3 mt -100.8 119.98 56.89 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 115.916 -0.584 . . . . 73.23 110.881 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.5 142.55 90.68 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.467 2.111 . . . . 65.11 113.122 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -55.07 -25.51 31.41 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.314 0.578 . . . . 35.41 111.434 175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 94' ' ' VAL . 9.3 t30 -81.33 8.76 8.4 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.481 -0.781 . . . . 73.54 111.842 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.98 -11.76 60.02 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.293 0.849 . . . . 71.0 113.293 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.4 p -139.51 140.12 37.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 122.119 -0.363 . . . . 61.33 111.936 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.03 -167.8 33.87 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.793 -0.718 . . . . 74.32 113.19 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.6 p-10 -105.87 141.6 37.02 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.494 0.317 . . . . 60.43 110.402 174.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 39' ' ' PHE . 29.3 mt -68.9 93.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 121.407 0.622 . . . . 73.22 110.649 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 67.8 p -97.31 -2.43 42.55 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.769 -0.65 . . . . 65.21 111.09 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.07 149.07 27.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.537 -0.756 . . . . 72.15 109.396 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.0 t -88.23 148.65 24.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.098 0.475 . . . . 55.04 111.648 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.5 25.7 60.53 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.075 -0.583 . . . . 75.4 113.697 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.802 ' HB ' HG22 ' A' ' 41' ' ' VAL . 76.9 mt -70.11 134.54 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 122.506 -0.408 . . . . 75.24 110.152 175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.708 HG12 ' HB3' ' A' ' 42' ' ' LYS . 19.6 mt -120.77 118.38 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.699 0.629 . . . . 72.01 112.699 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 82' ' ' ASN . 45.1 t -92.71 105.26 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 73.41 110.161 173.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.434 ' HD3' HG21 ' A' ' 46' ' ' VAL . 38.8 ttm180 -109.19 108.59 19.28 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.883 0.373 . . . . 75.45 111.998 -174.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -82.94 139.89 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.99 0.424 . . . . 61.44 111.731 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.87 126.34 57.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.889 -0.596 . . . . 73.43 110.824 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -118.55 148.62 42.46 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.317 0.58 . . . . 53.14 112.304 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -95.39 138.53 32.94 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.374 -0.83 . . . . 74.43 111.289 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 74' ' ' TYR . 3.3 tmtp? -69.78 124.03 22.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.016 0.436 . . . . 62.22 110.54 176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 75' ' ' LYS . 56.4 mt -85.79 102.31 11.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.418 0.628 . . . . 60.55 110.438 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 102' ' ' ILE . 36.3 mt -114.54 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.739 0.78 . . . . 71.11 110.235 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -176.72 170.89 2.33 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.23 -1.396 . . . . 73.23 107.23 -174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.578 ' O ' HG13 ' A' ' 104' ' ' VAL . 6.7 p -77.64 77.48 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-O 122.643 1.211 . . . . 72.2 112.615 -171.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.6 m 61.59 15.85 7.17 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.583 -1.189 . . . . 72.11 112.286 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.14 96.69 3.93 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.155 0.502 . . . . 72.54 111.916 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.6 m -124.45 131.79 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.131 -0.486 . . . . 63.14 110.912 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.66 -43.76 95.76 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.618 0.599 . . . . 63.12 112.618 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 69.92 -51.16 0.64 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.685 0.794 . . . . 75.51 112.255 -175.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 p 53.82 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.944 0.897 . . . . 74.14 113.367 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.82 -112.76 4.92 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.123 -0.561 . . . . 71.33 112.762 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -148.67 -43.13 0.15 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.277 0.561 . . . . 75.54 110.668 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.82 90.07 2.9 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.674 -0.694 . . . . 64.2 112.031 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 pp -169.93 165.53 9.56 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.41 112.361 174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.3 mt -124.69 106.7 29.37 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.854 -0.612 . . . . 61.13 111.15 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.49 -167.7 0.31 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.995 2.463 . . . . 71.3 112.79 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.13 136.43 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 120.9 0.381 . . . . 70.14 111.489 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -72.4 114.03 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.496 -0.32 . . . . 73.22 111.164 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 63.04 179.8 0.15 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.175 0.59 . . . . 75.31 112.248 -176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mm 64.34 117.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.184 0.516 . . . . 74.31 111.072 -171.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.411 HG13 ' OD1' ' A' ' 122' ' ' ASN . 26.1 pt -80.03 175.15 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.768 0.318 . . . . 32.41 111.247 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.411 ' OD1' HG13 ' A' ' 121' ' ' ILE . 15.0 m120 72.53 -61.83 0.49 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.31 0.644 . . . . 75.02 111.823 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.4 t 66.75 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.034 0.534 . . . . 74.02 112.144 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -61.93 118.08 6.78 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.235 0.54 . . . . 75.34 112.017 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.23 6.26 0.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.221 0.823 . . . . 72.41 113.221 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 49.33 60.86 3.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 121.087 0.47 . . . . 71.24 112.158 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 23.3 t -80.86 80.06 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.143 0.497 . . . . 70.01 111.414 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 mp -72.71 101.48 3.09 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.454 0.538 . . . . 62.5 112.454 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -97.61 104.21 16.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.877 -0.416 . . . . 74.41 109.877 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -96.36 118.81 33.66 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 74.52 111.479 -175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -78.43 150.99 32.95 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.169 0.433 . . . . 72.34 112.169 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.67 -166.09 1.16 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.263 -0.426 . . . . 73.44 110.71 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -148.66 133.73 18.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.973 0.416 . . . . 71.12 111.597 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -128.02 108.18 10.45 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.279 0.561 . . . . 73.2 111.174 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.954 -0.546 . . . . 72.25 111.611 -179.525 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.451 ' HG2' ' N ' ' A' ' 35' ' ' ASP . 56.0 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.509 0.195 . . . . 73.05 111.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.451 ' N ' ' HG2' ' A' ' 34' ' ' MET . 24.8 t70 79.91 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.019 0.928 . . . . 73.45 111.819 177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.5 m -160.26 136.72 8.84 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 122.189 -0.319 . . . . 72.51 111.294 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -87.88 88.55 7.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.214 0.531 . . . . 73.22 110.038 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -77.98 104.43 8.54 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 74.2 111.937 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.589 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 91.4 m-85 -76.76 88.2 3.39 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.177 0.513 . . . . 73.13 110.0 171.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 60' ' ' THR . 78.8 p -125.72 166.49 16.68 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.747 -0.66 . . . . 62.34 111.642 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 92' ' ' ILE . 71.2 t -121.45 114.3 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.864 -0.607 . . . . 61.12 111.694 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 12.6 tppt? -73.79 131.61 41.73 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.005 -0.543 . . . . 74.34 110.846 174.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.53 113.45 43.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.854 0.359 . . . . 75.43 110.453 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 42' ' ' LYS . 39.8 mt-10 -113.68 145.9 40.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.982 0.42 . . . . 61.0 110.962 -177.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.544 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 40.2 m-85 -117.81 107.39 14.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.898 0.38 . . . . 73.23 110.452 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 29.9 m -120.4 162.48 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 112.362 0.504 . . . . 65.42 112.362 -169.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -78.24 -170.79 2.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.019 0.438 . . . . 63.5 111.705 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.66 -17.05 63.47 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.093 0.775 . . . . 74.55 113.093 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -88.97 -26.72 21.35 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 75.32 110.908 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.41 25.12 5.09 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.147 -0.479 . . . . 71.23 113.004 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.46 122.49 47.5 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.791 0.329 . . . . 74.13 110.523 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 10.1 pt-20 -65.87 128.98 38.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.125 0.964 . . . . 75.33 112.353 -174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -108.52 4.97 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.361 -1.29 . . . . 73.33 111.232 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -154.46 150.74 22.52 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.204 -0.453 . . . . 53.34 111.3 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -50.94 145.96 23.01 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.587 2.191 . . . . 55.14 113.213 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 83.2 p -103.69 144.16 31.82 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.458 -0.792 . . . . 74.44 111.243 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 42' ' ' LYS . 26.7 m-20 -103.05 166.46 10.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 65.24 112.098 -175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.6 m -135.5 104.49 5.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.895 -0.593 . . . . 55.24 110.401 174.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.7 mt -87.19 115.94 24.93 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.889 0.376 . . . . 75.31 111.678 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.411 ' HA ' HG22 ' A' ' 40' ' ' THR . 9.1 t -96.35 -0.74 49.01 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 120.972 0.415 . . . . 75.11 111.71 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -73.96 134.92 43.18 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.46 -0.336 . . . . 63.22 110.517 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ASN . 45.2 t80 -51.73 -34.65 39.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.911 0.386 . . . . 53.43 110.985 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -100.57 86.76 3.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.874 0.369 . . . . 75.52 110.659 172.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -69.61 88.02 0.5 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.099 0.952 . . . . 74.11 110.202 177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.54 108.26 24.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.369 -0.832 . . . . 53.31 109.989 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.6 t -112.57 176.04 5.18 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.276 0.56 . . . . 64.44 111.92 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 p -140.78 143.79 33.4 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 115.778 -0.646 . . . . 74.1 111.589 -177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.62 132.18 36.73 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.983 1.788 . . . . 61.21 111.979 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.544 ' HE3' ' CZ ' ' A' ' 45' ' ' TYR . 95.4 mttt -89.12 144.87 25.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.637 -0.256 . . . . 74.44 111.221 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -79.5 77.15 6.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.597 0.713 . . . . 74.45 110.052 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.5 mt -69.52 121.58 82.78 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-N 115.758 -0.655 . . . . 75.41 111.608 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.2 97.55 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.468 2.112 . . . . 72.13 113.074 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.15 0.77 33.55 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.236 -0.507 . . . . 30.41 113.552 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.8 145.49 49.81 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.369 0.604 . . . . 75.54 112.357 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' HG12 ' A' ' 101' ' ' ILE . 47.2 tptt -122.21 141.18 51.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.655 -0.702 . . . . 63.31 110.94 -178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.5 tp -57.58 109.0 0.62 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.17 0.509 . . . . 70.3 111.934 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -71.57 -51.5 23.09 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 75.51 111.065 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -159.67 159.87 33.52 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.254 0.55 . . . . 53.0 111.74 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.8 mm -99.12 136.55 20.49 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 115.815 -0.63 . . . . 72.24 111.646 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.1 153.16 46.42 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.055 2.503 . . . . 44.25 113.017 177.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -60.19 -20.18 57.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.572 0.582 . . . . 73.34 112.572 -176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.21 30.79 7.12 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.21 0.448 . . . . 63.32 112.21 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 67.89 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.471 0.545 . . . . 72.15 112.471 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.1 p -140.48 136.5 33.03 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.707 -0.224 . . . . 71.25 111.081 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.05 -151.25 8.63 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.523 -0.846 . . . . 61.03 113.831 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.667 HD22 HG23 ' A' ' 88' ' ' THR . 0.9 OUTLIER -122.8 122.43 38.65 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 122.964 0.506 . . . . 72.22 111.359 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 HG12 HG23 ' A' ' 41' ' ' VAL . 41.4 mt -58.16 96.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 121.152 0.501 . . . . 74.03 111.424 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.667 HG23 HD22 ' A' ' 86' ' ' ASN . 66.3 p -104.53 1.0 29.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.345 0.593 . . . . 62.3 111.087 176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -158.44 162.02 37.52 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.809 -0.632 . . . . 64.3 110.324 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 39' ' ' PHE . 6.1 t -102.74 149.57 24.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.239 0.542 . . . . 74.13 112.262 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.43 12.09 70.6 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 116.057 -0.519 . . . . 74.23 113.346 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.635 ' HB ' HG22 ' A' ' 41' ' ' VAL . 71.4 mt -68.86 126.73 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 O-C-N 122.659 -0.318 . . . . 74.53 110.547 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 17.0 mt -112.78 117.19 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.308 0.575 . . . . 74.03 112.166 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.6 t -94.39 111.74 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.497 -0.774 . . . . 51.43 110.124 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 36.8 mtt180 -108.35 111.15 22.93 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.627 0.602 . . . . 73.34 112.627 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -84.01 126.65 33.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.859 -0.61 . . . . 75.14 110.285 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 11.8 mm -98.18 132.11 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.191 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -125.16 144.45 50.43 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.758 0.651 . . . . 74.44 112.758 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.58 144.96 28.95 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.817 -0.629 . . . . 73.43 109.88 167.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -74.84 121.67 22.19 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.873 -0.517 . . . . 60.22 111.536 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 75' ' ' LYS . 64.1 mt -70.82 107.62 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 120.957 0.408 . . . . 71.22 111.541 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.3 mm -89.84 -37.21 9.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.905 0.383 . . . . 73.22 110.638 175.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 t70 71.5 131.13 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.311 -0.859 . . . . 62.3 110.954 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.65 1.84 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.413 0.523 . . . . 44.42 112.413 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.3 t 64.45 -72.32 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.727 0.411 . . . . 72.33 111.494 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 14.9 t80 64.49 19.25 11.74 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.006 0.522 . . . . 75.33 111.602 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 109' ' ' GLU . 83.8 t -73.73 136.7 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.923 0.392 . . . . 72.43 111.053 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -55.03 -30.59 59.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.8 0.667 . . . . 74.35 112.8 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.5 ' H ' HG12 ' A' ' 107' ' ' VAL . 46.7 mt-10 -56.42 -37.96 70.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.291 -0.413 . . . . 74.53 111.358 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.651 HG23 ' H ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -103.96 -69.45 0.8 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.439 -0.346 . . . . 65.54 111.414 176.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.651 ' H ' HG23 ' A' ' 110' ' ' THR . . . 53.93 15.65 5.17 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.15 0.42 . . . . 64.33 114.15 -179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -96.95 -6.26 36.0 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 117.392 0.596 . . . . 65.23 111.627 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -100.36 91.46 4.72 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.605 -0.27 . . . . 51.31 110.784 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -127.73 -165.01 1.42 Allowed 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.001 0.429 . . . . 73.0 111.361 -178.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.1 mt 71.22 102.86 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.595 -0.73 . . . . 73.31 112.855 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.58 105.14 1.56 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.626 2.217 . . . . 75.01 112.68 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.04 96.64 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.409 0.623 . . . . 73.11 111.483 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.66 145.52 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 112.169 0.433 . . . . 72.04 112.169 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.18 107.54 9.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.264 -0.425 . . . . 74.11 110.765 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.3 mt -90.9 95.4 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.128 0.489 . . . . 64.25 111.461 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.0 pt -95.16 145.78 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.851 -0.613 . . . . 75.41 110.944 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.74 -172.92 4.35 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.284 0.564 . . . . 70.14 111.834 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.0 t -76.69 -175.1 3.25 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.253 -0.43 . . . . 64.55 110.48 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -57.43 109.79 0.75 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.042 0.448 . . . . 63.34 110.71 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.92 7.34 1.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.043 -0.526 . . . . 71.34 112.328 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 54.08 36.62 25.13 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.931 0.396 . . . . 71.12 111.372 -174.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.2 m -51.56 134.19 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.654 0.612 . . . . 54.21 112.654 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 25.9 tp -132.6 15.23 4.43 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.888 -0.596 . . . . 64.23 110.772 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.04 94.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.312 0.577 . . . . 62.34 112.343 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -103.08 113.29 26.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.93 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -129.91 170.39 14.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.053 0.454 . . . . 64.32 111.412 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -103.57 174.34 5.91 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.001 0.429 . . . . 62.41 111.026 178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -85.6 -171.62 3.7 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.47 -0.332 . . . . 72.14 111.578 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -153.99 136.17 14.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.03 0.443 . . . . 73.21 111.946 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.532 -0.747 . . . . 65.3 111.458 175.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.718 0.294 . . . . 75.53 110.321 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.81 -63.0 1.5 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.104 0.478 . . . . 62.13 111.484 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.3 p -70.96 120.79 17.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.211 -0.45 . . . . 74.4 111.431 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -52.38 -64.62 0.76 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.402 0.281 . . . . 73.13 111.722 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 51.33 72.99 0.33 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.98 0.512 . . . . 63.51 112.368 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -59.8 88.36 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.038 0.447 . . . . 73.54 110.887 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.2 p -139.37 161.29 37.83 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.449 0.642 . . . . 72.02 111.649 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 92' ' ' ILE . 80.7 t -113.78 105.99 19.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 43.42 111.61 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 43' ' ' VAL . 53.7 tttt -72.41 147.74 45.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.392 -0.367 . . . . 74.15 110.822 175.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' N ' ' HG2' ' A' ' 42' ' ' LYS . 7.8 t -126.55 113.14 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 120.726 0.298 . . . . 63.31 111.172 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -102.5 145.09 30.1 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.474 0.654 . . . . 75.02 111.642 174.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.677 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 67.0 m-85 -122.95 103.18 8.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.878 -0.601 . . . . 73.22 109.578 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.67 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.9 m -120.82 145.92 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 112.896 0.702 . . . . 64.42 112.896 -168.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.4 169.71 8.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.492 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.23 -18.21 14.99 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.184 0.809 . . . . 74.3 113.184 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -95.63 12.71 28.76 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.155 0.502 . . . . 64.2 111.129 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.65 3.19 86.73 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.871 -0.604 . . . . 71.4 114.064 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.58 116.45 23.16 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.425 -0.456 . . . . 64.1 110.682 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 9.5 pt-20 -67.02 114.64 5.96 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.329 1.061 . . . . 71.11 111.114 -176.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.4 pt -91.2 -0.08 9.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 114.671 -1.149 . . . . 70.13 111.759 -174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.677 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -148.89 156.59 40.88 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.374 -0.375 . . . . 63.03 111.825 -172.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.31 136.36 73.18 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.905 2.403 . . . . 74.53 113.786 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.5 m -82.85 130.51 35.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.975 -0.557 . . . . 61.45 110.78 176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -99.92 166.91 10.83 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.115 0.483 . . . . 72.44 111.952 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.7 m -129.94 104.41 7.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.685 -0.689 . . . . 55.34 110.743 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.562 HD13 ' HB2' ' A' ' 64' ' ' TYR . 98.6 mt -83.89 108.51 16.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.139 0.495 . . . . 74.11 111.208 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.3 t -92.07 -7.01 49.92 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.763 -0.653 . . . . 74.25 111.55 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.02 130.36 37.34 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.976 -0.557 . . . . 75.45 111.43 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.1 t80 -51.51 -57.9 7.79 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.979 0.418 . . . . 73.23 111.353 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 80.89 8.98 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.274 0.559 . . . . 63.1 110.235 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' HB2' HD13 ' A' ' 59' ' ' LEU . 47.5 p90 -77.92 126.23 30.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.579 0.704 . . . . 72.44 111.923 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 93.1 t -131.21 109.59 16.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.6 -0.727 . . . . 60.53 109.436 175.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.6 p -93.87 161.06 14.46 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.311 0.576 . . . . 41.45 112.332 -172.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -130.1 145.05 55.62 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 115.864 -0.607 . . . . 43.45 111.904 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.89 114.9 4.03 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.212 1.941 . . . . 71.12 111.769 171.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.0 mttm -59.32 156.11 13.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.89 0.7 . . . . 75.02 112.89 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.4 90.29 3.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.831 -0.622 . . . . 74.3 110.141 172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.5 mt -101.16 104.21 31.19 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.028 -0.533 . . . . 73.13 110.932 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.37 105.05 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.398 2.066 . . . . 73.02 112.687 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.15 10.62 23.79 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.197 -0.525 . . . . 72.21 113.771 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 47.1 m-85 -130.91 142.0 50.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 117.467 0.633 . . . . 65.15 112.414 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -112.53 122.03 46.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.647 -0.706 . . . . 65.0 110.752 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.83 116.69 9.61 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.966 -0.459 . . . . 75.11 111.239 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.416 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 19.3 ptt180 -88.97 -32.24 17.74 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.821 0.304 . . . . 62.31 111.821 -178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 77' ' ' ARG . 12.9 pt-20 -160.45 161.39 32.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.286 0.565 . . . . 73.44 112.19 -177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -116.2 127.85 26.44 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.62 -0.718 . . . . 71.11 110.996 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.55 146.62 96.8 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.818 2.345 . . . . 73.12 113.435 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.04 -32.06 63.69 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.03 0.443 . . . . 74.13 112.187 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 17.4 p-10 -94.05 23.51 4.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.146 0.424 . . . . 74.33 112.146 -176.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.99 -27.69 65.92 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.273 0.471 . . . . 72.32 112.273 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 75.6 p -135.34 129.7 33.85 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.594 -0.275 . . . . 62.11 111.345 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.12 -154.35 23.11 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.705 -0.76 . . . . 72.22 113.638 176.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 16.5 p-10 -120.03 144.62 47.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.905 0.482 . . . . 61.22 111.028 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 41' ' ' VAL . 50.6 mt -66.07 94.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.518 0.675 . . . . 74.12 110.786 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.6 p -100.44 -32.76 10.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.227 -0.897 . . . . 73.43 110.896 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -104.92 171.97 7.03 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.128 -0.487 . . . . 73.43 111.246 177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.5 p -74.84 -73.48 0.24 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.136 0.421 . . . . 71.34 112.136 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.95 84.66 0.55 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 116.204 -0.453 . . . . 74.22 113.635 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.588 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.3 mt -88.89 132.85 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 O-C-N 122.514 -0.403 . . . . 73.45 110.515 177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.2 mt -119.87 110.79 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.204 0.526 . . . . 71.34 111.926 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.7 t -89.69 116.22 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.943 -0.571 . . . . 73.24 110.103 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -115.53 107.66 15.44 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.146 0.424 . . . . 70.34 112.146 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -85.33 135.11 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.351 -0.386 . . . . 72.11 111.209 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.416 HG21 ' CZ ' ' A' ' 77' ' ' ARG . 16.7 mm -107.74 124.89 64.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.679 0.276 . . . . 70.2 111.653 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.441 ' HB3' ' HB3' ' A' ' 74' ' ' TYR . 69.6 m-85 -119.86 141.85 49.19 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.217 0.532 . . . . 63.21 111.647 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 77' ' ' ARG . 23.0 m-20 -93.3 124.53 37.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.713 -0.676 . . . . 70.52 110.255 169.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.4 115.25 4.44 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.275 0.559 . . . . 74.34 111.633 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 103' ' ' ASP . 57.5 mt -72.48 122.46 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.85 -0.613 . . . . 73.31 111.071 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mm -69.67 -24.21 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.235 0.54 . . . . 71.41 110.705 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' N ' HG22 ' A' ' 101' ' ' ILE . 17.4 t70 78.28 163.27 0.21 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.193 -0.912 . . . . 74.4 111.365 170.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 104' ' ' VAL . 2.7 p -116.9 49.98 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.857 0.837 . . . . 74.13 112.995 -168.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.9 m 79.88 16.73 0.78 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.036 -0.984 . . . . 73.1 112.338 176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -104.01 2.33 32.12 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.391 0.515 . . . . 64.05 112.391 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.8 m -109.06 148.73 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.928 0.394 . . . . 75.3 111.821 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -90.51 151.22 21.45 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.974 0.416 . . . . 74.24 111.54 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.42 -58.11 8.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.21 -0.45 . . . . 75.03 111.963 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.488 ' HB ' HD23 ' A' ' 114' ' ' LEU . 47.8 p -87.33 -77.17 0.34 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.583 -0.28 . . . . 74.42 111.091 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 50.25 -87.18 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 N-CA-C 114.833 0.693 . . . . 62.34 114.833 175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -62.09 -56.79 15.37 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.267 0.469 . . . . 45.03 112.267 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -72.79 -67.85 0.53 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.735 0.643 . . . . 62.2 112.735 -169.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.488 HD23 ' HB ' ' A' ' 110' ' ' THR . 60.7 mt 67.02 -167.93 0.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 121.297 0.57 . . . . 74.41 112.105 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD12 ' HD2' ' A' ' 116' ' ' PRO . 16.9 tp -141.89 134.33 13.81 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 116.178 -0.464 . . . . 74.22 111.807 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD2' HD12 ' A' ' 115' ' ' LEU . 84.0 Cg_endo -82.1 169.38 14.54 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.709 2.273 . . . . 53.51 113.274 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.88 117.9 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.299 0.571 . . . . 60.23 111.303 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.0 p -163.76 122.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.057 -0.52 . . . . 65.11 111.763 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -171.2 99.15 0.2 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.302 -0.408 . . . . 70.44 111.174 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 71.1 mt -139.98 122.97 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.03 0.443 . . . . 71.34 111.672 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 57.7 mt -129.76 108.41 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 116.382 -0.372 . . . . 72.33 110.57 174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -138.28 96.56 3.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.416 0.627 . . . . 70.03 111.538 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.7 p -127.15 148.59 50.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.737 -0.665 . . . . 71.5 110.386 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.1 29.23 18.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.031 0.443 . . . . 74.23 111.177 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 67.43 5.71 4.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.57 0.748 . . . . 74.51 112.514 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 52.66 87.11 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.164 0.506 . . . . 61.12 112.19 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.8 t -72.84 95.57 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.88 0.371 . . . . 74.55 110.331 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.7 tp -138.01 22.72 2.83 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.16 0.505 . . . . 74.21 111.908 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -77.58 71.14 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.193 0.52 . . . . 75.52 110.252 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -90.68 43.87 1.17 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.824 0.676 . . . . 74.5 112.824 -173.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -61.31 105.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.125 0.488 . . . . 75.51 111.144 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.54 127.26 31.89 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.018 -0.537 . . . . 71.02 110.942 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -136.82 147.79 46.78 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 111.957 0.354 . . . . 72.4 111.957 -176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m170 63.2 -178.42 0.15 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.992 0.517 . . . . 71.04 111.449 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 119.257 -0.402 . . . . 71.11 111.538 177.956 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.814 0.301 . . . . 63.2 111.814 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -72.21 -75.22 0.14 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.998 0.428 . . . . 72.44 111.276 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.6 m -81.16 138.3 35.88 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.182 -0.463 . . . . 74.24 111.068 177.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -57.19 108.77 0.56 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.291 0.567 . . . . 73.33 110.754 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -54.89 91.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.54 -0.755 . . . . 40.42 112.988 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 87' ' ' ILE . 23.2 m-30 -87.42 150.27 23.9 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.053 171.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 75.4 p -127.47 144.12 51.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.433 0.635 . . . . 32.22 112.261 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 92' ' ' ILE . 89.3 t -104.22 128.24 57.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.787 -0.642 . . . . 74.3 111.659 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD2' ' HB2' ' A' ' 56' ' ' SER . 8.1 tppt? -89.87 131.29 35.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.73 0.3 . . . . 72.25 110.91 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 113.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.787 0.327 . . . . 75.3 110.36 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' A' ' 42' ' ' LYS . 39.3 mt-10 -112.43 149.24 32.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.023 0.44 . . . . 74.0 111.394 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 70.9 m-85 -124.4 107.58 11.27 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.396 -0.366 . . . . 74.14 110.061 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 34.8 m -120.34 150.2 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 113.716 1.006 . . . . 64.41 113.716 -168.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -72.37 168.51 18.25 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.693 -1.14 . . . . 65.15 111.421 176.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.85 -22.66 26.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.233 0.827 . . . . 74.2 113.233 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -89.9 -5.96 56.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.953 0.406 . . . . 73.44 111.673 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.24 28.29 13.62 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.129 -0.487 . . . . 65.05 113.971 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.64 118.84 36.76 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.832 0.316 . . . . 71.11 110.792 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 8.9 pt-20 -62.93 106.76 0.87 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 122.543 1.163 . . . . 75.32 111.85 -177.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.41 ' H ' HG12 ' A' ' 53' ' ' ILE . 10.1 pt -86.49 5.11 3.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.336 -1.302 . . . . 71.34 112.483 -173.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 45' ' ' TYR . . . -150.91 156.5 35.67 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 111.956 0.354 . . . . 70.21 111.956 -171.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.1 145.54 42.18 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.525 2.15 . . . . 51.33 112.765 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.598 ' HB2' ' HD2' ' A' ' 42' ' ' LYS . 98.5 p -104.95 151.22 24.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.164 0.507 . . . . 74.1 111.411 -176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -111.27 165.04 12.26 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.204 0.526 . . . . 73.41 112.025 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.5 m -135.23 104.9 6.07 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.849 -0.614 . . . . 75.01 110.933 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.35 130.08 35.23 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.808 0.337 . . . . 73.4 111.62 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -109.89 1.96 19.52 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.28 0.562 . . . . 64.33 111.217 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.13 134.48 41.28 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.987 -0.551 . . . . 62.33 111.072 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -49.59 -57.06 7.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.863 0.363 . . . . 53.25 111.298 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -84.69 86.74 7.29 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.956 -0.465 . . . . 74.15 110.347 173.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -71.09 96.62 1.36 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.814 . . . . 65.21 110.978 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG13 HG22 ' A' ' 84' ' ' THR . 47.3 t -105.78 109.1 26.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.04 -0.527 . . . . 63.35 109.651 173.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.495 ' OG ' HG11 ' A' ' 94' ' ' VAL . 93.0 p -99.99 171.2 7.99 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.037 0.446 . . . . 74.33 111.687 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.9 p -138.75 150.37 65.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.144 -0.48 . . . . 53.22 111.719 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.5 170.52 16.08 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.471 2.114 . . . . 63.42 112.357 171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -130.76 139.95 50.28 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.168 0.508 . . . . 72.53 111.571 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.43 90.63 2.19 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.216 0.531 . . . . 70.23 110.409 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.0 mt -89.74 122.8 67.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.716 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.84 99.18 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.606 2.204 . . . . 55.32 113.02 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.8 0.91 30.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.274 -0.489 . . . . 60.41 113.369 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -128.63 144.85 51.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.452 0.644 . . . . 73.32 112.635 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.49 ' HB2' HD11 ' A' ' 101' ' ' ILE . 19.3 ttpp -117.14 119.84 36.48 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.501 -0.772 . . . . 71.31 111.082 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 tp -54.0 123.23 11.98 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.887 0.375 . . . . 70.42 110.945 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.2 -58.79 2.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.344 0.592 . . . . 73.24 111.433 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.26 163.42 40.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.794 -0.639 . . . . 63.43 110.854 -176.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.7 mm -93.14 131.88 32.02 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 121.1 0.476 . . . . 54.22 111.349 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 38.3 Cg_endo -67.92 145.29 67.69 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.026 2.484 . . . . 73.51 113.148 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -59.91 -28.58 67.71 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.59 0.71 . . . . 70.42 110.64 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.529 HD21 HG22 ' A' ' 92' ' ' ILE . 8.3 t30 -91.46 15.49 12.21 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.162 -0.926 . . . . 74.42 111.353 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HA ' HG13 ' A' ' 94' ' ' VAL . . . -65.37 -44.94 86.05 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.627 0.603 . . . . 45.33 112.627 -177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.458 HG22 HG13 ' A' ' 65' ' ' VAL . 71.5 p -123.61 159.89 28.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.496 -0.32 . . . . 74.32 111.668 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.25 -166.74 30.63 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.052 -0.594 . . . . 43.4 113.238 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -113.1 142.92 45.19 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 122.705 -0.291 . . . . 60.31 111.046 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG21 ' HB2' ' A' ' 39' ' ' PHE . 54.3 mt -68.2 94.36 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.442 0.639 . . . . 75.13 110.716 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.1 p -103.59 -30.58 10.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.397 -0.82 . . . . 74.05 111.111 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -117.81 177.86 4.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.095 0.474 . . . . 64.12 111.748 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 66.2 p -98.66 149.71 22.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.119 -0.491 . . . . 63.31 111.871 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.59 49.75 71.02 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 116.187 -0.461 . . . . 63.55 114.006 174.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 41' ' ' VAL . 65.2 mt -76.22 128.67 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 O-C-N 122.575 -0.367 . . . . 72.15 111.36 -178.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 42' ' ' LYS . 41.9 mm -109.7 106.34 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.346 0.498 . . . . 63.4 112.346 -176.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.621 HG13 ' HA ' ' A' ' 83' ' ' ALA . 40.7 t -91.05 99.38 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 120.763 0.316 . . . . 53.14 110.672 172.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -110.05 110.48 21.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.426 0.528 . . . . 73.05 112.426 -174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -84.17 147.59 27.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.092 0.472 . . . . 74.3 111.98 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.5 mm -110.77 127.89 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.955 -0.566 . . . . 75.21 111.355 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -125.88 137.21 53.72 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.19 0.519 . . . . 73.5 111.84 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -84.55 131.53 34.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.665 -0.698 . . . . 63.42 110.741 172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.9 118.06 13.2 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.932 0.396 . . . . 75.23 110.924 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 75' ' ' LYS . 42.8 mt -84.52 104.37 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.039 0.447 . . . . 73.33 111.295 -177.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.0 mm -84.05 -13.5 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.634 0.731 . . . . 75.34 110.404 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -70.41 -1.13 9.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.642 -0.708 . . . . 75.44 112.046 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.66 -4.48 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.258 -0.428 . . . . 74.11 111.71 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 63.4 m 69.48 -50.55 0.61 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.139 0.575 . . . . 71.32 111.304 -172.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.8 t80 60.5 26.86 16.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.579 0.704 . . . . 75.41 111.284 174.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 108' ' ' ASP . 8.4 p -166.86 169.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.521 -0.763 . . . . 71.31 110.346 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 107' ' ' VAL . 31.1 t70 79.5 159.63 0.18 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.716 0.806 . . . . 74.01 112.126 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.38 -20.79 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.689 -0.687 . . . . 72.4 111.643 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 82.4 p -142.87 45.7 1.57 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.829 0.347 . . . . 62.05 110.947 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -48.01 -59.35 6.3 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.121 0.808 . . . . 75.41 115.121 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -127.37 -79.23 0.59 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.391 0.595 . . . . 74.43 111.69 -178.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -142.21 99.5 3.52 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 71.1 110.499 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 114' ' ' LEU . 1.9 pt? -176.35 144.73 0.56 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.99 0.424 . . . . 74.04 111.776 -174.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 29.9 mt -127.39 91.39 46.21 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-O 121.169 0.509 . . . . 75.44 110.822 171.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.04 126.74 8.86 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.905 2.404 . . . . 44.23 113.437 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.1 t -81.82 113.29 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.095 0.474 . . . . 61.33 110.694 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.84 175.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 73.41 111.891 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -92.75 127.86 38.41 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.22 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 120' ' ' ILE . 3.0 mp -98.89 100.51 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.126 0.489 . . . . 61.42 110.463 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 58.0 mt -98.93 116.94 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.067 0.46 . . . . 63.5 111.79 -178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -141.97 105.86 4.73 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.123 -0.49 . . . . 70.52 110.319 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 124' ' ' GLU . 30.9 t -122.16 -172.37 2.44 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.165 0.186 . . . . 44.44 111.12 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 123' ' ' SER . 45.7 tt0 74.97 -46.21 0.59 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.828 0.677 . . . . 74.52 112.828 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.85 -4.2 6.37 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.105 0.78 . . . . 75.24 113.105 -177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.33 0.63 55.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.606 0.595 . . . . 53.15 112.606 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.71 89.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.928 0.394 . . . . 55.03 111.873 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.08 117.49 29.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.776 0.322 . . . . 65.44 110.481 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.19 146.75 31.6 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.233 0.54 . . . . 73.33 112.046 -177.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -130.85 77.33 1.78 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.097 0.475 . . . . 71.5 110.649 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -85.01 77.43 10.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.083 0.468 . . . . 73.11 112.152 -174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 16.1 p80 176.56 151.44 0.16 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 72.42 110.057 173.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -63.85 98.72 0.21 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.094 0.474 . . . . 74.13 111.928 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -78.49 103.05 8.17 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.258 0.551 . . . . 73.02 110.098 174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.1 t60 . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.687 -0.673 . . . . 74.14 111.735 -174.459 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' A' ' 34' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.669 0.271 . . . . 74.13 111.178 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -76.36 107.93 8.96 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.998 0.428 . . . . 73.4 110.692 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.4 t -162.86 150.37 13.44 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.873 0.368 . . . . 71.31 111.591 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -80.92 69.19 7.44 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.057 0.456 . . . . 74.23 111.444 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -84.29 109.47 17.83 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.182 0.515 . . . . 72.43 111.187 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' HB3' HG21 ' A' ' 87' ' ' ILE . 70.1 m-85 -75.63 98.77 4.12 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.885 -0.598 . . . . 72.25 111.537 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 79.3 p -122.43 154.87 37.19 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.375 0.607 . . . . 64.4 112.262 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.595 HG22 ' HB ' ' A' ' 92' ' ' ILE . 92.6 t -113.52 106.1 20.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.836 -0.62 . . . . 73.22 110.869 175.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.2 tmtp? -93.23 116.67 29.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.334 0.587 . . . . 54.13 110.986 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -92.62 121.09 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 115.95 -0.568 . . . . 63.43 111.942 -176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.06 138.66 40.92 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.409 0.623 . . . . 75.34 111.21 176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -110.98 98.05 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.337 -0.616 . . . . 75.51 109.337 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.694 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 24.1 m -120.95 155.39 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 112.852 0.686 . . . . 74.42 112.852 -166.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.12 175.22 10.79 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.015 -0.539 . . . . 72.41 109.969 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -7.87 2.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.832 1.049 . . . . 61.34 113.832 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.35 -10.4 56.39 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.173 0.511 . . . . 73.35 110.866 176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.33 -5.08 82.88 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.961 -0.563 . . . . 71.2 112.86 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.07 136.14 33.41 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.432 0.293 . . . . 61.13 110.672 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.694 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 12.1 pt-20 -72.54 154.71 40.67 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.977 0.894 . . . . 63.2 112.448 -172.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.7 pt -131.36 6.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.517 -1.219 . . . . 75.41 110.926 -175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -162.51 143.89 7.96 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.793 -0.64 . . . . 75.12 111.288 -172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -44.48 134.53 9.49 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.15 2.567 . . . . 61.33 113.935 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.3 p -85.01 161.12 19.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.464 -0.789 . . . . 75.3 112.264 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -121.66 163.28 19.26 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.878 -0.601 . . . . 74.13 110.811 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -138.06 104.46 5.24 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.126 0.488 . . . . 74.13 111.277 178.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.6 mt -88.12 117.53 27.07 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.275 -0.42 . . . . 71.5 111.221 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -97.0 -0.76 46.81 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.986 0.422 . . . . 64.43 111.443 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.51 134.2 46.35 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.418 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 82.3 t80 -50.62 -56.88 9.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 111.886 0.328 . . . . 74.12 111.886 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 86.31 6.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.053 0.454 . . . . 75.13 110.298 177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CD1' HG21 ' A' ' 41' ' ' VAL . 48.8 p90 -79.78 124.95 29.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.26 0.552 . . . . 74.13 111.584 -176.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.57 HG13 HG22 ' A' ' 84' ' ' THR . 90.0 t -125.61 109.45 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 54.31 109.598 173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.9 t -90.94 173.69 7.83 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.72 0.637 . . . . 51.21 112.72 -172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 p -141.83 148.13 48.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.543 -0.753 . . . . 31.51 110.727 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.07 -175.62 1.29 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.098 1.865 . . . . 74.11 112.398 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -137.47 134.15 35.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.803 0.811 . . . . 62.31 111.238 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.55 78.69 0.58 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.358 -1.292 . . . . 75.41 111.175 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' TYR . 48.1 mt -86.58 122.31 71.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.862 -0.608 . . . . 75.01 111.788 -174.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.27 110.49 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.912 2.408 . . . . 54.31 113.021 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.12 10.56 57.23 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.268 -0.491 . . . . 72.13 112.928 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB2' ' HB ' ' A' ' 71' ' ' ILE . 62.9 m-85 -131.76 144.02 50.65 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.703 0.763 . . . . 74.33 112.366 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -117.14 120.54 38.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.127 -0.942 . . . . 75.11 110.625 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 tp -55.4 110.37 0.68 Allowed 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.791 -0.568 . . . . 72.23 111.557 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -70.53 -58.65 3.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 73.32 111.518 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.31 155.29 34.85 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.133 0.492 . . . . 72.34 111.567 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.7 mt -98.27 122.56 53.61 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.908 -0.587 . . . . 74.25 110.539 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 24.3 Cg_endo -59.01 147.64 89.12 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.907 2.404 . . . . 61.45 113.836 -174.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -56.74 -22.78 38.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.447 0.641 . . . . 65.42 110.323 171.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 37.9 t30 -102.59 57.31 0.78 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.167 -0.924 . . . . 62.44 110.614 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -114.57 -30.14 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.915 -0.49 . . . . 53.03 112.219 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.57 HG22 HG13 ' A' ' 65' ' ' VAL . 69.1 p -136.15 129.34 31.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.419 -0.355 . . . . 73.34 111.082 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.86 -163.9 37.6 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.928 -0.653 . . . . 60.03 113.151 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.9 p-10 -107.95 144.17 35.58 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.489 -0.418 . . . . 61.34 111.299 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 39' ' ' PHE . 51.4 mt -67.57 94.58 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 121.362 0.601 . . . . 75.23 110.667 178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.0 p -97.13 -28.46 14.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 74.21 111.167 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -121.18 172.64 7.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.219 -0.446 . . . . 65.01 110.391 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -103.61 162.79 12.76 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.003 -0.436 . . . . 65.42 111.191 173.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 39.32 97.69 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.032 -0.604 . . . . 71.43 112.86 -176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.595 ' HB ' HG22 ' A' ' 41' ' ' VAL . 62.9 mt -79.79 112.89 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.603 -0.351 . . . . 75.31 110.773 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 38.7 mt -97.86 124.25 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.931 0.396 . . . . 60.14 111.31 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 82' ' ' ASN . 86.1 t -105.48 102.57 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.325 -0.398 . . . . 64.45 110.834 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -100.18 109.68 21.94 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.1 0.778 . . . . 71.25 113.1 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -86.45 120.83 28.2 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.13 -0.486 . . . . 73.34 110.202 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mm -90.17 130.52 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.331 -0.395 . . . . 71.02 111.674 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -119.76 155.73 31.93 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.29 0.567 . . . . 73.22 111.231 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -103.66 115.27 30.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 73.53 110.287 172.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -58.75 118.18 5.42 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.025 0.44 . . . . 74.24 111.091 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.8 mt -85.26 115.61 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.217 0.532 . . . . 74.21 112.189 -173.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.0 mp -82.32 -37.11 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.101 -0.5 . . . . 75.4 109.999 174.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 31.7 t70 70.5 152.79 0.11 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.099 -0.955 . . . . 74.51 111.685 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.4 m -86.65 35.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.604 . . . . 75.42 111.92 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.6 t -80.86 38.12 0.44 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.218 0.533 . . . . 23.04 111.479 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.88 90.29 5.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.934 0.397 . . . . 73.51 111.887 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.6 p -111.14 137.01 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.135 0.493 . . . . 71.24 111.315 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -104.71 31.62 4.63 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.871 0.367 . . . . 74.24 111.726 -176.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 110' ' ' THR . 10.0 pt-20 -73.94 -37.07 64.67 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.787 0.662 . . . . 72.24 112.787 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 109' ' ' GLU . 19.5 p -91.72 144.7 25.24 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 122.081 -0.387 . . . . 75.43 111.945 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.6 72.09 2.44 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.304 -0.474 . . . . 62.41 112.512 177.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -84.89 -56.93 3.32 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.938 0.399 . . . . 74.21 111.85 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -136.36 100.88 4.5 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.252 0.548 . . . . 52.03 111.412 -175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.657 ' N ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -131.3 68.75 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.83 0.824 . . . . 53.12 111.478 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 24.2 tp -103.23 131.98 21.57 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.773 -0.649 . . . . 72.34 110.963 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.72 108.2 0.23 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.59 2.194 . . . . 74.34 112.875 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 p -85.65 131.12 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.22 0.534 . . . . 61.31 112.188 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.06 93.57 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.225 0.536 . . . . 73.01 111.344 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -144.37 151.68 39.63 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.111 -0.495 . . . . 72.31 110.71 176.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 120' ' ' ILE . 2.5 mp -79.61 90.11 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.323 0.582 . . . . 64.22 111.336 -176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.2 pt -76.1 130.74 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.077 -0.51 . . . . 72.43 110.428 174.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -133.9 147.98 51.18 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.398 0.518 . . . . 72.23 112.398 -174.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 38.7 t -163.72 -162.97 0.75 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.774 -0.648 . . . . 64.25 110.045 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 75.8 -57.42 0.57 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.149 0.796 . . . . 64.43 113.149 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.49 -9.41 41.9 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.434 0.902 . . . . 61.04 113.434 -177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.15 27.89 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.791 0.663 . . . . 73.31 112.791 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.23 137.95 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 112.691 0.626 . . . . 72.22 112.691 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.13 97.35 7.46 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.314 0.578 . . . . 72.21 110.855 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.48 179.64 2.9 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.731 -0.668 . . . . 51.25 111.953 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -154.93 -175.39 5.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.637 -0.256 . . . . 73.4 110.976 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -133.11 156.52 47.28 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.487 0.184 . . . . 71.04 110.746 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -98.51 164.42 12.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.192 0.52 . . . . 63.11 112.273 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -132.51 147.84 52.37 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.964 -0.562 . . . . 75.43 111.514 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 31.2 m170 -120.18 113.8 20.98 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.627 -0.508 . . . . 73.35 109.627 172.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 76.2 m80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 123.61 0.764 . . . . 74.03 110.886 -168.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.812 0.339 . . . . 61.54 110.966 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.96 91.13 0.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 73.22 111.386 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.1 m -156.74 -61.35 0.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.823 0.344 . . . . 74.51 111.919 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -122.17 16.92 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 111.833 0.309 . . . . 74.41 111.833 -175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 48.57 65.72 1.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.112 0.482 . . . . 73.25 111.236 -175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.453 ' HB3' HG21 ' A' ' 87' ' ' ILE . 84.6 m-85 -63.83 104.21 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.871 -0.604 . . . . 65.11 111.649 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.3 p -128.28 151.26 49.51 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.206 0.527 . . . . 61.41 111.692 179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.767 HG22 ' HB ' ' A' ' 92' ' ' ILE . 99.5 t -117.5 113.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.939 -0.573 . . . . 74.43 110.921 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 56' ' ' SER . 8.9 tmtt? -91.95 116.73 29.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.274 0.559 . . . . 74.41 110.989 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.0 t -92.86 113.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.34 -0.391 . . . . 64.44 110.836 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 95' ' ' ARG . 37.0 mt-10 -103.22 122.65 45.18 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.428 0.632 . . . . 60.44 111.317 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 73.1 m-85 -95.86 99.71 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.864 -0.607 . . . . 63.44 109.424 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.721 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 25.7 m -120.42 155.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.893 0.701 . . . . 73.2 112.893 -165.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -72.06 172.1 10.71 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.24 -0.436 . . . . 71.21 110.247 172.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 97' ' ' ILE . . . -63.39 -0.32 0.84 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.268 0.84 . . . . 65.4 113.268 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -91.33 -20.19 22.14 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.2 0.524 . . . . 63.42 110.976 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.6 -0.13 46.11 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.145 -0.48 . . . . 61.0 113.13 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.99 41.1 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.839 -0.212 . . . . 65.1 110.993 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 13.3 pt-20 -70.5 133.86 47.19 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.945 0.879 . . . . 72.1 111.823 -174.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.3 pt -109.42 5.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.868 -1.06 . . . . 74.11 111.768 -174.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.05 159.38 31.23 Favored Pre-proline 0 N--CA 1.469 0.477 0 CA-C-N 116.635 -0.257 . . . . 75.33 111.683 -172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -52.09 119.24 5.46 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 122.274 1.983 . . . . 51.11 112.926 175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.44 ' CB ' ' HE2' ' A' ' 42' ' ' LYS . 58.5 m -82.27 162.28 22.36 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.533 -0.758 . . . . 74.3 111.492 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -112.12 161.47 16.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.408 0.623 . . . . 62.02 111.954 -179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.2 m -131.44 109.96 10.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.73 -0.668 . . . . 61.22 110.384 175.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -102.57 115.27 30.23 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.325 -0.398 . . . . 62.33 111.775 -177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -96.98 -7.05 34.05 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.989 0.423 . . . . 65.41 110.896 173.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.38 135.19 56.52 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.294 0.638 . . . . 74.33 111.78 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -51.98 -43.08 63.41 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.704 0.288 . . . . 75.42 111.186 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -94.0 97.26 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.818 0.342 . . . . 70.05 110.519 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.405 ' CD2' HG11 ' A' ' 41' ' ' VAL . 26.6 p90 -81.33 90.3 6.13 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.881 0.848 . . . . 72.1 110.174 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 HG13 HG22 ' A' ' 84' ' ' THR . 45.9 t -106.35 109.81 29.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.94 -0.573 . . . . 73.22 110.195 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.1 p -91.19 172.7 8.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.871 0.693 . . . . 74.32 112.871 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.6 p -143.34 135.35 13.13 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.871 -0.604 . . . . 62.45 111.433 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HB3' HD22 ' A' ' 76' ' ' LEU . 52.2 Cg_endo -71.11 116.19 4.59 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 121.943 1.762 . . . . 63.24 112.261 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 68.5 mttm -74.87 153.85 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.091 0.472 . . . . 64.25 111.725 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -81.04 99.41 8.44 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.09 -0.505 . . . . 72.42 110.418 175.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.63 112.98 65.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.478 -0.328 . . . . 72.44 111.395 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 97.96 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.627 2.218 . . . . 52.43 113.099 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 109.32 5.02 30.52 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.3 -0.476 . . . . 53.13 114.106 177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -127.26 142.31 51.5 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 117.745 0.772 . . . . 64.52 112.883 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -115.31 118.18 32.52 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.908 -1.042 . . . . 73.14 111.658 -174.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.427 HD22 ' HB3' ' A' ' 68' ' ' PRO . 40.9 tp -65.06 123.18 18.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.812 -0.555 . . . . 74.25 111.616 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -29.06 14.52 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.093 0.405 . . . . 75.33 112.093 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -158.22 153.27 25.39 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.096 0.474 . . . . 75.51 111.88 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 72.8 mt -99.23 123.49 48.49 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.976 -0.556 . . . . 74.41 109.734 170.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.1 Cg_endo -53.61 148.86 33.73 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.081 2.521 . . . . 71.12 113.851 -173.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -58.91 -21.34 57.61 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.973 -0.558 . . . . 75.43 112.159 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 94' ' ' VAL . 3.5 p-10 -116.51 39.04 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.786 0.327 . . . . 74.5 111.774 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -83.64 -15.89 47.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.984 0.421 . . . . 65.45 111.855 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.548 HG22 HG13 ' A' ' 65' ' ' VAL . 76.0 p -140.38 129.36 23.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.352 -0.385 . . . . 75.42 111.033 -178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.88 -168.15 36.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.646 -0.787 . . . . 74.12 113.233 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -108.37 141.1 40.7 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.093 0.473 . . . . 55.41 111.474 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 39' ' ' PHE . 54.5 mt -63.66 95.5 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.35 0.595 . . . . 74.42 110.506 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.5 p -98.58 -6.77 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.943 -0.571 . . . . 75.33 111.585 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -158.4 168.87 25.8 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 116.439 -0.346 . . . . 62.13 110.631 176.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.5 t -92.57 155.64 17.65 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.217 0.451 . . . . 70.01 112.217 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.98 48.97 24.23 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.224 -0.513 . . . . 62.2 113.495 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 41' ' ' VAL . 73.8 mt -98.06 135.49 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 120.915 0.388 . . . . 74.0 110.656 176.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 56.1 mt -124.99 132.26 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.221 0.534 . . . . 64.41 111.536 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 82' ' ' ASN . 61.5 t -108.56 111.1 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.074 -0.512 . . . . 63.52 110.567 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 81.1 mtt180 -107.3 109.78 21.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.086 0.773 . . . . 74.13 113.086 -175.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -84.78 118.33 24.39 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.807 -0.633 . . . . 73.12 110.355 172.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 48' ' ' ALA . 22.7 mm -91.19 118.38 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 116.085 -0.507 . . . . 71.23 111.422 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -108.39 171.94 7.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.633 0.73 . . . . 72.34 112.254 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -128.38 123.22 33.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.255 -0.884 . . . . 70.42 109.647 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.73 112.4 3.68 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.991 0.424 . . . . 71.23 111.179 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 103' ' ' ASP . 51.7 mt -77.19 125.46 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.14 0.495 . . . . 70.22 111.22 -174.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.495 ' O ' HG22 ' A' ' 102' ' ' ILE . 24.0 mm -76.55 14.35 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 121.333 0.587 . . . . 61.33 112.284 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.537 ' H ' HG22 ' A' ' 101' ' ' ILE . 30.5 t70 -73.32 13.82 0.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.34 0.591 . . . . 74.53 112.362 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.5 m -112.95 28.08 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 122.156 -0.34 . . . . 72.13 111.339 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.1 m 70.12 -69.18 0.18 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.045 0.538 . . . . 62.34 110.366 -173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.9 t80 67.14 2.99 2.99 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.351 0.871 . . . . 71.33 113.351 168.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.6 t -133.94 122.99 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.199 0.523 . . . . 70.13 112.404 -176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -136.02 -34.28 0.81 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.356 0.598 . . . . 65.41 110.616 171.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -75.04 -70.76 0.4 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.666 -0.697 . . . . 63.15 109.975 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 19.7 p -157.56 167.58 29.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.973 0.509 . . . . 71.31 110.908 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.56 -166.41 38.61 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.086 -0.578 . . . . 60.31 112.812 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.669 ' HG2' ' H ' ' A' ' 113' ' ' ASP . 3.9 ttmp? -148.68 -174.59 4.65 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.977 -0.379 . . . . 72.12 109.977 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.669 ' H ' ' HG2' ' A' ' 112' ' ' LYS . 6.2 m-20 -59.74 88.49 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.279 0.561 . . . . 60.35 112.069 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 pp -173.65 154.65 2.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.305 -0.861 . . . . 70.44 110.024 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -97.81 165.2 15.91 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.161 0.43 . . . . 64.53 112.161 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -65.54 97.15 0.31 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.279 1.986 . . . . 71.41 112.518 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.52 75.44 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.902 0.858 . . . . 71.42 111.548 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.37 109.63 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 115.799 -0.637 . . . . 75.31 111.92 -176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.96 118.1 33.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.301 -0.409 . . . . 73.5 109.985 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.816 HG22 HD12 ' A' ' 121' ' ' ILE . 7.7 mt -84.51 157.97 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 112.029 0.381 . . . . 74.4 112.029 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.816 HD12 HG22 ' A' ' 120' ' ' ILE . 3.6 mp 55.2 65.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.919 0.866 . . . . 73.14 110.382 -170.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -142.43 12.86 1.95 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.757 -0.656 . . . . 71.25 111.373 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 81.6 p -80.25 163.19 24.18 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.052 0.454 . . . . 73.31 111.779 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 63.22 14.07 7.45 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.916 -0.584 . . . . 75.32 112.469 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -90.41 -8.56 50.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.99 0.424 . . . . 64.12 111.203 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.71 88.75 2.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.19 -0.459 . . . . 70.34 111.583 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.04 103.76 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.261 0.553 . . . . 61.14 111.251 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 86.1 mt -99.09 24.09 8.27 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.054 0.454 . . . . 73.44 111.599 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.07 13.15 1.9 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.824 0.676 . . . . 62.42 112.824 -177.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -89.64 141.72 28.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.881 0.372 . . . . 75.33 111.468 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -102.95 130.93 50.18 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.706 0.632 . . . . 63.22 112.706 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -162.48 121.65 2.27 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.041 0.386 . . . . 74.32 112.041 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -92.98 133.43 36.13 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.354 -0.385 . . . . 70.42 111.019 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 31.5 m80 59.63 -172.02 0.12 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 121.014 0.435 . . . . 74.43 111.497 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.597 -0.716 . . . . 73.23 111.029 172.734 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.521 0.2 . . . . 64.23 111.164 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 t70 61.72 14.98 6.56 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.589 0.589 . . . . 72.23 112.589 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.6 m -117.62 144.78 44.85 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.96 -0.462 . . . . 61.25 111.595 -176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -106.11 -64.59 1.14 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.558 -0.292 . . . . 72.21 111.132 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 45.33 79.86 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.099 0.777 . . . . 65.03 113.099 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 33.5 m-85 -61.41 95.35 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.009 0.433 . . . . 54.42 110.679 172.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.3 p -135.24 164.65 27.24 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.173 0.511 . . . . 53.41 112.104 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG22 ' HB ' ' A' ' 92' ' ' ILE . 57.4 t -126.48 105.15 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.975 -0.557 . . . . 74.32 111.408 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.492 ' HE3' ' HB3' ' A' ' 56' ' ' SER . 1.3 tmtp? -85.78 121.97 29.19 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.088 0.47 . . . . 73.24 110.911 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 94' ' ' VAL . 38.8 t -104.29 119.01 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.385 -0.37 . . . . 54.54 111.662 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.419 ' HB2' ' CG ' ' A' ' 95' ' ' ARG . 41.1 mt-10 -104.29 148.3 26.52 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.304 0.573 . . . . 72.23 111.138 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.538 ' CE1' ' HE2' ' A' ' 69' ' ' LYS . 84.0 m-85 -122.66 99.0 6.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 74.14 110.378 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.686 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 33.2 m -119.52 157.43 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.263 -0.426 . . . . 71.41 111.595 -172.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -94.47 -175.19 3.55 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.044 0.45 . . . . 65.14 111.552 -177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.67 -13.05 60.76 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.808 0.67 . . . . 53.11 112.808 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -85.88 -20.62 28.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.333 0.587 . . . . 74.52 110.262 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.73 7.65 41.53 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.765 -0.652 . . . . 64.42 113.359 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.16 131.25 46.21 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.74 -0.27 . . . . 63.4 111.12 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' VAL . 14.1 pt-20 -68.84 100.42 1.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.413 1.102 . . . . 72.53 111.164 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.407 ' H ' HG12 ' A' ' 53' ' ' ILE . 15.3 pt -76.41 3.53 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.759 -1.11 . . . . 71.43 112.306 -177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.91 153.44 31.54 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.625 -0.261 . . . . 63.32 111.339 -175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.59 138.51 84.98 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.2 1.934 . . . . 75.02 112.494 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.492 ' HB3' ' HE3' ' A' ' 42' ' ' LYS . 66.2 m -96.44 143.46 27.45 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.91 0.386 . . . . 71.13 111.697 -177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -100.72 166.64 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.354 0.597 . . . . 75.51 112.331 -177.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -129.67 103.93 7.13 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.85 -0.614 . . . . 74.21 110.436 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 41' ' ' VAL . 85.8 mt -78.38 116.17 18.61 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.121 0.486 . . . . 65.04 111.996 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.7 t -88.97 -15.51 34.04 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.714 -0.675 . . . . 44.42 111.659 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.8 128.75 37.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.306 -0.407 . . . . 71.41 111.609 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 86' ' ' ASN . 84.7 t80 -52.59 -50.77 62.36 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 74.21 111.186 177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -81.53 80.99 7.77 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.843 -0.536 . . . . 73.4 110.397 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CG ' HG21 ' A' ' 41' ' ' VAL . 45.1 p90 -69.45 103.49 2.04 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.816 0.817 . . . . 74.31 110.931 -178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.0 t -117.1 108.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.42 -0.809 . . . . 75.3 109.078 174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.5 p -103.27 148.03 26.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.033 0.444 . . . . 71.11 111.938 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.7 p -119.11 150.01 48.13 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.017 -0.538 . . . . 71.32 111.645 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.49 169.0 8.87 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.502 2.135 . . . . 64.31 111.927 169.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 45' ' ' TYR . 66.9 mttm -125.39 148.27 48.85 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.917 -0.49 . . . . 71.41 111.398 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -70.78 90.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.163 0.506 . . . . 62.43 110.576 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.9 mt -98.19 122.07 55.25 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.183 -0.462 . . . . 54.11 111.281 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.55 113.07 1.96 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.419 2.079 . . . . 75.51 113.293 -176.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.7 9.08 60.27 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 116.237 -0.438 . . . . 65.13 113.478 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -128.47 145.5 51.08 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.937 0.875 . . . . 65.4 113.194 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.72 136.87 52.37 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.575 -1.193 . . . . 70.32 110.098 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.6 tp -67.22 106.8 2.14 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.676 -0.64 . . . . 74.35 110.704 177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 77' ' ' ARG . 26.7 ttt180 -70.75 -47.25 60.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.236 -0.438 . . . . 63.54 111.288 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.447 ' HG2' ' HB ' ' A' ' 97' ' ' ILE . 9.4 pt-20 -163.67 157.67 19.53 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.06 0.457 . . . . 74.44 111.842 -175.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.8 mt -109.69 122.68 38.54 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 116.271 -0.422 . . . . 74.35 110.838 177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.557 ' HG2' ' HB2' ' A' ' 83' ' ' ALA . 13.6 Cg_endo -55.29 145.26 67.58 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.251 2.634 . . . . 73.14 114.211 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -58.9 -19.17 39.94 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.92 0.711 . . . . 65.11 112.92 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.413 ' O ' ' HE2' ' A' ' 64' ' ' TYR . 23.0 p-10 -116.2 32.63 6.0 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.715 0.265 . . . . 74.31 111.715 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.557 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . . . -77.34 -28.68 53.15 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.922 0.712 . . . . 52.11 112.922 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.1 p -136.06 129.32 31.76 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 111.89 0.33 . . . . 73.23 111.89 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.39 -149.21 10.89 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.894 -0.67 . . . . 72.03 113.44 177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 62' ' ' TYR . 15.1 p-10 -118.39 137.32 53.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.709 0.404 . . . . 64.33 110.938 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 39' ' ' PHE . 52.9 mt -63.87 95.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.503 0.668 . . . . 74.32 111.16 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 63.2 p -108.08 12.84 26.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.645 -0.707 . . . . 64.05 110.848 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -150.05 156.14 41.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.493 -0.776 . . . . 61.04 110.471 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 39' ' ' PHE . 73.1 p -73.73 -37.65 65.04 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.764 0.653 . . . . 41.1 112.764 -174.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -127.96 75.99 0.41 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.023 -0.608 . . . . 33.23 113.807 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 41' ' ' VAL . 64.2 mt -91.13 140.09 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.592 -0.358 . . . . 74.13 110.809 177.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.0 mt -125.79 128.01 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.171 0.51 . . . . 70.43 111.739 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 43' ' ' VAL . 93.5 t -110.35 109.71 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.943 -0.571 . . . . 62.41 110.876 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.419 ' CG ' ' HB2' ' A' ' 44' ' ' GLU . 16.6 mtt180 -107.14 109.24 21.02 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.525 0.565 . . . . 70.11 112.525 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.15 132.12 34.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.889 0.376 . . . . 65.32 111.096 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' HG2' ' A' ' 78' ' ' GLU . 23.2 mm -102.26 131.86 49.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.947 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -118.28 136.18 53.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.017 0.437 . . . . 75.43 111.558 177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.65 130.16 36.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.65 -0.5 . . . . 75.42 109.65 172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -70.35 115.1 9.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.156 0.503 . . . . 72.55 111.39 -177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.0 mt -65.39 118.63 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.053 -0.521 . . . . 75.0 111.599 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 45.0 mm -70.76 82.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.909 0.861 . . . . 70.25 110.284 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -138.86 5.87 2.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.892 -1.049 . . . . 65.13 110.469 -177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 106' ' ' TYR . 30.0 m -93.84 0.89 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.154 -0.93 . . . . 73.24 111.762 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.6 m 69.23 -13.0 0.38 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.262 0.838 . . . . 63.3 113.262 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.428 ' H ' HG23 ' A' ' 104' ' ' VAL . 71.0 m-85 -75.67 86.08 2.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 73.4 112.003 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.1 m -127.72 -166.82 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.936 -0.574 . . . . 71.22 110.758 176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -76.58 158.17 31.37 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.003 0.43 . . . . 75.14 111.584 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -129.19 5.76 5.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.822 0.675 . . . . 75.14 112.822 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -143.52 -55.7 0.39 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.803 1.038 . . . . 72.41 113.803 -171.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 174.04 57.91 0.05 OUTLIER Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.607 -0.806 . . . . 65.1 113.395 -174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -126.47 -68.67 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.175 0.512 . . . . 74.32 110.208 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -155.66 94.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.46 0.648 . . . . 65.22 110.139 174.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 114' ' ' LEU . 2.4 pp -115.65 149.94 37.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.844 -0.616 . . . . 64.43 111.213 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pp -90.68 165.12 23.71 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 112.146 0.424 . . . . 71.44 112.146 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.88 114.55 2.21 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.932 2.421 . . . . 74.54 113.173 177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 p -76.51 112.23 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 121.514 0.673 . . . . 72.23 110.795 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.26 -170.98 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.6 -0.727 . . . . 74.35 112.21 -175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.57 107.21 2.85 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.167 0.508 . . . . 64.34 111.64 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 27.3 pt -123.45 153.57 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.259 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.9 mp -73.73 81.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 121.581 0.705 . . . . 63.54 110.307 178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -170.05 -174.06 1.68 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.001 -1.0 . . . . 54.52 110.06 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 92.9 p -140.09 164.46 29.97 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.019 0.378 . . . . 72.41 112.019 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 60.55 23.61 13.31 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.302 0.572 . . . . 53.44 111.006 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 62.4 9.85 3.59 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.937 -0.574 . . . . 60.53 111.957 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 58.46 29.46 18.34 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.516 0.561 . . . . 30.05 112.516 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.83 163.02 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.708 0.633 . . . . 74.5 112.708 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 59.5 mt -110.44 33.67 4.37 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.077 -0.511 . . . . 61.32 112.109 -173.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.69 84.45 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.458 0.647 . . . . 75.51 112.549 -176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.48 141.54 37.38 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.762 -0.654 . . . . 74.22 110.168 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 67.91 131.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.977 0.417 . . . . 62.24 111.326 176.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 133' ' ' HIS . 56.0 t60 -143.79 -39.55 0.3 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.194 0.812 . . . . 62.4 113.194 -173.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 132' ' ' HIS . 88.4 m-70 71.04 148.11 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.054 0.542 . . . . 71.14 112.153 -173.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -169.15 133.68 1.46 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.069 -0.514 . . . . 71.2 110.853 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.76 -0.638 . . . . 75.5 111.964 -177.159 . . . . . . . . 0 0 . 1 stop_ save_